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Rheumatoid Arthritis (RA) is a chronic autoimmune disease, characterised by high-
grade inflammation. People with RA experience pain, fatigue, functional disability and 
compromised psychological well-being. These patients typically spend long periods of the day 
engaged in sedentary behaviour, which may exacerbate negative RA health outcomes.  
This thesis was guided by the Behavioural Epidemiology Framework, and provided 
novel evidence in the field of sedentary behaviour research in RA. Primarily, the activPAL and 
ActiGraph accelerometer were validated for measurement of sedentary time and physical 
activity (PA) in RA (Chapter 2). These devices were subsequently employed in the longitudinal 
study comprising Chapters 4-6. In Chapter 4, longitudinal associations were revealed between 
several clinically- and patient-important RA outcomes with sedentary, standing and stepping 
time. These relationships were largely bi-directional. Grounded in self-determination theory, 
Chapter 5 demonstrated that autonomous motivation to reduce sedentary behaviour was 
negatively associated with sedentary time, and positively related to time engaged in standing, 
stepping and light-intensity PA in RA. Chapter 6 tested hypothesised models of sedentary 
behaviour change, which suggested fostering autonomous motivation to reduce sedentary 
behaviour in people with RA, may promote changes in sedentarity to the extent that it might 
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Rheumatoid Arthritis (RA) is a chronic autoimmune disease, characterised by high-
grade systemic inflammation. The heightened inflammatory burden of RA contributes to 
debilitating joint pain, fatigue and functional disability, symptomatic of the condition (Smolen, 
Aletaha, & McInnes, 2016a; Uhlig, Moe, & Kvien, 2014), as well as increased risk of 
cardiovascular disease (CVD) (Avina-Zubieta, Thomas, Sadatsafavi, Lehman, & Lacaille, 
2012). Further, people with RA are at high risk of psychological comorbidities (e.g., 
depression) (Matcham, Rayner, Steer, & Hotopf, 2013). According to a report by the National 
Rheumatoid Arthritis Society (NRAS), over half of people with RA leave employment within 
6 years of diagnosis (NRAS, 2010). 
RA is the most common inflammatory arthritis, with a global prevalence of 0.5-1% 
(Uhlig et al., 2014; Wasserman, 2018). The clinical treatment of RA currently targets the 
control of inflammatory disease activity (‘treat to target’), with the aim of decelerating joint 
damage, alleviating symptoms of pain, improving physical function and preventing the onset 
of chronic diseases (e.g., CVD) (Smolen et al., 2017). This approach involves the use of 
pharmacological methods, including the prescription of disease-modifying anti-rheumatic 
drugs (DMARDs) (Ferro, Elefante, Luciano, Talarico, & Todoerti, 2017; Smolen et al., 2017). 
These therapeutic agents are initiated as early as possible in the disease course to achieve these 
targets (Smolen et al., 2017).  
However, there remains an ‘unmet need’ on behalf of patients with RA regarding these 
specific treatment objectives. Firstly, sometimes control of RA disease activity by drug 
treatment is not achieved (Taylor, Moore, Vasilescu, Alvir, & Tarallo, 2016). Secondly, even 
when medication is successfully controlling RA disease activity, patients may still report pain, 
fatigue, functional disability and compromised mental health, or experience a ‘flare-up’ in 
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which a bout of heightened inflammation worsens symptoms (Santos et al., 2019; Taylor et al., 
2016). Thus, treatment regimens that serve to tightly control inflammation (e.g., 
pharmacological intervention) and promote self-management to attenuate important RA 
symptoms (e.g., non-pharmacological intervention), might be warranted (Santos et al., 2019; 
Taylor et al., 2016). 
Non-pharmacological methods of managing RA outcomes include physical activity 
(PA) (Santos et al., 2019), and the ideology of ‘exercise as medicine’ has been explored in this 
population. A growing body of research has investigated associations between engagement in 
PA, with disease outcomes in RA. The available evidence indicates beneficial associations to 
exist between PA of a moderate-to-vigorous intensity (MVPA, ≥3 metabolic equivalents 
[METs]), with outcomes such as systemic inflammation, disease activity, functional disability, 
pain, fatigue, psychological well-being and CVD risk in this population (Cooney et al., 2011; 
de Jong et al., 2003; Hammam, Ezeugwu, Rumsey, Manns, & Pritchard-Wiart, 2019; 
Loppenthin et al., 2015; Metsios & Kitas, 2018; Metsios, Stavropoulos-Kalinoglou, & Kitas, 
2015; Plasqui, 2008; Rahnama & Mazloum, 2012; Rongen-van Dartel et al., 2015; Verhoeven 
et al., 2016). Despite this, evidence suggests that people with RA are physically inactive. That 
is, they do not engage in sufficient levels of MVPA to accrue the reported benefits to health 
(Lee et al., 2012; Sokka et al., 2008; Tierney, Fraser, & Kennedy, 2012; Yu et al., 2015b).  
Over the last decade, an increasing amount of research attention has focused on 
sedentary behaviour, defined as any waking behaviour expending energy ≤1.5 METs whilst in 
a sitting/reclining/lying posture (Sedentary Behaviour Research Network [SBRN], 2012; 
Tremblay et al., 2017) (e.g., sitting whilst watching television, reading a book or travelling in 
a vehicle), and its role in the development of poor health in non-RA individuals (Biswas et al., 
2015; Carson et al., 2014; de Rezende, Rey-Lopez, Matsudo, & do Carmo Luiz, 2014; Ford & 
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Caspersen, 2012; Healy, Matthews, Dunstan, Winkler, & Owen, 2011; Okely et al., 2019; 
Rosenberg et al., 2016; Santos et al., 2012). Sedentary behaviour is a distinct construct from 
physical inactivity, demonstrating independent health risks (e.g., all-cause, CVD and cancer 
mortality) in different populations (Patterson et al., 2018). Levels of accelerometer-assessed 
sedentary time have been reported to exceed 9h/day in people with RA (Fenton, Veldhuijzen 
van Zanten, Duda, Metsios, & Kitas, 2018b), with cross-sectional studies reporting 
associations between high levels of sedentary time with higher disease activity, functional 
disability and CVD in these patients (Fenton et al., 2018b; Fenton et al., 2017; Hammam et al., 
2019).  
Reasons cited for lack of engagement in MVPA among people with RA include pain, 
fatigue and functional disability (Larkin, Kennedy, Fraser, & Gallagher, 2017; Tan, Pugh, 
Humby, & Morrissey, 2019; Veldhuijzen van Zanten et al., 2015). A recent qualitative study 
(Larkin et al., 2017) remarked on how the symptoms of RA (e.g., pain and fatigue) were 
reported as barriers to participation. One patient stated, “sometimes the pain is so bad you just 
don’t know you know and I’m just thinking how the hell am I going to get upstairs today”. 
Patients in this study also acknowledged their physical limitations, and described the 
importance of ‘pacing’ themselves with regard to PA engagement. The authors highlighted that 
PA guidelines for the RA population should consider the pragmatisms with meeting optimum 
PA recommendations among these patients. 
This has led to research exploring the potential of light-intensity PA (LPA [1.6-2.9 
METs]) for improving health in RA. It has been noted that populations with reduced physical 
function (e.g., older adults) may find LPA participation more realistic than MVPA to achieve 
(Buman et al., 2010; Ekwall, Lindberg, & Magnusson, 2009; Manns, Dunstan, Owen, & Healy, 
2012). Although very much in their infancy, cross-sectional studies have demonstrated 
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associations between higher LPA with lower disease activity and functional disability, 
attenuated CVD risk and enhanced psychological well-being in RA (Fenton et al., 2018c; 
Hammam et al., 2019; Khoja, Almeida, Chester Wasko, Terhorst, & Piva, 2016). In addition, 
research has demonstrated a strong inverse correlation between LPA with sedentary time in 
RA (Fenton, et al., 2017) which further highlights the potential of LPA for improving health in 
this patient group. Specifically, increasing LPA whilst simultaneously reducing sedentary time 
could induce positive health outcomes relevant to this patient group. 
With this in mind, interventions targeting sedentary behaviour change in RA might 
offer a non-pharmacological method of managing important disease outcomes. However, the 
low quantity and quality of previous research in this field hinders the development of such 
interventions. The Behavioural Epidemiology Framework (BEF) (Sallis, Owen, & 
Fotheringham, 2000) specifies a series of steps that are required to inform the development of 
evidence-based behaviour change interventions (Figure 1.1). This framework underlines the 
importance of validating measures to assess the behaviour in question (e.g., sedentary 
behaviour) and subsequently employing validated measures to; 1) establish associations 
between behaviour with health, and 2) identify determinants of the behaviour that can be 
targeted by intervention. Importantly, each stage of this framework should be addressed in the 
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A major limitation of RA studies seeking to establish the health consequences and 
determinants of sedentary behaviour and PA in these patients, is the employment of a cross-
sectional design. Cross-sectional studies cannot infer cause and effect in the examined 
relationships. Longitudinal studies can provide insight into how change in one variable (e.g., 
sedentary time) relates to change in another (e.g., pain in RA) over time, and these relationships 
can be tested with experimental studies further down the line (Carlson & Morrison, 2009; 
Solem, 2015). Additionally, until recently, our understanding of the levels, health outcomes 
and determinants of sedentary time and PA in RA has largely been based on studies employing 
self-report methods to quantify engagement in these behaviours (Fenton et al., 2018b), which 
are limited in their validity and reliability (Atkin et al., 2012; Healy et al., 2011a; Sylvia, 
Bernstein, Hubbard, Keating, & Anderson, 2014). Device-based measures are being 
increasingly used in RA studies to objectively measure sedentary time and PA, but have not 
been validated specifically for use in this population. Research which validates these devices 
is critical in order to accurately determine levels of sedentary time and PA, and understand the 
relationships between health with these behaviours in RA. Additionally, it is important to 
establish the determinants of sedentary behaviour and PA in these patients, to develop 
modifiable targets for intervention. 
Investigation into the determinants of sedentary behaviour has certainly not been 
forthcoming in RA, but studies have begun to explore the factors influencing PA in this patient 
group.  Importantly, the debilitating features of RA disease have been suggested to be causes, 
as well as consequences, of sedentary behaviour and PA levels in this patient group (Thomsen 
et al., 2015; Veldhuijzen van Zanten et al., 2015). Nevertheless, the potential bi-directional 
nature of these relationships has not been tested in people with RA. Psychosocial factors (e.g., 
motivation) have also been suggested as determinants of PA among people with RA 
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(Hurkmans et al., 2010; Yu et al., 2015a), but little research exists in this domain for sedentary 
behaviour. In a qualitative study by Thomsen et al. (2015), participants reported that sedentary 
behaviour engagement was a consequence of “when symptoms dominate”, such as pain and 
fatigue. In addition, enhancing motivation for reducing sedentary behaviour in RA patients, 
was suggested as a strategy to elicit sedentary behaviour change in this population. 
When research questions seek to establish the modifiable determinants of sedentary 
behaviour and PA in people with RA, such as motivation, they should be theoretically informed 
(Hurkmans et al., 2010; Michie et al., 2008; Yu et al., 2015a). Self-determination theory (SDT) 
(Deci & Ryan, 1985) may offer a framework for understanding the motivational processes 
underpinning engagement in these behaviours among RA patients. SDT is a theory of 
motivation increasingly applied to the context of PA promotion (Teixeira, Carraca, Markland, 
Silva, & Ryan, 2012), and postulates that variability in the reasons ‘why’ individuals choose 
to engage in behaviour holds implications for levels of participation (Deci & Ryan, 1987, 2000, 
2008a, 2008b; Ryan & Deci, 2000). This ‘why’ is referred to as ‘quality of motivation’, with 
more autonomous reasons for engagement (high quality, e.g., engaging in behaviour because 
it is personally important, or for enjoyment) being linked to higher levels of PA, with the 
reverse true for more controlled reasons for engagement (low quality, e.g., engaging in 
behaviour for others’ approval, or to avoid guilt). To date, there are a couple of cross-sectional 
RA studies demonstrating that more autonomous motivation to engage in PA promotes higher 
levels of self-reported PA in these patients (Hurkmans et al., 2010; Yu et al., 2015a). Studies 
are yet to employ an SDT lens to explore the role of quality of motivation as a determinant of 
sedentary behaviour in RA.  
It is clear that there is a requirement for intervention development targeting changes in 
sedentary behaviour and PA in people with RA, but the current state of evidence is not 
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sufficient to design them to high quality. With this in mind, the overarching aim of this thesis 
was to develop the evidence base required to inform development of interventions targeting 
sedentary behaviour and PA, in people living with RA. In line with the BEF, specific aims 
were first, to validate devices (the ActiGraph accelerometer and activPAL3µTM) for 
measurement of sedentary time and PA among RA patients (Chapter 2). Then, in a longitudinal 
study, employ these devices in order to; 1) determine associations between pertinent aspects of 
RA health with objectively-assessed sedentary time and PA in RA – exploring the presence of 
bi-directional relationships (Chapter 4), and 2) investigate relationships between autonomous 
and controlled motivation to reduce sedentary behaviour, with objectively-assessed sedentary 
time and PA in RA (Chapter 5). Finally, informed by Chapters 4 and 5, to test models of 
sedentary behaviour change to examine sequential relationships between quality of motivation 
to reduce sedentary behaviour, with objectively-assessed behaviours, and in turn, important 
RA outcomes (Chapter 6). 
 
Rheumatoid arthritis 
Disease characteristics, prevalence and diagnosis 
Rheumatoid Arthritis (RA) is a chronic autoimmune disease, characterised by elevated 
inflammatory load. Articular disease manifestations, resulting from high-grade inflammation, 
include joint pain, stiffness and swelling, musculoskeletal deterioration, and functional 
disability in this patient group (Smolen et al., 2016a; Uhlig et al., 2014). Further, people with 
RA can experience debilitating fatigue, increased risk of cardiovascular disease (CVD) and 
compromised psychological well-being (Avina-Zubieta et al., 2012; Katz, 2017b; Matcham et 
al., 2013). Most likely stemming from the physical and psychological implications of RA, 
unemployment is not an uncommon consequence of the disease for some patients (Berner et 
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al., 2018; Cross et al., 2014; Hansen et al., 2016), with over half the population leaving work 
within 6 years of diagnosis (NRAS, 2010). 
Affecting 0.5-1% of adults worldwide, RA is particularly prevalent in individuals aged 
30-50 years old, women, smokers and those with a genetic predisposition (family history) of 
the disease (Deane et al., 2017; Smolen et al., 2016a; Uhlig et al., 2014; Wasserman, 2018). 
The pathophysiology of RA is unclear, but a combination of genetic and environmental factors 
has been proposed to initiate chronic sequela of RA. An interplay of several cell types (e.g., 
fibroblast-like synoviocytes, macrophages, T lymphocytes) at the synovial membrane of the 
affected person’s joint, is believed to cause over-expression of inflammatory biomarkers (e.g., 
high-sensitivity C-reactive protein [hsCRP], erythrocyte sedimentation rate [ESR]) at the site 
(Angelotti et al., 2017). Thus, such inflammatory biomarkers are considered in the process of 
clinical diagnosis, and subsequently targeted in the treatment of the disease (Demoruelle, 
Deane, & Holers, 2014; Shrivastava et al., 2015).  
RA is clinically diagnosed according to the American College of Rheumatology-
European League Against Rheumatism (ACR-EULAR) (Aletaha et al., 2010). Specifically, a 
person is diagnosed with RA if they have synovitis (inflammation at the synovial membrane) 
in ≥1 joint, with no alternate explanation for the synovitis, and a score ≥6 (range = 1-10) based 
on 4 domains; 1) number and location of affected joint/s (score: 0 = 1 large joint [shoulders, 
elbows, hips, knees, ankles]; 1 = 2-10 large joints; 2 = 1-3 small joints [metacarpophalangeal 
joints, proximal interphalangeal joints, 2nd-5th metatarsophalangeal joints, thumb 
interphalangeal joints, wrists] with/without involvement of large joints; 3 = 4-10 small joints 
with/without involvement of large joints; 5 = >10 joints [can involve other joints not listed, 
e.g., temporomandibular] with at least 1 small joint), 2) abnormal serology results (score: 0 = 
negative rheumatoid factor and negative anti−citrullinated protein antibody; 2 = low-positive 
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rheumatoid factor or low-positive anti−citrullinated protein antibody; high-positive rheumatoid 
factor or high-positive anti−citrullinated protein antibody), 3) abnormal levels of CRP and ESR 
(score: 0 = normal CRP and normal ESR; 1 = abnormal CRP or abnormal ESR), and 4) duration 
of experiencing symptoms (score: 0 = <6 weeks; 1 = ≥6 weeks). 
 
Treatment and management of rheumatoid arthritis   
The treatment of RA involves tight control and close monitoring of inflammatory 
disease activity. Pharmacological intervention is the first-line treatment of RA, and has 
significantly advanced during the last 30 years (Smolen et al., 2017). Termed ‘treat-to-target’, 
therapeutic agents, such as disease-modifying anti-rheumatic drugs (DMARDs), are prescribed 
to RA patients as early as possible in the course of disease (Smolen et al., 2017). The aim is to 
regulate inflammation and in turn, attenuate the burden of pain and functional disability, as 
well as decreasing the risk of comorbidities, such as CVD (Ferro et al., 2017; Saag et al., 2008; 
Singh et al., 2016; Smolen et al., 2017; Taylor et al., 2016). RA disease activity is routinely 
measured in clinical practice via the extensively validated Disease Activity Score-28 (DAS-
28), and is used to inform clinical decisions regarding pharmacological treatment (e.g., 
initiating, continuing and/or adjusting patient medication) (Prevoo et al., 1995; Smolen et al., 
2016b; van Gestel, Haagsma, & van Riel, 1998; Weinblatt et al., 2006).  
 
Rheumatoid arthritis and health 
Broadly speaking, research with a focus on health in RA investigate the prevalence, 
aetiology and treatment of well-established patient-reported outcomes, such as pain, fatigue, 
physical function and psychological well-being (Boers et al., 2014; Kirwan et al., 2007; van 
Tuyl & Boers, 2015), which may all contribute to the individual’s quality of life.  
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Pain. Pain is defined as “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage, or described in terms of such damage” (Merksey, 
Lindblom, & Mumford, 1979). Pain is the most frequently reported symptom in patients with 
RA, and can lead to the development of other disease outcomes, such as fatigue, quality of life 
and psychological well-being (Brandstetter et al., 2017; Madsen, Danneskiold-Samsoe, 
Stockmarr, & Bartels, 2016; Walsh & McWilliams, 2014).  
 
Fatigue. Fatigue in RA is perceived by patients as distinct from typical experiences of 
tiredness, described as “exhausting”, “overwhelming”, “frustrating” and often “unpredictable” 
(Hewlett et al., 2005; Repping-Wuts, Uitterhoeve, van Riel, & van Achterberg, 2008). Fatigue 
has a debilitating impact on overall well-being and quality of life, and exacerbates challenges 
of managing additional RA symptoms (Katz, 2017a). After pain, fatigue is the second most 
commonly reported symptom among people with RA, with management of fatigue regarded 
by patients as paramount for remission (Katz, 2017a). It has been reported that severe fatigue 
affects 41% of people with RA (Overman, Kool, Da Silva, & Geenen, 2016), with multifaceted 
symptoms of fatigue experienced between 88%-98% of patients (Hewlett et al., 2005).  
 
Physical function. Impaired physical function in RA comprises reversible (e.g., joint 
pain and swelling) and irreversible (e.g., structural joint damage and deformity) components 
(Aletaha, Smolen, & Ward, 2006). Reduced physical function has a profound impact on 
psychological well-being and quality of life in people with RA (Englbrecht, Kruckow, Araujo, 
Rech, & Schett, 2013; Radner, Smolen, & Aletaha, 2011; Uhlig et al., 2014; Wan et al., 2016). 
Physical function is assessed widely in clinical practice, using the Health Assessment 
Questionnaire (HAQ) (Fries, Spitz, Kraines, & Holman, 1980). 
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Psychological well-being. The health burden of RA often compromises a patient’s 
psychological well-being (Gettings, 2010; Isik, Koca, Ozturk, & Mermi, 2007; Lok, Mok, 
Cheng, & Cheung, 2010; Matcham et al., 2013). Indeed, it has been reported that depressive 
symptoms, characterised by persistent low mood, and loss of pleasure and interest in activities 
(World Health Organisation [WHO], 2019a), may be affecting 66% of the RA population, with 
17% of patients currently diagnosed with major depressive disorder (Fiest et al., 2017). RA 
and comorbid depression pose a significant risk in terms of mortality within this population 
(Margaretten, Julian, Katz, & Yelin, 2011).  
 
Quality of life. Quality of life has been defined as “a broad ranging concept affected in 
a complex way by the person’s physical health, psychological state, personal beliefs, social 
relationships and their relationship to salient features of their environment” (WHO, 2019b). 
Pain, fatigue, impaired physical function and compromised psychological well-being in RA, 
mean that people living with this disease typically report low quality of life (Matcham et al., 
2014; Rosa-Goncalves, Bernardes, & Costa, 2018; Senra et al., 2017; Uhlig et al., 2014; Wan 
et al., 2016). Although both physical and mental factors comprising quality of life are adversely 
affected in RA, it has been reported that the physical aspects (e.g., pain, physical function) are 
compromised to a greater extent than mental aspects, in this patient group (Matcham et al., 
2014). 
 
The role of inflammation. The aforementioned RA disease outcomes have been 
associated with increased inflammation in RA, although multiple mechanisms have been 
proposed. Predominantly, inflammatory disease activity is reported to play a critical role in the 
reversible (e.g., joint pain and swelling) and irreversible (e.g., structural joint damage and 
deformity) RA disease manifestations that affect physical function (Hazes, 2003; Walsh & 
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McWilliams, 2014). The aetiology of fatigue in RA is unclear, but recent reviews in the area 
have alluded to a link between RA disease activity with fatigue in this patient group (Katz, 
2017a, 2017b; Madsen et al., 2016). Indeed, studies have demonstrated associations between 
biomarkers of inflammation (e.g., CRP) and DAS-28, with fatigue in RA (Madsen et al., 2016; 
van Steenbergen, Tsonaka, Huizinga, Boonen, & van der Helm-van Mil, 2015). Similarly to 
pain, it has been accepted that the role of inflammation does not independently contribute to 
fatigue in these patients. For example, mediators including pain, functional disability and 
depression, between RA disease activity and fatigue have been demonstrated in the literature, 
as well as continual reporting of fatigue symptoms among patients with well-controlled RA 
disease activity (Druce, Jones, Macfarlane, & Basu, 2015; Olsen, Lie, Kvien, & Zangi, 2016).  
It has also been hypothesised that heightened inflammation in RA is associated with 
depressive symptoms in this patient group (Nerurkar, Siebert, McInnes, & Cavanagh, 2019). 
Research has demonstrated that elevated systemic inflammatory biomarkers (e.g., CRP) are 
related to depression in the general population (Chamberlain et al., 2019; Strawbridge et al., 
2015), and that the relationship between inflammation and depression is bi-directional 
(Kiecolt-Glaser, Derry, & Fagundes, 2015). A recent review published in the Lancet (Nerurkar 
et al., 2019) supports the contention that although pain and fatigue do have a role to play in the 
development of depressive symptomology, the mechanistic action of inflammatory mediators 
on the hypothalamic-pituitary-adrenal axis in RA, may also contribute to depression in these 
patients. Although prescribed medication aims to reduce the negative inflammatory effects of 
RA, there are 2 main challenges of relying on such medication for the simultaneous treatment 
of RA and depressive symptoms; 1) we do not wholly understand the link between 
inflammation and depression in RA, and 2) people with RA and depression demonstrate lack 
of compliance to prescribed medication (Margaretten et al., 2011).  
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Finally, recent research has shown an inverse association between disease activity and 
quality of life in RA, that is, lower disease activity is linked to more highly-rated quality of life 
(Rosa-Goncalves et al., 2018). This is unsurprising, as disease activity is well-established as a 
fundamental determinant of pain, fatigue, impaired physical function and compromised 
psychological well-being in this patient group, all of which impact quality of life (Matcham et 
al., 2014; Rosa-Goncalves et al., 2018; Senra et al., 2017; Uhlig et al., 2014; Wan et al., 2016). 
Sometimes, the ‘treat-to-target’ approach via pharmacological intervention is not 
successful in controlling inflammatory disease activity (Taylor et al., 2016). Additionally, 
patients with well-controlled disease activity may still experience pain, fatigue, functional 
disability and compromised psychological well-being, or a bout of inflammation (‘flare-up’) 
may occur which exacerbates symptoms (Santos et al., 2019; Taylor et al., 2016). Further, these 
health-related factors may interact, and simultaneously contribute to the patient experience of 
RA (Englbrecht et al., 2013; Kojima et al., 2009; Kwan, Koh, Leong, & Wee, 2014). This, 
together with pharmacological treatment entailing high overall healthcare costs (advancements 
in medication have incurred a 300% increase in direct healthcare costs) (Chaudhari, 2008), has 
led to non-pharmacological intervention warranting attention (Santos et al., 2019; Taylor et al., 
2016). Indeed, a combination of pharmacological (to control inflammatory disease activity) 
and non-pharmacological (potentially addressing more than just inflammatory disease activity, 
and offering RA self-management techniques) intervention, might be a sound approach to the 
management of RA. 
Physical activity (PA) offers a non-pharmacological method of disease management 
and improvement in RA, and has been recently recommended for this purpose by ACR and 
EULAR (Rausch Osthoff et al., 2018). These are highly-regarded scientific and educational 
associations, providing evidence-based recommendations to be applied to clinical practice and 
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daily management of rheumatic and musculoskeletal diseases. Indeed, accumulating evidence 
underlines the benefits of PA of a moderate-to-vigorous intensity (MVPA, ≥3 metabolic 
equivalents [METs]) for improving RA outcomes, for example, reduced systemic 
inflammation and disease activity, improved functional disability, pain and fatigue, and 
enhanced psychological well-being (Cooney et al., 2011; de Jong et al., 2003; Loppenthin et 
al., 2015; Metsios & Kitas, 2018; Metsios et al., 2015; Plasqui, 2008; Rahnama & Mazloum, 
2012; Rongen-van Dartel et al., 2015; Verhoeven et al., 2016). Additionally, MVPA shows 
potential to reduce the overall healthcare costs inherent to pharmacological RA treatment and 
is completely safe (Hernandez-Hernandez & Diaz-Gonzalez, 2017; Metsios & Kitas, 2018; 
Metsios et al., 2011). Until recently, the focus in such recommendations has been on PA, but 
EULAR has recently remarked on emerging evidence that sedentary behaviour is adversely 
associated with RA outcomes, and that there is a requirement to build upon the scarce evidence 
base that currently exists in this area (Agca et al., 2017; Rausch Osthoff et al., 2018). For 
example, sedentary behaviour has been associated with higher RA disease activity and 
functional disability (Fenton et al., 2018b).  
Against this backdrop, the primary aim of this thesis is to investigate the correlates of 
sedentary behaviour in people with RA. A large body of research has examined the correlates 
of MVPA in this patient group, but sedentary behaviour is distinct from MVPA, and shown to 
have independent hazards to health in the general population (Biswas et al., 2015; Carson et 
al., 2014; de Rezende et al., 2014; Ford & Caspersen, 2012; Healy et al., 2011b; Rosenberg et 
al., 2016; Santos et al., 2012). With this in mind, MVPA will be introduced in this thesis to 




Sedentary behaviour has been defined as any waking behaviour characterised by energy 
expenditure ≤1.5 METs while in a sitting, reclining, or lying posture (SBRN, 2012; Tremblay 
et al., 2017) (Figure 1.2). There exists a wealth of opportunities for sedentary behaviour across 
life domains (e.g., travelling in a vehicle, working at a computer, watching television, reading 
a book) (Ainsworth et al., 2011), and technological innovation has facilitated increased 
sedentary behaviour in recent decades (Bailey, 2017).  
A common error previously made in this field, is the incorrect inference of 
sedentariness from physical inactivity. Sedentary behaviour and physical inactivity are distinct 
behaviours, with the latter defined as insufficient purposeful participation in MVPA (van der 
Ploeg & Hillsdon, 2017). Indeed, an individual can be classed as both sedentary and physically 
inactive, sedentary and physically active, or non-sedentary and physically inactive (Owen, 
Sparling, Healy, Dunstan, & Matthews, 2010; van der Ploeg & Hillsdon, 2017). For example, 
an individual who spends the majority of their day sitting, and who also fails to meet 
recommended guidelines for participation in MVPA (150min/week in MPA or 75min/week in 
VPA) (Chief Medical Officer [CMO], 2019), would be classed as sedentary and physically 
inactive. In contrast, a person would be considered sedentary and physically active where 
sitting constitutes a large part of their day, but they still manage to meet recommended 
guidelines for participation in MVPA. Alternatively, by failing to engage in recommended 
levels of MVPA, but spending time in light-intensity PA (LPA), an individual can be classed 
as non-sedentary and physically inactive. This revised line of thinking has led to researchers 
investigating the independent and simultaneous contributions of different behavioural 





Figure 1.2	The movement continuum – energy requirements of sleep, sedentary behaviour, 
light-intensity physical activity, moderate-intensity physical activity and vigorous-intensity 
physical activity.	
 
Sedentary behaviour and health 
The problem of sedentariness is receiving increased attention due to high prevalence of 
this behaviour among youth, adults and older adults, coupled with growing evidence for the 
role of sedentary time in the development of poor health. For example, epidemiological 
research indicates that adolescents accumulate 6h/day of accelerometer-assessed sedentary 
time, and sedentary time estimates increase with age (Collings et al., 2014). For adults, the 
National Health and Nutrition Examination Survey (NHANES) (Healy et al., 2011b) indicated 
that sedentary time represents around 50-60% of waking hours when measured with 
accelerometry. Still, older adults (≥60 years old) represent the most sedentary age group, with 
sedentary time estimates of approximately 9h/day (Harvey, Chastin, & Skelton, 2015). 
Research examining the health consequences of sedentary behaviour has mostly been 
conducted among adults. Recent findings have indicated associations between increased 
sedentary time with heightened mortality and morbidity, and that these are independent from 
the accrual of MVPA participation (Biswas et al., 2015). In this regard, sedentary time has been 
consistently linked with increased inflammation in clinical and non-clinical populations, and it 
has been proposed that this may represent a mechanism through which sedentary behaviour 
leads to greater risk of poor health (Carson et al., 2014; Carter, Hartman, Holder, Thijssen, & 
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Hopkins, 2017; Falconer et al., 2014; Ford & Caspersen, 2012; Healy et al., 2011b; Henson et 
al., 2013). Indeed, prospective studies have demonstrated high levels of sedentary time to 
associate with worsened cardiometabolic health, of which heightened systemic inflammation 
is an established factor (Biswas et al., 2015; Carson et al., 2014; Fitzgerald et al., 2015; 
Hamilton, Hamilton, & Zderic, 2014). Further, a recent systematic review and dose-response 
meta-analysis have reported that total sitting time and television viewing time, were associated 
with greater risk of several major chronic disease outcomes, including all-cause, CVD and 
cancer mortality, as well as incident diabetes (Patterson et al., 2018).  
Sedentary behaviour has also been deemed hazardous for health in older adults, of 
whom exhibit similar levels of accelerometer-assessed sedentary time to people with RA. 
Indeed, it has been reported that RA patients spend approximately 9h/day engaged in sedentary 
behaviour (Fenton et al., 2018b). Interestingly, numerous studies with older adults have 
demonstrated links between sedentary time with deleterious health consequences very relevant 
to disease outcomes experienced by RA patients. For example, sedentary time accumulated by 
older adults has been associated with poorer cardiometabolic health, increased pain and fatigue, 
and reduced physical function, depression and all-cause mortality, often independent from 
MVPA participation (Balboa-Castillo, Leon-Munoz, Graciani, Rodriguez-Artalejo, & Guallar-
Castillon, 2011; de Rezende et al., 2014; Dogra & Stathokostas, 2012; Okely et al., 2019; Park, 
Thogersen-Ntoumani, Veldhuijzen van Zanten, & Ntoumanis, 2018; Rosenberg et al., 2016; 
Santos et al., 2012; Sardinha, Santos, Silva, Baptista, & Owen, 2015; Seguin et al., 2012; van 
der Berg et al., 2014).  
A more recent review to that of Biswas et al. (2015), showed that mortality risk resulting 
from sedentarity, decreased in physically active individuals (Ekelund et al., 2016). Specifically, 
Ekelund and colleagues (2016) indicated that 60-75min/day of MVPA is the optimal target to 
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diminish this deleterious consequence associated with sedentary time. However, achieving this 
quantity of daily MVPA might be challenging, particularly in populations with reduced 
physical function (e.g., RA). Certainly, people with RA typically do not achieve recommended 
levels of MVPA per week (Tierney et al., 2012). This is both unfortunate and concerning, 
considering the large body of research promoting MVPA for improving important RA 
outcomes.  
It has been proposed that RA symptomology, including pain, fatigue and disability, 
contribute to the perception among RA patients that MVPA is unachievable, resulting in low 
participation (Larkin et al., 2017; Tan et al., 2019; Veldhuijzen van Zanten et al., 2015). Indeed, 
in their systematic review, Veldhuijzen van Zanten and colleagues (2015) found that several 
quantitative and qualitative studies reported “pain”, “fatigue”, “mobility” and “stiffness” as 
key RA-specific barriers to PA and exercise. In a recent qualitative study, barriers to PA was 
an emerging theme among RA patients (Larkin et al., 2017). Consistent with findings by 
Veldhuijzen van Zanten et al. (2015), a participant explained, “you could be on top of the 
mountain, feeling just wonderful and then you know you’d get sick and you’ve such a setback, 
you’re back down at the bottom again”, and another reported, “sometimes the pain is so bad 
you just don’t know you know and I’m just thinking how the hell am I going to get upstairs 
today”. An additional theme emerging from this study was “limits and pacing”, whereby 
participants recognised their limits when it came to engaging in PA. This has led to research 
exploring the potential of LPA participation for improving health in RA (Fenton et al., 2018c; 
Khoja et al., 2016). 
Cross-sectional studies have demonstrated associations between LPA with improved 
disease activity, physical function and psychological well-being in people with RA (Fenton et 
al., 2018c; Khoja et al., 2016). In addition, LPA demonstrates a strong inverse correlation with 
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sedentary time in people with RA (Fenton et al., 2017), and therefore demonstrates greater 
potential than MVPA for replacing sedentary time in day-to-day life (Paul et al., 2014). Further, 
LPA engagement might be viewed as more feasible for these patients (Manns et al., 2012). 
Research examining associations between LPA and health have been conducted in populations 
with reduced mobility, including older adults (Buman et al., 2010; Ekwall et al., 2009), people 
with osteoarthritis (White, Lee, Song, Chang, & Dunlop, 2017) and individuals who have 
suffered from a stroke or spinal cord injury (Manns et al., 2012). Such studies list benefits LPA 
pose to health in these populations (e.g., better physical function and quality of life) but do not 
recommend excluding MVPA participation from daily activity. Rather, LPA is viewed a 
‘stepping stone’ to improved health and perhaps, future participation in higher-intensity PA. 
Promoting MVPA participation is an unsuccessful intervention strategy to reduce 
sedentary time (Martin et al., 2015; Prince, Saunders, Gresty, & Reid, 2014). With this in mind, 
interventions targeting sedentary behaviour change in RA might focus on increasing LPA, 
offering a non-pharmacological method of managing important disease outcomes. However, 
the low quantity and quality of previous research in this field hinders the development of such 
interventions. Thus, more high-quality research should be conducted to ascertain relationships 
between sedentary behaviour, LPA and health in RA. 
 
Measurement of free-living sedentary behaviour and physical activity 
Studies examining relationships between sedentary behaviour and PA with health 
outcomes in different populations, rely on accurate measurement of these behaviours. The 
implications of unreliable and invalid measurement of these behaviours are concerning, 
particularly when confirming population prevalence of these behaviours, the dose-response 
relationships between behaviour and health, and the efficacy of behaviour change 
interventions, that guide policy. The sections that follow will provide a description and critical 
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evaluation of common measures employed to quantify these behaviours, outlining their 
employment in RA studies to provide evidence for the link between sedentary behaviour, LPA 
and health, to date. 
Current measurement techniques that attempt to assess sedentary behaviour and PA are 
split broadly into self-report measures and objective measures. Self-report methods encompass 
questionnaires (e.g., International Physical Activity Questionnaire [IPAQ]) (Craig et al., 2003) 
and diaries (e.g., Bouchard Physical Activity Record) (Bouchard et al., 1983). Questionnaires, 
such as the IPAQ, are the most frequently-employed measure of sedentary behaviour and PA 
in large-scale epidemiological and observational studies, due to ease of application, relatively 
low cost and low burden on participants (Atkin et al., 2012; Healy et al., 2011a; Sylvia et al., 
2014). Device-based measures being increasingly employed to objectively quantify habitual 
levels of time spent sedentary and in PA in the general population, include accelerometers (e.g., 
ActiGraph accelerometer [ActiGraph, LLC., Pensacola, Florida, USA]) and posture sensors 
(e.g., activPALTM [PAL Technologies Ltd., Glasgow, UK]) (Atkin et al., 2012; Edwardson et 
al., 2017; Healy et al., 2011a; Sylvia et al., 2014; Wijndaele et al., 2015). Accelerometers are 
typically small and lightweight, and afford the ability to continuously monitor free-living 
sedentary time and PA (Atkin et al., 2012; Healy et al., 2011a; Sylvia et al., 2014). The 
activPALTM is also small and lightweight, capable of quantifying free-living sitting/lying 
(sedentary), standing and stepping time (Edwardson et al., 2017). Consequently, 
accelerometers and the activPALTM have been administered in large-scale studies for 
surveillance of time spent sedentary and in PA in various countries, including the UK (e.g., 
UK Biobank, 1970 British Birth Cohort), USA (e.g., NHANES, Woman’s Health Study), 
Canada (e.g., Canadian Health Measures Survey) and Australia (e.g., AusDiab) (Colley et al., 
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2011; Dall et al., 2018; Doherty et al., 2017; Healy et al., 2011b; Healy et al., 2008; Lee & 
Shiroma, 2014; Troiano et al., 2008; Troiano, McClain, Brychta, & Chen, 2014).  
The decision to employ self-report and/or device-based measures to assess free-living 
sedentariness and PA in a population of interest, must be informed by a number of factors. 
First, prior to employing certain methods to measure behaviour, the specific characteristics of 
the behaviour should be considered. Indeed, sedentary behaviour, by definition, has 2 
fundamental components; 1) waking activity requiring ≤1.5 METs, and 2) activity undertaken 
in a sitting/reclining/lying posture (SBRN, 2012; Tremblay et al., 2017). Thus, sedentary 
behaviour research methodology should employ measures which accurately assess both energy 
expenditure and posture. Further, it is essential that measures accurately capture the energy 
requirements of behaviour to quantify PA intensity.  
Second, the manner in which sedentary behaviour is accumulated throughout the day 
holds variable implications for health. Specifically, longer sedentary bouts (the duration of 
uninterrupted sedentary time) and less sedentary breaks (the frequency of interruptions in 
sedentary time) have been associated with negative health outcomes in clinical and non-clinical 
populations (de Rezende et al., 2014; Healy et al., 2011b). Measures of sedentariness should 
therefore enable accurate assessment of these patterns. 
Third, an understanding of the context of sedentary behaviour and PA is important to 
assist in developing more targeted interventions (Kim & Welk, 2015a). For example, one 
domain of sedentary behaviour may hold worse implications for health compared to another 
(e.g., sitting, watching television vs. sitting, reading) (Hallgren et al., 2019; Hallgren et al., 
2018). Additionally, work-based interventions targeting reductions in sedentary time might not 
be appropriate for those in the teaching profession, but perhaps more suited to employees 
working at a computer for most of the day (Thivel et al., 2018).  
 24 
Correspondingly, principles representing the multifaceted components of sedentary 
behaviour and PA relevant for health, have been proposed. Following suit from the reputable 
‘FITT’ acronym (Montoye, 2000), which relates to the multidimensional nature of PA, the 
‘SITT’ acronym (Tremblay, Colley, Saunders, Healy, & Owen, 2010) has been developed for 
sedentary behaviour. ‘SITT’ informs the researcher of the various characteristics that should 
be considered when measuring sedentary behaviour.  
 
Components of sedentary behaviour – SITT: 
• S = sedentary behaviour frequency (number of sedentary bouts of a certain duration) 
• I = interruptions (number of sedentary breaks during sedentary time) 
• T = time (duration of sedentary behaviour) 
• T = type (context of sedentary behaviour) 
 
Presently, no single measurement tool exists that fulfils the aforementioned criteria in 
its entirety. Certainly, self-report (e.g., questionnaires and diaries) and device-based 
assessments (e.g., accelerometers and posture sensors) attempt to capture free-living sedentary 
behaviour, but only measure the ‘SITT’ principles in part. Questionnaires and diaries typically 
attempt to gauge the duration of engagement in sedentary behaviour (SITT)1. Self-report diaries 
also offer a measure of the context in which these behaviours occurred (SITT). However, these 
measures fail to capture sedentary bouts (SITT) and breaks (SITT). 
 
 
1 This is termed ‘sedentary time’. Sedentary time refers to the sum of all sedentary behaviours 
that are undertaken throughout the course of a day. For example, time spent travelling to work 
by car, sitting working at an office desk, and watching television during leisure time all 
represent different sedentary behaviours, but accumulate to contribute towards ‘total sedentary 
time’ (O’Brien, Duda, Kitas, & Fenton, 2018). 
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Device-based measures seemingly address more ‘SITT’ principles compared to self-report 
(SITT), but cannot capture the context of sedentary behaviour (SITT). Accelerometers and 
posture sensors afford the ability to continuously assess behaviour throughout the day, in order 
that estimates of free-living sedentary time (SITT), as well as sedentary bouts (SITT) and 
sedentary breaks (SITT), can be determined. Further, sleep and sedentariness can be 
distinguished by applying suitable research-informed analytical procedures to these data, 
allowing inclusion of solely waking behaviour in subsequent analysis. 
Self-report and device-based measurement methods succumb to several limitations, 
which are unique from one another, relating to validity and reliability when attempting to 
capture sedentary behaviour (and PA). 
 
Self-report measures. Self-report measures are subject to social desirability bias and 
inaccuracies in participant recall, and require a certain level of cognitive ability which may 
pose a challenge to populations such as older adults (Atkin et al., 2012; Cleland, Ferguson, 
Ellis, & Hunter, 2018; Healy, et al., 2011a; Seymour et al., 2001; Sylvia et al., 2014). 
Furthermore, questionnaires that seek to capture sedentary behaviour are usually adapted from 
instruments designed to assess PA, or include a single item to assess sedentary time, and 
demonstrate poor accuracy (Dall et al., 2017).  
In addition, the validity of questionnaire measures is typically based on the strength of 
an association (via correlation or regression analysis) between self-reported PA and sedentary 
behaviour with a measure entailing superior validity (e.g., accelerometry), when it is the 
agreement between these measures that provides greater insight into their accuracy (Bland & 
Altman, 1986). Indeed, recent studies in adults have sought to assess the agreement between 
questionnaire-based assessments of PA and sedentary time against accelerometers and posture 
sensors, respectively (Chastin et al., 2018; Wanner et al., 2016). For example, Chastin et al. 
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(2018) evaluated the agreement between 18 self-report measures of sedentary time vs. the 
activPALTM (gold standard measure of free-living sedentary time). Bland-Altman plots showed 
large mean differences (ranging from approximately 8h/day underestimation to 4h/day 
overestimation), and wide 95% limits of agreement (LOA [ranging from approximately 
10h/day to 17h/day]), between measures of self-reported sedentary time vs. activPALTM-
assessed sedentary time. 
Additionally, Wanner et al. (2016) used Bland-Altman analysis to determine the 
agreement between the IPAQ vs. a widely-employed accelerometer (ActiGraph GT3X) for 
measurement of PA in an adult population. Resulting Bland-Altman plots demonstrated a large 
mean difference (approximately 13h/week) and wide 95% LOA, approximately = -38h/week 
– 11h/week, between these measures of MVPA. In this instance, most data points were below 
zero, representing overestimation of MVPA when using the IPAQ vs. accelerometry to 
measure this behaviour. 
 
Objective measures. Device-based measures offer a more objective approach to 
measurement of sedentary time and PA and therefore address several of the limitations posed 
by self-report (Atkin et al., 2012; Janz, 2006). Still, despite overcoming some shortcomings of 
self-report measures, research employing device-based measures of sedentary time and PA 
encounter challenges distinct from questionnaire- and diary-based methods. For example, the 
accompanying costs associated with purchasing the device can be high, and their means of 
attachment can often lead to low compliance (e.g., accelerometers worn on the hip) (Edwardson 
et al., 2017; Matthews, Hagstromer, Pober, & Bowles, 2012). Further, data reduction can be 
time-consuming for the researcher, and may result in data loss due to participant non-
compliance (Edwardson et al., 2017; Matthews et al., 2012). Indeed, device wear criteria 
chosen by the researcher may discount participants from subsequent statistical analysis and 
 27 
could introduce selection bias (Matthews et al., 2012). Finally, widely-used data reduction 
techniques (e.g., researcher-selected device wear criteria and accelerometer cut-points) for 
obtaining estimates of PA and sedentary time might not be generalisable to all populations 
(Pedisic & Bauman, 2015). Thus, more validation studies are required to ascertain the accuracy 
of these measures in different populations and establish population-specific analytical 
procedures to apply during data reduction. 
With this in mind, it might be appropriate for research to employ both self-report and 
device-based measures of sedentary behaviour (and PA), in order to optimally capture free-
living behaviour (Bann et al., 2015; Rosenberg et al., 2016). Importantly, the researcher should 
consider if the measure being deliberated, has been validated for use in the population of 
interest. Certainly, different populations (e.g., RA adults vs. non-RA adults) are likely to have 
varying perceptions, physiological requirements and activity patterns. Thus, a ‘one size fits all’ 
approach to measurement of free-living behaviour might lead to inaccurate estimates of 
sedentary time and PA (Aguilar-Farias, Brown, & Peeters, 2014; Copeland & Esliger, 2009; 
Fenton et al., 2018b; Kowalski, Rhodes, Naylor, Tuokko, & MacDonald, 2012; Santos-Lozano 
et al., 2013).  
In the following section, current measures used to capture engagement in sedentary 
behaviour and PA among people with RA will be described, and the advantages and 
disadvantages of each measure in this specific population will be discussed. 
 
Measurement of free-living sedentary behaviour and physical activity in rheumatoid 
arthritis 
To date, self-report measures, such as the IPAQ, are common place in research 
measuring habitual PA and sedentary behaviour in people living with RA, but have been 
criticised due to the tendency of patients to over-report levels of PA and under-report levels of 
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sedentary behaviour when using these methods (Yu et al., 2015b). Indeed, Yu et al. (2015b) 
used Bland-Altman analysis to compare the agreement between IPAQ-assessed vs. 
accelerometer-assessed PA and sedentary time in people with RA. Consistent with studies in 
adults (Chastin et al., 2018; Wanner et al., 2016) and other populations with reduced physical 
function, for example older adults (Ryan et al., 2018) and patients with lower back pain 
(Schaller, Rudolf, Dejonghe, Grieben, & Froboese, 2016), the authors discovered that patients 
overestimated MPA and underestimated sedentary time when responding to a questionnaire 
(IPAQ), compared to the criterion of accelerometry (ActiGraph GT3X). Specifically, the mean 
differences between IPAQ-assessed vs. accelerometer-assessed MPA and sedentary time were 
approximately 1h/day and 10h/day, with data points positioned mostly below zero 
(representing overestimation) and above zero (representing underestimation), respectively.  
As such, researchers would not be well-informed to select self-report measures for 
quantitative measurement of sedentary time and PA in studies with RA patients. Albeit the 
advantages of some self-report measures to provide contextual information regarding specific 
sedentary behaviours and PA settings, estimates of these behaviours should be determined 
using instruments that assess them more objectively in this patient group (Fenton et al., 2018b; 
Yu et al., 2015b). There now exists significant opportunity to employ device-based monitoring 
to the surveillance of sedentary time and PA in the RA population (Semanik et al., 2010). The 
following sections outline 2 such devices, the ActiGraph accelerometer and activPALTM, 
validated and subsequently employed in this thesis for measurement of these behaviours in RA. 
 
ActiGraph accelerometer. The ActiGraph accelerometer is the most frequently 
employed accelerometer in field-based research (Duncan et al., 2018). The triaxial ActiGraph 
accelerometer (e.g., GT3X+) is typically worn on the right hip (Figure 1.3) and is a valid and 
reliable measure of sedentary time and PA in adults (Aadland & Ylvisaker, 2015; Santos-
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Lozano et al., 2013). This device can capture human movement (accelerations) on the vertical 
(Y), horizontal right-left (X) and horizontal front-back (Z) axes, which can be used to 
determine the vector magnitude of these accelerations (vector magnitude [VM] = Ö(axisY2 + 
axisX2 + axisZ2)). Accelerations are recorded over user-defined time intervals (epochs), which 
are converted by the manufacturer’s software (Actilife) into ‘activity counts’.  
During ‘accelerometer data reduction’ (Masse et al., 2005), using Actilife, the 
researcher applies non-wear criteria to accelerometer data, coined as the “structural foundation 
in the data reduction process” (Semanik et al., 2010). Non-wear criteria determine the 
participant is not wearing the device, when a pre-determined (by the researcher) duration of 
consecutive ‘0’ activity counts is reached. This aims to distinguish between non-wear and 
sedentary time, which can also be characterised by consecutive ‘0’ activity counts (e.g., 
sedentary time = <100 counts/min). The researcher then decides how many valid hours 
constitute a ‘valid day’, and how many valid days comprise a ‘valid week’. This determines 
whether the participant has worn the device for a sufficient period of time, and will be included 
in subsequent analysis. These decisions should be based on previous research demonstrating 
the optimal non-wear criteria for a specific population to gain the most accurate estimates of 
free-living behaviour. Seminak and colleagues (2010) supported the use of non-wear criteria = 
≥60 min or ≥90 min of consecutive ‘0’ counts, worn ≥10 h/day to constitute a valid day in 
people with RA. Typically in accelerometry studies with adults, ≥4 valid days/week, inclusive 
of ≥1 weekend day, comprise a valid week (Troiano et al., 2008). These criteria have been 
applied in previous RA studies (Fenton et al., 2017; Fenton et al., 2018b; Yu et al., 2015b). 
Based on valid participant data, researcher-developed algorithms (referred to as ‘cut-
points’) are applied to the accelerometer activity counts, in order to quantify time spent in 
different intensities of activity (sedentary behaviour, LPA, MPA and VPA). The most common 
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accelerometer cut-point employed to assess sedentary time is <100 counts/min (Gorman et al., 
2014). This is a uniaxial (Y-axis) cut-point, which originates from a validation study of the 
ActiGraph accelerometer, conducted among adolescent girls (Treuth et al., 2004). Following 
publication, the <100 counts/min accelerometer cut-point was subsequently employed in the 
NHANES to estimate population prevalence of sedentary time among American adults 
(Matthews et al., 2008). In conjunction, uniaxial accelerometer cut-points were employed to 
the NHANES data to estimate the frequency and duration of LPA and MVPA (LPA, 100-2019 
counts/min; MVPA, ³2020 counts/min) among this cohort. These PA cut-points were defined 
by Troiano et al. (2008), on the basis of weighted averages of criteria from 4 calibration studies 
(Brage, Wedderkopp, Franks, Andersen, & Froberg, 2003; Freedson, Melanson, & Sirard, 
1998; Leenders, Sherman, Nagaraja, & Kien, 2001; Yngve, Nilsson, Sjostrom, & Ekelund, 
2003), and have since been frequently employed in studies of sedentariness and PA in RA 
(Fenton et al., 2017; Fenton et al., 2018c). 
However, more recently, researchers have started to move away from the assumption 
that ‘one size fits all’, and there has been an increase in the number of population-specific 
accelerometer cut-points developed (Aguilar-Farias et al., 2014; Copeland & Esliger, 2009; 
Motl, Snook, Agiovlasitis, & Suh, 2009; Nero, Benka Wallen, Franzen, Stahle, & Hagstromer, 
2015; Sandroff, Riskin, Agiovlasitis, & Motl, 2014; Santos-Lozano et al., 2013). Still, 
researchers employing accelerometry in RA studies are heavily reliant on algorithms developed 
in validation studies of healthy adults (Troiano et al., 2008), since no RA-specific 
accelerometer cut-points have been derived. This is particularly problematic when we consider 
that the physiology and associated activity patterns of people living with RA are likely to differ 
substantially to those among ‘healthy adults’ in the general population (e.g., a relatively higher 
basal metabolic rate is characteristic of RA) (Metsios et al., 2008). As such, there is an urgent 
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requirement for validation studies to develop RA-specific accelerometer cut-points to permit 
more accurate measurement of accelerometer-assessed sedentary time and PA in RA (O’Brien 
et al., 2019). Further, to ensure progress in this field, it is essential that the validity of these 
accelerometer cut-points for the measurement of free-living behaviour is established (O’Brien 
et al., 2019).  
Despite several advantages relative to self-report, accelerometers are limited in their 
ability to measure posture – an important facet of the characterisation of sedentary behaviour. 
That is, the established definition of sedentary behaviour stipulates a consideration of both low 
energy expenditure (£1.5 METs) and a sitting/reclining/lying posture (SBRN, 2012; Tremblay 
et al., 2017). Indeed, whilst cut-points can be applied to accelerometer data to provide an 
(indirect) measure of energy expenditure, accelerometers are less able to detect the posture at 
which low-energy behaviours are undertaken (An, Kim, & Lee, 2017; Kozey-Keadle, 
Libertine, Lyden, Staudenmayer, & Freedson, 2011). In this way, the activPALTM posture 
sensor offers an advance over accelerometers for free-living assessment of sedentary time, and 
is currently considered the gold standard to measure sedentary time in field-based research 









Figure 1.3 The ActiGraph GT3X+ – typical placement on the right hip of the participant 
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ActivPALTM posture sensor. The activPALTM is a small, lightweight device, typically 
worn attached to the front of the right thigh, in a mid-anterior position (Edwardson et al., 2017) 
(Figure 1.4). The activPALTM uses proprietary algorithms to classify free-living behaviour, 
based on posture and acceleration, as sitting/lying (sedentary), standing and stepping over 
continuous 24-h time periods (Edwardson et al., 2017). The activPALTM also attempts to 
monitor the number of steps and sit-stand transitions (Edwardson et al., 2017). The activPALTM 
has demonstrated high validity for measurement of sedentary time in different populations 
when compared against the criterion of direct observation, thus is considered the gold standard 
measure of free-living sedentary time (Chastin & Granat, 2010; Edwardson et al., 2017; Kozey-
Keadle et al., 2011; Sellers et al., 2016). Less frequently, the activPALTM is used to measure 
time spent stepping as an estimate of PA. However, the activPALTM is limited to the extent at 
which these data can be accurately interpreted to determine PA intensity, which is currently 
estimated based on step cadence (Montoye, Pivarnik, Mudd, Biswas, & Pfeiffer, 2017; Steeves 
et al., 2015).  
To date, only 1 study has validated the activPALTM against direct observation in the RA 
population (Larkin et al., 2016). In this study, participants wore an activPALTM whilst lying, 
sitting, standing, walking on a treadmill, and undertaking 10 activities of daily living (ADLs 
[e.g., reading a newspaper, washing and drying dishes, placing bed linens on pillows and 
duvet]). In analysis, t-tests indicated overall estimates of time spent sedentary, standing and 
stepping (s) from the activPALTM vs. direct observation did not significantly differ. Linear 
regression also demonstrated a strong relationship between time spent sedentary (r = .74), 
standing (r = .86) and stepping (r = .93) derived from the activPALTM compared to direct 
observation. However, Bland and Altman (1986) explained that regressions indicating the 
strength of a relationship does not provide scope to determine the degree of agreement between 
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2 methods. Indeed, it would be surprising to find non-significant comparability of methods that 
measure the same variables (Bland & Altman, 1986).  
Lack of high quality validation studies of the activPALTM in people with RA, coupled 
with the fact that this device predominantly provides a measure of sedentary time, has resulted 
in a small number of studies employing this device for assessment of sedentary time and PA 
in this patient group. Rather, existing RA studies have employed the activPALTM to quantify 
sedentary time only (Thomsen et al., 2017). In addition, to date, most research with RA patients 
has been undertaken with PA as their focal point, thus have employed accelerometers for this 
purpose. Indeed, few studies have focused on the correlates of sedentary time in the RA 







Figure 1.4 The activPAL3µTM – typical placement on the right thigh of the participant  
 
Both the ActiGraph accelerometer and activPALTM enable measurement of components 
of ‘FITT’ and ‘SITT’, but cannot capture the context of sedentary behaviour and PA. Extant 
studies have used a combination of objective and self-report measures of sedentariness and PA 
in an attempt to address this limitation (Bann et al., 2015; Rosenberg et al., 2016), but this 
places high burden on the participant. To date, no studies have used a combination of an 
accelerometer and posture sensor to simultaneously capture free-living sedentary time and PA 
in RA patients, which may offer the most accurate means to assess both of these behaviours. 
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Specifically; 1) accelerometry offers a potential ‘valid’ measure of LPA, MPA and VPA 
(where population-specific accelerometer cut-points are developed/used), but is unable to 
capture posture to properly assess sedentary time (An et al., 2017; Kozey-Keadle et al., 2011), 
and 2) the ability of the activPALTM to ascertain the intensity of free-living behaviour is 
dubious, but is currently regarded as the gold standard measure of free-living sedentary time 
(Chastin & Granat, 2010; Edwardson et al., 2017; Kozey-Keadle et al., 2011; Sellers et al., 
2016). 
It is important that levels of engagement in sedentary behaviour and PA are accurately 
quantified in the RA population when drawing conclusions regarding the health-related 
correlates of these behaviours in this patient group. Measuring both sedentariness and PA will 
lead to further knowledge regarding the associations they hold with relevant RA outcomes, 
such as disease activity, pain, fatigue, functional disability, psychological well-being and 
quality of life. Indeed, sedentariness has been shown to induce deleterious consequences to 
health in the general population, that are relevant to important disease features of RA (Balboa-
Castillo et al., 2011; de Rezende et al., 2014; Dogra & Stathokostas, 2012; Okely et al., 2019; 
Park et al., 2018; Rosenberg et al., 2016; Santos et al., 2012; Sardinha et al., 2015; Seguin et 
al., 2012; van der Berg et al., 2014). Further, the possible links between LPA and health are 
particularly compelling in RA, due to the; 1) more feasible nature of LPA participation 
compared to MVPA in these patients (Manns et al., 2012), 2) strong likelihood that sedentary 
time is replaced by LPA throughout the day among people with RA (Fenton et al., 2017), and 
3) demonstrated health benefits of LPA participation in other populations with reduced 
physical function, for example, older adults (Buman et al., 2010; Ekwall et al., 2009). Given 
that most research in the area is based on the wide-ranging benefits of MVPA for RA health, 
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there is a gap in knowledge relating to the relationships between sedentary behaviour and LPA 
with health outcomes in RA. 
Although the methods of measuring levels of sedentary behaviour and LPA currently 
employed in RA studies are mixed (employing self-report and device-based measures), the 
following sections will present some previous research that has focused on the levels and 
health-related correlates of these behaviours in this patient group.  
 
Sedentary behaviour, physical activity and health in rheumatoid arthritis 
It has been reported that people with RA typically spend long periods of time engaged 
in sedentary behaviour, with recent accelerometry studies suggesting people with this condition 
can spend up to 9 waking h/day sedentary (Fenton et al., 2018b).  
Research has begun to examine the implications of this behaviour for clinically- and 
patient-important RA outcomes, such as disease activity, pain, fatigue and physical function 
(Fenton et al., 2018b). Such investigations have employed either self-report or device-based 
methods to quantify sedentary time. The following sections describe the paucity of studies that 
have examined the relationships between sedentary behaviour, LPA and health, relevant to this 
thesis. Table 1.1 summarises these studies. 
Khoja et al. (2016) designed a cross-sectional study to examine the associations 
between accelerometer-assessed sedentary time and LPA, with disease activity and functional 
disability in people with RA. The Sensewear Armband (Tierney, Fraser, Purtill, & Kennedy, 
2013) was employed for measurement of sedentary time and LPA. Disease activity and 
functional disability were assessed with the DAS-28 and HAQ, respectively. Findings showed 
significant positive correlations between sedentary time with disease activity (ß = .34) and 
functional disability (ß = .43). Significant inverse associations were found for ‘very light-
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intensity physical activity’ and ‘light-intensity physical activity’ with disease activity (ß = -.27 
and ß = -.28, respectively) and functional disability (ß = -.28 and ß = -.26, respectively).  
There were some important limitations emerging from the study by Khoja and 
colleagues (2016). First, sedentariness was incorrectly defined as behaviour expending energy 
≤1 MET, instead of ≤1.5 METs (SBRN, 2012; Tremblay et al., 2017). Second, the authors 
divided LPA into 2 separate behaviours, ‘very light-intensity physical activity’ (1.1-1.9 METs) 
and ‘light-intensity physical activity’ (2.0-2.9 METs), inconsistent with the widely-accepted 
characterisation of LPA as activities requiring energy expenditure between 1.6-2.9 METs 
(Norton, Norton, & Sadgrove, 2010). Thus, these imprecisions would have led to the authors 
erroneously classifying sedentary time as ‘very light-intensity physical activity’. This, together 
with the cross-sectional design of this study, does not provide strong evidence for an 
association between sedentary time and LPA, with RA disease activity and functional 
disability. Therefore, findings should be interpreted with caution. 
More recently, Summers, Booth, Brooke-Wavell, Barami and Clemes (2019) 
conducted a cross-sectional study to determine whether the degree of active disease in females 
with RA was associated with levels of ActiGraph GT3X+-assessed sedentary time, LPA and 
MVPA. DAS-28 was employed to classify participants as having low disease activity (DAS-
28 ≤3.2) or moderate to high disease activity (DAS-28 >3.2). Summers and colleagues (2019) 
reported significant differences between both groups of RA patients, in terms of sedentary time 
and LPA. Specifically, those with low disease activity spent 10% less time engaged in 
sedentary behaviour and 18% more time in LPA, than patients with moderate to high disease 
activity. Interestingly, the proportion of sedentary time and LPA in the RA groups did not differ 
from a group of ‘healthy controls’. However, both groups of RA patients spent 40% less time 
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engaged in MVPA compared to the control group. The cross-sectional design of this study 
reduces its quality, but it does give scope for future prospective research in this area. 
In another cross-sectional study (Greene et al., 2006), participants with RA responded 
to a single-item on the Physical Activity and Disability Survey (PADS), reading, “On average, 
how many hours per day are you sitting or lying down, not counting when you sleep at night?”, 
in order to assess their sedentary time. Findings demonstrated positive associations between 
sedentary time with functional disability (ß = .28), measured by the HAQ. However, the single 
item in the PADS has not been validated to measure sedentary time in these patients, and may 
have resulted in inaccurate estimates of this behaviour (Dall et al., 2017).  
Giles, Bartlett, Andersen, Fontaine and Bathon (2008) also used a cross-sectional study 
design, demonstrating that increased self-reported television viewing time was related to 
increased HAQ-assessed functional disability, in people with RA. Television viewing has been 
used in other RA studies as an indicator of sedentary time (Kramer, Fontaine, Bathon, & Giles, 
2012), which is problematic when we consider that not all sedentary behaviours occur in this 
context. Thus, the quality of such studies are reduced when the selected measure fails to 
encapsulate the entirety of behaviour.  
Fenton et al. (2018c) investigated the sequential cross-sectional associations between 
lower-limb functional disability (to ‘rise’ and ‘walk’) measured by the HAQ, ActiGraph 
GT3X-assessed LPA and psychological well-being in people with RA. Interestingly, no 
significant association was present between lower-limb functional disability with LPA, which 
builds on popular opinion that this intensity of PA might be more realistic to achieve for this 
patient group (Manns et al., 2012). Additional findings from the aforementioned study (Fenton 
et al., 2018c) revealed a significant, positive association between ActiGraph GT3X-assessed 
LPA with subjective vitality (ß = .27), and a significant, negative association with depressive 
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symptoms (ß = -.29), measured by the Subjective Vitality Scale (SVS) (Ryan & Frederick, 
1997) and Hospital Anxiety and Depression Scale (Zigmond & Snaith, 1983), respectively. As 
such, this study generated the first evidence for the potential of LPA to improve subjective 
vitality and depressive symptoms, in people with RA. However, this study had a small sample 
size (n = 50), and only included only patients with low to moderate functional disability, 
meaning these findings cannot be generalised to patients with high-level functional disability.  
Building on evidence from their own cross-sectional study, a longitudinal study by 
Prioreschi, Hodkinson, Tikly and McVeigh (2014) sought to examine the relationships between 
accelerometer-assessed sedentary behaviour and PA with health outcomes in RA, following 
DMARD treatment. Findings demonstrated a significant positive relationship between 
sedentary behaviour, with duration of early morning stiffness (ß = .69) in RA. Further, the 
authors described that with a reduction in sedentary behaviour, there was an increase in LPA. 
This suggested that, following DMARD treatment, sedentary time was being replaced by LPA 
rather than MVPA. Despite its longitudinal design, there were some limitations to this study. 
First, the Actical accelerometer was employed to measure sedentary behaviour, LPA, MPA 
and VPA, but only daily average activity counts within each ‘threshold’ were derived for 
subsequent analysis. This does not give full insight into the specific duration (e.g., mins/day) 
of free-living sedentary behaviour and PA. Second, although early morning stiffness is an 
important indicator of disease activity in this patient group, the DAS-28 offers a more 
comprehensive evaluation of RA disease activity. Finally, the small sample size (n = 18) and 
mostly ‘obese’ participants in this longitudinal study, limits the extent to which these results 
can be generalised to the wider RA population.  
A randomised controlled trial has recently been conducted to test the effectiveness of a 
behaviour change intervention (motivational counselling and SMS reminders) to, primarily, 
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reduce sedentary time in people with RA (Thomsen et al., 2017). Of secondary interest in this 
study were RA disease outcomes, including self-reported pain (measured via visual analogue 
scale [VAS]), fatigue (measured via VAS and the Multidimensional Fatigue Inventory [MFI]) 
(Smets, Garssen, Bonke, & De Haes, 1995), functional disability (measured via the HAQ) and 
quality of life (measured via the 36-item Short Form Survey Instrument-Physical and Mental 
Component Scale) (Alonso et al., 2004). Findings demonstrated reductions in activPALTM-
assessed sedentary time for patients enrolled into the intervention group vs. control group. 
Secondary findings revealed improvements in self-reported pain, fatigue, functional disability 
and quality of life alongside these reductions in activPALTM-assessed sedentary time, for 
patients from the intervention group vs. control group.  
A strength to the study by Thomsen et al. (2017) was its randomised controlled design. 
However, arguably, this trial is seemingly premature in testing the efficacy of an intervention 
for reducing sedentary time in RA. Indeed, although research in this domain has alluded to 
links between sedentary time and RA health, these findings are still in their infancy and have 
been criticised for their quality. Typically, the rationale for conducting such an intervention 
study would rely on a solid evidence base that establishes the links between behaviour and 
health, as outlined by Sallis et al. (2000) in their Behavioural Epidemiology Framework (BEF 
[Figure 1.1]). Further, to our knowledge, there have been no studies to date that have explored 
the determinants of engagement in sedentary behaviour among people with RA, vital for 
establishing modifiable intervention targets. This point is again, outlined by Sallis and 
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Contribution of this thesis 
In a recent review, Fenton et al. (2018b) identified a paucity of high-quality research 
investigating associations between sedentary behaviour with pertinent aspects of health in RA. 
The authors strongly recommended that research adopt a “more rigorous approach” concerning 
the methodology employed, to ensure progress in this field. In addition, the potential of LPA 
for improving health has sparked interest, particularly among research focused on populations 
with reduced physical function which may prevent them from meeting recommended MVPA 
guidelines (Manns et al., 2012). Again, there is not enough high-quality research available to 
confirm whether partaking in LPA is sufficient to yield the same health benefits posed by 
MVPA participation in RA. 
The BEF (Sallis et al., 2000) is a useful tool when gauging research progression in a 
particular field, setting out several ‘phases’ to facilitate identification of knowledge gaps that 
are critical to address prior to the development, delivery and evaluation of interventions to 
improve health in specific populations. Following these steps in the target population, ensures 
that resulting interventions are based on rigorous evidence and consider the unique 
characteristic of each population, and therefore have greater potential to be effective at 
promoting behaviour change. 
The following sections will outline the ‘phases’ of the BEF specified by Sallis et al. 
(2000), and detail how these have formed the basis for Chapters 2-4 in the current thesis. ‘Phase 
1’ and ‘Phase 2’ of this framework are reciprocally linked (Figure 1.5), and for the purposes of 
this thesis, are reverse-ordered. Specifically, the study comprising Chapter 2 is a validation of 
device-based measures of sedentary time and PA in RA, in order to ‘develop methods for 
measuring the behaviour’ (‘Phase 2’). These validated measures of sedentary time and PA are 
then employed (general methodology – Chapter 3) in the longitudinal study comprising 
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Chapter 4, to establish relationships between RA health outcomes with sedentary time and PA 









Figure 1.5 The reciprocal link between ‘Phase 1’ and ‘Phase 2’ of the Behavioural 
Epidemiology Framework (Sallis et al., 2000), informing Chapters 2-4 of this thesis. 
 
‘Phase 1 – Establish links between behaviour and health’. Primarily, studies should 
identify and record the health-related correlates of behaviour in specific populations, to 
emphasise the importance of future intervention and thus justify progression to the next phases 
(e.g., ‘Phase 3 – Identify factors that influence the behaviour’). That is, ‘Phase 1’ establishes if 
there is a link between the target behaviour (e.g., sedentarity) and health (e.g., RA outcomes), 
leading to insight regarding whether changing behaviour is associated with change in health. 
How does this thesis address ‘Phase 1’ of the Behavioural Epidemiology Framework? 
Chapter 1 of this thesis has provided an overview of previous research that has investigated 
associations between sedentary behaviour, PA and health in RA. Notably, there are 
substantially less studies examining the links between sedentary behaviour and LPA, compared 
with MVPA, with health in people with RA. Further, a number of studies examining the health-
related correlates of sedentary behaviour and LPA are cross-sectional. Indeed, only 2 studies 
(1 x longitudinal and 1 x randomised controlled trial) have employed non-cross-sectional 
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designs for examining associations between sedentariness and LPA, with pertinent health 
outcomes in people with RA (Prioreschi et al., 2014; Thomsen et al., 2017). To their detriment, 
cross-sectional studies only provide a ‘snapshot’ of information (extracted from a single 
moment in time) and therefore offer no information relating to an individual’s longer-term 
health and behaviour (Carlson & Morrison, 2009; Solem, 2015). Consequently, cross-sectional 
studies fail to offer insight into whether factors such as pain, fatigue, functional disability, 
quality of life and psychological well-being in RA, are causes or consequences of these 
behaviours, or both. Indeed, the potential bi-directional nature of these relationships has not 
been tested in people with RA. Although, it has been suggested that cross-sectional studies 
should first establish, ‘quickly and easily’, whether associations exist between the variables of 
interest (e.g., RA health with sedentary time), prior to conducting longitudinal studies (Carlson 
& Morrison, 2009; Caruana, Roman, Hernández-Sánchez, & Solli, 2015; Solem, 2015). Then, 
by gathering data beyond one moment in time, longitudinal studies offer more insight into 
change in one variable ‘predicting’ change in another variable (Carlson & Morrison, 2009; 
Solem, 2015). 
As such, Chapter 4 of this thesis provides the first longitudinal evidence regarding 
associations between change in health with change in objectively-assessed sedentary time and 
PA, in people with RA. In addition, the presence of significant bi-directional associations in 
these longitudinal relationships was investigated, providing important insight into the potential 
causes (‘predictors’) and consequences (‘outcomes’) of sedentary time and PA, related to 
relevant aspects of RA health. 
 
‘Phase 2 – Develop methods for measuring the behaviour’.  The accurate 
measurement of behaviour (e.g., sedentary time and PA) is crucial for inclusion in all studies 
that aim to establish links between these behaviours and other factors (e.g., health, 
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hypothesised determinants) in certain populations. Existing or new measures of behaviour 
should be validated for use in the population of interest. 
How does this thesis address ‘Phase 2’ of the Behavioural Epidemiology Framework? 
Chapter 1 of this thesis has also outlined and critically analysed current measurement 
techniques utilised in previous RA studies to assess free-living sedentary behaviour and PA. 
Several studies have relied on self-report measures of sedentary behaviour and PA in RA. 
Lately, device-based measures (e.g., accelerometers and posture sensors), enabling more 
objective assessment of these behaviours, are becoming increasingly employed as the ‘measure 
of choice’ in this patient group (Fenton et al., 2018b; Semanik et al., 2010). Indeed, the validity 
and reliability of objective measures exceed that of self-report (Healy et al., 2011a; Sylvia et 
al., 2014). However, there is a severe lack of evidence validating device-based measures for 
objectively quantifying sedentary time and PA specifically in RA, limiting their application in 
this patient group (O’Brien et al., 2019).  
Subsequently, Chapter 2 of this thesis comprehensively validated the ActiGraph 
accelerometer and activPAL3µTM for the objective measurement of sedentary time and PA in 
RA (O’Brien et al., 2019). Primarily, in the laboratory, the ActiGraph GT3X+ was calibrated 
against indirect calorimetry to develop the first RA-specific triaxial (VM) accelerometer cut-
points for measurement of sedentary time, LPA and MPA. The activPAL3µTM was also 
validated in the laboratory, assessing its accuracy against direct observation for measurement 
of sedentary, standing and stepping time. Then, using these data, agreement between GT3X+-
assessed and activPAL3µTM-assessed free-living sedentary time was evaluated, employing both 
the novel RA-specific cut-point and the widely-used non-RA (<100 counts/min) cut-point 
(Troiano et al., 2008). Finally, within-person estimates of sedentary time, LPA and MPA, 
 45 
quantified using RA-specific cut-points vs. the widely-used non-RA cut-points, were 
compared. 
The validation study comprising Chapter 2, is a vital step forward in sedentary 
behaviour and PA research in RA, furthering knowledge regarding options for accurately 
measuring these behaviours in this patient group. Indeed, findings confirmed validity of the 
activPAL3µTM as the gold standard measure of free-living sedentary time in RA, and established 
the superior validity of the newly-developed RA-specific sedentary time cut-point vs. the 
widely-used non-RA sedentary time cut-point in this patient group. Additionally, the RA-
specific cut-points were sensitive and specific for measuring sedentary time, LPA and MPA in 
RA. These devices were therefore subsequently employed to assess sedentary time and PA in 
the longitudinal study of this thesis (Chapters 4-6). The background relevant to Chapters 5 and 
6 will be described in the following sections. 
 
The determinants of sedentary behaviour and physical activity in rheumatoid arthritis 
Interventions seeking to promote sedentary behaviour change (e.g., reducing sedentary 
time, increasing LPA) should target factors that influence these behaviours (determinants). The 
determinants of sedentary behaviour and LPA in RA could include both debilitating features 
of the disease (e.g., pain, fatigue, functional disability) (Thomsen et al., 2015; Veldhuijzen van 
Zanten et al., 2015) as well as psychosocial factors (e.g., motivation, self-efficacy) (Hurkmans 
et al., 2010; Yu et al., 2015a). 
Chapter 4 of this thesis examines the former, testing whether aspects of health in RA 
(e.g., pain, fatigue, functional disability) are ‘predictors’ of levels of sedentary time and LPA 
in this patient group, as well as ‘outcomes’. If the relationships between RA health with 
sedentary time and LPA emerge as bi-directional, then it would follow that levels of 
 46 
engagement in sedentary time and LPA may represent a consequence and cause of variability 
in health states among people with RA. In the instance that reciprocal relationships between 
sedentary time and LPA with RA features are observed in RA, it holds that interventions to 
reduce sedentary time (and promote LPA) may have the potential to improve health outcomes 
in these patients.  
Intervening to promote sedentary behaviour change in RA is likely to be a challenging 
undertaking, but might be achieved if an understanding of patient motivation to engage in the 
target behaviour (e.g., sedentary behaviour, LPA) is gained. Indeed, in their critical overview 
of existing health-related behaviour change policies and practices, Kelly and Barker (2016) 
concluded that “a careful, thoughtful science that leads to a deep understanding of the nature 
of what motivates people”, is fundamental to the development and implementation of 
interventions targeting health-related behaviours (e.g., sedentary behaviour). The authors also 
insist that this “academic” approach to behaviour change addresses the misassumption that 
simply providing an individual with information (verbally or written) regarding the health 
consequences of the target behaviour, is sufficient to promote sustained behaviour change. 
With this in mind, research questions exploring motivation for sedentary behaviour change in 
this patient group should be theoretically informed (Hurkmans et al., 2010; Michie et al., 2008; 
Yu et al., 2015a). Indeed, research grounded in psychological theory facilitates understanding 
of the psychological processes hypothesised to underlie behaviour change. 
In the context of PA, several theories underpinning human motivation have guided 
research seeking to further knowledge and understanding regarding the motivational processes 
underlying PA behaviour change. For example, social cognitive theory (Bandura, 1986), theory 
of planned behaviour (Ajzen, 1985), achievement goal theory (Nicholls, 1989) and self-
determination theory (SDT) (Deci & Ryan, 1985), have all been employed to study the role of 
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motivation in promoting PA behaviour change. Social cognitive theory considers that 3 
interacting factors, including personal (e.g., expectations), environmental (e.g., social norms) 
and behavioural (e.g., self-efficacy), lead to engaging in the target behaviour (Bandura, 1986). 
Theory of planned behaviour postulates that an individual’s intentions drive behaviour, 
stemming from attitude towards a target behaviour, subjective norms surrounding the target 
behaviour and perceptions that the target behaviour can be adopted with the available resources 
and opportunities (perceived behavioural control, e.g., self-efficacy) (Ajzen, 1985). 
Achievement goal theory posits that an individual can evaluate their competence in particular 
behavioural settings (e.g., engaging in PA) based on self-referencing (e.g., personal interest, 
effort, improvement) and normative-referencing (perception of the ability of others). The 
former orientation is considered as more desirable, and associated with better outcomes 
regarding behaviour engagement (Nicholls, 1989). 
Arguably, SDT provides a more comprehensive model of the motivational processes 
underpinning human behaviour, compared with other theories of motivation. Certainly, SDT 
does not just focus on the magnitude (quantity) of motivation as other theories do, but posits 
that the type and orientation (quality) of ‘why’ a person chooses to engage (or disengage) in a 
behaviour, also holds important implications for levels of engagement (Deci & Ryan, 1987, 
2000, 2008a, 2008b; Ryan & Deci, 2000). Specifically, central to SDT is that an individual’s 
motivation may vary in its degree of relative autonomy, with more autonomous reasons for 
engagement (e.g., behaviour is enjoyable and personally important) linked to an increased 
likelihood of adopting and persisting with a behaviour (e.g., reducing sedentary time and 
increasing LPA). In contrast, more controlled reasons for participation (e.g., other people’s 
approval, feeling guilty) are linked to a lesser chance of sustaining behaviour (Deci & Ryan, 
1987, 2000, 2008a, 2008b; Ryan & Deci, 2000). The following sections provide an overview 
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of SDT, and introduces extant research that has employed SDT to understand the motivational 
processes underpinning change in sedentary behaviour and PA. 
 
Self-determination theory 
The development of SDT by renowned researchers, Edward L. Deci and Richard M. 
Ryan, commenced approximately 50 years ago (Deci & Ryan, 2008b). In 1985, ‘Intrinsic 
Motivation and Self-Determination in Human Behaviour’ (Deci & Ryan, 1985) was published 
to provide the first comprehensive overview of SDT, and its applications and implications in 
the real world. Since then, this theory of motivation has expanded and been cited widely in 
research seeking to understand the multitude of processes underpinning the adoption and 
adherence of behaviour, including in the context of PA (Deci & Ryan, 1987, 2000, 2008a, 
2008b; Ryan & Deci, 2000).  
According to Ryan and Deci (2000), “motivation produces”. That is, motivation is a 
highly valued determinant of behaviour in research, scoping from healthcare to sports 
coaching, hypothesised by SDT to vary in both quantity and quality. As such, the degree of 
motivation (‘what’), as well as the variability in the reasons attributed to engagement in 
behaviour (‘why?’), has an impact on whether an individual initially takes up a behaviour, and 
subsequently continues to engage in the behaviour long-term (Deci & Ryan, 2000). 
Importantly, the quality of an individual’s motivation is more highly-regarded as a predictor of 
long-term behaviour and important outcomes (e.g., psychological well-being) than the amount 
(quantity) of motivation an individual possesses (Deci & Ryan, 2008a, 2008b).  
SDT posits that behavioural engagement can be regulated by more self-determined 
(originating from within self) or externally derived reasons. Specifically, SDT positions 6 
different ‘qualities’ of motivation regulation on a continuum (Figure 1.6), ranging from ‘non-
regulation’ (non-self-determined) to ‘intrinsic regulation’ (self-determined) (Ryan & Deci, 
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2000). Organismic integration theory (Deci & Ryan, 1985), a sub-theory of SDT, postulates 
that ‘extrinsic motivation’ (behaviour motivated by external forces or regulations) convenes 
between the extreme constructs of ‘amotivation’ (entirely lacking volition or desire to engage 
in behaviour) and ‘intrinsic motivation’ (behaviour motivated by internal reasons, motivation 
is completely from the self). Amotivation, comprised of ‘non-regulation’, is characterised by 
indifference and apathy towards behaviour. Extrinsic motivation encompasses ‘external 
regulation’, ‘introjected regulation’, ‘identified regulation’ and ‘integrated regulation’, 
becoming increasingly more self-determined from first listed, to last.  
Sources of external regulation to engage in behaviour include extrinsic monetary 
reward or pressure from others. Introjected regulation occurs when behaviour is controlled by 
‘intrapersonal’ factors, such as to avoid feelings of guilt, or to retain pride. Identified regulation 
is viewed as relatively more self-determined than the former, with reasons for the adoption and 
maintenance of behaviour attributed to the identification of personally valued benefits of 
engagement. Similarly, integrated regulation for behaviour occurs when identified regulations 
for behaviour emanate wholly from the self and correspond to the individual’s ambitions and 
principles. Finally, intrinsic motivation, encapsulating ‘intrinsic regulation’, has been 
advocated as exclusively, the construct representing “the positive potential of human nature”, 
where an individual purposely seeks out behaviour due to the enjoyment and challenges it 
presents (Ryan & Deci, 2000). 
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Figure 1.6 The self-determination continuum (Deci & Ryan, 2000) 
 
Identified, integrated and intrinsic regulation, and external and introjected regulation, 
represent internal and external loci of causality, respectively. Combining these regulations to 
result in composite constructs, is a frequent occurrence in SDT-based research seeking to 
examine relationships between more autonomous vs. more controlled motivation regulations 
for behaviour, with health behaviours (e.g., PA). Specifically, identified, integrated and 
intrinsic regulation are combined to form ‘autonomous motivation’2, and external and 
introjected regulation are combined to form ‘controlled motivation’ (Deci & Ryan, 2008a, 
2008b). Therefore, behaviour driven by autonomous motivation is characterised by personal 
choice and volition, and aligns completely with the individual’s personal values (Deci & Ryan, 
2008a, 2008b). Contrastingly, behaviour determined by controlled motivation is associated 
with extrinsic rewards and pressure, as well as to avoid guilt or for pride (Deci & Ryan, 2008a, 
2008b). It has been postulated that autonomous motivation links to more adaptive outcomes 
(e.g., adoption and maintenance of the target behaviour) and more controlled motivation relates 
to lack of uptake and non-adherence (Deci & Ryan, 2008a, 2008b). 
2 Integrated regulation was not assessed as part of this thesis, as this construct has not been 
shown to a great degree, as independent from identified regulation (Lonsdale, Hodge, & Rose, 
2008). In addition, the Behavioural Regulation in Exercise Questionnaire-2 (Markland & 
Tobin, 2004), employed in this thesis does not encompass integrated regulation in its 
calculation of autonomous motivation. Thus, identified regulation and intrinsic motivation 
were joined to compute autonomous motivation in this thesis.  
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Self-determination theory – sedentary behaviour and physical activity research 
SDT has provided a theoretical framework in previous research that attempts to 
understand the role of quality of motivation in the adoption and maintenance of PA among 
non-clinical and clinical populations (Duda et al., 2014; Fasczewski, Gill, & Rothberger, 2018; 
Fortier, Duda, Guerin, & Teixeira, 2012; Milne, Wallman, Guilfoyle, Gordon, & Corneya, 
2008; Teixeira et al., 2012), including RA (Fenton et al., 2018c; Hurkmans et al., 2010; Yu et 
al., 2015a).  
Research conducted by Hurkmans et al. (2010), was the first study to examine the role 
of autonomous and controlled motivation as determinants of PA in a large sample of RA 
patients. Findings revealed that higher autonomous regulation style in these individuals was 
related to higher levels of self-reported PA (ß = .33). However, this study had limitations. First, 
it employed a cross-sectional design and therefore only provided a ‘snapshot’ of patients’ 
quality of motivation and PA levels at one moment in time, which may not be fully 
representative. Further, cross-sectional studies do not provide any insight into causality, and 
must be followed up with more rigorous study designs (longitudinal and experimental studies). 
Second, the Short Questionnaire to Assess Health-Enhancing Physical Activity (Wendel-Vos, 
Schuit, Saris, & Kromhout, 2003) assessed PA, which potentially succumbed to the 
disadvantages of self-report (e.g., social desirability bias, inaccurate participant recall).  
Extending this initial study by Hurkmans et al. (2010), Yu et al. (2015a) investigated 
autonomous regulation for engagement in PA, with levels of self-reported PA and subjective 
vitality among people with RA. Autonomous motivation was measured employing the 
Behavioural Regulation in Exercise Questionnaire-2 (BREQ-2) (Markland & Tobin, 2004), 
levels of PA were self-reported using the Godin-Shepard Leisure Time Physical Activity 
Questionnaire (Godin & Shephard, 1985) and subjective vitality was captured via the SVS. 
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Structural equation modelling in this study revealed that autonomous motivation to engage in 
PA was positively associated with PA (ß = .30) and subjective vitality (ß = .40). Similarly to 
the study by Hurkmans et al. (2010), this study had a large sample size, but employed a cross-
sectional design and self-reported measures of PA. 
Few studies have used an SDT perspective to assess quality of motivation in the context 
of sedentary behaviour, with extant research taking place in non-RA groups (Babic et al., 2016; 
De Cocker, De Bourdeaudhuij, Cardon, & Vandelanotte, 2015; Quartiroli & Maeda, 2014; 
Smith et al., 2017). A cross-sectional study by Quartiroli and Maeda (2014) used an SDT lens 
to examine the associations between quality of motivation to engage in PA (using the BREQ-
2) with self-reported sedentary time (employing the IPAQ), in individuals aged between 17-30 
years old. Intrinsic and identified regulations for PA were negatively linked with self-reported 
sedentary time (ρ = -.11 and ρ = -.07, respectively), however, again, the cross-sectional nature 
of this study reduces the extent to which we can understand any causal associations. In addition, 
sedentary time was self-reported using a single item included in the IPAQ, reducing the 
accuracy of sedentary time estimates (Dall et al., 2017). Finally, the BREQ-2 was not adapted 
to measure quality of motivation to reduce sedentary behaviour, retaining its original form 
which assesses quality of motivation to engage in PA. Given that sedentary behaviour is a 
distinct construct from PA, potentially entailing different motives for engagement, such 
questionnaires should be adapted to assess specifically, quality of motivation to 
engage/disengage in sedentary behaviour. For example, the Motivation to Limit Screen-time 
Questionnaire developed in adolescents (Lubans et al., 2013). 
Against this backdrop, Chapter 5 of this thesis builds on Chapter 4, to examine the role 
of autonomous and controlled motivation to reduce sedentary behaviour in RA, through 
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examining longitudinal associations with objectively-assessed sedentary time and LPA in these 
patients. 
 
Contribution of this thesis 
 Following ‘Phase 1’ and ‘Phase 2’ of the BEF (Sallis et al., 2000), ‘Phase 3’ informed 








Figure 1.7 ‘Phase 1’, ‘Phase 2’ and ‘Phase 3’ of the Behavioural Epidemiology Framework 
(Sallis et al., 2000), informing Chapters 2-6 of this thesis. 
 
‘Phase 3 – Identify factors that influence the behaviour’. The relationships between 
hypothesised determinants of behaviour (e.g., quality of motivation to reduce sedentary 
behaviour) and behaviour (e.g., sedentary time) should be analysed using validated measures, 
informed by theories of behaviour change (e.g., SDT). This investigation will then establish 
modifiable targets for intervention. 
How does this thesis address ‘Phase 3’ of the Behavioural Epidemiology Framework? 
Identifying the modifiable determinants of sedentary time and LPA in RA, is essential in order 
to design interventions that have the potential to support people with RA to reduce their 
sedentary time (e.g., by increasing LPA). In the sections above, the relevance of SDT as a 
framework to identify malleable psychosocial correlates of sedentary time and PA in different 
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populations, including RA, has been outlined (Hurkmans et al., 2010; Quartiroli & Maeda, 
2014; Yu et al., 2015a). Thus, the longitudinal study comprising Chapters 5 and 6 of this thesis 
is grounded in SDT, and extends findings from previous RA studies, to examine how quality 
of motivation to reduce sedentary behaviour may influence levels of objectively-assessed 
sedentary time in this patient group. Specifically, Chapter 5 presents new evidence regarding 
longitudinal relationships between change in autonomous and controlled motivation to reduce 
sedentary behaviour, using the BREQ-2 (adapted for measuring quality of motivation to reduce 
sedentary behaviour), with change in objectively-assessed sedentary time and LPA, in RA. 
Chapter 6 of this thesis builds on Chapter 5, and brings in information from Chapter 4, to test 
models of sedentary behaviour change and pertinent aspects of RA health, using an SDT 
perspective. Specifically, Chapter 6 examines how the quality of motivation to reduce 
sedentary behaviour possessed by an individual with RA, relates to their engagement in 
sedentary time and LPA, and in turn, holds implications for variability in RA health. Device-
based measures of sedentary time and PA validated in Chapter 2 of this thesis, were employed 
in the longitudinal studies comprising Chapter 5 and 6. Akin to our overarching hypothesis that 
interventions to reduce sedentary time (and increase LPA) may be relevant in RA, health 
variables demonstrating bi-directional associations with sedentary time and LPA in Chapter 4 
of this thesis (emerging as ‘predictors’ and ‘outcomes’ of sedentary time and LPA), were 
stipulated as ‘outcomes’ in Chapter 6, testing models of sedentary behaviour change. 
 
Thesis aims 
 This thesis investigates the health-related and psychosocial correlates of objectively-
assessed sedentary time and LPA in people with RA. Chapter 2 validates 2 device-based 
measures of sedentary time and PA, which are subsequently employed in the longitudinal 
studies comprising Chapters 4-6. The study in Chapter 4 specifically examines bi-directional 
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relationships between pertinent aspects of health in RA, with objectively-assessed sedentary 
time and LPA in these patients. Then, grounded in SDT, Chapter 5 studies the associations 
between autonomous and controlled motivation to reduce sedentary behaviour with 
objectively-assessed sedentary time and LPA in RA. Finally, Chapter 6 persists with an SDT 
perspective to test models of sedentary behaviour change, which hypothesise sequential 
relationships between autonomous and controlled motivation to reduce sedentary behaviour 
with objectively-assessed sedentary time and LPA (specifically, standing), and in turn, health 
outcomes in RA. The aims of this thesis are: 
 
Aim 1: Validation of device-based assessments of sedentary time and PA in RA (Chapter 2). 
a) To develop RA-specific triaxial accelerometer cut-points (criterion standard = indirect 
calorimetry) for sedentary time, LPA and MPA measurement. Also, to validate the 
activPAL3µTM (criterion standard = direct observation) for measurement of sedentary, standing 
and stepping time (laboratory validation). Then, using these data; b) to compare the validity 
of the new RA-specific triaxial sedentary time accelerometer cut-point vs. the widely-used non-
RA uniaxial sedentary time accelerometer cut-point (<100 counts/min) for measurement of 
free-living sedentary time in RA, against the gold standard (activPAL3µTM). To also compare 
within-person estimates of free-living sedentary time, LPA and MPA, quantified using the new 
RA-specific triaxial accelerometer cut-points vs. widely-used non-RA uniaxial accelerometer 
cut-points (field validation). 
 
Aim 2: To assess longitudinal associations between pertinent aspects of RA health with 
objectively-assessed sedentary time and PA in RA, and investigate if these associations may 
be bi-directional (Chapters 4 and 6). 
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Aim 3: Using an SDT lens, to assess longitudinal associations between quality of motivation 
to reduce sedentary behaviour with objectively-assessed sedentary time and PA in RA 
(Chapters 5 and 6). 
 
Aim 4. Informed by Chapters 4 and 5, to examine sequential associations between quality of 
motivation to reduce sedentary behaviour with objectively-assessed sedentary time and PA, 


































Overview of participants recruited to all studies of this thesis 
All data analysed in this thesis originated from 1 sample of n = 104 RA patients, 
recruited from Russells Hall Hospital, Dudley. All participants recruited underwent the 
methodology outlined in Chapter 3 of this thesis. In addition, n = 22 of these participants gave 
their consent to participate in an ‘additional’ laboratory validation study, comprising Chapter 
2 of this thesis. Figure 1.8 illustrates how the data collected by employing these 2 protocols 




Figure 1.8 Overview of participants recruited to all studies comprising chapters of this thesis.  




Loss to follow-up, due to: planed termination of data collection (n = 47), lack of time (n = 3) 
Participants recruited from the same hospital in Dudley, England 
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Abstract 
Aim: The accurate measurement of sedentary time and physical activity (PA) is 
essential to establish relationships between these behaviours with pertinent Rheumatoid 
Arthritis (RA) outcomes. A laboratory-based and free-living protocol was conducted to 
determine: 1a) RA-specific triaxial accelerometer cut-points for sedentary time, light-intensity 
PA (LPA) and moderate-intensity PA (MPA) (criterion, indirect calorimetry); 1b) validity of 
the activPAL3µTM for measurement of sedentary, standing and stepping time (criterion, direct 
observation); 2) accuracy of the (new) RA-specific vs. non-RA cut-points for measuring free-
living sedentary time (criterion, activPAL3µTM). Methods: Laboratory-based: RA patients (n 
= 22) were fitted with a GT3X+ accelerometer, activPAL3µTM posture sensor and indirect 
calorimeter. Whilst video-recorded, participants undertook 11 activities representing different 
intensities. Field-based: RA patients (n = 100) wore a GT3X+ and activPAL3µTM for 7 days. 
Results: Laboratory-based: ROC curve generated RA-specific cut-points (counts/min) were: 
sedentary time = ≤244; LPA = 245–2501; MPA = ³2502. Bland-Altman plots revealed good 
agreement between activPAL3µTM-assessed vs. directly observed behaviours (mins). 95% 
limits of agreement (LOA [lower–upper]) = 0.1–0.2 sedentary; -0.7–1.1 standing; -1.2–0.6 
stepping. Field-based: Bland-Altman plots showed narrower 95% LOA for sedentary time 
(min/day) estimated by the RA-specific cut-point (≤244 counts/min = -42.6–318.0) vs. the non-
RA cut-point (<100 counts/min = -19.6–432.0), compared to the activPAL3µTM. Conclusion: 
The activPAL3µTM is a valid measure of sedentary time in RA. Novel RA-specific 
accelerometer cut-points were sensitive and specific for measuring sedentary time, LPA and 
MPA in these patients, and demonstrated superior agreement with the activPAL3µTM for 
measurement of sedentary time, compared to the non-RA cut-point. 
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Introduction 
Research evidence supports the benefits of physical activity (PA) for improving health-
related outcomes among people with Rheumatoid Arthritis (RA). More recently, studies also 
suggest sedentary behaviour (waking behaviour ≤1.5 metabolic equivalents (METs), whilst in 
a sitting/reclining/lying posture) (SBRN, 2012; Tremblay et al., 2017) is adversely associated 
with RA outcomes (Fenton et al., 2018b). However, most evidence regarding the role of both 
sedentary time and PA in RA is based on studies employing self-report methods to quantify 
engagement in these behaviours (Fenton et al., 2018b; Verhoeven et al., 2016). 
 Device-based assessments of sedentary time and PA offer a more objective measure of 
behaviour, and have demonstrated superior validity and reliability relative to self-report 
instruments (Atkin et al., 2012; Chastin et al., 2018; Edwardson et al., 2017; Healy et al., 2011a; 
Sylvia et al., 2014). Consequently, such devices are being more readily used to measure 
sedentary time and PA in different populations, including in RA (Fenton et al., 2018b; Semanik 
et al., 2010). Currently, accelerometers (e.g., ActiGraph [ActiGraph, LLC., Pensacola, Florida, 
USA]) are the most commonly-employed device in RA studies, owing to their ability to 
estimate the frequency, intensity and duration of free-living behaviour. The accelerometer 
generates sedentary time and PA estimates based on the number of accelerations (‘activity 
counts’) accumulated, via application of researcher-selected ‘accelerometer cut-points’. These 
cut-points specify whether the activity undertaken is sedentary, or PA of a light (LPA), 
moderate (MPA) or vigorous (VPA) intensity. However, whilst the advantages of 
accelerometry to measure sedentary time and PA are being increasingly recognised by RA 
researchers, several limitations exist regarding their application in this patient group.  
 First, few accelerometers have been specifically validated in people with RA. 
Consequently, existing RA studies employing accelerometers have relied upon validation 
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studies conducted among non-RA populations, to inform their analytical approach. For 
example, RA studies to date have largely employed uniaxial (Y-axis) accelerometer cut-points 
(Matthews et al., 2008; Troiano et al., 2008) developed in validation studies of healthy 
participants, to quantify sedentary time and PA among people with RA. Consequently, the 
validity of extant sedentary time and PA estimates may be affected and should be interpreted 
with caution, as RA patients differ markedly to people without RA in terms of their physiology, 
physical function and associated activity patterns. For example, RA patients demand a 
relatively higher basal metabolic rate compared to the general population (Metsios et al., 2008), 
underlying the limitation of applying accelerometer cut-points developed based on the energy 
requirements of behaviours in non-RA populations. Also important to highlight, is that 
commonly-employed cut-points are typically uniaxial, and generate sedentary time and PA 
estimates using data captured by a single axis (Y-axis) of movement. Technological 
advancements are such that triaxial accelerometers are now common place, and are able to 
capture data across the Y-axis (vertical), X-axis (horizontal right-left) and Z-axis (horizontal 
front-back), to provide a more valid assessment of behaviour (Choi, Ward, Schnelle, & 
Buchowski, 2012; Evenson et al., 2015). Thus, it is critical that RA-specific triaxial 
accelerometer cut-points are developed and validated for measurement of sedentary time and 
PA in RA. 
 Still, a key limitation of accelerometers is their inability to characterise posture – a key 
characteristic of sedentary behaviour (SBRN, 2012; Tremblay et al., 2017). Specifically, 
accelerometers work on the basis that all movements registered below a ‘sedentary time cut-
point’ are by default, classed as sedentary (Heesch, Hill, Aguilar-Farias, van Uffelen, & Pavey, 
2018). However, low-movement behaviours may occur in a sitting or standing posture, but 
both may record accelerations that register below the ‘sedentary time cut-point’. Thus, 
 62 
accelerometers may lead to an overestimation of sedentary time by misclassifying low-
movement standing behaviours as sitting (sedentary). The activPALTM (PAL Technologies 
Ltd., Glasgow, UK) is a combined posture sensor and accelerometer that addresses this 
limitation, and is able to accurately classify behaviours as sitting/lying (sedentary), standing or 
stepping. To date, studies in both clinical and non-clinical populations have demonstrated high 
validity of the activPALTM for measuring these behaviours when compared to direct 
observation (Edwardson et al., 2017; Kozey-Keadle et al., 2011; Sellers et al., 2016). As such, 
it is considered the ‘gold standard’ for measurement of free-living sedentary time (Chastin & 
Granat, 2010; Edwardson et al., 2017; Kozey-Keadle et al., 2011; Sellers et al., 2016). Still, 
the activPALTM primarily offers a measure of sedentary behaviour, rather than frequency, 
intensity and duration of PA. Consequently, few RA studies have employed the activPALTM to 
assess sedentary time as well as PA, with extant research employing this device focusing 
specifically on the role of sedentary behaviour in RA (Thomsen et al., 2017).  
 Considering exponential growth in research centred on the role of sedentary behaviour 
and PA for improving RA disease outcomes, it is critical that objective devices are properly 
validated for use in this population. Therefore, the overarching aim of the current study was to 
validate a commonly employed accelerometer (ActiGraph GT3X+) and the activPAL3µTM, for 
measurement of sedentary time and PA in RA. This validation study used a laboratory and 
field-based approach. Specific objectives were to; 1a) validate the GT3X+ against indirect 
calorimetry to generate RA-specific triaxial (vector magnitude [VM]) accelerometer cut-points 
for sedentary time, LPA and MPA, and 1b) validate the activPAL3µTM against direct 
observation for measurement of sedentary, standing and stepping time (laboratory validation). 
Then, using these data; 2) compare the validity of the new RA-specific triaxial sedentary time 
cut-point vs. the widely-used non-RA uniaxial sedentary time accelerometer cut-point (<100 
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counts/min) (Matthews et al., 2008; Troiano et al., 2008) for measurement of free-living 
sedentary time in RA, against the gold standard (activPAL3µTM), and 3) compare within-person 
estimates of free-living sedentary time, LPA and MPA, quantified using the new RA-specific 
vs. commonly used non-RA accelerometer cut-points (Matthews et al., 2008; Troiano et al., 
2008) (field validation). 
 
Method 
Participants and recruitment 
Participants were recruited from outpatient clinics at Russells Hall Hospital (The 
Dudley Group NHS Foundation Trust). Eligibility criteria: a clinical diagnosis of RA (Aletaha 
et al., 2010) and aged ³18 years old. For Objective 1, patients were required to be able to 
ambulate independently. For Objectives 2 and 3, patients were eligible if they could ambulate 
independently, or with an assistive device. All participants provided written informed consent. 




The protocol for this study has been previously published, detailing the methodologies 
and analytical approaches employed (O’Brien et al., 2019), but are briefly described herein. 
 
Objective 1: Laboratory-based validation  
Participants (n = 22) reported to the laboratory, having fasted (12h prior) and refrained 
from exercise (48h prior). Upon arrival, participants completed physical assessments (e.g., 
body-mass index, Disease Activity Score-28) (Prevoo et al., 1995), and completed the Health 
Assessment Questionnaire (Fries et al., 1980). Participants were then fitted with the 
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activPAL3µTM, GT3X+, heart rate monitor (Polar Electro Oy Ltd., Kempele, Finland) and 
Cortex Metalyzerâ 3B (indirect calorimeter [Cortex Biophysik, Leipzig, Germany]) for the 
duration of the laboratory validation (approximately 2h). For direct observation, a video camera 
(Everio, JVC Ltd., USA) was set up overlooking the laboratory. All equipment was time-
synchronised to facilitate accurate comparison between time-stamped raw data collected by the 
activPAL3µTM, GT3X+ and criterions (indirect calorimetry = VO2 [ml•kg•min] and METs; 
direct observation = video camera recordings).  
Participants undertook 11 activities, comprising 6 standardised activities and 5 
activities of daily living (ADLs [randomised]). Laboratory testing component activities ranged 
from 1.3-3.5 METs and were 6-min in duration (Copeland & Esliger, 2009). Five-min rest 
periods separated ADLs, to allow heart rate and VO2 to return to resting levels (Copeland & 
Esliger, 2009; Evenson et al., 2015; Santos-Lozano et al., 2013). 
 
Objectives 2 and 3: Field-based validation 
Participants (n = 104) attended the laboratory to complete physical assessments, as per 
Objective 1. They then wore the activPAL3µTM and GT3X+ for 7 days, to assess free-living 
sedentary time and PA (O’Brien et al., 2018). 
 
Measures 
GT3X+. The GT3X+ (19g; 4.6cm x 3.3cm x 1.5cm) is a triaxial accelerometer that 
records accelerations on 3 axes (vertical [Y], horizontal right-left [X] and horizontal front-back 
[Z]), over researcher-defined time periods (epochs). These data are used to compute vector 
magnitude (VM = Ö(axisY2 + axisX2 + axisZ2)), which is the outcome employed to quantify 
sedentary time and PA. For this study, accelerometers were set to sample movement in 1-s 
epochs at a rate of 30 Hertz. Participants wore the GT3X+ attached to an elastic belt on their 
 65 
right hip (Aguilar-Farias et al., 2014; Pfister et al., 2017; Santos-Lozano et al., 2013; Troiano 
et al., 2008). For Objective 1, the device was worn for the whole laboratory validation protocol. 
For Objectives 2 and 3, participants wore the device for 7-days during all waking hours, 
removing only for water-based activities.  
 
ActivPAL3µTM. The activPAL3µTM (9g; 2.35cm x 4.3cm x 0.5cm) is a combined 
posture sensor and accelerometer that measures free-living behaviour over consecutive 24-h 
periods. Participants wore the activPAL3µTM in a mid-anterior position on the right thigh, 
attached with a waterproof adhesive dressing (Edwardson et al., 2017). For Objective 1, the 
activPAL3µTM was worn for the duration of the laboratory-based protocol. For Objectives 2 and 
3, participants wore the device for 7 days, 24h/day.  
 
Indirect calorimetry. Indirect calorimetry (Cortex Metalyzerâ 3B) was the criterion 
standard for validating the accelerometer. The Cortex Metalyzerâ 3B uses a breath-by-breath 
system to directly measure an individual’s concentration of inspired oxygen (O2) and expired 
carbon dioxide (CO2). These data are used to calculate VO2 (ml•kg•min) and METs, using 
MetaSoftâ (Cortex Biophysik, Leipzig, Germany). 
 
Direct observation. Direct observation was the criterion standard for validating the 
activPAL3µTM. A video camera was set up on a tripod overlooking the laboratory. 
 
Data reduction and statistical analysis 
Objective 1: Laboratory-based validation  
GT3X+ and indirect calorimetry. The manufacturer’s software (Actilife [ActiGraph, 
LLC., Pensacola, Florida, USA]) was used to download time-stamped GT3X+ data in the 
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format of triaxial (VM) activity counts. Data were downloaded in counts/s, and converted to 
counts/min for analysis.  
Metasoftâ was used to download and export breath-by-breath VO2 data from the 
Cortex Metalyzerâ 3B. In Microsoft Excel, second-by-second VO2 data were averaged across 
each min to compute the average VO2 (ml•kg•min) for each min of activity. These data were 
then graphed to identify mins in which steady state VO2 was achieved within each laboratory 
testing component (steady state = variation within ± .50 ml•kg•min). Steady state was identified 
as occurring in the final 2 min of each activity (min 4-6).  
VO2 (ml•kg•min) and GT3X+ data (counts/min) were therefore averaged across min 4-
6 of each laboratory testing component, to provide ‘steady state’ VO2 and GT3X data for each 
activity. These data were exported into SPSS (Chicago, USA) for statistical analysis. Where 
participants did not reach steady state VO2 during an activity, their data recorded for that 
particular activity were excluded. 
Statistical analysis:  First, average (steady state) VO2 data were converted into METs 
(1 MET = 3.5 ml•kg•min) and then classified as sedentary (≤1.5 METs), LPA (1.6-2.9 METs) 
or MPA (≥3 METs). Using these classifications, data were recoded to create binary variables 
for use in Receiver Operating Characteristic (ROC) curve analysis, to define RA-specific 
triaxial (VM) accelerometer cut-points for sedentary time, LPA and MPA. Specifically, data 
were recoded as sedentary/not sedentary, or MPA/not MPA using binary indicators (1/0). ROC 
curves identified the VM activity count maximising sensitivity (y-axis) and specificity (x-axis) 
for correctly classifying behaviour as sedentary or MPA. The area under the curve (AUC) value 
was also calculated (AUC criteria: 0.90-1.00 = excellent; 0.80-0.89 = good; 0.70-0.79 = fair; 
0.60-0.69 = poor; <0.60 = failure).  
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ActivPAL3µTM and direct observation. PAL Connect (PAL Technologies, Ltd., 
Glasgow, UK) was used to download and export activPAL3µTM time-stamped data to Microsoft 
Excel. Time spent sedentary, standing and stepping, as well as number of steps and sit-stand 
transitions, were displayed every 15s. For direct observation, the researcher observed all video 
camera recordings, recording engagement in sitting/lying (sedentary), standing or stepping, as 
well as counting steps and sit-stand transitions, every 15s for the 6-min duration of each 
activity.  
Statistical analysis: Means (M) and standard deviations (SD) were calculated for 
activPAL3µTM-assessed and directly observed time spent sedentary, standing and stepping 
(min), and number of steps and sit-stand transitions. Bland-Altman analysis calculated 95% 
limits of agreement (LOA [lower–upper]) between activPAL3µTM-assessed vs. directly 
observed behaviours, using the M and SD of the differences (min) between the 2 measures (M 
± (SD x 1.96)) (Bland & Altman, 1986; Giavarina, 2015). Further, percentage accuracy for 
activPAL3µTM-assessment vs. direct observation of behaviours was computed (% accuracy = 
(activPAL value/direct observation value) x 100). 
 
Objectives 2 and 3: Field-based validation  
Actilife was used to download 7-day GT3X+ data (1-s epochs) and check non-wear 
(criteria = ³60 min of consecutive zero counts, spike tolerance of 2 min) (Semanik et al., 2010; 
Troiano et al., 2008). Participants’ data were retained for inclusion in statistical analysis where 
accelerometers were worn for ³10h/day on ³4 days (including ³1 weekend day) (Semanik et 
al., 2010; Troiano et al., 2008). The RA-specific triaxial (VM) accelerometer cut-points 
(developed in Objective 1) and non-RA uniaxial (Y-axis) accelerometer cut-points (Troiano et 
al., 2008: sedentary time = <100 counts/min; LPA = 100-2019 counts/min; MPA = 2020-5998 
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counts/min) (Matthews et al., 2008; Troiano et al., 2008), were then applied to 7-day GT3X+ 
data to derive estimates of free-living sedentary time, LPA and MPA (min/day). 
For the activPAL3µTM, PAL Connect was used to download and export daily movement 
data (15-s epochs) that corresponded to valid days measured via the GT3X+. Sleep time was 
manually removed from activPAL3µTM data using wear-time logbooks, self-reported waking 
and sleeping time, and sleep-periods identified from GT3X+ data analysis. Estimates of free-
living activPAL3µTM-assessed sedentary time (min/day) were then calculated using PAL 
Connect proprietary algorithms. 
Statistical analysis: For Objective 2, Bland-Altman analysis calculated 95% LOA 
(lower–upper) between GT3X+- and activPAL3µTM-assessed free-living sedentary time, for 
both RA-specific and non-RA accelerometer cut-points. LOA were calculated using the M and 
SD of the differences (min/day) between estimates of GT3X+- (RA-specific and non-RA cut-
points) and activPAL3µTM-assessed sedentary time (M ± (SD x 1.96)). For Objective 3, paired 
samples t-tests compared sedentary time, LPA and MPA estimates (min/day), derived from 
RA-specific vs. non-RA accelerometer cut-points. 
 
Results 
Objective 1: Laboratory-based validation  
Twenty-two people with RA, (86% female, n = 19), participated in the laboratory 













Objectives 2 and 3 
Age (years) 53.7 ± 12.5 58.5 ± 12.1 
BMI (kg/m2) 27.4 ± 5.7 28.9 ± 6.1 
Height (m) 1.7 ± 0.1 1.6 ± 0.1 
Weight (kg) 74.9 ± 18.0 80.0 ± 20.5 
Body fat (%) 34.6 ± 9.3 35.6 ± 8.5 
RA duration (years) 6.7 ± 6.3 10.6 ± 10.5 
DAS-28 3.2 ± 1.7 4.0 ± 1.5 
HAQ 0.8 ± 0.7 1.3 ± 0.8 
BMI, body-mass index; RA, Rheumatoid Arthritis; DAS-28, Disease Activity Score-28; HAQ, 
Health Assessment Questionnaire 
Note: M ± SD shown for age, BMI, height, weight, body fat percentage, RA duration, DAS-28 
and HAQ score. DAS-28 was calculated using Erythrocyte Sedimentation Rate, 28 swollen-
and-tender joint count and visual analogue scale (overall health from 0 [very good] – 100 [very 
poor]). HAQ scores were defined as, ability to undertake activities of daily living (0 = without 
any difficulty, 1 = with some difficulty, 2 = with much difficulty, 3 = unable to do). 
 
 
GT3X+ and indirect calorimetry. Table 2.2 reports the M ± SD for GT3X+ activity 
counts and METs during steady state VO2. Activity intensities (METs) achieved included 
sedentary (e.g., 0.8 ± 0.2, reading a newspaper), LPA (e.g., 1.9 ± 0.3, ironing and folding 
clothes) and MPA (e.g., 3.4 ± 0.4, walking at 4.8km/h). Table 2.3 reports results of ROC curve 
analysis and the RA-specific accelerometer cut-points maximising sensitivity and specificity. 
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The AUC demonstrated ‘excellent’ fit for RA-specific sedentary time (AUC = 1.00) and MPA 
(AUC = 0.94) cut-points. 
 
Table 2.2 Objective 1: Descriptive statistics for laboratory validation of the ActiGraph GT3X+ 
accelerometer 
Activity (MET values – 







Standardised testing component 1    
Lying (1.3 METs) 20 0 ± 0 0.6 ± 0.2 
Sitting (1.3 METs) 22 0 ± 0 0.7 ± 0.2 
Standing (1.3 METs) 18 141 ± 45 0.8 ± 0.2 
Activities of daily living    
Reading a newspaper (1.3 METs) 19 7 ± 13 0.8 ± 0.2 
Washing and drying dishes (1.8 METs) 15 518 ± 315 1.8 ± 0.3 
Ironing and folding clothes (2.0 METs) 12 549 ± 279 1.9 ± 0.3 
Placing bed linens on pillows and duvet (2.5 METs) 18 1051 ± 526 2.3 ± 0.5 
Sweeping the floor (3.3 METs) 17 1675 ± 502 2.3 ± 0.6 
Standardised testing component 2    
Walking at 3.2 km/h (2.8 METs) 19 2148 ± 571 2.7 ± 0.7 
Walking at 4 km/h (3.0 METs) 20 3120 ± 637 3.2 ± 0.8 
Walking at 4.8 km/h (3.5 METs) 18 3944 ± 882 3.4 ± 0.4 
VM, vector magnitude; METs, metabolic equivalents  
Note: MET values according to the Compendium of Physical Activities (Ainsworth et al., 
2011) are specified next to each activity of the laboratory protocol. M ± SD are shown for 
ActiGraph GT3X+ accelerometer activity counts (VM) and METs, averaged across min 4-6 of 
each activity. Number of participants (n) included in analysis are shown per activity. 
Participants who did not reach steady state VO2 (± 0.5 ml•min•kg) during min 4-6 were 
excluded from that particular activity.  
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(VM activity counts/min) 
Sensitivity Specificity AUC 
Sedentary time £ 244 0.99 0.03 1.00 
LPA > 244 – < 2502 X X X 
MPA ³ 2502 0.87 0.11 0.94 
RA, Rheumatoid Arthritis; VM, vector magnitude; LPA, light-intensity physical activity; 
MPA, moderate-intensity physical activity; AUC, area under the curve; X, does not apply 
Note: RA-specific triaxial accelerometer cut-points were developed for measurement of 
sedentary time, LPA and MPA, based on average VM activity counts/min and energy 
expenditure (METs) during steady state VO2 (± 0.5 ml•min•kg) during min 4-6 of each activity. 
LPA accelerometer cut-points were defined using the upper cut-point threshold of sedentary 
time, and the lower cut-point threshold of MPA. The AUC represented the accuracy of the RA-
specific accelerometer cut-points (0.90-1.00 = excellent; 0.80-0.89 = good; 0.70-0.79 = fair; 
0.60-0.69 = poor; <0.60 = failure).  
 
 
ActivPAL3µTM and direct observation. Table 2.4 reports the M ± SD for 
activPAL3µTM-assessed and directly observed behaviours during the laboratory testing 
procedure. When compared to direct observation, the activPAL3µTM accurately classified 
duration of sedentary, standing and stepping behaviours, as well as step number, >98% of the 
time. For number of sit-stand transitions, classification accuracy was 72%. 
Mean differences for activPAL3µTM-assessed vs. directly observed behaviours were 
computed (sedentary time, 0.1 ± 0.1 min; standing, 0.2 ± 0.5 min; stepping, -0.3 ± 0.5 min; 
steps, -30 ± 44; sit-stand transitions, 2 ± 1). Bland-Altman analysis (Figure 2.1) demonstrated 
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narrow 95% LOA (lower–upper), for sedentary (-0.1–0.2), standing (-0.7–1.1) and stepping (-
1.2–0.6) time (min). For number of steps, 95% LOA were wider (-116–57). As only M = 5 ± 
1 and M = 7 ± 0 sit-to-stand transitions were recorded by the activPAL3µTM and direct 
observation, respectively, Bland-Altman plots could not be produced for this outcome.  
 







Sedentary (total min) 18.1 ± 0.1 18.0 ± 0.0 99.6 
Standing (total min) 29.2 ± 0.8 28.9 ± 0.6 99.2 
Stepping (total min) 18.8 ± 0.8 19.1 ± 0.6 98.4 
Steps (total number) 2044 ± 122 2074 ± 144 98.6 
Sit-stand transitions (total number) 5 ± 1 7 ± 0 72.1 
Note: M ± SD are shown for total activPAL3µTM-assessed and directly observed time spent 
sitting/lying (sedentary), standing and stepping (total min), and number of steps and sit-stand 
transitions during each activity of the laboratory protocol. The percentage accuracy for 
activPAL3µTM-assessment vs. direct observation of each behaviour is also shown (% accuracy 
= (activPAL3µTM value/direct observation value) x 100). 
 
 
Objectives 2 and 3: Field-based validation 
A total n = 100 participants provided valid 7-day GT3X+ and corresponding 
activPAL3µTM data (96% of n = 104). Descriptive statistics for the sample are reported in Table 
2.1. Accelerometer-derived behaviour estimates (min/day) were; sedentary time = 686.1 ± 72.4 
(RA-specific accelerometer cut-points) and 754.7 ± 62.5 (non-RA accelerometer cut-points), 
LPA = 112.6 ± 36.1 (RA-specific accelerometer cut-points) and 86.8 ± 26.2 (non-RA 
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accelerometer cut-points), and MPA = 84.6 ± 34.5 (RA-specific accelerometer cut-points) and 
32.6 ± 19.4 (non-RA accelerometer cut-points). 
 
 
Figure 2.1 Objective 1: Bland-Altman plots showing agreement (mean difference and 95% 
limits of agreement [LOA]) for time spent sitting/lying (sedentary), standing, and stepping, as 
well as number of steps, between the activPAL3µTM vs. direct observation. 
 
Key: 
 Mean difference 




Objective 2: For the RA-specific cut-point (≤244 counts/min, VM) vs. the 
activPAL3µTM, Bland-Altman analysis revealed a mean difference of 137.7 ± 92.0, with 95% 
LOA (lower–upper) = (-42.6–318.0), for sedentary time (min/day) (Figure 2.2). The majority 
of data points were positioned above zero and followed a downward trend, whereby a lower 
mean difference between measures was observed at higher levels of sedentary time. 
Compared to the RA-specific cut-point, the non-RA cut-point (<100 counts/min, Y-
axis) demonstrated a greater mean difference (206.2 ± 115.2) and wider 95% LOA (lower–
upper) = (-19.6–432.0) vs. the activPAL3µTM for sedentary time (min/day). Bland-Altman 
analysis for the non-RA cut-point revealed most data points were scattered above zero, and a 
downward trend was observed (lower mean difference between measures at higher levels of 
sedentary time). 
 
Figure 2.2 Objective 2: Bland-Altman plots showing agreement (mean difference and limits of 
agreement [LOA]) between accelerometer-assessed vs. activPAL3µTM-assessed sedentary time. 
Accelerometer cut-points applied were; RA-specific (VM) accelerometer cut-points (derived 
from Objective 1 of this study), and non-RA (Y-axis) accelerometer cut-points. 
 
Key: 
 Mean difference 
  Lower and upper LOA (95%) 
 75 
Objective 3: Paired samples t-tests demonstrated significant differences (p<.05) 
between sedentary time, LPA and MPA estimates (min/day) from RA-specific vs. non-RA 
specific accelerometer cut-points. 
 
Discussion 
The accurate assessment of sedentary behaviour and PA in RA is essential to determine 
population prevalence of these behaviours, establish dose-response relationships between 
sedentary behaviour and PA with pertinent disease outcomes, and examine the efficacy of 
interventions supporting sedentary and PA behaviour change in this patient group.  The current 
study validated  the ActiGraph accelerometer and activPAL3µTM – 2 devices readily used in 
sedentary behaviour and PA research – for objective measurement of sedentary time and PA 
in people with RA.  
To date, RA studies employing accelerometers have largely relied on the application of 
non-RA cut-points to quantify free-living sedentary time and PA in this population (Fenton et 
al., 2017; Fenton et al., 2018c). However, exponential growth in research focused on 
understanding the role of sedentary time and PA for health in different populations, has 
underlined a critical need for the development of population-specific accelerometer cut-points, 
which consider the unique physiology and associated movement patterns of the target 
population (Aguilar-Farias et al., 2014; Copeland & Esliger, 2009; Motl et al., 2009; Santos-
Lozano et al., 2013). In response, this is the first study to calibrate the commonly-employed 
ActiGraph accelerometer and define RA-specific triaxial (VM) accelerometer cut-points, for 
valid measurement of sedentary time, LPA and MPA in RA. In our sample of n = 100 RA 
patients, daily sedentary time, LPA and MPA estimates significantly differed when applying 
RA-specific vs. non-RA cut-points to free-living accelerometer data. Given that our RA-
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specific cut-points were derived according to energy requirements of behaviour among people 
with RA, we argue that the sedentary time and PA estimates generated by application of our 
novel cut-points are likely to provide more valid assessments of behaviour. We therefore 
recommend using the RA-specific cut-points proposed herein, in future studies employing 
accelerometry to quantify free-living sedentary time, LPA and MPA in RA.  
Still, whilst the development RA-specific cut-points is an important step forward for 
research in this domain, a key drawback of accelerometers is their inability to differentiate 
between low-movement behaviours, undertaken in sitting vs. standing postures. Thus, this 
study also assessed the accuracy of the activPAL3µTM for measurement of sedentary, standing 
and stepping time in RA. Only one study has previously examined the ability of the activPAL 
to validly assess posture in RA (Larkin et al., 2016). Larkin et al. (2016) employed regression 
analysis to report strong associations between activPALTM-assessed sitting/lying, standing and 
stepping time with directly observed behaviour. However, it would be surprising to find a non-
significant relationship between 2 methods that are designed to measure the same variable. 
Advancing the study by Larkin and colleagues (2016), we employed Bland-Altman analysis 
and reported high levels of agreement between activPAL3µTM-assessed vs. directly observed 
behaviours (Bland & Altman, 1986; Dogan, 2018), and observed high classification accuracy 
(>98% for sedentary, standing and stepping time). This is in line with past research in non-RA 
populations (Edwardson et al., 2017; Sellers et al., 2016) and further supports the 
recommendation that the activPALTM be considered the gold standard assessment of free-living 
sedentary time (Chastin & Granat, 2010; Edwardson et al., 2017; Kozey-Keadle et al., 2011; 
Sellers et al., 2016), including among people with RA.  
On the basis of this recommendation, we examined the validity of the RA-specific 
sedentary time cut-point for assessment of free-living sedentary time in RA, using the 
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activPAL3µTM as the criterion standard. Comparing sedentary time quantified using the RA-
specific cut-point vs. the activPAL3µTM, results revealed a mean difference of 2.3h/day. Bland-
Altman plots demonstrated most data points to fall above zero, suggesting overestimation of 
sedentary time using the RA-specific cut-point. Still, 95% LOA for sedentary time estimates 
reported herein, were not dissimilar to other validation studies comparing agreement between 
accelerometers and the activPAL3µTM for assessment of sedentary time in other populations 
(e.g., -1.9–3.6 (Aguilar-Farias et al., 2014) and -3.3–4.2 (Pfister et al., 2017) h/day). In 
addition, compared to the activPAL3µTM, our RA-specific cut-points produced a smaller mean 
difference, and narrower 95% LOA, relative to the non-RA cut-point (<100 counts/min) 
commonly used in studies of sedentary time (Matthews et al., 2008; Troiano et al., 2008). Thus, 
it is possible that the observed global lack of agreement between accelerometer and 
activPALTM-assessed sedentary time reflects an overall reduced proficiency of accelerometers 
to accurately measure sedentary time, rather than relatively compromised validity of the RA 
cut-points described herein. 
The difference between sedentary time estimates derived from the RA-specific cut-
point vs. activPAL3µTM in this study (and others) (Aguilar-Farias et al., 2014; Pfister et al., 
2017) could be attributed to an inability of accelerometers to differentiate between low-
movement behaviours undertaken in a sitting vs. standing posture. Our data supports this as a 
plausible explanation for 2 reasons. First, participants’ average MET values during ‘standing’ 
in the laboratory protocol was ≤1.5 METs (0.8 ± 0.2 METs), which is the energy requirement 
used to define sedentary behaviour. Second, the downward trend observed in Bland-Altman 
plots suggests agreement between accelerometer- and activPAL3µTM-assessed sedentary time 
improves at higher levels of sedentary time where lower levels of PA (including standing) are 
likely to occur. That is, for people with high levels of sedentary time, standing may occupy less 
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of daily waking behaviour and therefore there is less opportunity to misclassify standing time. 
In a recent study comparing accelerometer and activPALTM-assessed sedentary time, Aguilar-
Farias et al. (2014) demonstrated that their population-specific sedentary time VM cut-points 
(e.g., <60 counts/min) were better able to detect combined activPAL3µTM-assessed sedentary 
and standing time (AUC = 0.82), compared to activPAL3µTM-assessed sedentary time alone 
(AUC = 0.73). 
In summary, results suggest that where possible, future studies should employ the 
activPAL3µTM to gain more valid estimates of sedentary time in people with RA. When this is 
not an option, the RA-specific cut-point represents a more valid alternative compared to the 
non-RA cut-point of <100 counts/min (Matthews et al., 2008; Troiano et al., 2008) for the 
assessment of sedentary time in this population. However, these recommendations should be 
considered in the context of study limitations. First, the nature of the laboratory validation 
meant that a free-living environment could not be wholly achieved, only replicated. Still, the 
laboratory protocol was informed by similar validation studies conducted in RA and non-RA 
populations, and included several activities typically undertaken in a free-living environment 
(Copeland & Esliger, 2009; Kim & Welk, 2015b; Larkin et al., 2016). Second, our laboratory 
protocol was not designed to investigate interruptions in sedentary time, as measured by the 
activPAL3µTM, and this should be addressed in future research. Third, only 1 individual 
undertook direct observation procedures (e.g., viewing videos, documenting time spent 
sedentary) during laboratory validation of the activPAL3µTM. Although our findings are 
supported by those of Larkin et al. (2016), future studies employing 2 independent coders of 
direct observation data will enable inter- and intra-observer reliability to be established, and 
further support the validity of these results. Finally, participants included in both laboratory-
based and field-based protocols were mostly female with moderate RA disease activity. Thus, 
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whilst the proportion of females participating in this study is representative of the RA 
population (Wasserman, 2018), findings may be less generalisable to male RA patients, and 
those with more/less active disease. Future research should therefore confirm the validity of 
the newly-developed RA-specific accelerometer cut-points and activPAL3µTM in a different 
population of RA patients (e.g., males, more/less obese, higher/lower disease activity). Such 
findings might point to the development of accelerometer cut-points specific to different groups 
of RA patients (e.g., males, more/less obese, higher/lower disease activity). 
 
Conclusion 
The current study confirms the activPAL3µTM can be considered the gold standard for 
measurement of free-living sedentary time in RA. Further, RA-specific triaxial accelerometer 
cut-points presented herein, are sensitive and specific for measurement of sedentary time, LPA 
and MPA, and permit more accurate assessment of free-living sedentary time compared to 
commonly-employed non-RA cut-points (Matthews et al., 2008; Troiano et al., 2008). Thus, 
in the absence of the activPAL3µTM, our data supports use of the RA-specific cut-point for 

































The protocol for this study has been published in Mediterranean Journal of Rheumatology 
 81 
Overview 
This chapter details the methodology employed for a longitudinal study, comprising 
Chapters 4, 5 and 6 of this thesis1. In brief, n = 104 people with Rheumatoid Arthritis (RA) 
attended the hospital for data collection at baseline (Time Point 1 [T1] and 6-months later 
(Time Point 2 [T2]). The same protocol was employed at both time points. Data collected 
pertaining to health-related correlates and psychosocial determinants of sedentary behaviour 
are reported in Chapters 4 and 5, respectively. In Chapter 6, data are combined to test models 
relevant to promoting sedentary behaviour change in this population. Specific chapter titles 
and corresponding aims are: 
Chapter 4. The bi-directional associations of health with sedentary time and physical 
activity in Rheumatoid Arthritis: To assess longitudinal associations between pertinent aspects 
of Rheumatoid Arthritis (RA) health with objectively-assessed sedentary time and physical 
activity (PA) in RA, and investigate if these associations may be bi-directional. 
Chapter 5. The psychosocial determinants of sedentary time and physical activity in 
Rheumatoid Arthritis: a self-determination theory perspective: Using a self-determination 
theory (SDT) lens, to assess longitudinal associations between quality of motivation to reduce 
sedentary behaviour with objectively-assessed sedentary time and PA in RA. 
  Chapter 6. Exploring the role of autonomous motivation to reduce sedentary 
behaviour and improve Rheumatoid Arthritis outcomes: testing models of sedentary 
behaviour change: Informed by Chapters 4 and 5, to examine sequential associations between 
quality of motivation to reduce sedentary behaviour with objectively-assessed behaviours, and 
in turn, RA outcomes. 
1 The protocol for this longitudinal study has previously been published, (O’Brien et al., 2018) 
outlining all measures undertaken by participants. For the purposes of this thesis, the content 
of the published chapter has been amended to reflect current aims (details the methodologies 
and analysis directly relevant to thesis Chapters 4, 5 and 6). 
 82 
Method 
Participants and recruitment 
Participants were recruited from Rheumatology outpatient clinics at Russells Hall 
Hospital in Dudley, England. Inclusion criteria: a clinical diagnosis of RA according to the 
American College of Rheumatology-European League Against Rheumatism (ACR-EULAR) 
criteria (Aletaha et al., 2010) and aged ≥18 years old. Exclusion criteria: wheelchair users and 
those unable to ambulate independently with the use of an assistive device.  
Eligible patients were approached about the study during Rheumatology outpatient 
clinics. Patients were provided with information about study procedures and given the 
opportunity to ask the researcher any questions. Willing patients provided informed consent to 
participate in the study. This study was approved by the local National Health Service Research 




This study adopted a longitudinal design. Participants were asked to visit the hospital 
at 2 time points; baseline (T1) and 6-month follow-up (T2). At each time point, participants 
were asked to undertake 2 visits (‘Visit 1’ and ‘Visit 2’) separated by a 7-day period. Specific 
protocols employed are described below and illustrated in Figure 3.1. 
 
Visit 1. Participants visited the hospital to undertake physical assessments and complete 
questionnaires. At the end of Visit 1, participants were fitted with an activPAL3µTM (PAL 
Technologies Ltd., Glasgow, UK) and ActiGraph GT3X+ accelerometer (ActiGraph, LLC., 
Pensacola, Florida, USA) to wear for the subsequent 7 days, in order to measure habitual (daily) 
time spent sedentary, standing and stepping, and engaged in LPA and MPA. The researcher 
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gave verbal and written instructions, plus a demonstration, regarding how to wear each device. 
Participants were also provided with wear time logbooks to report device removal/replacement.  
 
Visit 2. After 7 days, participants retuned to the hospital to provide a fasting blood 
sample, and undergo assessment of their RA disease activity (Disease Activity Score-28 [DAS-
28]) During this visit, participants also completed questionnaires to report their experiences of 
pain and fatigue over the previous 7 days. The activPAL3µTM, ActiGraph GT3X+ and wear 




Participant characteristics. Information was recorded pertaining to participants’ 
biological sex, age, ethnicity, marital status, date of diagnosis, existing chronic conditions (e.g., 
heart disease, diabetes, depression), current medical treatment and smoking status. 
 
Anthropometrics and resting blood pressure. Taken in duplicate, height, weight and 
body composition were measured with participants bare-foot, whilst wearing light and loose-
fitting clothing. Height was measured to the nearest 0.1cm using a stadiometer (SECA, 
Leicester Height Measure). Weight was measured to the nearest 0.1kg using Tanita body 
composition scales (Tanita BC-418 MA P). Body-mass index (BMI) was calculated as weight 
(kg)/height (m)2. Body fat (%) was measured using Tanita scales via bioelectrical impedance 
analysis. For each measure, a third assessment was conducted if the 2 measures differed by ± 
0.5, and an average computed (average value = (value 1 + value 2 + value 3)/3). 
Resting blood pressure (BP [systolic and diastolic]) was taken in duplicate with an 
automatic BP machine (Mindray Accutorr PLUS). The BP cuff was placed over the brachial 
 84 
artery as standard, after the participant had rested in a supine position for 5 min (Panoulas et 
al., 2007). 
 
Questionnaires. Validated questionnaires were administered to the participant to 
assess health-related and psychosocial correlates of sedentary behaviour and PA. At Visit 1, 
questionnaires assessed physical function, quality of life, subjective vitality, depressive 
symptoms and quality of motivation to reduce sedentary behaviour. Questionnaires are detailed 
below and shown in Table 3.1.  
Health Assessment Questionnaire. The Health Assessment Questionnaire (HAQ) is the 
most valid measure of functional disability in RA (Fries et al., 1980), used routinely in clinical 
practice as a marker of RA disease severity (Fenton et al., 2017; Khoja et al., 2016; Kirwan & 
Reeback, 1986; Ramey, Raynauld, & Fries, 1992; Rouse et al., 2014). The HAQ assesses 
participants’ ability to undertake activities of daily living (ADLs) referring to the preceding 2 
weeks. ADLs are categorised into the following 8 sections: ‘dressing and grooming’, ‘rising’, 
‘eating’ ‘walking’ ‘hygiene’, ‘reach’, ‘grip’ and ‘activities’. Participants were asked to rate 
their difficulty in undertaking specific tasks associated with each ADL, using the scale: 0 = 
without any difficulty; 1 = with some difficulty; 2 = with much difficulty; 3 = unable to do. 
For example, under the ‘rising’ section, participants were asked, “are you able to get in and out 
of bed?”. Average HAQ scores were computed to indicate ‘functional disability’, where higher 
scores indicate poorer functional disability (minimum score = 0; maximum score = 3). The 
HAQ demonstrated high internal reliability in this study (α = .91). 
Dartmouth Cooperative Functional Assessment Charts. Dartmouth Cooperative 
(DCOOP) Functional Assessment Charts were used to assess ‘general functional status’ as a 
more holistic indicator of physical function. The DCOOP has been validated and employed in 
previous research with clinical and non-clinical populations in this regard (Nelson, Landgraf, 
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Hays, Wasson, & Kirk, 1990). Similarly to the HAQ, participants’ self-reported ability to carry 
out ADLs over the previous 2 weeks was recorded using the DCOOP. However, the DCOOP 
offers a much broader assessment of physical function relative to the HAQ, asking participants 














 General functional status was computed as 
the sum of all subscales, where higher scores relate to poorer general functional status 
(minimum score = 1; maximum score = 30). High internal reliability was shown by the DCOOP 
in this study (α = .84). 
World Health Organisation Quality of Life Questionnaire. The World Health 
Organisation Quality of Life Questionnaire (short form [WHOQOL-BREF]) (WHO, 1998) has 
been recommended for assessing quality of life in RA patients (Taylor, Myers, Simpson, 
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McPherson, & Weatherall, 2004). In this study, participants responded to 7 items, relating to 
the ‘physical health’ domain of quality of life. Participants responded to items (e.g., “how well 
are you able to get around?”) on a 5-point scale, pertaining to perceived physical health over 
the previous 2 weeks. These items were summed and used in statistical analysis. Higher scores 
were associated with better perceived quality of life with regard to patients’ physical health 
(minimum score = 1; maximum score = 35). Internal reliability for the ‘physical health’ domain 
was low in this study (α = .22). This could be due to isolation of the ‘physical health’ domain 
from the WHOQOL-BREF (lessening items in the scale), and was not due to poor correlation 
between items with the total domain score (Tavakol & Dennick, 2011). 
Subjective Vitality Scale. The Subjective Vitality Scale (SVS) was used to assess 
participants’ positive peak psychological functioning (Ryan & Frederick, 1997). Following the 
stem, “during the previous 2 weeks”, participants responded to 6 statements (e.g., “I have been 
feeling alive and vital”, “I have had energy and spirit”) on a 7-point scale (1 = not true at all to 
7 = very true). The SVS has been validated in RA (Rouse et al., 2015), and employed in studies 
examining associations between PA and psychological well-being in these patients (Fenton et 
al., 2018c). Average scores were computed, with higher scores representing greater subjective 
vitality (minimum score = 1; maximum score = 7), for use in statistical analysis. In the current 
study, the SVS exhibited high internal reliability (α = .96). 
Hospital Anxiety and Depression Scale. The prevalence of depressive symptoms was 
measured via the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983). 
This scale comprises 7 items to assess depressive symptoms, and has been previously validated 
in RA (Treharne, Lyons, Booth, & Kitas, 2007). Following the stem, “how have you been 
feeling generally over the past 2 weeks”, participants were asked to rate their agreement with 
each of the 7 items (e.g., “I feel as if I am slowed down”) on a 4-point scale. Scores across the 
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7 items were summed to represent prevalence of depressive symptoms (minimum score = 0; 
maximum score = 21). High internal reliability was demonstrated by the HADS in this study 
(α = .80). 
Behavioural Regulation in Exercise Questionaire-2 (adapted for reducing sedentary 
behaviour). Based on Self-Determination Theory (SDT) (Deci & Ryan, 1985), the Behavioural 
Regulation in Exercise Questionaire-2 (BREQ-2) (Markland & Tobin, 2004) measures a 
person’s quality of motivation to engage in PA by assessing their external, introjected, 
identified and intrinsic regulations, as well as amotivation. This questionnaire has been 
validated for use in populations with chronic musculoskeletal pain (Brooks et al., 2018) and 
employed in RA studies examining the associations between quality of motivation for PA with 
levels of PA engagement (Rouse et al., 2014; Yu et al., 2015a). For this study, the BREQ-2 
was adapted to measure ‘quality of motivation for reducing sedentary behaviour’. Specifically, 
the stem, “I take part in physical activity” was adapted to read, “I aim to reduce my sedentary 
behaviour”. Participants were asked to respond to 19 items assessing intrinsic regulation (4 
items; e.g., “because I enjoy doing this”), identified regulation (4 items; e.g., “because I value 
the benefits of doing this”), introjected regulation (3 items; e.g., “because I feel guilty when I 
am not doing this”), external regulation (4 items; e.g., “because my friends and family say I 
should”) and amotivation (4 items; e.g., “but I think doing this is a waste of time”). Participants 
were asked to rate their agreement with each statement on a 5-point scale (1 = strongly disagree; 
2 = disagree; 3 = neutral; 4 = agree; 5 = strongly agree) in reference to their motivation to 
reduce sedentary behaviour over the previous 4 weeks. Previous research has developed or 
adapted questionnaires to assess quality of motivation to reduce sedentary behaviour using an 
SDT lens (Lubans et al., 2013).  
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To avoid any misinterpretation of the concept of ‘reducing sedentary behaviour’ by 
participants, the questionnaire opened with a definition of ‘reducing sedentary behaviour’ 
which read, “reducing sedentary behaviour refers to your overall attempts to spend less time 
sitting or lying down, not just your attempts to more frequently interrupt periods of sitting with 
physical activity or standing”. Participants were also provided with examples to illustrate ways 
people might reduce their sedentary behaviour, including, “getting off the bus at a station 
before the station nearest to your destination, so that you have to walk further and sit for less 
time”. This provided participants with context regarding ‘reducing sedentary behaviour’ prior 
to completing the questionnaire. Participants’ understanding was also checked by the 
researcher before they completed the questionnaire. 
For this study, average scores for each subscale were computed, and used to produce 
composite scores for autonomous motivation (identified regulation + intrinsic regulation) and 
controlled motivation (external regulation + introjected regulation) (minimum score = 2; 
maximum score = 10). In this way, an initial understanding would be gained regarding the role 
of autonomous and controlled motivation to reduce sedentary behaviour in sedentary time and 
PA in RA. This ‘first step’ would provide a basis for future research in this patient group, which 
could extend to investigating the independent roles of external, introjected, identified and 
intrinsic regulations in sedentary behaviour and PA engagement. Additionally, computation of 
autonomous and controlled motivation to reduce sedentary behaviour increased the statistical 
power of regression models by reducing the number of variables in analysis. This method is 
also consistent with other studies using the BREQ-2 to measure quality of motivation to engage 
in PA in RA (Yu et al., 2015a) and non-RA (Vancampfort et al., 2013) populations.  
High internal reliability was demonstrated by the adapted BREQ-2 used in this study 
for autonomous (α = .87) and controlled motivation (α = .81) to reduce sedentary behaviour. 
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Sedentary behaviour and physical activity. 
ActivPAL3µTM. The activPAL3µTM is a small, lightweight device (9g; 2.35cm x 4.3cm x 
0.5cm) typically worn in a mid-anterior position on the right thigh, and affords the ability to 
measure free-living behaviour over consecutive 24-h periods. Specifically, the activPAL3µTM 
classifies free-living behaviour based on posture and acceleration. The activPAL3µTM is 
considered the gold standard measure of sedentary time (Chastin & Granat, 2010; Edwardson 
et al., 2017; Kozey-Keadle et al., 2011; Sellers et al., 2016) and in this thesis, we have validated 
this device as a measure of sedentary, standing and stepping time in RA (Chapter 2) (O’Brien 
et al., 2019). From here on, the activPAL3µTM will be referred to more broadly, as the 
‘activPAL’. 
PAL Connect (PAL Technologies Ltd., Glasgow, UK) was used to set up the activPAL 
for recording, and to download and analyse data. The activPAL was set to record data in 15-s 
epochs. The researcher attached the device via an adhesive, waterproof dressing (Tegaderm) 
to the mid-anterior position of the participant’s right thigh (Edwardson et al., 2017). 
Participants were asked to wear the activPAL for 24h/day to enable assessment of habitual time 
spent sitting/lying (sedentary), standing and stepping, as well as number of steps and sit-stand 
transitions. If the participant removed the activPAL for any reason, they were asked to record 
this in wear time logbooks provided. 
Participants’ data were downloaded from the device (using PAL Connect) to a 
Microsoft Excel (Microsoft Corporation, Redmond, USA) format for analysis. Sleep time was 
determined using self-reported information from wear time logbooks, in conjunction with sleep 
periods identified via ActiGraph GT3X+ accelerometer data. The ActiGraph GT3X+ 
accelerometer protocol requested participants to wear the device only during waking hours, 
and to remove the device upon going to bed. Thus, enabling sleep time to be identified by 
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periods of accelerometer non-wear, registered during typical sleep (bedtime-waking) hours 
(e.g., 22:00-6:00). Sleep time identified by ActiGraph GT3X+ accelerometer data was checked 
against self-reported sleep (bedtime-waking) hours recorded in wear time logbooks. 
Participants were required to have worn the activPAL for ³10h/day on ³4 days, 
including ³1 weekend day, to be included in subsequent statistical analysis (Edwardson et al., 
2017). The average daily waking time spent sedentary, standing and stepping (min/day), as 
well as the average daily percentage of time spent in these behaviours (activPAL-assessed 
behaviour per day [%] = (activPAL-assessed behaviour [min/day]/total activPAL wear time 
[min/day]) x 100), were calculated for use in subsequent statistical analysis. On this basis, n = 
2 and n = 1 were excluded from cross-sectional and longitudinal analysis, respectively. 
Participants were required to have valid activPAL data at T1 and T2 to be included in 
longitudinal analysis (included: n = 53). 
ActiGraph GT3X+ accelerometer. The ActiGraph GT3X+ triaxial accelerometer (19g; 
4.6cm x 3.3cm x 1.5cm) records accelerations over researcher-selected time periods (‘epochs’) 
on the vertical (Y), horizontal right-left (X) and horizontal front-back (Z) axes. Data on these 
axes are then used to calculate the vector magnitude (VM) using the equation, VM = Ö(axisY2 
+ axisX2 + axisZ2). From here on, the ActiGraph GT3X+ accelerometer will be referred to more 
simply as the ‘GT3X+’.  
In the current study, the GT3X+ was initialised to record accelerations in 1-s epochs. 
The device was attached to an adjustable elastic belt and worn on the participant’s right hip in 
a vertical position (Aadland & Ylvisaker, 2015; Matthews et al., 2012; Troiano et al., 2008). 
Participants were asked to remove the device only for sleeping and water-based activities (e.g., 
swimming, bathing), and to record all removal/replacement in wear time logbooks provided. 
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Following 7-day GT3X+-assessment of sedentary time and PA, data were downloaded 
using Actilife (ActiGraph, LLC., Pensacola, Florida, USA). Non-wear criteria applied to 
accelerometer data were; ≥60 min of consecutive ‘0’ counts, with a spike tolerance of 2 min 
(Troiano et al., 2008). For accelerometer data to be considered valid, participants were required 
to have worn the accelerometer for ≥10h/day on ≥4 week days, including ≥1 weekend day, to 
be included in subsequent statistical analysis (Semanik et al., 2010; Troiano et al., 2008). On 
this basis, n = 4 participants were excluded from cross-sectional data analysis and n = 3 
excluded from longitudinal data analysis. Participants were required to have valid GT3X+ data 
at T1 and T2 to be included in longitudinal analysis (included: n = 51). 
Sedentary time, light-intensity PA (LPA) and moderate-intensity PA (MPA) were 
assessed by applying RA-specific triaxial (VM) accelerometer cut-points (VM counts/min: 
sedentary time = ≤244; LPA = 245-2501; MPA = ≥2502) to these data, as defined and validated 
in Chapter 2 of this thesis (O’Brien et al., 2019). The average daily time spent sedentary, and 
in LPA and MPA (min/day), as well as the average daily proportion of time spent in these 
behaviours (GT3X+-assessed behaviour per day [%] = (GT3X+-assessed behaviour 
[min/day]/total GT3X+ wear time [min/day]) x 100), were computed for use in subsequent 
statistical analysis. 
 
Visit 2  
Fasting blood sample. After a ≥12-h fast, blood was taken from the inside of the 
participant’s arm and collected in appropriate vacutainers. Samples were used to measure 
serum biomarkers of inflammation (high-sensitivity C-reactive protein [hsCRP], erythrocyte 
sedimentation rate [ESR]). Levels of ESR were determined using standard laboratory 
procedures and hsCRP was quantified using Enzyme-Linked Immunosorbent Assays (ELISAs 
[MP Biomedicals, UK]). 
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Disease Activity Score-28. The DAS-28 is an established and validated measure of RA 
disease activity, and used routinely in clinical practice. The DAS-28 enables clinicians to make 
important decisions regarding RA patients’ course of treatment, and is underscored as a key 
clinically important outcome by the EULAR (Prevoo et al., 1995; Smolen et al., 2016b; van 
Gestel et al., 1998; Weinblatt et al., 2006). 
The DAS-28 comprises assessment of joint swelling and tenderness, in conjunction 
with a marker of systemic inflammation and patients’ self-reported overall health. For 
measurement of DAS-28, the number of swollen and tender joints in 28 synovial joints of the 
body (hands, wrists, elbows, shoulders, knees) was examined by the researcher. The degree of 
swelling was visually assessed and self-reported by the researcher. Tenderness was assessed 
via participants’ self-report when light pressure was applied to the joint by the researcher. The 
number of swollen and tender joints was used in conjunction with patients’ ESR (mm/h) and a 
self-reported degree of overall health (Visual Analogue Scale, ranging from 0 [very good] to 
100 [very poor]), to determine participants’ DAS-28 via a clinical calculator. Criteria used by 
clinicians for interpretation of DAS-28 scores is: ≤3.2 = low disease activity, >3.2 – ≤5.1 = 
moderate disease activity and >5.1 = high disease activity (Makinen et al., 2007). 
 
Questionnaires. Validated questionnaires were administered to the participant on Visit 
2 to assess RA-related pain and fatigue during the 7-day study week (Table 3.1). This was 
because pain and fatigue are highly variable day-to-day, and so this research sought to capture 
data that aligned with objectively-assessed sedentary time and PA over the same 7 days. 
McGill Pain Questionnaire. The McGill Pain Questionnaire (MPQ) has been developed 
and validated to evaluate pain in RA (Hawker, Mian, Kendzerska, & French, 2011; Sokka, 
2005). The MPQ measures total pain (15 items), representing the sum of sensory (sum of 11 
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items [e.g., “throbbing”, “sharp”, “hot-burning”]) and affective (sum of 4 items [e.g., “tiring-
exhausting”, “sickening”, “cruel-punishing”]) dimensions of pain (Melzack, 1987). 
Participants responded to each item by rating to what degree they identified with the descriptor 
(0 = none; 1 = mild; 2 = moderate; 3 = severe) over the previous 7 days. Total pain (total pain 
[15 items] = sensory pain [11 items] + affective pain [4 items]) was used in statistical analysis 
(minimum score = 0; maximum score = 45). Higher pain scores indicated higher degree of 
pain. High internal reliability was demonstrated by the MPQ in this study (α = .93). 
Multidimensional Assessment of Fatigue. The Multidimensional Assessment of Fatigue 
(MAF) is a 15-item measure of global fatigue, developed and validated for use in RA (Hewlett, 
Hehir, & Kirwan, 2007). This scale has been extensively employed in previous studies of 
fatigue in RA (Belza, 1995; Vlietstra et al., 2019). For each item, the MAF requires participants 
to rate their degree of fatigue, and what extent fatigue interfered with their ability to carry out 
specific activities (e.g., “household chores”, “bathe or wash”, “cook”) over the previous 7 days, 
on a scale from 1 = not at all to 10 = a great deal. A global fatigue index was calculated 
(minimum score = 0; maximum score = 50). Higher global fatigue scores related to poorer 
fatigue outcomes. In this study, the MAF showed high internal reliability (α = .98). 
 
Power calculation. Power calculations were conducted with G*Power (version 
3.1.9.3) using data from the Physical Activity in Rheumatoid Arthritis (PARA) randomised 
controlled trial (Trial Number: ISRCTN04121489). In the PARA study, GT3X accelerometers 
measured sedentary time, LPA and MVPA in a subsample of RA participants, and hsCRP was 
measured as a biomarker of systemic inflammation. Cross-sectional accelerometer data were 
available for n = 61 participants. A priori power calculation indicated that a sample size of n = 
125 would be sufficient to detect statistically significant relationships (power = 0.80, α error 
of probability = .05) between daily sedentary time and LPA with hsCRP. To ensure the 
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robustness of our calculations for detecting significant changes in broader RA outcomes, we 
also conducted power calculations for other RA outcomes assessed in the PARA study. For 
this, cross-sectional GT3X data, HAQ (physical function, n = 61), QRISK-2 (cardiovascular 
risk, n = 61) and subjective vitality (subjective vitality, n = 59) scores were used. A priori 
power calculation confirmed minimum sample sizes of n = 82 (physical function) and n = 114 
(subjective vitality), would ensure adequate statistical power (power = 0.80, α error of 















Note: Recruitment, data collection and statistical analysis were conducted by Ciara O’Brien. 
Ciara completed Good Clinical Practice, phlebotomy and DAS-28 training during the period 
of PhD study. Ciara assisted the biomedical scientists at Russells Hall Hospital, Jacqueline 
Smith and Janet Imeson-Wood, to spin and pipette blood samples. Jacqueline and Janet 
analysed blood samples using Enzyme-Linked Immunosorbent Assays, to measure hsCRP. 
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Overview of participants recruited to studies in Chapters 4-6 of this thesis 
In total, n = 104 people living with RA were recruited to this longitudinal study and 
underwent the protocols detailed above at baseline. These participants comprise the study 
samples for Chapters 4, 5 and 6 of this thesis.  
Figure 3.2 displays the flow of participants through the study, and details the number 




Figure 3.2 Overview of recruited participants in the longitudinal studies of Chapters 4-6.  





Cross-sectional data (T1): activPAL (n = 102), GT3X+ (n = 100) 
Loss to follow-up, due to: planned termination of data collection (n = 47), lack of time (n = 3) 
Longitudinal data (T2): activPAL (n = 53), GT3X+ (n = 51)  
 
Participants recruited from the same hospital in Dudley, England 
6-month period between T1 and T2 (no intervention) 
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Participant characteristics 
Table 3.2 provides an overview of participant characteristics for RA patients recruited 
to this longitudinal study. Below, the demographics of the sample, as well as important features 
of their RA disease, physical health and levels of sedentary time and PA, are described at T1 
and T2. The results of statistical tests employed to examine any differences in these variables 
at T2, which may occur due to participants lost to follow-up or invalid activPAL or GT3X+ 
data, are reported. 
 
Demographics. At T1, 71% of the sample were female. This is representative of the 
RA population, in which the proportion of females is higher than males (Deane et al., 2017; 
Wasserman, 2018). Participants were also largely Caucasian (n = 99), with the remainder of 
the sample Asian-Indian (n = 2), Black Caribbean (n = 2) or Arab (n = 1). The majority of 
participants reported their marital status as ‘married’ (n = 67), with others reporting that they 
were ‘single’ (n = 12), ‘divorced’ (n = 12), ‘widowed’ (n = 11) or ‘with a partner’ (n = 2). On 
average, participants were 58 years old, with n = 34 participants (33%) ≥65 years old 
(considered ‘older adults’) (Sparling, Howard, Dunstan, & Owen, 2015).  
 
RA disease and treatment regimen. At T1, on average, participants had moderate RA 
disease activity (DAS-28 >3.2 – ≤5.1) (Makinen et al., 2007) and moderate-severe disease 
severity (average HAQ score ranged between 1-2) (Bruce & Fries, 2003). Average disease 
duration was approximately 10 years. Overall, 90% of participants were on disease-modifying 
anti-rheumatic drugs (DMARDs), 14% were on anti-tumour necrosis factor (anti-TNF) 
treatment and 18% reported taking non-steroidal anti-inflammatory drugs (NSAIDs).  
 
Physical health. According to RA-specific BMI criteria (Stavropoulos-Kalinoglou et 
al., 2007), on average, participants in this study were classed as ‘obese’ (>28kg/m2), with 
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35.78% body fat, at T1. Twenty-nine participants were taking blood pressure medication to 
treat high BP, and comorbidities included depression (n = 14), asthma (n = 9), type 2 diabetes 
(n = 4), underactive thyroid (n = 4), CVD (angina, ischemic heart disease [n = 3]), chronic 
obstructive pulmonary disease (n = 2), glaucoma (n = 1), hyperthyroidism (n=2), type 1 
diabetes (n = 1), anxiety (n = 1), post-traumatic stress disorder (n = 1) and breast cancer (n = 
1). Participants’ BP was higher than normal range, according to the ‘normotension’ BP 
phenotype (clinically measured systolic BP <120 mmHg; clinically measured diastolic BP <80 
mmHg) (Blood Pressure UK, 2008), and BP values were comparable to other studies in RA 
(Yu et al., 2018).  
 
Sedentary time and physical activity. At T1, average daily sedentary time estimates 
were 9h/day and 11h/day for the activPAL and GT3X+, respectively. A larger proportion of 
the day was spent in activPAL-assessed standing (4h/day) compared to stepping (2h/day). 
Similarly, participants spent greater time in GT3X+-assessed LPA (2h/day) compared to MPA 
(1h/day). 
Independent samples t-test and chi-square analysis demonstrated no significant 
differences between participants included at T2 (n = 54), and those lost between time points 
(lost to follow-up, n = 50), regarding all measured variables (all p>.05): demographic factors 
(biological sex, ethnicity, marital status and age), RA disease (RA duration, disease activity 
[DAS-28] and disease severity [HAQ functional disability]), treatment regimen (DMARDs, 
anti-TNF treatment and NSAIDs), physical health (BMI [kg/m2], body fat [%] number of 
comorbidities, BP) and objectively-assessed behaviour (% activPAL- and GT3X+-assessed 
behaviour per day). 
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THE BI-DIRECTIONAL ASSOCIATIONS OF HEALTH WITH SEDENTARY TIME 




 Aim: This study examined longitudinal associations between pertinent aspects of RA 
health with device-assessed sedentary time and physical activity (PA) in Rheumatoid Arthritis 
(RA). The presence of bi-directional associations was also tested. Method: RA patients 
completed physical assessments and questionnaires to measure pain, fatigue, physical function, 
quality of life and psychological well-being. A fasting blood sample determined high-
sensitivity C-reactive protein (hsCRP) and erythrocyte sedimentation rate. Disease Activity 
Score-28 (DAS-28) was assessed. Participants wore an activPAL and GT3X+ to measure free-
living 7-day sedentary time and PA. This protocol was repeated after 6 months. Statistical 
analysis: In regressions, health variables were modelled as ‘predictors’ of sedentary time and 
PA. Bi-directional path analysis were conducted to determine whether RA health could be a 
cause and consequence of sedentary time and PA. Results: Longitudinal regression analysis 
revealed that change in health outcomes were associated with change in activPAL-assessed 
sedentary time (hsCRP [ß = .45], pain [ß = .28], fatigue [ß = .29], general functional status [ß 
= .42], quality of life [ß = -.38], subjective vitality [ß = -.40]), and associated with activPAL-
assessed standing (hsCRP [ß = -.40], pain [ß = -.30], fatigue [ß = -.32], general functional status 
[ß = -.44], quality of life [ß = .41], subjective vitality [ß = .37]) and stepping time (depressive 
symptoms [ß = -.23]). Most relationships were shown to be bi-directional. Conclusion: 
ActivPAL-assessed behaviours showed a multitude of associations with RA health. Several of 
these relationships were bi-directional in nature – pertinent aspects of health in RA, might be 
a cause and consequence of sedentary time and PA in this patient group. This provides scope 
for intervention targeting sedentary behaviour change in order to improve important clinically- 




Rheumatoid Arthritis (RA) is a chronic autoimmune condition (Angelotti et al., 2017) 
affecting 0.5-1% of adults worldwide (Uhlig et al., 2014; Wasserman, 2018). High-grade 
systemic inflammation that is characteristic of RA, causes musculoskeletal deterioration which 
contributes to joint pain and functional disability in these patients (Smolen et al., 2016a; Uhlig 
et al., 2014). People with RA may also experience high levels of fatigue and depression (Katz, 
2017a, 2017b; Matcham et al., 2013). These disease manifestations can adversely impact the 
patient’s quality of life (Matcham et al., 2014; Rosa-Goncalves et al., 2018; Senra et al., 2017).  
RA is typically treated with pharmacological treatment, which has considerably 
improved over the last 3 decades. A strategy termed ‘treat-to-target’ involves early intervention 
with traditional disease-modifying anti-rheumatic drugs (DMARDs), such as methotrexate, 
and the more recently introduced biologic DMARDs, such as anti-tumour necrosis factor (anti-
TNF) treatments, aiming to tightly control RA inflammatory disease activity, which is usually 
monitored with the Disease Activity Score-28 (DAS-28) (Prevoo et al., 1995; Smolen et al., 
2017; van Gestel et al., 1998; Versteeg et al., 2018). However, treat-to-target approaches to RA 
management are occasionally ineffective at controlling disease activity, while many patients 
who achieve well-controlled disease activity still report symptoms such as pain, fatigue, 
functional disability and compromised psychological well-being (Santos et al., 2019; Taylor et 
al., 2016). Additionally, advances in treatment has incurred a 300% increase in direct 
healthcare costs (Chaudhari, 2008). Thus, non-pharmacological management of RA and a shift 
towards more ‘holistic’ methods, has attracted considerable research interest among healthcare 
professionals, academics and patients (Metsios & Kitas, 2018; Santos et al., 2019; Scott, 
Machin, Mallen, & Hider, 2018; Summers et al., 2019). A combination of pharmacological 
and non-pharmacological methods has been suggested for the treatment of RA (Scott et al., 
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2018). While advancements in pharmaceutical intervention has dramatically improved 
clinically- and patient-important outcomes, non-pharmacological methods can offer self-
management of RA, and potentially alleviate the impact of disease that ‘treat-to-target’ 
approaches do not directly address (e.g., subjective experiences of pain and fatigue) (Santos et 
al., 2019; Scott et al., 2018; Taylor et al., 2016).  
Physical activity (PA) has been advocated as a non-pharmacological approach for 
managing disease among people with RA, with specific recommendations for participation 
endorsed by leading organisations worldwide (e.g., European League Against Rheumatism 
[EULAR] and American College of Rheumatology) for research into the management of RA 
(Rausch Osthoff et al., 2018; Santos et al., 2019). Certainly, the benefits of moderate-to-
vigorous-intensity PA (MVPA, ≥3 metabolic equivalents [METs]) for improving disease 
outcomes in people with RA has been extensively documented. For example, studies indicate 
higher levels of MVPA are beneficially associated with systemic inflammation, disease 
activity, physical function, pain, fatigue and psychological well-being in this patient group 
(Cooney et al., 2011; de Jong et al., 2003; Loppenthin et al., 2015; Metsios & Kitas, 2018; 
Metsios et al., 2015; Plasqui, 2008; Rahnama & Mazloum, 2012; Rongen-van Dartel et al., 
2015; Verhoeven et al., 2016). However, debilitating symptoms of RA, such as pain, fatigue 
and compromised physical function, may prevent a patient engaging in MVPA (Tan et al., 
2019; Veldhuijzen van Zanten et al., 2015). People with RA may therefore engage in low levels 
of MVPA (Tierney et al., 2012) and spend long periods of the day engaged in sedentary 
behaviour (Fenton et al., 2018b). 
Sedentary behaviour is defined as any waking activity expending energy ≤1.5 METs 
whilst in a sitting/reclining/lying posture (SBRN, 2012; Tremblay et al., 2017). It is distinct 
from ‘physical inactivity’ which is more precisely operationalised as lack of engagement in 
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recommended levels of MVPA (Owen et al., 2010; van der Ploeg & Hillsdon, 2017). Sedentary 
behaviour is regarded as hazardous for health, with increasing evidence linking it with elevated 
inflammation in clinical and non-clinical populations (Carson et al., 2014; Carter et al., 2017; 
Falconer et al., 2014; Ford & Caspersen, 2012; Healy et al., 2011b; Henson et al., 2013). 
Adverse associations between sedentarity with pain, fatigue, physical function and depression 
have also been documented in older adults (Balboa-Castillo et al., 2011; Dogra & Stathokostas, 
2012; Okely et al., 2019; Park et al., 2018; Rosenberg et al., 2016; Santos et al., 2012; Sardinha 
et al., 2015; Seguin et al., 2012; van der Berg et al., 2014).  
Fenton et al. (2018b) reported that people with RA typically spend 9h/day engaged in 
sedentary behaviour. The high accrual of sedentary time in this patient group, may perpetuate 
negative health outcomes already prevalent in RA, but few studies have examined these 
relationships. For example, sedentary time has been related to both clinically- and patient-
important outcomes among people with RA (e.g., disease activity and physical function) 
(Fenton et al., 2018b; Summers et al., 2019; Thomsen et al., 2017). In a recent qualitative study, 
there was a call for interventions to reduce sedentary time in the RA population (Thomsen et 
al., 2015). However, prior to their development, it is critical that high-quality evidence is 
generated to establish the relationships between sedentariness with health in RA. In addition, 
we must consider that by reducing sedentary time, naturally, upright behaviours requiring >1.5 
METs (PA) will constitute an increased proportion of their day. Interestingly, ‘non-exercise’ 
behaviours, encompassing sedentary behaviour and light-intensity PA (LPA, 1.6-2.9 METs), 
have been reported to comprise most of the waking day in RA (Hammam et al., 2019; Summers 
et al., 2019). Thus, it is of value to investigate the role of LPA, as well as sedentary behaviour, 
for health in RA.  
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Participation in LPA has been associated with health outcomes in non-RA populations. 
For example, LPA has been linked with improved physical function in older adults (Buman et 
al., 2010; Ekwall et al., 2009; Marques et al., 2014) and people with osteoarthritis (White et 
al., 2017). RA studies are in their infancy, but have revealed associations between engagement 
in LPA with lower disease activity, better physical function and enhanced psychological well-
being (Fenton et al., 2018c; Khoja et al., 2016; Summers et al., 2019). LPA also shows a strong 
inverse correlation with sedentary time among people with RA (Fenton et al., 2017), suggesting 
that replacing sedentary time with LPA is a viable approach to sedentary behaviour change in 
this patient group. Thus, LPA might be a vehicle for increasing levels of PA and possibly 
reduce the burden of disease in this patient group, particularly where pain, fatigue and 
functional disability might preclude engagement in MVPA (Tan et al., 2019; Veldhuijzen van 
Zanten et al., 2015). 
The notably low quantity and quality of studies investigating important relationships 
between sedentary behaviour and LPA with health indicators in RA, has been highlighted by 
EULAR (Rausch Osthoff et al., 2018) and several researchers (Fenton et al., 2018b; O’Brien 
et al., 2018). Certainly, most evidence elucidating relationships between sedentary behaviour 
and LPA with pertinent RA outcomes is based on cross-sectional studies, which reduces the 
predictive value of the role of sedentary time and LPA with health in this patient group (Carlson 
& Morrison, 2009; Solem, 2015). For example, important RA symptomology, such as pain and 
fatigue, could be determinants of higher sedentarity and lower levels of LPA, and/or 
consequences of these behaviours. Indeed, some cross-sectional studies propose health 
variables as outcomes of sedentary time and LPA (Fenton et al., 2018c; Khoja et al., 2016), 
whilst others suggest health variables are predictors of these behaviours in RA (Summers et 
al., 2019). It is important to discover if these relationships are reciprocal by nature, in order to 
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confirm scope to intervene and subsequently improve health outcomes in this patient group 
(van der Ploeg & Hillsdon, 2017). Research which moves beyond cross-sectional design is 
therefore required to gain a deeper understanding about the potential bi-directionality of these 
associations. For example, longitudinal studies analyse data beyond a single moment in time 
and provide some insight into direction of change (Carlson & Morrison, 2009; Solem, 2015). 
Further, a number of extant cross-sectional studies rely on patients to accurately self-
report their sedentary time and PA accumulated throughout the day, which may introduce 
social desirability bias and errors in recall (Atkin et al., 2012; Healy et al., 2011a; Sylvia et al., 
2014). Device-based measurement methods, such as accelerometers and posture sensors, offer 
a more objective measure of free-living behaviour, with superior validity and reliability 
compared to self-report (Healy et al., 2011a; Sylvia et al., 2014). Accelerometers enable the 
frequency, intensity and duration of movement behaviour to be quantified, based on 
accelerations of human movement. However, the ability of accelerometers to detect posture 
(sitting/reclining/lying vs. standing) – a fundamental element of the definition of sedentary 
behaviour (SBRN, 2012; Tremblay et al., 2017) – is limited (An et al., 2017; Kozey-Keadle et 
al., 2011). The activPAL (PAL Technologies Ltd., Glasgow, UK) is a posture sensor that can 
distinguish between sitting and standing postures with high accuracy (Edwardson et al., 2017; 
Kozey-Keadle et al., 2011; Sellers et al., 2016). However, whilst the activPAL is considered 
the gold standard measure of free-living sedentary time (Chastin & Granat, 2010; Edwardson 
et al., 2017; Kozey-Keadle et al., 2011; Sellers et al., 2016), very few RA studies have 
employed this device to examine the role of sedentary time in RA (Thomsen et al., 2017). 
In the present study, device-based measures were employed to assess free-living 
sedentary time and PA, to; 1) determine associations between clinically- and patient-important 
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RA outcomes, with objectively-assessed sedentary time and PA, and 2) test the presence of bi-
directional relationships in these associations in people with RA. 
 
Method 
The methodology for the current study is described in Chapter 3 of this thesis. Figure 
4.1 illustrates the specific measures employed1. 
 
Statistical analysis 
Preliminary analysis: Statistical analysis was conducted using SPSS and AMOS 
software (IBM Corporation, Armonk, NY [version 24]). Descriptive statistics were computed 
for all measured variables at Time Point 1 (T1) and Time Point 2 (T2), and change scores 
(change = T2 – T1). Kolmogorov-Smirnov tests of normality were conducted to check 
normality of data, in addition to formal inspection of graphs (histograms, Q-Q plots). Non-
normally data were log-transformed to try and achieve normal distribution of data. However, 
despite applying suitable transformations (e.g., log transformation), normal distribution was 
not attained for several variables. Consequently, bootstrapping – a non-parametric resampling 
procedure – was employed in all subsequent regression analysis to account for non-normal 





1 For the remainder of Chapter 4, questionnaires will be referred to in acronym form. 
Specifically, Health Assessment Questionnaire = HAQ, Dartmouth Cooperative Functional 
Assessment Charts = DCOOP, World Health Organisation Quality of Life = WHOQOL-






  Figure 4.1 Protocol for Chapter 4 of this thesis. M
easures specific to this chapter are in bold. ESR, erythrocyte sedim
entation rate; H
sCRP, 
high-sensitivity C-reactive protein. This study em
ployed a longitudinal design. Participants visited the hospital for data collection at 2 tim
e 
points (‘Tim
e Point 1’ [T1] and 6-m
onth follow
-up ‘Tim
e Point 2’ [T2]). A




t T1 and T2, 
participants attended the hospital for ‘V
isit 1’ and ‘V
isit 2’, separated by 7 days.  
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Bootstrapping discards parametric statistical assumptions and robustly calculates 95% 
confidence intervals (CI) by resampling data (typically x ≥1000 samples) from the original 
sample (Efron, 1987; Efron & Tibshirani, 1986; Efron & Tibshirani, 1994; Hopkins, Marshall, 
Batterham, & Hanin, 2009; Puth, Neuhauser, & Ruxton, 2015). Bootstrapping has been 
recommended to deal with non-normal distribution of data, and has been applied in regression 
analysis (Wright, London, & Field, 2011) examining associations between health and 
behaviour (Fenton, Duda, Appleton, & Barrett, 2017). It has been argued that bootstrapping 
holds advantages over and above conventional statistical tests. For example, this resampling 
procedure is simple to undertake, avoids the challenges of assumption violation and simulates 
obtaining data from a large sample, which is ideal for research with small sample sizes 
(Scharkow, 2017; Wood, 2004). It has also been suggested that bootstrapping will be 
universally applied to sample data in future research, over and above selection of conventional 
parametric tests (Howell, 2007; Wright et al., 2011). 
 Bootstrapping is employed in research following consideration of; 1) whether the 
sample in the study represents the population in question, and 2) the sample size (Scharkow, 
2017). In this study, ‘bias-corrected and accelerated’ bootstrapping was applied to all data in 
regression and bi-directional path analysis, using 1000 samples with 95% CI (Efron & 
Tibshirani, 1986; Kruisdijk et al., 2017; Puth et al., 2015; Wright et al., 2011). Bias-corrected 
and accelerated bootstrapping (Efron, 1987) is a commonly-used method, and is recommended 
for application in small sample sizes, although a sample size of at least n = 20 for generating 
95% CI, and n = 50 for generating 99% CI, has been advocated (Chernick & LaBudde, 2011; 
Puth et al., 2015; Scharkow, 2017). Descriptive data in Chapter 3 indicated that our sample 
(longitudinal data set, n = 54) was predominantly female participants, with an average age of 
58 years old. This is representative of the RA population, as there are more females and disease 
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onset typically occurs beyond 30 years old (Wasserman, 2018). Additionally, participant 
characteristics of height, weight, BMI, body fat percentage, DAS-28, disease severity (HAQ) 
and disease duration were similar to other RA studies (Metsios et al., 2009; Sokka et al., 2008; 
Stavropoulos-Kalinoglou et al., 2013). 
Main analysis: Data analysis was conducted in 3 phases; 1) correlation and regression 
analysis examined cross-sectional relationships between health variables with objectively-
assessed sedentary time and PA at T1, 2) change scores were computed and used to examine 
longitudinal relationships between health variables with objectively-assessed sedentary time 
and PA, via correlation and regression analysis, and 3) results from regression analysis 
informed the final phase of investigation, testing bi-directional associations via path models. 
 
1) Cross-sectional analysis (T1) 
Pearson’s correlations were conducted using T1 data, to examine the cross-sectional 
bivariate associations between health (DAS-28, high-sensitivity C-reactive protein [hsCRP], 
pain, fatigue, HAQ functional disability, DCOOP general functional status, quality of life, 
subjective vitality and depressive symptoms) with activPAL-assessed sedentary, standing and 
stepping time, and GT3X+-assessed sedentary time, LPA and MPA (% waking behaviour per 
day). Following this, multivariate regression analysis explored cross-sectional associations 
between the aforementioned health variables with objectively-assessed behaviour, adjusting 
for age and biological sex. These co-variates were determined owing to the fact that that 
previous research suggests age and biological sex are associated with health parameters and 
free-living behaviour in RA (Fenton et al., 2017; Fenton et al., 2018c). 
The ultimate aim of this study is to produce findings that are relevant, and can be 
applied in clinical practice. With this in mind, regression models were constructed to align with 
a ‘clinical perspective’, in which RA disease is first hypothesised to influence lifestyle 
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behaviours (such as sedentary time and PA) (Hernandez-Hernandez, Ferraz-Amaro, & Diaz-
Gonzalez, 2014; Iversen et al., 2017). Therefore, health variables were entered into regression 
models as independent variables (‘predictors’) and activPAL- and GT3X+-assessed behaviours 
(% waking behaviour per day) were entered as dependent variables (‘outcomes’)2.  
Unstandardised bootstrapped coefficients (B) and 95% CI were computed to determine 
the direction and statistical significance of associations. Significant relationships were 
confirmed where bootstrapped 95% CIs did not cross zero. Standardised non-bootstrapped 
coefficients (ß) were also reported to aid interpretation of the strength of observed relationships 
(small = .1; medium = .3; large = .5) (Cohen, 1992). R2 values were interpreted as the unique 
variance in objectively-assessed sedentary time or PA explained by the health variable, age and 
biological sex. 
 
2) Longitudinal analysis (change from T1-T2) 
As per cross-sectional analysis, regression models examined whether change in health 
variables (T1-T2) significantly predicted change in activPAL- and GT3X+-assessed sedentary 
time and PA (T1-T2), adjusting for age and biological sex. Regression analysis were 






2ActivPAL- and GT3X+-assessed behaviours were entered into regression models expressed 
as percentages of device wear time (% behaviour per day = (device-assessed behaviour 
[min/day]/total device wear time [min/day]) x 100) in cross-sectional and longitudinal analysis 
to reduce the number of variables in each model, thus increasing statistical power. 
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3) Bi-directional analysis 
Results from longitudinal analysis were used to inform bi-directional analysis. 
Specifically, where health variables were significantly ‘predicting’ activPAL- and GT3X+-
assessed sedentary time and PA in longitudinal regression analysis (according to bootstrapped 
data), these associations were tested in path analysis to test bi-directionality. 
If significant associations observed in longitudinal regression analysis for non-
bootstrapped data were between known normally distributed variables (tested with 
Kolmogorov-Smirnov tests), these were included in bi-directional analysis. Additionally, we 
also considered that the smaller sample size for longitudinal analysis may have reduced the 
statistical power of regression models, relative to cross-sectional analysis. Therefore, any 
significant associations reported in cross-sectional models which demonstrated comparable 
effect sizes to longitudinal models (± ß = .1), were also tested with bi-directional path models. 
 
Figure 4.2 Example path model used to test for bi-directional associations 
T1, Time Point 1; T2, Time Point 2; ‘Health variable’, RA health variable; ‘Behaviour 
variable’, activPAL-assessed behaviour (sedentary, standing or stepping time) 
 
Note:   
 
Path specified between variables 
Bi-directional association tested 
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Figure 4.2 illustrates the model employed to investigate bi-directional associations 
between health variables with objectively-assessed sedentary time and PA. Owing to; 1) the 
small sample size (not permitting a full measurement model), and 2) several of the variables 
were ‘directly measured’ (DAS-28, hsCRP, activPAL- and GT3X-assessed behaviours), all 
variables were modelled as observed variables (Byrne, 2010). 
To explicate Figure 4.2, the ‘T2 health variable’ and ‘T2 behaviour variable’ represent 
change in the variable from T1 to T2. Thus, T2 variables in the model represent ‘change scores’ 
(since T1 variables are controlled for), and by correlating these T2 variables, we can test 
whether the changes of these variables are associated. A significant association observed 
between T2 variables specified in the model (changes in these 2 variables from T1 to T2 are 
correlated), indicates a bi-directional association. In this study, bootstrapped 95% CI were used 
to determine statistical significance – significant bi-directional associations were identified 
where the 95% CI did not cross zero. 
Good fit between the hypothesised bi-directional model and the data must also be 
confirmed in order to trust the parameters specified. Therefore, model fit was assessed using 
the chi-square statistic (χ2), comparative fit index (CFI), Tucker Lewis Index (TLI) and root 
mean square error of approximation (RMSEA, 90% CI). This selection of model fit indices is 
suited to small sample sizes (Schermelleh-Engel & Moosbrugger, 2003). Model fit criteria 
were; non-significant χ2 (p >.05), CFI and TLI values ≥.95, and RMSEA <.06 with 90% CI 
(lower boundary) containing 0, suggesting an excellent fit between the model and the data. 
Good model fit criteria were; non-significant χ2 (p >.05), CFI and TLI values ≥.90, and 
RMSEA <.08 with 90% CI (lower boundary) <.05 (Schermelleh-Engel & Moosbrugger, 2003; 
Schreiber, Nora, Stage, Barlow, & King, 2006).  
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It should also be noted, that diagonal arrows specified in the hypothesised model allow 
investigation of whether the ‘T1 health variable’ predicts change in the ‘T2 behaviour variable’, 
and vice versa (associations tested in prior regression models within this chapter). However, 
owing to the small sample size, we were unable to examine these associations via path models 
due to low statistical power.  
 
Results 
Key characteristics of the study sample have been previously reported in Chapter 3 
(Table 3.2) of this thesis. Table 4.1 presents the descriptive statistics for specific variables 
included in the current thesis chapter. Loss of participants between T1 and T2 (n = 50) was 
predominantly due to planned termination of data collection (n = 47) and  lack of time (n = 3).
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Cross-sectional analysis (T1) 
Table 4.2 reports results from cross-sectional bivariate correlation analysis carried out 
at T1. Table 4.3 and Table 4.4 report results from cross-sectional regression analysis with 
activPAL-assessed and GT3X+-assessed behaviours, respectively. 
Regression analysis (adjusted Model 2): For activPAL-assessed behaviours, significant 
positive relationships were observed between DAS-28, pain, HAQ functional disability and 
DCOOP general functional status with sedentary time. Significant negative associations were 
found between quality of life with sedentary time. The inverse significant associations were 
found with standing time, except for pain. DAS-28, pain, fatigue, HAQ functional disability 
and DCOOP general functional status were significantly negatively related to stepping time, 
and quality of life was significantly positively linked to stepping time. 
For GT3X+-assessed behaviours, DAS-28, pain, HAQ functional disability and 
DCOOP general functional status were significantly positively associated with sedentary time. 
Quality of life was significantly negatively associated with sedentary time. No RA health 
outcomes were associated with LPA. Significant negative associations were observed between 
DAS-28, hsCRP, pain, fatigue, HAQ functional disability and DCOOP general functional 
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Table 4.4 Linear regressions betw
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Longitudinal analysis  
Results from bivariate correlations conducted on longitudinal data are reported in Table 
4.5. Table 4.6 and Table 4.7 show results from longitudinal regression analysis employing the 
activPAL and GT3X+, respectively. 
Regression analysis (adjusted Model 2): For activPAL-assessed behaviours, change in 
hsCRP, pain, fatigue (non-bootstrapped only) and DCOOP general functional status was 
significantly positively associated with change in sedentary time. Change in quality of life and 
subjective vitality was significantly negatively associated with change in sedentary time. 
Change in hsCRP, pain, fatigue and DCOOP general functional status was significantly 
negatively related to change in standing time. Change in quality of life and subjective vitality 
was significantly positively associated with standing time. Change in depressive symptoms 
was significantly negatively related to change in stepping time. No significant associations 
were observed between RA health outcomes with GT3X+-assessed behaviours.    
Comparison of activPAL- and GT3X+-assessed sedentary time. Consistent associations 
between activPAL- and GT3X+-assessed sedentarity were observed for change in hsCRP, but 
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Table 4.6 Linear regressions betw
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Table 4.7 Linear regressions betw
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Bi-directional analysis 
A total of 15 models were tested to examine possible bi-directional relationships 
between health variables with activPAL-assessed behaviours. Results for standardised path 
coefficients (ß) and model fit are reported in Figures 4.3-4.4 and Table 4.8, respectively. 95% 
CI (lower – upper) are reported below. 
DAS-28 (.01 – .62), pain (.08 – .57) fatigue (.13 – .65) and DCOOP general functional 
status (.14 – .65) showed significant positive bi-directional associations with sedentary time. 
Quality of life (-.62 – -.05) and subjective vitality (-.72 – -.12) demonstrated significant 
negative bi-directional associations with sedentary time. Models demonstrated excellent fit to 
the data. The positive bi-directional relationship between hsCRP with sedentary time (-.09 – 
.66) was non-significant, but showed a medium effect size. Additionally, this model showed 
excellent fit to the data. 
Pain (-.57 – -.11), fatigue (-.70 – -.23) and DCOOP general functional status (-.64 – -
.12) showed significant negative bi-directional associations with standing time. Significant 
positive bi-directional relationships were observed between quality of life (.09 – .66) and 
subjective vitality (.12 – .70) with standing time. Models demonstrated excellent fit to the data. 
Negative bi-directional associations between DAS-28 (-.60 – -.05) and hsCRP (-.61 – .15) with 
standing time were non-significant, but with medium effect sizes. These models had excellent 
fit to the data. 
A negative bi-directional relationship between depressive symptoms with stepping time 
(-.41 – .04) was non-significant, with a small effect size. Nevertheless, the model showed 
excellent fit to the data.
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This study employed validated devices to objectively-assess sedentary time and PA in 
people living with RA, and examined cross-sectional and longitudinal associations between 
pertinent aspects of RA health with these behaviours in this patient group. The presence of bi-
directional associations was also tested. 
Findings at T1 revealed that on average, RA patients spent 9h/day (activPAL) and 
11h/day (GT3X+) sedentary. Reasons for higher estimates of GT3X+-assessed vs. activPAL-
assessed sedentary time could be due to the inability of accelerometry to detect posture (An et 
al., 2017; Kozey-Keadle et al., 2011), possibly resulting in some misclassification of time spent 
engaged in low-energy standing as sedentary time (see Chapter 2). Still, employing the 
activPAL and GT3X+ was an advantage. Specifically, the activPAL is the gold standard 
measure of free-living sedentary time (Chastin & Granat, 2010; Edwardson et al., 2017; Kozey-
Keadle et al., 2011; Sellers et al., 2016) and overcame the inability of the GT3X+ accelerometer 
to capture posture. The GT3X+ accelerometer had potential however to generate ‘valid’ 
estimates of LPA and MPA in these participants when applying RA-specific cut-points, 
addressing the uncertain validity of the activPAL to capture intensity of free-living behaviour. 
Thus, employing both devices in this study provided interesting insight into the disparities in 
sedentary time estimates and associations between RA health using the activPAL and GT3X+.  
Cross-sectional analysis revealed associations between several pertinent RA health 
outcomes (DAS-28, pain, HAQ functional disability, DCOOP general functional status 
[positive] and quality of life [negative]) with activPAL- and GT3X+-assessed sedentary time 
in RA. These are mostly consistent with other cross-sectional studies that have examined 
associations between RA health (DAS-28 and functional disability) with sedentary time (Giles 
et al., 2008; Greene et al., 2006; Khoja et al., 2016; Summers et al., 2019). For example, a 
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positive association between HAQ functional disability with self-reported and accelerometer-
assessed sedentary time was revealed by Greene et al. (2006) and Khoja et al. (2016), 
respectively. Khoja et al. (2016) also revealed a positive association between DAS-28 with 
accelerometer-assessed sedentary time in RA. More recently, Summers et al. (2019) compared 
daily accelerometer-assessed sedentary time between female RA patients with moderate to 
high disease activity (DAS-28 >3.2) vs. low disease activity (DAS-28 ≤3.2). Summers and 
colleagues (2019) reported significant differences in sedentary time between groups, whereby 
patients with moderate to high disease activity engaged in 10% more sedentary time per day, 
compared to patients with low disease activity. 
As well as investigating the links between a broader range of RA outcomes with 
sedentary time, the present study addressed several limitations emerging from previous work. 
First, the activPAL and GT3X+, validated for use in RA, were employed to quantify sedentary 
time, as opposed to self-report methods (Giles et al., 2008; Greene et al., 2006). Second, 
sedentary behaviour was defined according to the widely-accepted definition proposed by the 
Sedentary Behaviour Research Network (SBRN, 2012; Tremblay et al., 2017). Certainly, this 
was not considered by Khoja and colleagues (2016), who inaccurately defined sedentary 
behaviour (≤1 MET).  
This is the first study to examine cross-sectional associations between clinically- and 
patient-important health outcomes with the current gold standard measure of free-living 
sedentary time, the activPAL (Chastin & Granat, 2010; Edwardson et al., 2017; Kozey-Keadle 
et al., 2011; Sellers et al., 2016), among a relatively large sample of RA patients. An additional 
aim of the present study was to examine associations between RA health indicators with 
device-assessed PA, specifically activPAL-assessed standing and stepping time, and GT3X+-
assessed LPA and MPA. Results revealed associations between DAS-28, HAQ functional 
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disability, DCOOP general functional status (negative) and quality of life (positive) with 
activPAL-assessed standing and stepping time, with additional associations found between 
pain and fatigue (negative) with stepping time. Interestingly, no cross-sectional associations 
were found between any health outcomes with GT3X+-assessed LPA, despite the results 
relating to activPAL-assessed standing time. Akin to the earlier discussion, it is possible that 
the GT3X+ classified low-energy standing as sedentary time, and therefore the former 
behaviour would have not been included in GT3X+-derived estimates of LPA. Findings 
suggest that the targeted RA health outcomes hold important associations with activPAL-
assessed standing time, thus should be accurately measured in future work seeking to 
objectively-assess free-living behaviour in RA. 
No previous studies have employed the activPAL to examine relationships between RA 
health with standing and stepping time, and few studies have examined the association between 
accelerometer-assessed LPA in RA. Khoja et al. (2016), demonstrated cross-sectional negative 
associations between DAS-28 and HAQ functional disability with accelerometer-assessed 
LPA. However, like with sedentary behaviour, the authors erroneously defined LPA as 
occurring between 1.1-2.9 METs, restricting the accuracy of their results. In their cross-
sectional study, Summers et al. (2019) reported that female patients with moderate to high 
disease activity spent significantly less time in accelerometer-assessed LPA (18%), compared 
to those with low disease activity.  
Contrasting to the present study, Fenton et al. (2018c) did not observe a significant 
association between HAQ functional disability with objectively-assessed LPA in RA patients. 
Although, in their cross-sectional study, HAQ functional disability to ‘rise’ and ‘walk’ were 
isolated for analysis, whilst the present study included all components (‘dressing and 
grooming’, ‘rising’, ‘eating’ ‘walking’ ‘hygiene’, ‘reach’, ‘grip’ and ‘activities’). LPA 
 138 
typically encompasses activities undertaken as part of an individual’s everyday life. These 
activities may involve the ability to ‘rise’ and ‘walk’, but may also extend to the ability to, for 
example, ‘reach’ and ‘dress and groom’. Perhaps, therefore, Fenton et al. (2018c) did not 
capture a broad enough range of activities in the HAQ that closely represented overall levels 
of LPA, by solely including ‘rise’ and ‘walk’ in analysis. In addition, this cross-sectional study 
had a small sample size (n = 50), thus limiting its statistical power. 
The overarching limitations of previous work examining the associations between RA 
health with engagement in sedentary behaviour and LPA, is a cross-sectional design and a 
reliance on accelerometers. Although a cross-sectional design allows researchers to ‘quickly 
and easily’ detect and compare associations across a large number of variables, this 
methodological approach only provides information relating to one single moment in time (a 
‘snapshot’). This means that the data collected might not be representative of longer-term 
health and behaviour. Thus, resulting cross-sectional associations provide no inference 
regarding change in one variable (e.g., RA health), predicting change in another (e.g., RA 
sedentary time) (Carlson & Morrison, 2009; Caruana et al., 2015; Solem, 2015). However, the 
progression of observational research typically entails cross-sectional associations to be 
recognised between variables of interest in a population, preceding a longitudinal study to gain 
a deeper insight into ‘change predicting change’, or bi-directionality (Caruana et al., 2015).  
With this in mind, the present study conducted more rigorous examination of the 
associations between RA health with device-assessed sedentary time and PA in its subsequent 
analytical step – longitudinal analysis. Further, to gain more insight into whether change in RA 
health was a cause and consequence of change in sedentary time or PA, these longitudinal data 
were tested in bi-directional analysis. This is first study to examine both the longitudinal and 
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bi-directional associations between change in numerous ‘physiological’ and ‘psychological’ 
disease outcomes, with change in objectively-assessed sedentary time and PA in RA.  
Interestingly, results from longitudinal regression analysis revealed significant 
associations between change in RA health with change in activPAL-assessed behaviours only, 
particularly for sedentary and standing time, in people with RA. It might be that the activPAL 
is more sensitive with regard to detecting sedentarity and standing compared to the GT3X+, 
with the latter potentially misclassifying standing as sedentary time. Aligned with this point, 
Dontje et al. (2018) examined whether the activPAL was sensitive to detect ‘real change’ in 
sedentary time in different study designs with older adults, including longitudinal studies at 
group level. In this way, sensitivity was termed ‘responsiveness to change’, and findings 
demonstrated that the activPAL performed admirably in this regard. Of notable interest was 
the finding that the activPAL was ‘most responsive’ when average estimates of sedentary time 
were based on one day, rather than 7 days, in this sample of older adults. Although, the authors 
emphasised that the optimal activPAL monitoring period is 7 days to generate more reliable 
sedentary behaviour estimates. This has been reiterated in a recent review by Edwardson et al. 
(2017). In addition, when considering people living with RA may experience fluctuating 
disease activity (‘flare ups’) during a short period of time, which may affect their levels of 
sedentary time, a 7-day measurement protocol might provide a more reliable and valid 
representation of average daily behavioural patterns, than just a single day. As such, RA 
patients in this study wore the activPAL for 7 days (at T1 and T2) in order to assess their free-
living sedentary time (and standing and stepping time), and we posit that this device was highly 
sensitive to detecting change in these behaviours in this longitudinal study. 
Findings from the present longitudinal study revealed that change in hsCRP, pain, 
fatigue, DCOOP general functional status (positive), quality of life and subjective vitality 
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(negative) were related to change in activPAL-assessed sedentary time. The inverse 
associations were found for standing time. Results were first interpreted as RA health 
‘predicting’ behavioural outcomes in these patients (regression models were constructed to 
align with a ‘clinical perspective’). Indeed, inflammatory disease activity and debilitating 
features of RA (e.g., pain, fatigue) have been cited as reasons for engagement/disengagement 
in sedentary behaviour and PA in this patient group (Hernandez-Hernandez et al., 2014; Tan 
et al., 2019; Thomsen et al., 2015; Veldhuijzen van Zanten et al., 2015). Our findings suggest 
that changes in RA health may indeed be predictive of engagement in sedentary and standing 
behaviour in these patients. 
Past research has also underlined the possibility that sedentary behaviour and PA might 
be contributors to variability in RA health, as well as consequences of disease outcomes 
(Thomsen et al., 2015; Veldhuijzen van Zanten et al., 2015). This is the first study to examine 
this hypothesis, testing bi-directional associations between RA health with sedentary time and 
PA in these patients. This facilitated a deeper understanding regarding whether changes in these 
behaviours may have potential predictive value to determine changes in important RA 
outcomes. Results confirmed the presence of significant bi-directional associations between 
DAS-28, pain, fatigue, DCOOP general functional status, quality of life and subjective vitality 
with activPAL-assessed sedentary time. In addition, significant bi-directional associations 
were observed between these health outcomes (except DAS-28) with activPAL-assessed 
standing time.  
Bi-directional associations were not statistically significant between hsCRP with 
activPAL-assessed sedentary or standing time. Additionally, DAS-28 was not significantly bi-
directionally associated with activPAL-assessed standing time. However, the medium effect 
sizes indicated that with a larger sample size, these results might have emerged significant. It 
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is interesting to discern the clinical relevance of the present findings relating to RA disease 
activity. For example, a decrease in sedentary time of approximately 65 min/day, may lead to 
a decrease of 3.3mg/l in hsCRP or a decrease in DAS-28 of 0.5. DCOOP general functional 
status did show a significant bi-directional association with activPAL-assessed sedentary time 
– a decrease in sedentary time of approximately 65 min/day may decrease DCOOP general 
functional status score by 1 (e.g., responding to, “during the past 2 weeks, how would you rate 
your health in general?” with ‘4 = fair’ from ‘5 = poor’). 
The significant longitudinal associations, and medium effect sizes demonstrated in bi-
directional analysis, between hsCRP with sedentary time (positive) and standing (negative) in 
RA patients, are of particular interest in this study. Certainly, hsCRP is an important clinical 
biomarker of inflammatory RA disease activity, and elevated inflammation in this patient 
group has been implicated in the development of several patient-important outcomes (e.g., 
pain, fatigue, functional disability) (Hazes, 2003; Madsen et al., 2016; Nerurkar et al., 2019; 
Walsh & McWilliams, 2014). Present findings revealed that hsCRP was positively correlated 
with pain (ß = .35), fatigue (ß = .28) and DCOOP general functional status (ß = .30) in these 
RA patients. Thus, future research might consider examining whether hsCRP mediates the 
relationships between sedentariness and other health outcomes (such as those assessed herein). 
This will serve to address the ‘sedentary-inflammation’ hypothesis (Fenton & Kitas, 2016), 
which postulates a cyclical relationship between sedentary behaviour, inflammation and health 
outcomes in RA.  
Another compelling finding from the present study was the lack of significant 
longitudinal and bi-directional associations between depressive symptoms with device-based 
assessments of sedentary time in RA patients, compared to those for ‘physiological’ outcomes 
(e.g., hsCRP, pain, physical function). This disparity could be attributed to the fact that 
 142 
sedentarity encompasses both ‘mentally active’ (e.g., reading a book) and ‘passive’ (e.g., 
watching television) behaviours, demonstrated to have independent consequences for 
indicators of psychological well-being, such as depression (Hallgren et al., 2019; Hallgren et 
al., 2018). Specifically, a recent prospective study has demonstrated that engaging in mentally 
active sedentary behaviours for >3 h/day can reduce the risk of depression (Hallgren et al., 
2018). Hallgren et al. (2018) also revealed non-significant relationships between engagement 
in passive, or combined mentally active and passive (total), sedentary behaviours with incident 
depression. It is possible that RA participants in the present study engaged in more passive, or 
a combination of mentally active and passive, sedentary behaviours throughout the day, 
resulting in non-significant associations with depressive symptoms. These ‘types’ of sedentary 
behaviour are likely to have not affected associations with more ‘physiological’ RA outcomes, 
which may just rely on the posture of free-living behaviour and not the context by which it 
occurs. However, these interpretations cannot be confirmed due to the device-based methods 
employed in the present study, which did not take into account specific contexts of patients’ 
sedentary behaviour. Future research should address this, because if psychological benefit can 
result from sedentary behaviours which entail people with RA to be mentally active, then we 
must be cautious promoting reductions in sedentary time in this patient group. 
Current findings suggest sedentarity may represent both a consequence and cause of 
some clinically- and patient-important aspects of RA health (Figure 4.5). Additionally, 
considering the reciprocal associations with RA health, increasing standing time (concurrent 
to reducing sedentary time) may represent an avenue through which RA health could be 
improved. Indeed, the strong inverse correlation between sedentary and standing time (ß = -
.95), suggests that interventions which target replacing sedentary time with standing time, may 
be a feasible approach for intervention in these patients. Moreover, the standardised path 
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coefficients representative of the bi-directional associations between health with sedentary and 
standing time in this patient group were almost identical (e.g., DCOOP general functional 
status with sedentary time [ß = .43] and standing time [ß = -.42]). Together, these findings 
substantiate the potential of lower-intensity PA, such as standing behaviour, to displace 
sedentary time in this patient group for health benefits (‘sit less, stand more’). Experimental 
studies however, are required to confirm the causality of such associations.  
The present investigation was marked by a number of strengths. This was the first 
longitudinal study, inclusive of bi-directional analysis, to examine relationships between 
several clinically- and patient-important health outcomes, with free-living behaviour in RA. A 
wide range of variables highly relevant to ‘physiological’ and ‘psychological’ aspects of RA 
health were included, and measured via validated clinical assessments (e.g., DAS-28) and 
questionnaires (e.g., HAQ, MAF) in this population. Additionally, device-based assessments 
of sedentary time and PA (activPAL and GT3X+), validated specifically in RA, were employed 
for measurement of free-living behaviour in these patients. Novel insight into bi-directional 
associations between RA outcomes with sedentary and standing time, provided evidence 
relevant to the development of sedentary behaviour change interventions in this patient group.  
Some limitations of this study must be acknowledged. First, despite the large sample 
size in the cross-sectional study, the subsequent longitudinal study involved a reduced sample. 
However, no significant differences were found between participants included at T2, and those 
lost to follow-up between T1 and T2, based on measured variables. Bootstrapping was used in 
statistical analysis to overcome some issues relating to small sample size. Nevertheless, the 
sample size meant it was still not possible to test more sophisticated statistical models, 
including; structural equation models (full measurement models), bi-directional models which 
encompassed the relationships explored separately via regressions, and models that included 
 144 
multiple activity behaviours (e.g., sedentary and standing time). However, the latter approach 
may not have been possible due to multicollinearity between the behaviours comprising the 
majority of RA patients’ waking day (e.g., sedentary time and standing time and/or LPA).  
Further, ‘excellent model fit’ and consistent values for selected indices (e.g., RMSEA = .00) 
(Bandalos, 2018) in path analysis could be due to χ2 ≤ degrees of freedom (7) in each model.  
Additionally, the sample consisted of mostly female participants with moderate disease 
activity and severity. Whilst a higher proportion of females is representative of the RA 
population (Wasserman, 2018), findings from this study are limited in their generalisability to 
males with RA and those with more/less active disease. Further, this study did not gauge the 
intensity of activPAL-assessed stepping. However, to our knowledge, only 1 study has 
validated the activPAL to classify PA intensity (LPA and MPA) in ‘healthy adults’, which is 
not generalisable to RA (Lyden, Keadle, Staudenmayer, & Freedson, 2017). Finally, device-
assessed sedentary time and PA meant that the context of these behaviours could also not be 
determined – this must be addressed in future studies, particularly with regard to capturing 
mentally active and passive sedentary behaviours in RA. 
 
Conclusion 
Longitudinal associations between activPAL-assessed sedentary and standing time 
with several clinically- and patient-important RA outcomes in the present study were also bi-
directional in nature. As such, results suggest that sedentary and standing time may represent 
causes and consequences of variability in RA health. Future research should employ 
experimental study designs to test (via interventions) whether replacing sedentary time with 
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Aim: This study adopted a self-determination theory (Deci & Ryan, 1985) perspective, 
to examine longitudinal associations between autonomous and controlled motivation to reduce 
sedentary behaviour with levels of device-assessed sedentary time and physical activity (PA), 
in people with Rheumatoid Arthritis (RA). Method: RA patients visited the hospital for data 
collection at 2 time points, 6 months apart. The same protocols were undertaken at both time 
points, whereby participants attended the hospital for ‘Visit 1’ and ‘Visit 2’, 7 days apart. On 
each visit, participants undertook physical assessments to evaluate their general health and RA 
health. Additionally, they completed an adapted version of the Behavioural Regulation in 
Exercise Questionnaire-2 to assess their autonomous and controlled motivation to reduce 
sedentary behaviour. Participants wore an activPAL and GT3X+ for the subsequent 7 days, to 
measure free-living time spent sedentary (activPAL and GT3X+), standing and stepping 
(activPAL), and in light-intensity PA (LPA) and moderate-intensity PA (GT3X+). Results: 
Longitudinal regression analysis demonstrated that change in autonomous motivation to reduce 
sedentary behaviour was negatively associated with change in activPAL-assessed sedentary 
time (ß = -.44), and positively related to change in activPAL-assessed standing (ß = .38), and 
stepping (ß = .33) time. Change in autonomous motivation to reduce sedentary behaviour was 
negatively linked to change in GT3X+-assessed sedentary time (ß = -.36), with inverse 
associations observed for change in GT3X+-assessed LPA (ß = .35). Change in controlled 
motivation to reduce sedentary behaviour was not linked to any behaviours. Conclusion: 
Results suggest that autonomous motivation to reduce sedentary behaviour may represent a 
malleable psychosocial determinant of sedentary time among people with RA. Experimental 
research is required to establish the potential of targeting autonomous motivation to reduce 
sedentary behaviour for interventions promoting sedentary behaviour change in RA.   
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Introduction 
Rheumatoid Arthritis (RA) is a chronic autoimmune disease, characterised by 
heightened systemic inflammation (Angelotti et al., 2017) and affecting between 0.5-1% of 
adults worldwide (Uhlig et al., 2014; Wasserman, 2018). RA is debilitating for the patient, with 
inflammation-driven joint pain, as well as functional disability and fatigue all symptomatic of 
this condition (Smolen et al., 2016a; Uhlig et al., 2014). People with RA may also experience 
compromised mental health, with approximately 66% of patients experiencing depressive 
symptoms (Fiest et al., 2017; Katz, 2017a, 2017b; Matcham et al., 2013). 
Engagement in physical activity (PA) is recommended for the management of RA 
(Rausch Osthoff et al., 2018). This guidance is based on evidence which consistently 
demonstrates that higher levels of moderate-to-vigorous-intensity PA (MVPA, ≥3 metabolic 
equivalents [METs]) is associated with lower systemic inflammation and disease activity, less 
functional disability, pain and fatigue, and improved psychological well-being (Cooney et al., 
2011; de Jong et al., 2003; Loppenthin et al., 2015; Metsios & Kitas, 2018; Metsios et al., 2015; 
Plasqui, 2008; Rahnama & Mazloum, 2012; Rongen-van Dartel et al., 2015; Verhoeven et al., 
2016). However, despite the acknowledged health benefits, very few people living with RA 
undertake recommended levels of MVPA required to accrue benefits to health (Tierney et al., 
2012). Reasons reported for low levels of MVPA include pain and fatigue, as well as 
misconceived safety fears (e.g., exacerbated joint damage) (Veldhuijzen van Zanten et al., 
2015). In addition, rheumatology health professionals typically recommend MVPA in the form 
of scheduled, structured aerobic and/or resistance ‘exercise training’ for people with RA 
(Metsios & Kitas, 2018) which, considering the aforementioned patient-reported barriers to 
MVPA, may be perceived as too challenging for these patients. 
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Consequently, researchers are increasingly recognising the importance of ‘non-
exercise’ behaviours for clinical groups, who may experience mobility limitations due to 
disease characteristics (Manns et al., 2012), such as people with RA. Specifically, seeking to 
determine the potential relevance of sedentary behaviour (≤1.5 METs) and light-intensity PA 
(LPA, 1.6-2.9 METs), occurring lower down the PA continuum than MVPA, for clinically- 
and patient-important health outcomes. Indeed, for people with RA, ‘non-exercise’ behaviour 
comprises approximately 97% of the waking day (Hammam et al., 2019; Summers et al., 2019) 
and should not be discounted. Addressing these ‘non-exercise’ behaviours may offer an 
alternative approach to promoting more active lifestyles among people with RA, and perceived 
as more feasible. 
Sedentary behaviour is defined as waking behaviour requiring energy expenditure ≤1.5 
METs undertaken in a sitting/reclining/lying posture (SBRN, 2012; Tremblay et al., 2017). 
Common sedentary behaviours include sitting whilst reading a book or travelling in a vehicle 
(Ainsworth et al., 2011). For people with RA, evidence from cross-sectional studies suggests 
that more sedentary time is linked to higher disease activity and reduced physical function 
(Fenton et al., 2018b; Summers et al., 2019). Studies also indicate reverse cross-sectional 
associations for LPA, whereby links between LPA engagement with lower disease activity, 
improved physical function, less depressive symptoms and higher subjective vitality have been 
demonstrated in this patient group (Fenton et al., 2018c; Khoja et al., 2016; Summers et al., 
2019). In addition, data from this thesis (Chapter 4) has revealed longitudinal positive 
associations between sedentary time with high-sensitivity C-reactive protein (hsCRP), pain, 
fatigue and general functional status, and negative relationships with quality of life and 
subjective vitality. Reverse associations were found for standing time. Work presented in this 
thesis and others also, indicate that sedentary time and LPA are strongly inversely correlated 
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among people with RA (Fenton et al., 2017). This further highlights that promoting LPA may 
be a feasible approach to ameliorating the potential negative health consequences of sedentary 
time in this patient group. As such, interventions which focus on supporting people with RA 
to reduce their sedentary time and increase their LPA (e.g., replacing sedentary time with 
standing) may help to reduce the burden of disease for these individuals. 
However, prior to the development of sedentary behaviour change interventions in RA, 
it is essential that malleable determinants of this behaviour are established. Current evidence 
in this field points to populations most at need of changing their sedentary behaviour (e.g., 
older adults, patient groups), but little is known about the modifiable determinants of sedentary 
time that can potentially form intervention targets to elicit behaviour change (Chastin et al., 
2015a). A gap in knowledge regarding the determinants of sedentary behaviour ‘across the life 
course’ has been emphasised in a recent review and framework generated from an important 
body of work, ‘Determinants of Diet and Physical Activity’ (DEDIPAC) (Chastin et al., 2015a; 
Chastin et al., 2016). For example, Chastin et al. (2015a) emphasised the importance of 
confirming modifiable determinants of sedentary behaviour in older adults, who represent the 
‘most sedentary’ age group. The authors explain that understanding the most effective 
intervention strategies, such as targeting motivation, is of significant research priority. Finally, 
Chastin and colleagues (2015a) remarked on the paucity of qualitative and longitudinal studies 
in the area, which could provide greater insight into the ‘causes’ of sedentary behaviour. 
A transdisciplinary consensus framework, namely the ‘Systems of Sedentary 
behaviours’ (SOS-framework), has subsequently been developed (Chastin et al., 2016). The 
SOS-framework has identified groups of determinants (‘clusters’) that are expected to 
influence sedentary behaviour in youth, adults and older adults, and warrant investigation to 
inform behaviour change interventions. Specifically, the clusters include ‘Physical Health and 
 151 
Wellbeing’, ‘Social and Cultural Context’, ‘Built and Natural Environment’, ‘Psychology and 
Behaviour’, ‘Politics and Economics’ and ‘Institutional and Home Settings’. Interestingly, 
‘Psychology and Behaviour’, relating to the motivation of an individual, received the highest 
consensus percentage (80%) and was highly ranked as a research priority (2nd).  
With this in mind, it could be suggested that motivation may provide a focus for 
investigating the malleable determinants of sedentary behaviour in people with RA, who, 
similarly to older adults, exhibit high levels of sedentary time (Fenton et al., 2018b). Aside 
from the disease-related features that might contribute towards sedentarity in this patient group, 
motivation may play an additional or combined role in determining their levels of sedentary 
behaviour. Thomsen et al. (2015) suggested increasing patient motivation to reduce sedentary 
behaviour in RA, but to date, no studies have investigated motivation as a determinant of 
sedentary behaviour in RA.  
Research seeking to examine the role of motivation in sedentary behaviour change in 
people with RA, should be grounded in psychological theory (Michie et al., 2008). This allows 
for a deeper understanding into the motivational processes underlying this behaviour, and thus 
more specific targets can be established for interventions. Self-determination theory (SDT) 
(Deci & Ryan, 1985) might offer such a theoretical perspective. SDT has been extensively 
applied in the context of PA promotion, to understand the role of motivation in PA behaviour 
(Teixeira et al., 2012). The central assumption of SDT is that an individual’s quality of 
motivation is associated with the variability in engagement in the target behaviour (e.g., 
reducing sedentary behaviour). SDT posits that quality of motivation lies on a continuum 
ranging from controlled motivation (lower quality) to autonomous motivation (higher quality) 
(Deci & Ryan, 1985, 2008a, 2008b; Ryan & Deci, 2000). Behaviour occupies the ‘self-
determined’ tail of this continuum when the individual possesses autonomous motivation, and 
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the ‘non-self-determined’ end when controlled motivation is fostered. Behaviour is considered 
to be guided by autonomous motivation where one experiences identified regulation (engaging 
in behaviour due to identifying the benefits it presents, and valuing these benefits) and/or 
intrinsic regulation (engaging in behaviour because of enjoyment and interest). Conversely, 
controlled motivation is assumed to be operating where behaviours are guided by external 
regulation (driven by external factors, such as monetary gain or pressure) and/or introjected 
regulation (behaviour is compelled by internal factors, such as the avoidance of guilt or to 
retain pride). In the context of behaviour change, autonomous motivation is reported to result 
in more optimal uptake and long-term maintenance of the target behaviour, with more 
controlled motivation linked to lessened likelihood of adopting and persisting with the target 
behaviour (Deci & Ryan, 2008a, 2008b). 
Specifically considering PA behaviour change, research grounded in SDT has been 
conducted to understand the role of autonomous and controlled motivation towards variability 
in levels of PA in both clinical and non-clinical populations. Overall, results of this research 
suggest that where individuals experience more autonomous motivation, greater PA 
engagement is likely to result (Duda et al., 2014; Fasczewski et al., 2018; Fortier et al., 2012; 
Milne et al., 2008; Teixeira et al., 2012). To date, there are a paucity of studies using an SDT 
lens to examine whether RA patients’ quality of motivation predicts variability in PA in RA. 
This is substantiated by a recent review (Demmelmaier & Iversen, 2018), which reports that 
studies and interventions minimally apply any theory to investigate PA behaviour change in 
this patient group. Hurkmans and colleagues (2010) provided the first preliminary evidence in 
this area, highlighting that more autonomous motivation for PA was cross-sectionally linked 
with higher levels of self-reported PA in people with RA. In a later study, Yu et al. (2015a) 
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corroborated this finding, reporting a positive cross-sectional association between autonomous 
regulation style with engagement in self-reported PA in this patient group. 
Few studies in any population have examined the role of autonomous and controlled 
motivation with regard to sedentary behaviour. Studies to date have examined how autonomous 
and controlled motivation to engage in PA is associated with sedentary behaviour engagement, 
and have not been conducted in clinical populations (Quartiroli & Maeda, 2014; Rollo, Gaston, 
& Prapavessis, 2016). For example, Quartiroli and Maeda (2014) conducted a cross-sectional 
study to assess relationships between quality of motivation to engage in PA (employing the 
Behavioural Regulation in Exercise Questionnaire-2 [BREQ-2]) (Markland & Tobin, 2004) 
with self-reported sedentary time (via a single item on the International Physical Activity 
Questionnaire) (Craig et al., 2003) in young adults. Findings demonstrated that identified and 
intrinsic regulations for PA were negatively associated with sedentary time. However, this 
study assessed participants’ quality of motivation to engage in PA, rather than more 
specifically, autonomous and controlled motivation to reduce sedentary behaviour. Indeed, 
whilst sedentary time and PA are inversely associated, sedentary behaviour is an independent 
behaviour to PA (van der Ploeg & Hillsdon, 2017). Thus, sedentary behaviour is likely to be 
influenced by different determinants to those impacting engagement in PA (Chastin et al., 
2015a).  
More recent studies have examined the role of autonomous and controlled motivation 
to reduce sedentary behaviour for variability in sedentarity. Such studies have been conducted 
mostly in adolescents (Babic et al., 2016; Smith et al., 2017) and have investigated the 
effectiveness of interventions promoting autonomous motivation to limit screen-time. Further 
highlighting the importance of specifically measuring quality of motivation to reduce sedentary 
behaviour, Lubans et al. (2013) developed the Motivation to Limit Screen-time Questionnaire, 
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which is based on SDT and was subsequently employed in the studies by Babic et al. (2016) 
and Smith et al. (2017). These experimental studies revealed that increases in autonomous 
motivation to limit screen-time corresponded with reductions in adolescent screen-time. 
Similarly, a workplace intervention targeting autonomous motivation to reduce sedentary 
behaviour, lead to lower self-reported sedentariness in a group of adults (De Cocker et al., 
2015).  
These studies have provided some support for the role of autonomous motivation to 
reduce sedentary behaviour among these groups. However, generalising results from these 
studies to individuals with RA is a challenge, as these patients are likely to engage in different 
sedentary behaviours and for different reasons than adolescents and non-RA adults. Thus, there 
is a need for research examining quality of motivation to reduce sedentary behaviour, and its 
implications for sedentarity in RA. Therefore, the aim of this longitudinal study was to examine 
associations between autonomous and controlled motivation to reduce sedentary behaviour 
with objectively-assessed sedentary time and PA in people with RA. It is hypothesised that an 
increase in autonomous motivation to reduce sedentary behaviour will be associated with a 
decrease in device-assessed sedentary time, and an increase in device-assessed standing time, 
stepping time, LPA and MPA, in people living with RA. Conversely, an increase in controlled 
motivation to reduce sedentary behaviour is hypothesised to be related to an increase in device-
assessed sedentary time, and a decrease in device-assessed standing time, stepping time, LPA 
and MPA, in this patient group. 
 
Method 
The methodology for this study is described in detail in Chapter 3. Figure 5.1 illustrates 
the specific measures employed. 
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Figure 5.1 Protocol for Chapter 5 of this thesis. M
easures specific to this chapter are in bold. This study em
ployed a longitudinal design. 
Participants visited the hospital for data collection at 2 tim
e points (‘Tim
e Point 1’ [T1] and 6-m
onth follow
-up ‘Tim
e Point 2’ [T2]). A
t T1 




t T1 and T2, participants attended the hospital for ‘V
isit 1’ and ‘V
isit 2’, separated by 7 days. 
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Statistical analysis 
Preliminary analysis: All statistical analysis were conducted using SPSS (IBM 
Corporation, Armonk, NY [version 24]). Descriptive statistics were computed for all measured 
variables at Time Point 1 (T1) and Time Point 2 (T2), calculating change scores (change = T2 
– T1). Kolmogorov-Smirnov tests of normality and visual inspection of graphs (histograms, 
Q-Q plots) were conducted. Where data were non-normally distributed, log and square root 
transformations were employed to try and achieve a normal distribution. However, following 
such transformations, normal distribution could not be achieved for several variables.  
Bootstrapping is a non-parametric resampling method, whereby data is repeatedly 
tested from original sample data (typically x ≥1000 samples) to compute 95% confidence 
intervals (CI) (Efron, 1987; Efron & Tibshirani, 1986; Efron & Tibshirani, 1994; Hopkins et 
al., 2009; Puth et al., 2015). This procedure has been employed in previous studies conducting 
regression analysis with non-normally distributed data, due to evidence promoting its use over 
and above alternative non-parametric statistical tests (Scharkow, 2017; Wood, 2004). 
It has been recommended that bootstrapping only be applied to analysis with samples 
representative of the population of interest and of a sufficient size (Scharkow, 2017). ‘Bias-
corrected and accelerated bootstrapping’ (Efron, 1987) is commonly employed in smaller 
samples (typically n = 50) (Chernick & LaBudde, 2011; Puth et al., 2015; Scharkow, 2017). 
Owing to our small sample size and non-normally distributed data, we considered bias-
corrected and accelerated bootstrapping an appropriate approach to cross-sectional and 
longitudinal regression analysis in this study (1000 samples with 95% CI) (Efron & Tibshirani, 
1986; Kruisdijk et al., 2017; Puth et al., 2015; Wright et al., 2011). 
Main analysis: The main statistical analysis was conducted in 2 phases; 1) cross-
sectional associations (T1) between autonomous and controlled motivation to reduce sedentary 
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behaviour with device-assessed sedentary time and PA, were analysed using correlation and 
regression models, and 2) change scores were computed and employed in correlation and 
regression analysis to examine these associations longitudinally. 
 
1) Cross-sectional analysis (T1) 
Bivariate Pearson’s correlation and regression analysis were firstly employed to 
examine the cross-sectional associations between autonomous or controlled motivation to 
reduce sedentary behaviour, with activPAL-assessed sedentary, standing and stepping time, 
and GT3X+-assessed sedentary time, LPA and MPA, at T1.  
Autonomous and controlled motivation to reduce sedentary behaviour were entered 
separately into regression models as independent variables (‘predictors’). Dependent variables 
(‘outcomes’) were activPAL- and GT3X+-assessed behaviours (% waking behaviour per day)1. 
All models were adjusted for age and biological sex, hypothesised as likely to affect estimates 
of sedentary behaviour and PA in RA (Fenton et al., 2017; Fenton et al., 2018c).  
Significant associations were determined by examining 95% bootstrapped CIs and 
corresponding unstandardized bootstrapped coefficients (B). Significant relationships were 
confirmed where the bootstrapped 95% CI did not cross zero. In addition, standardised non-
bootstrapped coefficients (ß) were interpreted to establish the strength of associations (small = 
.1; medium = .3; large = .5) (Cohen, 1992). R2 values were reported to represent the unique 
variance in the dependent variable (sedentary time or PA), explained by the independent 
variable (autonomous or controlled motivation to reduce sedentary behaviour) and covariates 
(age and biological sex). 
 
1ActivPAL- and GT3X+-assessed behaviours were entered into regression models expressed 
as percentages of device wear time (% behaviour per day = (device-assessed behaviour 
[min/day]/total device wear time [min/day]) x 100) in cross-sectional and longitudinal analysis 
to reduce the number of variables in each model, thus increasing statistical power. 
 158 
 
2) Longitudinal analysis 
Regression analysis was employed to examine longitudinal associations between 
change in autonomous or controlled motivation to reduce sedentary behaviour (independent 
variables [‘predictors’]), with change in objectively-assessed sedentary time and PA 
(dependent variables [‘outcomes’]). Models were constructed and reported as per cross-
sectional analysis, using change scores for all measured variables. 
 
Results 
Key characteristics of the study sample are reported in Chapter 3 (Table 3.2). Table 5.1 
shows descriptive statistics relevant to this chapter. Planned termination of data collection (n 
= 47) and lack of time (n = 3) resulted in a loss of n = 50 participants in longitudinal analysis. 
 
Cross-sectional analysis (T1) 
Table 5.2 reports cross-sectional bivariate correlations at T1. Results of cross-sectional 
regression analysis are reported in Tables 5.3 and 5.4. 
Regression analysis (adjusted Model 2): For activPAL-assessed behaviours, results 
revealed autonomous motivation to reduce sedentary behaviour was significantly negatively 
associated with sedentary time, and significantly positively associated with standing and 
stepping time. Controlled motivation for reducing sedentary behaviour was negatively 
associated with stepping time.  
For GT3X+-assessed behaviours, regression models indicated autonomous motivation 
to reduce sedentary behaviour was significantly negatively related to sedentary time, and 
significantly positively associated with LPA and MPA. Controlled motivation to reduce 
sedentary behaviour was significantly positively associated with sedentary time, and 
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 Table 5.4 Linear regressions betw
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Longitudinal analysis  
Results from bivariate correlation analysis conducted on longitudinal data, are shown 
in Table 5.5. Results from longitudinal regression analysis are shown in Table 5.6 and Table 
5.7 for activPAL and GT3X+ behaviours, respectively. 
Regression analysis (adjusted Model 2): For activPAL-assessed behaviours, change in 
autonomous motivation to reduce sedentary behaviour was significantly negatively associated 
with change in sedentary time, and significantly positively related to change in standing and 
stepping time. For GT3X+-assessed behaviours, change in autonomous motivation to reduce 
sedentary behaviour was significantly negatively linked to change in sedentary time, with the 
reverse significant association observed for change in LPA. No significant relationships were 
found between change in controlled motivation for reducing sedentary behaviour with change 
in any activPAL- and GT3X+-assessed behaviours. 
Comparison of activPAL- and GT3X+-assessed sedentary time. Change in autonomous 
motivation to reduce sedentary behaviour was significantly negatively associated with change 
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Adopting an SDT lens (Deci & Ryan, 1985), this study aimed to examine longitudinal 
associations between autonomous and controlled motivation to reduce sedentary behaviour, 
with device-assessed sedentary time and PA in people with RA. Findings showed that 
autonomous motivation to reduce sedentary behaviour was associated with activPAL-assessed 
sedentary (negative), standing and stepping (positive) time, as well as GT3X+-assessed 
sedentary time (negative) and LPA (positive) in this patient group.  
Autonomous motivation to reduce sedentary behaviour accounted for between 11%-
19% of the variance in activPAL-assessed behaviours (sedentary time = 19%; standing time = 
14%; stepping time = 11%), and between 12%-13% of the variance in GT3X+-assessed 
behaviours (sedentary time = 13%; LPA = 12%). Little research exists in any population, 
including RA, that examines the determinants (‘predictors’) of sedentary behaviour. This 
therefore makes it difficult to compare the above findings, specific to sedentariness, to previous 
research. The study comprising Chapter 4 of this thesis provided some insight into the 
associations between clinically- and patient-important RA outcomes (modelled as ‘predictors’) 
with activPAL-assessed sedentary time (modelled as an ‘outcome’). From these ‘predictors’ 
(pain, fatigue, DCOOP general functional status, quality of life and subjective vitality), only 
hsCRP predicted higher variance in activPAL-assessed sedentary time (21%) than autonomous 
motivation to reduce sedentary behaviour (19%) in the current study. Additionally, only 
hsCRP, DCOOP general functional status and quality of life accounted for higher variance in 
activPAL-assessed standing time (16%, 17% and 17%, respectively) than autonomous 
motivation to reduce sedentary behaviour (14%) in this study. Finally, autonomous motivation 
to reduce sedentary behaviour predicted higher variance in activPAL-assessed stepping time, 
and GT3X+-assessed sedentary time and LPA, than all health-related variables measured in 
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Chapter 4 of this thesis. Thus, results from this thesis facilitates decisions regarding the ‘most 
important’ determinants of sedentary behaviour and PA, in order that these can be targeted as 
an area for future research and/or in behaviour change interventions in the RA population. 
Further research is required to assess whether the RA health outcomes described above are key 
predictors of sedentary time in RA, over and above autonomous motivation to reduce sedentary 
behaviour. 
Research in non-RA groups have examined the links between, specifically, autonomous 
and controlled motivation in a PA context. For example, Koponen, Simonsen and Suominen 
(2017) demonstrated that autonomous motivation held a positive association with self-reported 
PA in people living with type 2 diabetes (R2 = .13, for ‘perceived autonomy support’, 
‘autonomous motivation’ and ‘self-care competence’). Very few RA studies exist in this area. 
Preliminary research by Hurkmans et al. (2010) revealed that autonomous motivation was 
positively related to self-reported PA in this patient group, in which regulation style 
(autonomous and controlled motivation to engage in PA) explained 10% of the variance in PA 
levels. These values are similar to R2 values reported in the current study for PA-related 
behaviours (activPAL-assessed stepping time [11%] and GT3X+-assessed LPA [12%]). 
Importantly, regression analysis conducted in this study to examine associations 
between autonomous motivation to reduce sedentary behaviour with device-assessed sedentary 
time and PA in RA, only adjusted for device wear time, age and biological sex. It is likely that 
other factors contribute to engagement in these behaviours, such as body-mass index, 
education, socioeconomic status, disease activity and disease severity. Adjusting for such 
variables in future research might reduce the R2 values revealed in this study, which 
corresponded to the relationship between autonomous motivation to reduce sedentary 
behaviour with device-assessed sedentary time and PA in people with RA. 
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In a recent qualitative study, Thomsen et al. (2015) called for the development of 
interventions targeting reductions in sedentary behaviour in RA, not solely focused on MVPA 
promotion. Akin to this proposition, a review has recommended that in populations with 
reduced mobility, reductions in sedentary time and increases in LPA should be supported, 
which might be more realistic than MVPA to achieve among these cohorts (Manns et al., 2012). 
To our knowledge, the present research is the first longitudinal study to identify modifiable 
determinants of sedentary behaviour among people with RA (autonomous and controlled 
motivation to reduce sedentary behaviour). 
Results from both cross-sectional and longitudinal analysis suggested that patients who 
were motivated to reduce their sedentary behaviour for more autonomous reasons (e.g., 
because they value the benefits and/or enjoy doing so), engaged in less activPAL- and GT3X+-
assessed sedentary time. These findings suggest that interventions centred on promoting more 
identified and intrinsic reasons for reducing sedentary behaviour among people with RA, may 
offer an avenue to encourage sedentary behaviour change in this patient group. Such 
interventions could involve similar components to those successfully delivered in previous 
work targeting autonomous motivation to reduce sedentary behaviour (Babic et al., 2016; 
Smith et al., 2017). For example, researcher-led, interactive discussion and goal-setting using 
novel technologies (e.g., smartphones). However, these studies targeted autonomous 
motivation to reduce screen-time in adolescents, making it difficult to readily generalise to 
people with RA. Indeed, it is likely that these patients engage in sedentary behaviour for 
different reasons and in different contexts, compared to adolescents. For example, in their 
qualitative study, Thomsen et al. (2015) revealed that RA patients engage in sedentary 
behaviour “when symptoms dominate”, and this might entail reading and doing crossword 
puzzles (mentally active sedentary behaviours), as well as watching television (passive 
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sedentary behaviour). Interestingly, patients also alluded to engaging in sedentary behaviour 
due to lack of motivation, regardless of the debilitating symptoms of RA. The authors 
suggested that this was indicative of how sedentary behaviour had been immersed into their 
daily routine for self-management purposes. Arguably, this finding also suggests that 
motivation may independently, or in combination with RA disease features, influence 
sedentary behaviour engagement among this patient group. The research of Thomsen et al. 
(2015) further underlines the importance of the body of work in this thesis, which has examined 
the associations between clinically- and patient-important health outcomes (Chapter 4) and 
quality of motivation to reduce sedentary behaviour (the current Chapter 5), with levels of 
sedentary time in people with RA. 
An additional finding from the present longitudinal study warranting discussion, is that 
autonomous motivation to reduce sedentary behaviour was longitudinally positively associated 
with engagement in activPAL-assessed standing and stepping time, and GT3X+-assessed LPA 
in people with RA. These results might be due to shared variance between sedentary time and 
low-intensity PA, as indeed, these behaviours are highly inversely correlated. However, this 
premise cannot be wholly confirmed, as the behaviours of focus in this study (time in sedentary, 
standing, stepping and LPA behaviour) were tested in separate regression models. While this 
may be the case, interestingly, the association between autonomous motivation to reduce 
sedentary behaviour with sedentary time, measured by the gold standard activPAL, was 
stronger than the links held with standing, stepping and LPA. This suggests that autonomous 
motivation to reduce sedentary behaviour is a suitable target when specifically aiming to reduce 
sedentary time in RA patients, and changes in related behaviours (e.g., standing) might occur 
as a result. 
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The current study revealed that controlled motivation to reduce sedentary behaviour 
was not significantly associated with any objectively-assessed behaviours. These results are 
consistent with a systematic review in 2012 (Teixeira et al., 2012), which concluded mixed 
evidence for the relationship between controlled motivation with PA, with the majority of 
findings revealing a null association. Similarly, a recent study found no significant correlation 
between controlled motivation to engage in PA, with self-reported PA (as assessed with the 
International Physical Activity Questionnaire) (Craig et al., 2003) in schizophrenia patients 
(Costa et al., 2018). In the present study, examples of items pertaining to controlled motivation 
to reduce sedentary behaviour on the adapted BREQ-2 include, “I aim to reduce my sedentary 
behaviour…because other people say I should”, or “…because I feel guilty when I am not 
doing this”. Perhaps the null association between controlled motivation to reduce sedentary 
behaviour with sedentarity was because participants exhibiting high or low levels of sedentary 
time, did not perceive these as reasons for disengagement in sedentary behaviour. For example, 
a clinician may not have historically forcefully recommended reductions in sedentary time, or 
participants may not have experienced guilt from engagement in sedentary behaviour. This 
could possibly be due to lack of awareness regarding associations between sedentariness with 
health among people with RA, as this line of research is in its infancy. Still, based on evidence 
outlining the adverse role of controlled motivation for engagement in target behaviours (e.g., 
negative relationship with PA), minimising controlled reasons for reducing sedentary 
behaviour might still be important (Teixeira et al., 2012). In addition, controlled motivation 
has been shown to negatively affect physical and psychological well-being in individuals (Ng 
et al., 2012; Quested & Duda, 2011), which does not bode well for RA patients already 
experiencing compromised mental health (Matcham et al., 2013). 
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Research using an SDT perspective to examine autonomous and controlled motivation 
in the context of sedentary behaviour has only been conducted in non-RA populations (Babic 
et al., 2016; De Cocker et al., 2015; Gaston, De Jesus, Markland, & Prapavessis, 2016; 
Quartiroli & Maeda, 2014; Rollo et al., 2016; Smith et al., 2017). It is challenging to compare 
such studies with the present investigation, and this is not just attributed to limitations 
surrounding generalisability to RA patients. For example, Gaston et al. (2016) sought to 
examine the quality of motivation to engage in sedentary behaviour, and Quartiroli and Maeda 
(2014) used the BREQ-2 to measure quality of motivation to engage in PA, both examining 
associations with self-reported sedentary time. In this study, we examined motivation to reduce 
sedentary behaviour, which may provide more insight into determinants for interventions 
specifically aiming to reduce sedentarity in this patient group. Indeed, autonomous motivation 
to engage in sedentary behaviour would be challenging to change, as it would require efforts 
to prevent individuals undertaking behaviours they enjoy, or value the benefits of. In addition, 
sedentary behaviour change interventions specifically targeting reductions in sedentary time, 
rather than increasing PA, have been advocated to a greater extent (Thomsen et al., 2015). Akin 
to this point, it has been demonstrated in the general population that interventions aiming to 
increase MVPA as a vehicle to decrease sedentary time, are ineffective (Martin et al., 2015; 
Prince et al., 2014).     
Although the present study provides important evidence alluding to the relationship 
between autonomous motivation to reduce sedentary behaviour with sedentary time in RA, 
findings should be confirmed by experimental studies. Nevertheless, initial quantitative 
evidence has been provided, indicating that autonomous motivation to reduce sedentary 
behaviour may represent a determinant of sedentary time in RA, upon which robust and 
informed interventions can be developed in this patient group. Prior to developing 
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interventions, it may be insightful to examine the extent to which autonomous motivation to 
reduce sedentary behaviour predicts variability in sedentariness (and potentially LPA, 
including standing), to the extent that it holds implications for RA outcomes.  
Strengths of the present study include its longitudinal design and device-assessment of 
sedentary time and PA. This study also used a theoretical perspective (SDT) to address its 
research questions (Michie et al., 2008), which has been widely-applied in studies promoting 
behaviour change in different populations (e.g., PA, weight loss, smoking cessation) (Deci & 
Ryan, 1987, 2000, 2008a, 2008b; Ryan & Deci, 2000). Findings have provided initial evidence 
on autonomous motivation to reduce sedentary behaviour as a modifiable determinant of 
sedentary time and PA in RA. Overall, this research has added to the generally scarce evidence 
base regarding quality of motivation to reduce sedentary behaviour in any population, but 
specifically and importantly fills this gap in knowledge regarding people with RA. 
Notwithstanding these interesting and important findings, there are limitations that 
should be addressed. First, this longitudinal study had a small sample size. Bias-corrected and 
accelerated bootstrapping was applied in statistical analysis in an attempt to address this 
limitation. The application of these approaches, however, would have still resulted in reduced 
power. Nevertheless, significant associations between autonomous motivation to reduce 
sedentary behaviour with activPAL- and GT3X+-assessed behaviours were still observed, the 
strength of which may have been increased with a larger sample size. Further, most participants 
were female and had moderate disease activity and severity, limiting generalisability to males 
and those with higher/lower disease activity and severity. However, it should be noted that a 
larger percentage of people living with RA are female (Wasserman, 2018). In addition, 
although device-based measures validated in RA were employed in the present investigation, 
the context of free-living behaviour could not be determined. Insight into the specific domains 
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by which these behaviours occur would be interesting, and further inform intervention 
development and implementation. 
Finally, the present study did not incorporate all tenets of SDT that might have been 
relevant to sedentary time and PA in RA. An additional sub-theory of SDT, namely basic 
psychological needs satisfaction theory, postulates that humans have 3 basic psychological 
needs (‘autonomy’, ‘competence’ and ‘relatedness’) that enable them to foster intrinsic 
motivation (Deci & Ryan, 2000). Fulfilment of these needs leads to fostering more autonomous 
motivation towards a behaviour, as well as benefits in mental health (e.g., vitality and well-
being) (Ryan & Deci, 2000). Basic psychological needs satisfaction theory was not applied in 
this study, as this research first aimed to examine the role of autonomous and controlled 
motivation to reduce sedentary behaviour, as a malleable determinant of sedentary time and 
PA in people with RA.   
 
Conclusion 
 The present study provided support for the role of autonomous and controlled 
motivation to reduce sedentary behaviour for levels of sedentary time and PA among RA 
patients. Results suggest that where patients are motivated to reduce their sedentary behaviour 
for more autonomous reasons, they engage in less sedentary behaviour and more standing, 
stepping and LPA. Thus, the findings contribute to an empirical (and theoretical) bases 
regarding the development of RA interventions which target autonomous motivation to reduce 
sedentary behaviour, to encourage people living with this disease to reduce their sedentary time 
and increase LPA (including standing). However, future experimental studies which test the 
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 Aim: This study tested models of sedentary behaviour change, to examine whether 
autonomous motivation to reduce sedentary behaviour was associated with activPAL-assessed 
sedentary and standing time, and in turn, RA health outcomes. Method: RA patients completed 
questionnaires to measure pain, fatigue, physical function, quality of life, psychological well-
being and quality of motivation to reduce sedentary behaviour. High-sensitivity C-reactive 
protein (hsCRP) and erythrocyte sedimentation rate were measured via fasting blood samples. 
Disease Activity Score-28 (DAS-28) was assessed. Participants wore an activPAL and GT3X+ 
to measure free-living sedentary time and PA over 7 days. This protocol was repeated after 6 
months. Statistical analysis: Hypothesised path models were; autonomous motivation to 
reduce sedentary behaviour → sedentary time or standing time → DAS-28 and hsCRP (Model 
1), or pain, fatigue and subjective vitality (Model 2), or general functional status and quality 
of life (Model 3). Results: Path analysis revealed that change in autonomous motivation to 
reduce sedentary behaviour was significantly negatively linked to change in activPAL-assessed 
sedentary time (ß = -.43 [Model 1]; ß = -.44 [Models 2 and 3]), which in turn, significantly 
associated with hsCRP (ß = .45), fatigue (ß = .27), subjective vitality (ß = -.38), general 
functional status (ß = .41) and quality of life (ß = -.38). Change in autonomous motivation to 
reduce sedentary behaviour was significantly positively related to change in activPAL-assessed 
standing time (ß = .37 [Model 1]; ß = .38 [Models 2 and 3]), which in turn, significantly 
associated with hsCRP (ß = -.40), pain, (ß = -.27) fatigue (ß = -.30), subjective vitality (ß = 
.33), general functional status (ß = -.41) and quality of life (ß = .41). Conclusion: Findings 
suggest interventions targeting autonomous motivation to reduce sedentary behaviour, may 
predict variability in sedentary time and standing time among people with RA, to the extent 
that it may hold implications for several clinically- and patient-important health outcomes. 
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Introduction 
Rheumatoid Arthritis (RA) is an autoimmune disease, characterised by chronically 
elevated systemic inflammation (Angelotti et al., 2017). This leads to joint pain and stiffness, 
and declines in physical function (Smolen et al., 2016a; Uhlig et al., 2014). Extra-articular 
manifestations of RA also include fatigue and depression, both highly prevalent in RA. For 
example, 88-98% of people living with RA report symptoms of fatigue (Hewlett et al., 2005) 
and 17% are diagnosed with clinical depression (Fiest et al., 2017). 
Pharmacological treatment of RA has significantly improved in the last 30 years, 
whereby medication (e.g., disease-modifying anti-rheumatic drugs [DMARDs]) is commenced 
as early as possible in the disease course, with the aim of stringently controlling RA 
inflammatory disease activity (‘treat-to-target’) (Radner, Smolen, & Aletaha, 2014; Smolen et 
al., 2017; Versteeg et al., 2018; Weinblatt et al., 2006). Patient response to treatment is closely 
monitored by their Rheumatologist, using the Disease Activity Score-28 (DAS-28) (Prevoo et 
al., 1995; van Gestel et al., 1998). Often, RA disease activity is not optimally controlled with 
pharmacological treatment, and even when it is, patients may continue to report debilitating 
symptomology (e.g., pain, fatigue, functional disability, poor psychological well-being) 
(Santos et al., 2019; Taylor et al., 2016). In addition, novel therapeutic RA treatment has 
incurred very high healthcare costs (Chaudhari, 2008). Therefore, non-pharmacological 
management of RA has received increasing research attention, for example advocating 
increased engagement in physical activity (PA) (Santos et al., 2019).  
It has been widely demonstrated that PA can improve a number of pertinent health 
outcomes among people with RA. Specifically, participation in moderate-to-vigorous PA 
(MVPA, ≥3 metabolic equivalents [METs]), has been shown to attenuate systemic 
inflammation, disease activity, functional disability, pain and fatigue, and enhance 
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psychological well-being (Cooney et al., 2011; de Jong et al., 2003; Loppenthin et al., 2015; 
Metsios & Kitas, 2018; Metsios et al., 2015; Plasqui, 2008; Rahnama & Mazloum, 2012; 
Rongen-van Dartel et al., 2015; Verhoeven et al., 2016). However, evidence suggests that 
people with RA typically do not engage in levels of MVPA recommended to yield such benefits 
(Tierney et al., 2012). It has been reported that debilitating symptomology of RA (e.g., pain, 
fatigue, functional disability) is a barrier to MVPA participation (Tan et al., 2019; Veldhuijzen 
van Zanten et al., 2015). These barriers consequently reduce the potential of MVPA as a 
pragmatic non-pharmacological method of improving health in this patient group. However, 
movement exists on a continuum, ranging from sedentary behaviour (waking behaviour 
expending ≤1.5 METs, whilst sitting/reclining/lying) (SBRN, 2012; Tremblay et al., 2017) 
through to light-intensity PA (LPA [e.g., incidental movement, lifestyle-embedded activities, 
1.6-2.9 METs]), to higher-intensity MVPA. Thus, whilst MVPA and ‘exercise’ are most often 
considered necessary for health gains, RA studies should not discount the health impacts of 
‘non-exercise behaviours’ that occur lower down the continuum, such as sedentary behaviour 
and LPA. 
Although in their infancy, RA studies have investigated the links between sedentary 
behaviour and LPA with disease outcomes. Specifically, cross-sectional studies suggest that 
sedentary behaviour is positively associated with RA disease activity and functional disability, 
with the reverse associations reported for LPA (Fenton, et al., 2018c; Khoja et al., 2016; 
Summers et al., 2019). Additionally, LPA has been negatively linked with depressive 
symptoms, and positively related to subjective vitality in a recent cross-sectional study (Fenton 
et al., 2018c).  
 Cross-sectional and longitudinal data from this thesis (Chapter 4), has consolidated and 
extended this research. Indeed, longitudinal associations were demonstrated between 
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activPAL-assessed sedentary and standing time with several clinically- and patient-important 
RA outcomes (e.g., high-sensitive C-reactive protein [hsCRP], pain, fatigue, physical function, 
quality of life and subjective vitality). With further statistical examination of longitudinal data, 
it was concluded that these relationships were bi-directional, suggesting an opportunity to 
intervene at the behavioural level (sedentary and standing time) to improve pertinent RA health 
outcomes. Also notable, was the strong inverse correlation between activPAL-assessed 
sedentary time with activPAL-assessed standing time (ß = -.95). This, together with the point 
that these behaviours represent a large proportion of a patient’s waking day (approximately 
97%) (Hammam et al., 2019; Summers et al., 2019), underlines the potential of reducing 
sedentary behaviour and promoting LPA as a pragmatic, feasible and effective option to 
improve health among people with RA (Manns et al., 2012).  
In order to develop effective sedentary behaviour change interventions, it is critical to 
identify the malleable determinants of the targeted behaviour (Chastin et al., 2015a; Chastin et 
al., 2016). Interventions can then aim to modify these determinants, and consequently increase 
the likelihood of behaviour change. In their qualitative study, Thomsen et al. (2015) suggested 
that enhancing motivation to reduce sedentary behaviour in RA patients might elicit sedentary 
behaviour change among this patient group. This proposition has been supported in the recently 
developed ‘Systems of Sedentary behaviours’ framework (SOS-framework) (Chastin et al., 
2016) that highlights ‘Psychology and Behaviour’ (encompassing motivation) as a highly 
ranked research priority for establishing factors influencing sedentary behaviour ‘across the 
life course’. Employing a theoretical basis for such research questions is important to 
understand the specific motivational processes underlying behaviour change. Self-
determination theory (SDT) (Deci & Ryan, 1985) has provided such a basis in several 
behaviour change contexts (e.g., PA, weight loss, smoking cessation) (Deci & Ryan, 1987, 
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2000, 2008a, 2008b; Ryan & Deci, 2000) to understand the variability in the reasons why an 
individual engages in the targeted behaviour for behavioural outcomes. Thus, there is scope to 
investigate the role of motivation in reducing sedentary behaviour in RA, using an SDT lens.  
A central tenet of SDT is the concept of ‘quality of motivation’, proposed to lie on a 
continuum from controlled motivation (lower quality) to autonomous motivation (higher 
quality) (Deci & Ryan, 1985, 2008a, 2008b; Ryan & Deci, 2000). Autonomous motivation is 
reported to be operating where behaviour is directed by identified regulation (e.g., identifying 
the benefits of behaviour) and/or intrinsic motivation (e.g., enjoyment of the behaviour), 
resulting in more optimal engagement and maintenance of the target behaviour (Deci & Ryan, 
2008a, 2008b). Conversely, controlled motivation, specifically external regulation (e.g., 
external pressure) and/or introjected regulation (e.g., engaging in behaviour to avoid feelings 
of guilt), is proposed to hold negative implications for uptake of and adherence to the target 
behaviour (Deci & Ryan, 2008a, 2008b). 
Autonomous motivation towards PA has been linked to higher levels of engagement 
and long-term maintenance of PA in clinical and non-clinical populations (Duda et al., 2014; 
Fasczewski et al., 2018; Fortier et al., 2012; Milne et al., 2008; Teixeira et al., 2012; 
Vancampfort et al., 2013). For example, Vancampfort et al. (2013) revealed that in patients 
with schizophrenia, more autonomous motivation towards PA was associated with higher 
levels of PA (walking and MVPA). In RA, few studies have examined the role of autonomous 
and controlled motivation in PA engagement among people with RA (Demmelmaier & Iversen, 
2018). Cross-sectional studies by Hurkmans et al. (2010) and Yu et al. (2015a) have provided 
preliminary evidence in this area, revealing positive correlations between autonomous 
motivation towards PA with levels of self-reported PA, in this patient group. 
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There is a paucity of studies grounded in SDT, investigating how autonomous and 
controlled motivation to reduce sedentary behaviour contributes to the variability in sedentarity 
in any population, including RA. Current research has predominantly focused on the role of 
quality of motivation for reductions in screen-time among adolescents (Babic et al., 2016; 
Smith et al., 2017), using the Motivation to Limit Screen-time Questionnaire (Lubans et al., 
2013) which is based on SDT. These studies demonstrated that enhanced autonomous 
motivation to reduce screen-time (e.g., “I try to limit my screen-time because I believe it is 
important”) was related to reductions in screen-time among adolescents. Similarly, a recent 
online-based intervention grounded in SDT (and other theories of motivation, e.g., theory of 
planned behaviour), led to self-reported reductions in sedentary behaviour among adults in the 
workplace (De Cocker et al., 2015). However, despite using an SDT perspective, this study did 
not specifically target autonomous motivation to reduce sedentary behaviour as part of the 
intervention. Additionally, the study by De Cocker and colleagues (2015) did not examine 
whether changes in autonomous motivation to reduce sedentary behaviour represented the 
psychological mechanism by which the intervention accounted for reductions in sedentarity. 
Rather, this intervention was directed at modifying key constructs outlined by the theory of 
planned behaviour, and measured changes in self-efficacy, attitudes and intentions to reduce 
and interrupt sitting time.  
The longitudinal study comprising Chapter 5 of this thesis provided the first insight into 
the relationships between autonomous motivation and controlled motivation to reduce 
sedentary behaviour, with levels of this behaviour in RA. These observational data indicated 
that increased autonomous motivation to reduce sedentary behaviour was associated with a 
decrease in device-assessed sedentary time, with the reverse true for device-assessed standing 
time in these patients. However, to provide a particularly compelling rationale for developing 
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and implementing interventions targeting autonomous motivation to reduce sedentary 
behaviour for improving health in RA, research is required which seeks to determine the degree 
by which variability in sedentary and standing time, attributable to autonomous motivation to 
reduce sedentary behaviour, may hold meaningful implications for clinically- and patient-
important RA outcomes (e.g., DAS-28, pain, fatigue).  
The aim of Chapter 6 of this thesis is to test models of sedentary behaviour change, 
which assumes autonomous motivation to reduce sedentary behaviour is linked to variability 
in device-assessed sedentary and standing time, and in turn, relevant RA health outcomes 
(autonomous motivation to reduce sedentary behaviour → activPAL-assessed sedentary time 
[or standing time] → RA outcomes). These models will be based on findings from Chapters 4 
and 5. Thus, it is hypothesised that an increase in autonomous motivation to reduce sedentary 
behaviour will be linked to a decrease in activPAL-assessed sedentary time, and an increase in 
activPAL-assessed standing time. In turn, it is hypothesised that a decrease in activPAL-
assessed sedentary time and an increase in activPAL-assessed standing time, will be associated 
with a decrease in DAS-28, hsCRP, pain, fatigue and DCOOP general functional status, and 
an increase in subjective vitality and quality of life.  
 
Method 
Chapter 3 of this thesis details the methodology for this chapter. The measures 
employed in the current chapter are shown in Figure 6.11.  
 
1 For the remainder of Chapter 6, questionnaires will be referred to in acronym form. 
Specifically, Health Assessment Questionnaire = HAQ, Dartmouth Cooperative Functional 
Assessment Charts = DCOOP, World Health Organisation Quality of Life = WHOQOL-
BREF, Subjective Vitality Scale = SVS, and Hospital Anxiety and Depression Scale = 
HADS, Behavioural Regulation in Exercise Questionnaire = BREQ-2
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Figure 6.1 Protocol for Chapter 6 of this thesis. M
easures specific to this chapter are in bold. ESR, erythrocyte sedim
entation rate; H
sCRP, 
high-sensitivity C-reactive protein. This study em
ployed a longitudinal design. Participants visited the hospital for data collection at 2 tim
e 
points (‘Tim
e Point 1’ [T1] and 6-m
onth follow
-up ‘Tim
e Point 2’ [T2]). A




t T1 and T2, 
participants attended the hospital for ‘V
isit 1’ and ‘V
isit 2’, separated by 7 days. 
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Statistical analysis 
Preliminary analysis: SPSS and AMOS software (IBM Corporation, Armonk, NY 
[version 24]) were used to carry out statistical analysis. Descriptive statistics at Time Point 1 
(T1) and Time Point 2 (T2) were computed, in addition to calculating change scores between 
T1 and T2, for all measured variables (change = T2 – T1). Kolmogorov-Smirnov tests of 
normality and visual inspection of graphs (histograms, Q-Q plots) established that data were 
not entirely normally distributed, therefore non-parametric procedures were used to analyse the 
data. Specifically, bootstrapping (a non-parametric resampling procedure) was employed in 
path analysis to test all hypothesised models. 
The bootstrapping process involves intensively resampling data (typically x ≥1000 
samples) from the original sample data to establish 95% confidence intervals (CI), which are 
interpreted to determine statistical significance (Efron, 1987; Efron & Tibshirani, 1986; Efron 
& Tibshirani, 1994; Hopkins et al., 2009; Puth et al., 2015). Bootstrapping is advocated to deal 
with non-normal data in small sample sizes, it is simple to apply and can be used in an 
assortment of statistical tests (e.g., regression analysis, structural equation modelling) 
(Scharkow, 2017; Wood, 2004; Wright et al., 2011). This procedure is considered after 
determining whether the sample is representative of the population of interest, and is of an 
adequate size (Scharkow, 2017). Further, there are different means of bootstrapping data, with 
‘bias-corrected and accelerated bootstrapping’ being one of the most commonly-employed, 
particularly with smaller sample sizes (≥ n = 50) (Puth et al., 2015; Scharkow, 2017). 
Considering our sample is n = 54, and representative of the general RA population, we 
considered bias-corrected and accelerated bootstrapping was appropriate to analyse data in this 
study. Indeed, our sample is characterised by mostly females, and participants had an average 
age of 58 years old. In this population, more females than males are diagnosed with RA, and 
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disease onset usually occurs beyond 30 years old (Wasserman, 2018). Further, participants’ 
height, weight, BMI, body fat percentage, DAS-28, disease severity (HAQ) and disease 
duration is similar to descriptive data from other RA studies (Metsios et al., 2009; Sokka et al., 
2008; Stavropoulos-Kalinoglou et al., 2013). 
 
Path analysis 
Specifying the models: Path analysis was employed to examine hypothesised 
associations between autonomous and controlled motivation to reduce sedentary behaviour 
with activPAL-assessed sedentary or standing time, and in turn, RA outcomes. This approach 
is superior to correlation and regression analysis due to the additional insight it provides 
regarding inter-relationships between variables. Specifically, path analysis allows; 1) 
examination of a proposed dependent variable (e.g., activPAL-assessed sedentary time) as an 
independent variable predicting additional dependent variables (e.g., pain) in the model, and 
2) indirect, as well as direct, associations to be observed within the model.  
Results from longitudinal regression analysis in Chapters 4 and 5 of this thesis, were 
used to inform construction of path models in this study. Owing to bi-directional associations 
observed in Chapter 4, there is a rationale to intervene at the behavioural level (e.g., reduce 
sedentary time and increase standing time). As such, behavioural variables were modelled as 
‘predictors’ of RA health variables, and health variables specified as ‘outcomes’. Only 
activPAL-assessed sedentary and standing time were included in the hypothesised models, as 
these behaviours held bi-directional associations (of at least medium effect size [= .3]) with 
assessed health variables (Chapter 4). 
On this basis, 6 hypothesised models were tested to examine sequential relationships 
between change in autonomous and controlled motivation to reduce sedentary behaviour, with 
change in activPAL-assessed sedentary or standing time, and in turn, change in RA health 
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outcomes. Health outcomes were grouped in each model, in terms of their similarities and what 
made conceptual sense. Those grouped in the same models were as follows; Model 1) DAS-28 
and hsCRP (RA disease activity), Model 2) pain, fatigue and subjective vitality (common 
symptomology), and Model 3) DCOOP general functional status and quality of life (holistic 
indicators of health).  
Figure 6.2 illustrates the framework guiding construction of each model. Paths are 
specified to test the hypothesis that change in autonomous and controlled motivation to reduce 
sedentary behaviour will predict change in activPAL-assessed behaviour, and in turn, 
variability in health outcomes in RA. In addition, the path models permit examination of the 
indirect effects of change in autonomous and controlled motivation to reduce sedentary 
behaviour on RA health outcomes (via activPAL-assessed behaviours).  
Despite controlled motivation to reduce sedentary behaviour not revealing longitudinal 
associations with free-living sedentary or standing time in these patients (Chapter 5), 
autonomous and controlled motivation to reduce sedentary behaviour were concurrently 
incorporated into hypothesised path models. Indeed, controlled motivation is an important facet 
of SDT, and can be experienced in combination with autonomous motivation towards a specific 
behaviour (e.g., sedentary behaviour) (Phillips & Johnson, 2018). For example, an individual 
may be able to experience both autonomous (e.g., because they value the benefits) and 
controlled (e.g., because someone tells them to) motivation to reduce sedentary behaviour at 
the same time. Thus, it is important to understand the independent and relative contributions 
of each to inform future sedentary behaviour change interventions among people with RA. This 
is also in alignment with previous studies exploring RA patients’ quality of motivation in a PA 




Figure 6.2 Hypothesised model of sedentary behaviour change 





To ensure adequate statistical power, all variables are modelled as observed variables 
(rather than latent variables) to reduce the number of parameters in the model. Specifically, 
due to the small sample size, we were not able to test a full measurement model (specifying 
latent variables) for factors assessed via questionnaire (e.g., autonomous and controlled 
motivation to reduce sedentary behaviour) (Byrne, 2010). In addition, objectively-assessed 
behaviours were expressed in models as percentages of device wear time (% waking behaviour 
per day) to reduce the number of variables in each model, thus increasing statistical power. 
Each behaviour being tested (sedentary and standing time) were modelled separately due to 
high correlations exhibited between behaviours (ß = -.95) (van der Ploeg & Hillsdon, 2017). 
Path analysis with maximum likelihood estimation was employed in conjunction with 
bias-corrected and accelerated bootstrapping (1000 samples) to test all hypothesised models. 
Statistically significant direct and indirect relationships between variables were determined by 
examination of bootstrapped 95% CI. Where the CI did not cross zero, a significant effect is 
assumed. Standardised coefficients (ß) are also reported to facilitate interpretation of the 
strength of each association (small = .1; medium = .3; large = .5) (Cohen, 1992) for each path. 
Path between variables 
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Model fit was evaluated using fit indices appropriate for small sample sizes 
(Schermelleh-Engel & Moosbrugger, 2003). Specifically, the fit between the hypothesised 
models and the data were determined via examining the chi-square statistic (χ2), comparative 
fit index (CFI), Tucker Lewis Index (TLI) and root mean square error of approximation 
(RMSEA; 90% confidence intervals [CI]). A non-significant χ2 (p > .05), CFI and TLI values 
≥ .95, and RMSEA < .06 with 90% CI (lower boundary) containing 0 indicate excellent model 
fit. A non-significant χ2 (p > .05), CFI and TLI values ≥ .90, and RMSEA < .08 with 90% CI 
(lower boundary) < .05 suggest a good fit between the hypothesised model and the data. The 
strength and direction of path coefficients were also considered in assessing the validity of the 
models (Schermelleh-Engel & Moosbrugger, 2003; Schreiber et al., 2006). 
 
Results 
Information pertaining to demographics, RA disease and treatment regimen, and 
physical health that characterised the sample in this longitudinal study, have already been 
described in Chapter 3 (Table 3.2) of this thesis. Descriptive statistics relevant to this thesis 
chapter are reported in Table 6.1.  Loss of participants in longitudinal analysis (n = 50) was 
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 Overall, analysis revealed all path models to demonstrate an excellent fit to the data 
(Table 6.2). Path coefficients (ß) and 95% CIs (lower – upper) for direct associations observed 
in sedentary and standing time models are presented in Figures 6.3 to 6.8. Non-standardised 
path coefficients (B) and 95% CIs (lower – upper) are described in the text below. 
 
Sedentary time models 
 Results revealed autonomous motivation to reduce sedentary behaviour was 
significantly negatively associated with sedentary time in Models 1 to 3. Controlled motivation 
to reduce sedentary behaviour was not significantly associated with sedentary time in any 
model. 
 
Model 1 (DAS-28 and hsCRP). Direct effects: Sedentary time was significantly 
positively associated with hsCRP, but was not significantly associated with DAS-28. Indirect 
effects: Autonomous motivation to reduce sedentary behaviour was indirectly negatively 
associated with DAS-28 (B = -.12, 95% CI = -.26 – -.00) and hsCRP (B = -.19, 95% CI = -.37 
– -.03), via activPAL-assessed sedentary time. 
 
Model 2 (pain, fatigue and subjective vitality). Direct effects: Sedentary time was 
significantly positively associated with fatigue and significantly negatively associated with 
subjective vitality. Sedentary time was not significantly associated with pain. Indirect effects: 
Autonomous motivation to reduce sedentary behaviour was indirectly negatively associated 
with pain (B = -.11, 95% CI = -.22 – -.01) and fatigue (B = -.12, 95% CI = -.28 – -.02) and 
indirectly positively associated with subjective vitality (B = .01, 95% CI = .03 – .32), via 
activPAL-assessed sedentary time. 
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Model 3 (DCOOP general functional status and quality of life). Direct effects: 
Sedentary time was significantly positively associated with DCOOP general functional status 
and significantly negatively associated with quality of life. Indirect effects: Autonomous 
motivation to reduce sedentary behaviour was indirectly negatively associated with DCOOP 
general functional status (B = -.18, 95% CI = -.32 – -.06) and indirectly positively associated 





Figure 6.3 Sedentary time Model 1 (DAS-28 and hsCRP).  
DAS-28, Disease Activity Score-28; hsCRP, high-sensitivity C-reactive protein 
R2, variance explained in the dependent variable by the independent variable 
Note: * p < .05; ** p < .01. Dashed lines indicate a non-significant association. 
Paths were stipulated between DAS-28 and hsCRP due to their correlation, but have not been 







Figure 6.4 Sedentary time Model 2 (pain, fatigue and subjective vitality).  
R2, variance explained in the dependent variable by the independent variable 
Note: * p < .05; ** p < .01. Dashed lines indicate a non-significant association. 
Paths were stipulated between pain and fatigue, and fatigue and subjective vitality due to their 





Figure 6.5 Sedentary time Model 3 (DCOOP general functional status and quality of life).  
DCOOP, Dartmouth Cooperative Functional Assessment Charts 
R2, variance explained in the dependent variable by the independent variable 
Note: * p < .05; ** p < .01. Dashed lines indicate a non-significant association. 
Paths were stipulated between DCOOP general functional status and quality of life due to their 
correlation, but have not been included in this figure to facilitate interpretation. 
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Standing time models 
Results revealed autonomous motivation to reduce sedentary behaviour was 
significantly positively associated with standing time in Models 1 to 3. Controlled motivation 
to reduce sedentary behaviour was not significantly associated with standing time in any model. 
 
Model 1 (DAS-28 and hsCRP). Direct effects: Standing time was significantly 
negatively associated with hsCRP, but was not significantly associated with DAS-28. Indirect 
effects: Autonomous motivation to reduce sedentary behaviour was indirectly negatively 
associated with hsCRP (B = -.15, 95% CI = -.33 – -.00), via activPAL-assessed standing time. 
 
Model 2 (pain, fatigue and subjective vitality). Direct effects: Standing time was 
significantly negatively associated with pain and fatigue, and significantly positively 
associated with subjective vitality. Indirect effects: Autonomous motivation to reduce 
sedentary behaviour was indirectly negatively associated with pain (B = -.11, 95% CI = -.21 – 
-.01) and fatigue (B = -.11, 95% CI = -.27 – -.01), and indirectly positively associated with 
subjective vitality (B = .13, 95% CI = .02 – .29), via activPAL-assessed standing time. 
 
Model 3 (DCOOP general functional status and quality of life). Direct effects: 
Standing time was significantly negatively associated with DCOOP general functional status 
and significantly positively associated with quality of life. Indirect effects: Autonomous 
motivation to reduce sedentary behaviour was indirectly negatively associated with DCOOP 
general functional status (B = -.16, 95% CI = -.31 – -.04) and indirectly positively associated 






Figure 6.6 Standing time Model 1 (DAS-28 and hsCRP).   
DAS-28, Disease Activity Score-28; hsCRP, high-sensitivity C-reactive protein 
R2, variance explained in the dependent variable by the independent variable 
Note: * p < .05; ** p < .01. Dashed lines indicate a non-significant association. 
Paths were stipulated between DAS-28 and hsCRP due to their correlation, but have not been 





Figure 6.7 Standing time Model 2 (pain, fatigue and subjective vitality).  
R2, variance explained in the dependent variable by the independent variable 
Note: * p < .05; ** p < .01. Dashed lines indicate a non-significant association. 
Paths were stipulated between pain and fatigue, and fatigue and subjective vitality due to their 




Figure 6.8 Standing time Model 3 (DCOOP general functional status and quality of life).  
DCOOP, Dartmouth Cooperative Functional Assessment Charts 
R2, variance explained in the dependent variable by the independent variable 
Note: * p < .05; ** p < .01. Dashed lines indicate a non-significant association. 
Paths were stipulated between DCOOP general functional status and quality of life due to their 
correlation, but have not been included in this figure to facilitate interpretation. 
 




χ2 CFI TLI RMSEA 90% CI (low–high) Model fit 
Sedentary time models       
DAS-28, hsCRP 5.23, p = .39 .99 .99 .03 .00 – .20 Excellent 
Pain, fatigue, subjective vitality 8.78, p = .36 .99 .97 .04 .00 – .17 Excellent 
DCOOP general functional status, 
quality of life 
4.98, p = .42 1.00 1.00 .00 .00 – .19 Excellent 
       
Standing time models       
DAS-28, hsCRP 4.90, p = .43 1.00 1.01 .00 .00 – .19 Excellent 
Pain, fatigue, subjective vitality 8.56, p = .38 .99 .98 .04 .00 – .17 Excellent 
DCOOP general functional status, 
quality of life 
5.21, p = .39 .99 .99 .03 .00 – .20 Excellent 
 
DAS-28, Disease Activity Score-28; hsCRP, high-sensitivity C-reactive protein; DCOOP, Dartmouth 
Cooperative Functional Assessment Charts 
χ2, chi-square statistic; CFI, comparative fit index; TLI, Tucker Lewis index; RMSEA, root mean square error of 
approximation; CI, confidence intervals 
Note: These models preceded with autonomous and controlled motivation to reduce sedentary behaviour. For χ2, 
degrees of freedom were 5 for models with 2 health outcomes, and 8 for models with 3 health outcomes. 
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Discussion 
The present study adopted an SDT lens (Deci & Ryan, 1985) to test models of sedentary 
behaviour change in people with RA. Specifically, path analysis revealed that change in 
autonomous motivation to reduce sedentary behaviour was consistently negatively associated 
with changes in activPAL-assessed sedentary time, or positively associated with changes in 
activPAL-assessed standing time, which in turn, linked to changes in clinically- and patient-
important health outcomes in RA. This study’s findings extended and were consistent with the 
findings from Chapters 4 and 5 of this thesis, and is the first to test such sequential relationships 
in this patient group. 
Consistent with conclusions from Chapter 5, findings suggest that autonomous 
motivation to reduce sedentary behaviour might be a suitable modifiable target in interventions 
aiming to reduce sedentary time in RA. This is supported by recent qualitative research in this 
patient group, that suggested interventions designed to enhance motivation to reduce 
sedentarity, may offer an effective avenue for sedentary behaviour change (Thomsen et al., 
2015). Previous sedentary behaviour change interventions have been grounded in SDT, 
specifically targeting reductions in screen-time in adolescents (Babic et al., 2016; Smith et al., 
2017). For example, Babic et al. (2016) delivered an ‘interactive seminar’, ‘eHealth messaging’ 
and a ‘behavioural contract’ to foster autonomous motivation to limit participants’ screen-time. 
Throughout this intervention, goal-setting was encouraged, and adolescents developed a list 
relating to the barriers to and benefits of reducing their screen-time, as well as citing ways by 
which they could overcome these barriers. Similarly, Smith et al. (2017) developed a 
‘researcher-led seminar’ (e.g., addressing the consequences of excessive screen-time) and 
‘Smartphone application and website’ (e.g., supporting goal-setting for behaviour change and 
providing motivational messages), which enhanced autonomous motivation in adolescents to 
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reduce their screen-time. Both interventions effectively reduced screen-time in these 
participants.  
Informed by examples of previous research, sedentary behaviour change interventions 
in people with RA may entail researcher-led, interactive sessions, with an online element for 
goal-setting, in order to enhance autonomous motivation to reduce their sedentary behaviour. 
However, although these interventions have proved successful for screen-time reduction in 
adolescents, the efficacy of these intervention techniques cannot be generalised and applied to 
interventions for individuals with RA. Indeed, people living with RA are likely to differ in 
terms of their motives to engage in sedentary behaviour (e.g., to manage RA symptoms), and 
the context in which sedentary behaviour takes place. For example, Thomsen and colleagues 
(2015) reported that people with RA engage in sedentary behaviours such as completing 
crosswords and reading the newspaper, in addition to watching the television. Prior to 
intervention development targeting autonomous motivation to reduce sedentary behaviour for 
changes in sedentary in this patient group, further research should experimentally confirm these 
relationships. Additionally, identifying the common domains by which sedentary behaviour 
takes place among people with RA is important to inform intervention development, 
specifically to; 1) determine their “sedentary space” that could potentially be adapted (Chastin, 
et al., 2015a), and 2) ensure that the more ‘unhealthy’ sedentary behaviours are targeted (e.g., 
‘passive’ sedentary behaviour) rather than those that may benefit patient mental health (e.g., 
‘mentally active’ sedentary behaviour) (Hallgren et al., 2019; Hallgren et al., 2018). 
In contrast to autonomous motivation, controlled motivation to reduce sedentary 
behaviour was not found to associate with sedentary time in these analysis. These results align 
with previous research in a PA context, whereby fostering more autonomous motivation holds 
positive associations with PA levels, whilst less internalised reasons for behaviour (controlled 
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motivation) have been negatively related to this behaviour, or shown no association at all 
(Costa et al., 2018; Teixeira et al., 2012). Interestingly, a recent study suggested that solely 
promoting autonomous motivation might not optimally lead to positive PA behaviour change 
(Phillips & Johnson, 2018). The authors suggested that there is scope to further investigate the 
interaction of autonomous and controlled motivation towards engagement in PA, as behaviour 
partly driven by the latter regulation might not always result in deleterious consequences for 
levels of PA. This is supported in sedentary behaviour studies, whereby higher controlled 
motivation to limit screen-time, was associated with less screen-time among adolescents 
(Lubans et al., 2013). However, this association was weak, and controlled motivation has been 
detrimentally linked with indicators of physical and psychological well-being in the general 
population (Ng et al., 2012; Quested & Duda, 2011). Therefore, considering that compromised 
psychological well-being is already prevalent among these patients (Fiest et al., 2017), 
fostering controlled motivation to reduce sedentary time in people with RA should be avoided.  
This is the first study to examine the extent to which variability in sedentary time 
predicted by autonomous motivation to reduce sedentary behaviour, was beneficially 
associated with several clinically- and patient-important RA disease outcomes. Results 
revealed autonomous motivation to reduce sedentary behaviour accounted for 18-19% of the 
variance in sedentary time. In turn, sedentary time demonstrated significant positive 
relationships with hsCRP, fatigue and DCOOP general functional status, and negative 
associations with subjective vitality and quality of life. Translating the present findings to 
relative benefit for patients and clinicians, results demonstrate that increasing autonomous 
motivation to reduce sedentary behaviour by 2 on the BREQ-2 scale (e.g., responding to, “I 
aim to reduce my sedentary behaviour…because I enjoy doing this”, or “…because I value the 
benefits of doing this” from ‘2 = disagree’ to ‘4 = agree’) would equate to a reduction in 
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approximately 1h/day of sedentary time. In turn, this reduction in sedentary time would 
correspond to a 3.8mg/l decrease in hsCRP, a decrease in fatigue score by 2, an improvement 
in subjective vitality score by 1, enhanced DCOOP general functional status score by 3 and 
increased quality of life score by 1. Whilst results for DAS-28 and pain were not significant, 
results suggest that a decrease in sedentary time by 1h/day may result in improved DAS-28 by 
0.3 and pain score by 3. 
These associations are promising, when we consider that there is relative lack of 
information regarding the potential benefits of reducing sedentary time in RA, relative to 
promoting MVPA. Still, it is important to note that the hypothesised model only accounted for 
between 7%-21% of the variance in hsCRP (21%), fatigue (7%), subjective vitality (14%), 
DCOOP general functional status (17%) and quality of life (15%). Thus, adopting a more 
comprehensive approach towards identifying and targeting other modifiable contributors 
towards sedentary behaviour engagement among people with RA, at the individual, 
environmental and organisational level, as well as the inter-relationships between these factors, 
is paramount (Chastin et al., 2016). That is, whilst this is the first study to underscore the 
significance of autonomous motivation to reduce sedentary behaviour for levels of sedentary 
time and associated health outcomes among people living with RA, it is important to 
acknowledge that this is only one factor to consider when developing strategies to reduce 
sedentarity among people living with RA.  
Recently, Thomsen et al. (2017) delivered a 16-week intervention aiming to reduce RA 
patients’ sedentary time. This intervention was based on behavioural choice theory (Epstein & 
Roemmich, 2001) and targeted an individual’s self-efficacy (Bandura, 2004) to promote 
‘reducing sitting time’, via ‘motivational interviewing’. This intervention was effective at 
reducing activPAL-assessed sedentary time by, on average, 1.61h/day and beneficial 
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improvements in health (e.g., pain measured via visual analogue scale) were observed. 
However, whilst demonstrating some success, the content and target of this intervention was 
not evidence-based. Specifically, the determinant targeted (self-efficacy) was not identified on 
the basis of evidence highlighting the role of self-efficacy for influencing sedentary behaviour 
among people with RA. Moreover, only ‘general self-efficacy’ was assessed, rather than ‘self-
efficacy to reduce sitting time’ specifically. This is incongruent with the manner in which the 
intervention was framed (that is, with reference to reducing sitting time), limiting accurate 
appraisal of intervention efficacy from a theoretical perspective. Arguably, the present study 
provides more scope for identifying potential modifiable intervention targets, as we specifically 
measured autonomous motivation to reduce sedentary behaviour. Of course, experimental 
studies must be conducted to confirm the associations observed herein.  
Interestingly, Thomsen et al. (2017) suggested sedentary time was replaced by standing 
time in their intervention. In the present study, activPAL-assessed sedentary and standing time 
exhibited a strong inverse correlation, and interpretation of these data relates to these 
behaviours sharing variance. That is, significant positive associations between autonomous 
motivation to reduce sedentary behaviour with standing time might be reflective of the 
relationship autonomous motivation to reduce sedentary behaviour holds with sedentary time, 
rather than the fact that RA patients were autonomously motivated to stand per se. These 
behaviours were likely to displace each other throughout the patient’s day, which may be why 
similar links between sedentary and standing time with clinically- and patient-important RA 
outcomes were observed in path analysis. However, experimental models are required to 
examine a ‘displacement association’ between these behaviours and the subsequent 
relationships with RA health.  
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Still, results from the present study may suggest that encouraging people with RA to 
‘sit less and stand more’ may lead to improvements in clinically- and patient-important health 
outcomes in RA. Not only may this prove beneficial to health, but this may offer a pragmatic 
health promotion message among this patient group. Indeed, reducing daily sedentary time by 
endorsing ‘upright’ behaviours has been advocated in a recent protocol with the Cochrane 
Collaboration, for interventions aiming to reduce sedentary behaviour in older adults (Chastin 
et al., 2017). In addition, interventions focused on ‘non-exercise’ behaviours have been 
recommended as an alternative to MVPA for people with reduced physical function (Manns et 
al., 2012). These findings are compelling for research seeking to establish the potential of 
reducing sedentary time and increasing standing time for attenuating the disease burden among 
people with RA. 
Limitations of the present study must be acknowledged. First, similarly to path analysis 
undertaken in Chapter 4, ‘excellent model fit’ was consistently reported, suggesting that 
specified parameters in the hypothesised model could be trusted. It is important to note, 
however, that in 2 models (Model 3, sedentary time and Model 1, standing time), χ2 ≤ degrees 
of freedom, which may have resulted in ‘excellent model fit’ and consistent values for the 
selected indices (e.g., RMSEA = .00) (Bandalos, 2018). Second, the sample size would have 
reduced the statistical power of this study. Indeed, non-significant associations between 
sedentary and standing time with DAS-28, and sedentary time with pain, were in the expected 
direction, and effect sizes were in line with those observed in previous studies where sedentary 
time is significantly related to disease outcomes (Greene et al., 2006; Khoja et al., 2016). 
Bootstrapping was employed in path analysis in an attempt to address some concerns of 
reduced sample sizes, but issues related to the composition of hypothesised models remained. 
For example, due to the small sample size, more complex structural equation models could not 
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be tested. Indeed, we could not model separate BREQ-2 questionnaire items as latent variables, 
or include sedentary and standing time together in these analysis. However, incorporating both 
sedentary and standing time in the same hypothesised models may have resulted in 
multicollinearity, as seemingly, RA patients spend most of their waking day engaging in these 
behaviours.  
Third, the sample in the present study was predominantly made up of female 
participants. Whilst this is representative of the target population, the present study is limited 
in its ability to generalise findings to males with RA. These participants also had moderate 
disease activity and severity, which again reduces the degree of generalisability to RA patients 
with more/less active disease. Next, the present study did not consider the 3 basic psychological 
needs of ‘competence’, ‘autonomy’ and ‘relatedness’ in the hypothesised model, a fundamental 
sub-theory of SDT (basic psychological needs satisfaction theory). Fulfilment of these basic 
needs has been shown to lead to more autonomous motivation towards behaviour and benefit 
psychological well-being (Ryan & Deci, 2000). The role of the basic needs in the context of 
reducing sedentary behaviour, as antecedents to autonomous motivation to reduce sedentary 
behaviour was not examined here. The aim of this study was to first investigate whether 
autonomous and controlled motivation to reduce sedentary behaviour was related to sedentary 
and standing time in people with RA, in turn, associating with pertinent aspects of their health. 
Finally, activPAL-assessment of free-living behaviour gave no scope to determine the context 
by which sedentary and standing time occurred. This is important knowledge for intervention 
design, in order to provide valuable information regarding the domain and type of these 
behaviours. 
Notwithstanding these limitations, the present study had several strengths. Despite not 
capturing the context of free-living behaviour, this study employed the activPAL which is 
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considered the current gold standard measure of free-living sedentary time. This device has 
been validated against direct observation for measurement of sedentary and standing time in 
RA, demonstrating >98% accuracy (Chapter 2). Additionally, the analytical approach adopted 
allowed us to test models, which examined hypothesised associations between autonomous and 
controlled motivation to reduce sedentary behaviour → sedentary or standing time → clinically- 
and patient-important disease outcomes in RA. These results could be subsequently used to 
inform the development of an intervention, grounded in SDT, to reduce sedentary time in RA, 
which may have the potential to improve pertinent health outcomes in people with RA.    
 
Conclusion 
 This is the first study to test models of sedentary behaviour change in people with RA, 
using an SDT lens. Specifically, present findings suggest autonomous motivation to reduce 
sedentary behaviour may predict variability in sedentary time among people with RA, to the 
extent that it may hold implications for several clinically- and patient-important health 
outcomes. As such, results indicate that autonomous motivation to reduce sedentary behaviour, 
might be a viable and malleable target in interventions aiming to reduce the burden of disease 
for people with RA, via sedentary behaviour change (e.g., decrease sedentary time, increase 
standing time). However, whilst this study provides interesting insight into these sequential 


































 The Behavioural Epidemiology Framework (BEF) (Sallis et al., 2000) has guided the 
studies which comprise this thesis (Figure 7.1). The overarching aim was to provide new 
evidence regarding sedentary behaviour in RA, and begin to establish an evidence-base to 
inform the development of theory-based behaviour change interventions to reduce sedentary 
behaviour in RA. 
First, addressing ‘Phase 2’ of the BEF, Chapter 2 validated the activPAL and GT3X+ 
for measurement of sedentary time and physical activity (PA) in people living with RA. These 
devices were subsequently employed in the longitudinal studies of Chapters 4-6 (conducted 
over 6 months), which addressed ‘Phase 1’ and ‘Phase 3’ of the BEF. Specifically, Chapter 4 
examined longitudinal associations, including bi-directional relationships, between activPAL-
and GT3X+-assessed sedentary time and PA, with clinically- and patient-important RA disease 
outcomes. Following this, Chapter 5 used an SDT lens (Deci & Ryan, 1985) to examine 
longitudinal associations between autonomous and controlled motivation to reduce sedentary 
behaviour, with activPAL and GT3X+-assessed sedentary time and PA in this patient group. 
Finally, building on knowledge generated in Chapters 4 and 5, Chapter 6 tested hypothesised 
models of sedentary behaviour change. This final experimental chapter was informed by 
Chapters 4 and 5 of this thesis, and examined longitudinal associations between autonomous 
and controlled motivation to reduce sedentary behaviour with activPAL-assessed sedentary 
time or standing time, and in turn, clinically- and patient-important RA disease outcomes. 
Figure 7.1 demonstrates the novel contribution each chapter of this thesis has made to the 




 Figure 7.1 The contribution of this thesis – guided by the Behavioural Epidem
iology Fram
ew
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, cross-sectional associations present; T1 – T2, longitudinal associations 
present;                 bi-directional associations present;                  indirect association present via sedentary or standing tim
e 
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Taken together, results demonstrated that the activPAL and GT3X+ are valid for 
measuring sedentary time and PA in people with RA (Chapter 2). Further, the RA-specific 
triaxial accelerometer cut-point developed in this study, was shown to be more accurate than a 
widely-used non-RA uniaxial accelerometer cut-point (<100 counts/min) (Troiano et al., 2008) 
at quantifying free-living sedentary time in people with RA. Findings from Chapter 4 revealed 
longitudinal associations between RA health features and activPAL-assessed sedentary and 
standing time, providing novel evidence to suggest these relationships may be reciprocal. This 
suggests scope to intervene at the behavioural level (e.g., reduce sedentary time, increase 
standing time) to reduce the burden of disease for people with RA.  
Prior to intervention development, it is important that modifiable determinants of 
sedentary behaviour are established to form targets for such interventions. Thus, the study in 
Chapter 5 was grounded in SDT to explore the malleable determinants of sedentary behaviour 
in RA. Results demonstrated that autonomous motivation to reduce sedentary behaviour was 
associated with activPAL-assessed sedentary, standing and stepping time, as well as GT3X+-
assessed sedentary time and light-intensity PA (LPA). This indicates that autonomous 
motivation to reduce sedentary behaviour might be a malleable target for future interventions 
targeting sedentary behaviour change in RA. Finally, Chapter 6 demonstrated that autonomous 
motivation to reduce sedentary behaviour predicted variability in levels of activPAL-assessed 
sedentary time, to the extent it holds implications for clinically- and patient-important disease 
outcomes in people with RA. 
The following sections reiterate the main discussion points from Chapters 2, 4, 5 and 6 
of this thesis, outlines their practical implications and limitations, and provides direction for 
conducting future research in the field of sedentary behaviour in RA.  
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Summary of research findings 
Validation of the activPAL and ActiGraph accelerometer in rheumatoid arthritis  
How does this thesis address ‘Phase 2’ of the Behavioural Epidemiology Framework? 
Chapter 2 of this thesis comprised a comprehensive validation study in order to specifically; 
1a) validate the GT3X+ against indirect calorimetry to generate RA-specific triaxial (vector 
magnitude [VM]) accelerometer cut-points for sedentary time, light-intensity PA (LPA) and 
moderate-intensity PA (MPA), and 1b) validate the activPAL against direct observation for 
measurement of sedentary, standing and stepping time (laboratory validation). Then, using 
these data; 2) compare the validity of the new RA-specific triaxial sedentary time cut-point vs. 
the widely-used non-RA uniaxial sedentary time accelerometer cut-point (<100 counts/min) 
(Matthews et al., 2008; Troiano et al., 2008) for measurement of free-living sedentary time in 
RA, against the gold standard (activPAL), and 3) compare within-person estimates of free-
living sedentary time, LPA and MPA, quantified using the new RA-specific vs. commonly 
used non-RA accelerometer cut-points (Troiano et al. 2008) (field validation). 
Previous studies examining the levels of accelerometer-assessed sedentary time and PA 
in people with RA, in order to draw links between these behaviours with health, have mostly 
employed non-RA uniaxial cut-points calibrated in ‘healthy’ populations (Matthews et al., 
2008; Troiano et al., 2008). However, given the different physiological requirements and 
associated activity profiles of the RA population (Metsios et al., 2008), these estimates of 
sedentary time and PA should be interpreted with caution. Indeed, there is increasing 
recognition of the necessity to develop and employ population-specific cut-points for accurate 
measurement of these behaviours, in different populations (Aguilar-Farias et al., 2014; 
Copeland & Esliger, 2009; Motl et al., 2009; Santos-Lozano et al., 2013). Addressing this 
critical need, this study was the first to calibrate the ActiGraph accelerometer against indirect 
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calorimetry (criterion standard) to define RA-specific triaxial (VM) accelerometer cut-points 
for measurement of sedentary time, LPA and MPA, in RA. The triaxial nature of accelerometry 
has been complimented in previous studies, highlighting its value over and above uniaxial 
accelerometer analysis when quantifying sedentary time and PA (Choi et al., 2012; Evenson et 
al., 2015). For example, such studies have suggested that when triaxial cut-points are applied, 
measurement error with regard to device position or rotation is removed, and non-wear can be 
more easily distinguished from sedentary time. 
 Results from this chapter also revealed that free-living sedentary time, LPA and MPA 
estimates significantly differed with application of RA-specific triaxial cut-points vs. non-RA 
uniaxial cut-points (Troiano et al., 2008) to free-living accelerometer data in this patient group 
(n = 100). As a result, it was concluded that the newly-developed RA-specific cut-points should 
be employed in future sedentary behaviour and PA research in this population, since these were 
developed on the basis of the specific energy requirements of activity for people with RA. Still, 
when recommending our RA-specific sedentary time cut-point in future work, it is important 
to consider the limitations of accelerometry to accurately assess behavioural posture (An et al., 
2017; Kozey-Keadle et al., 2011) – a fundamental component of the widely-accepted definition 
of sedentary behaviour, stipulated by the Sedentary Behaviour Research Network (SBRN, 
2012; Tremblay et al., 2017). Accelerometers classify sedentary time based on activity counts 
recorded below a specified cut-point (in this case, ≤244 VM counts/min). In this way, low 
activity counts represent low-energy expenditure, and thus low-movement behaviours. This is 
problematic when we consider that low-movement, non-sedentary behaviours (e.g., standing) 
might fall within this threshold and be inaccurately classified as sedentary. With this in mind, 
the activPAL posture sensor was validated against direct observation for measuring sedentary, 
standing and stepping time in people with RA. Findings supported previous research conducted 
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among other populations to confirm that the activPAL is valid for measurement of sedentary 
time in RA (>98% accurate), and should therefore be considered the gold standard measure of 
free-living sedentary time in this population (Chastin & Granat, 2010; Edwardson et al., 2017; 
Kozey-Keadle et al., 2011; Sellers et al., 2016).  
As such, there existed great potential to further explore the validity of the RA-specific 
sedentary time accelerometer cut-point using the activPAL as the criterion, to evaluate its 
accuracy for measuring free-living sedentary time (outside of the laboratory setting) among 
people with RA.  Results from this free-living validation study, revealed a mean difference of 
2.3h/day between sedentary time estimates generated by the RA-specific cut-point vs. the 
activPAL. Interpretation of Bland-Altman plots alluded to an overestimation of sedentary time 
where the RA-specific cut-point was employed. However, Bland-Altman plots also revealed 
that the RA-specific cut-point generated a smaller mean difference and narrower 95% limits of 
agreement relative to the non-RA cut-point, when compared to the activPAL. Overall, results 
suggest that whilst Receiver Operating Characteristic curve analysis generated sensitive and 
specific sedentary time cut-points, employing these in free-living research demonstrated that 
accelerometers lack agreement with the gold standard activPAL in RA, and may overestimate 
sedentary time. Still, findings indicate these RA-specific cut-points provide more valid 
estimates of sedentary time among this this patient group, relative to non-RA cut-points which 
have been almost exclusively employed to study sedentary behaviour in RA. 
Akin to above discussion, it is conceivable that the differences in sedentary time 
estimates between the RA-specific cut-point vs. the activPAL resulted from some 
misclassification of standing time, as sedentary time. Two main points were argued to support 
this contention. First, in the laboratory-based validation, resulting average MET values during 
‘standing’ (0.8 ± 0.2 METs) were below the threshold for defining sedentary behaviour (≤1.5 
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METs). Second, Bland-Altman plots illustrated a downward trend, alluding to improved 
agreement between sedentary time estimates derived from the accelerometer vs. the activPAL 
as sedentary time increased. People with RA are less likely to engage in standing time if they 
spend most of their waking day sedentary, thus there exists less opportunity for accelerometers 
to misclassify standing time. To support our interpretation of these data, Aguilar-Farias et al. 
(2014) revealed that their population-specific sedentary time VM cut-point (e.g., <60 
count/min) was more accurate at classifying activPAL-assessed sedentary and standing time, 
compared to activPAL-assessed sedentary time. 
In sum, findings revealed that the activPAL accurately assesses sedentary, standing and 
stepping time in people with RA. Newly-developed RA-specific triaxial accelerometer cut-
points were sensitive and specific for measurement of free-living sedentary time, LPA and 
MPA in these patients, and were more accurate at assessing sedentary time than widely-used 
non-RA cut-points. It was recommended that future research in RA use the activPAL in 
instances where sedentary time is the outcome of interest. If this is not possible, use of our RA-
specific cut-points was advocated over employment of non-RA cut-points, acknowledging the 
caveat that these may misclassify some standing time as sedentary. 
 
Bi-directional associations between health with sedentary time and physical activity in 
rheumatoid arthritis 
How does this thesis address ‘Phase 1’ of the Behavioural Epidemiology Framework? 
In the longitudinal study comprising Chapter 4, the activPAL and GT3X+ (employing newly-
developed RA-specific accelerometer cut-points from Chapter 2) were used to assess free-
living sedentary time and PA in people with RA, in order to specifically; 1) determine the 
associations between clinically- and patient-important RA outcomes, with objectively-assessed 
sedentary time and PA, and 2) examine whether these associations may be bi-directional.  
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This study overcame 2 key limitations of previous research, specifically their cross-
sectional design and application of self-report to measure sedentary time and PA. Results of 
this study provided new evidence demonstrating longitudinal associations between several RA 
outcomes indicative of ‘physiological’ and ‘psychological’ health (high-sensitivity C-reactive 
protein [hsCRP], pain, fatigue, DCOOP general functional status, quality of life and subjective 
vitality), with activPAL-assessed sedentary and standing time. In addition, findings suggested 
the associations between some pertinent RA outcomes with activPAL-assessed sedentary and 
standing time were bi-directional. Some exceptions were observed, whereby significant cross-
sectional or longitudinal associations were not confirmed as significant in bi-directional 
analysis (e.g., between hsCRP with activPAL-assessed sedentary and standing time, and 
Disease Activity Score-28 [DAS-28] with activPAL-assessed standing time). However, 
medium effect sizes were reported for these relationships, and we proposed these relationships 
would emerge significant with a larger sample size. Indeed, relationships between sedentary 
behaviour and CRP have been demonstrated in previous studies (Henson et al., 2013; Stubbs 
et al., 2015). This represents a very compelling finding. For example, hsCRP represents a key 
clinical biomarker of inflammation in RA and is linked to a number of other disease features, 
such as pain and physical function. This was corroborated in our findings, whereby positive 
correlations were exhibited between hsCRP with pain (ß = .35) and DCOOP general functional 
status (ß = .30). With this in mind, it might be interesting to explore the ‘sedentary-
inflammation’ hypothesis proposed by Fenton and Kitas (2016), to examine whether 
exacerbation of systemic inflammation may represent a physiological mechanism through 
which sedentary behaviour may perpetuate disease outcomes in this patient group. Potential 
research directions aligned to this proposition are discussed later in this chapter. 
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Results from Chapter 4 provided novel and critical insight into the extent to which 
clinically- and patient-important disease outcomes might represent a cause and consequence 
of sedentary time (and standing time) in people with RA. With this in mind, these results point 
to a requirement for experimental studies that examine whether reducing sedentarity may 
improve RA outcomes, and confirm the value of sedentary behaviour change interventions for 
improving health indicators among people with RA. 
 
Psychosocial determinants of sedentary time and physical activity in rheumatoid 
arthritis: a self-determination theory perspective 
How does this thesis address ‘Phase 3’ of the Behavioural Epidemiology Framework? 
Grounded in SDT (Deci & Ryan, 1985), Chapter 5 of the current thesis also employed the 
activPAL and GT3X+ (applying RA-specific accelerometer cut-points) to examine 
longitudinal associations between autonomous and controlled motivation to reduce sedentary 
behaviour, with objectively-assessed sedentary time and PA in people with RA. 
The rationale for this study was provided by evidence for the bi-directional associations 
between clinically- and patient-important health outcomes in RA with objectively-assessed 
sedentary and standing time observed in Chapter 4. Specifically, observed reciprocal 
relationships between DAS-28, pain, fatigue, DCOOP general functional status, quality of life 
and subjective vitality with sedentary time, suggested that sedentary time might represent a 
valuable behavioural target for non-pharmacological intervention in RA. However, prior to 
developing an intervention to examine the role of sedentary behaviour change for improving 
RA outcomes, research is required to elucidate modifiable determinants of sedentary behaviour 
in this patient group (Chastin et al., 2015a).  
Currently, there is a lack of knowledge regarding malleable determinants of sedentary 
behaviour in any population. In an attempt to guide research addressing this evidence gap, the 
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‘Systems of Sedentary behaviours’ (SOS-framework) (Chastin et al., 2016) advocated research 
into ‘Psychology and Behaviour’ (encompassing motivation) as 1 of 6 top research priorities 
examining salient determinants of sedentary behaviour engagement across the life course. 
Aligned to this framework, the only qualitative study gaining insight into the experiences of 
sedentary behaviour among people with RA, recommended focusing on patient motivation to 
reduce sedentarity (Thomsen et al., 2015). With this in mind, the research questions comprising 
Chapter 5 of this thesis, were grounded in SDT – a psychological theory of motivation. The 
aim was to garner an understanding of the extent to which key tenets of SDT, applied to the 
context of sedentary behaviour – namely autonomous and controlled motivation to reduce 
sedentary behaviour – may associate with levels of sedentary time and PA in RA, and represent 
potential targets in sedentary behaviour change interventions.  
The central notion of SDT proposes that an individual’s degree of self-determined 
motivation towards a behaviour (e.g., reducing sedentary behaviour), holds important 
implications for engagement in that behaviour (e.g., sedentary time). SDT has been used 
effectively as a framework for sedentary behaviour change interventions in adolescent boys, 
whereby enhancing autonomous motivation to reduce screen-time led to reductions in screen-
time in this population (Babic et al., 2016; Smith et al., 2017). In this study, we adapted the 
BREQ-2 to assess autonomous and controlled motivation to reduce overall sedentary 
behaviour, to establish the extent that these may represent determinants of global sedentary 
behaviour.  
Longitudinal analysis revealed change in autonomous motivation to reduce sedentary 
behaviour was associated with change in activPAL- and GT3X+-assessed behaviours 
(sedentary, standing and stepping time, and LPA). Controlled motivation to reduce sedentary 
behaviour was not longitudinally associated with any device-assessed behaviour (in both 
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Chapters 5 and 6). It is possible that people with RA, and their family, friends and healthcare 
professionals, might not be fully aware of the negative health risks associated with sedentary 
behaviour. Indeed, this is a novel area of research and there is currently limited understanding 
of the specific health consequences of this behaviour, particularly in this patient group. Thus, 
people with RA might not experience guilt associated with sedentary behaviour engagement 
(e.g., “I aim to reduce my sedentary behaviour…because I feel guilty if I am not doing this”) 
and/or family/friends/healthcare professionals may not forcefully suggest that the patient 
should reduce their sedentarity (e.g., “I aim to reduce my sedentary behaviour…because I feel 
under pressure from others to do this”). Despite the null findings for this psychological 
construct, it has been proposed that minimising controlled motivation towards health 
behaviours might be important, due to; 1) the detrimental role it plays in engagement in such 
behaviours (e.g., PA) (Teixeira et al., 2012), and 2) the adverse associations it holds with 
physical and psychological well-being (Ng et al., 2012; Quested & Duda, 2011). The latter 
point is particularly important for people with RA, who commonly experience poor mental 
health (Matcham et al., 2013). 
Whilst an association between autonomous motivation to reduce sedentary behaviour 
with sedentary time might be expected, the association with time spent standing, stepping and 
in LPA, could represent shared variance between these behaviours. However, owing to the 
small sample size and high correlation between these behaviours, we were not able to enter 
sedentary time into regression models with standing, stepping or LPA variables (e.g., 
correlations with activPAL-assessed sedentary time were ß = -.95, ß = -.55 and ß = -.64 
respectively). Nevertheless, where effect sizes from separate regression models were 
compared, stronger associations were observed between autonomous motivation to reduce 
sedentary behaviour with activPAL-assessed sedentary time (ß = -.44) relative to those reported 
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for standing (ß = .38), stepping (ß = .33) and LPA (ß = .35). Results from Chapter 5 therefore 
provided original, longitudinal evidence, to suggest that autonomous motivation to reduce 
sedentary behaviour may represent a modifiable determinant of sedentary time in RA.  
 
The role of autonomous motivation to reduce sedentary behaviour and improve 
rheumatoid arthritis outcomes: models of sedentary behaviour change  
How does this thesis address ‘Phase 1’ and ‘Phase 3’ of the Behavioural Epidemiology 
Framework? Informed by the results of Chapters 4 and 5 of this thesis, the aim of Chapter 6 
was to test models of sedentary behaviour change in RA. Specifically, this model investigated 
whether autonomous motivation to reduce sedentary behaviour was linked to variability in 
device-assessed sedentary and standing time, and in turn, clinically- and patient-important RA 
outcomes (autonomous motivation to reduce sedentary behaviour → activPAL-assessed 
sedentary time [or standing time] → RA outcomes). 
Path analysis was employed to test the hypothesised relationships, and results revealed 
that change in autonomous motivation to reduce sedentary behaviour was consistently related 
to change in activPAL-assessed sedentary and standing time in this population. In turn, change 
in sedentary time was associated with change in several RA outcomes, including hsCRP, 
fatigue, subjective vitality, DCOOP general functional status and quality of life. Further, 
change in standing time was linked with change in all these health outcomes, with the addition 
of pain. Akin to results reported in Chapters 4 and 5 of this thesis, standardised path coefficients 
observed in path models were very similar for sedentary vs. standing time (with autonomous 
motivation to reduce sedentary behaviour and RA health indicators), which is likely to reflect 
the strong inverse correlation between these behaviours.  
In this study, change in autonomous motivation contributed to 18%-19% of the variance 
in activPAL-assessed sedentary time, which in turn, accounted for 7-21% of the variance in 
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health outcomes. These findings suggest that increasing an individual’s identified and/or 
intrinsic regulation towards reducing their sedentary behaviour (e.g., facilitating identification 
of the benefits of reducing their sedentary behaviour and/or their enjoyment of reducing their 
sedentary behaviour) might be a suitable malleable target for sedentary behaviour change 
interventions in these patients to improve important disease outcomes. Specifically, increasing 
autonomous motivation to reduce sedentary behaviour by a score of 2 on the BREQ-2 scale 
(e.g., responding to, “I aim to reduce my sedentary behaviour…because I value the benefits of 
doing this” or “…because I enjoy doing this”, from 2 = disagree to 4 = agree) might result in 
decreased sedentary time by approximately 1h/day. In terms of inflammatory disease activity, 
this in turn equates to a decrease of 3.8mg/l in hsCRP. In terms of particularly relevant 
symptoms for the patient, this corresponds to a decrease in fatigue by a score of 2 (e.g., 
responding to, “Over the past week, how often have you been fatigued?”, from 4 = every day 
to 2 = occasionally, but not most days).  
 In sum, this study has provided novel insight into the potential of autonomous 
motivation to reduce sedentary behaviour to attenuate the disease burden of RA, through 
changes in sedentary time in this patient group. 
 
Practical implications 
Findings from the current study are compelling, revealing that; 1) the activPAL and 
GT3X+ (applying RA-specific accelerometer cut-points) can be employed to accurately 
quantify sedentary time and PA in people with RA (with the caveat that the GT3X+ might 
overestimate sedentary time), 2) longitudinal associations exist between clinically- and patient-
important health outcomes in RA with sedentary time, and these are largely bi-directional, and 
3) autonomous motivation to reduce sedentary behaviour is longitudinally associated with 
sedentary time in this patient group, which in turn, are related to several clinically- and patient-
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important RA outcomes. Further, most longitudinal relationships with sedentary time 
demonstrated in Chapters 4-6, show the reverse associations with standing time in these 
patients. The following sections describe the practical implications of current findings. 
Levels of MVPA in the RA population are insufficient to yield benefits to health – the 
physically inactive status of this patient group is well known (Tierney et al., 2012). However, 
the population prevalence of sedentary time in RA has been documented to a much lesser 
extent. Given that the activPAL and GT3X+ have now been validated for measurement of 
sedentary time (and PA) in people with RA, these devices (preferably the activPAL) should be 
employed to establish levels of sedentarity among people with RA. The longitudinal studies 
comprising Chapters 4-6 provide some indication of levels of activPAL-assessed sedentary 
time in RA (9h/day), but these data were only collected in a small sample of people with RA 
(n = 102) and therefore cannot be generalised to RA patients beyond this particular cohort. 
Thus, larger studies employing the activPAL are required to determine levels of sedentariness 
which are typical of people living with RA. 
It was also demonstrated that there is a severe lack of research examining the health-
related correlates of sedentary behaviour in people with RA. Findings suggest that we must 
reframe research priorities imminently, to build upon this evidence base. Indeed, several 
clinically- and patient-important RA outcomes were related to free-living sedentary time, and 
analysis alluded to most of these associations being bi-directional in nature. Research efforts 
should be made to confirm these findings with rigorous experimental designs, which serve to 
elucidate whether reducing sedentary time will lead to significant improvements in RA 
outcomes investigated herein. 
A strong inverse correlation between sedentary and standing time, and reverse 
associations with health and psychosocial variables, were observed throughout the longitudinal 
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studies of this thesis. This suggests that promoting engagement in standing behaviours may 
offer a way to reduce sedentary time and potentially improve deleterious RA outcomes. 
Establishing links between sedentary behaviour and health in RA is a critical first step in 
developing a rationale for interventions in this patient group, which are able to test the health 
effects of reducing sedentary behaviour. However, we need to target malleable determinants 
of sedentary behaviour in interventions, shown to associate with sedentarity – thus, if targeted, 
these factors may have the potential to promote behaviour change. In longitudinal analysis, 
results from this thesis demonstrated that change in autonomous motivation to reduce sedentary 
behaviour was negatively linked to change in device-assessed sedentary time in RA. These 
findings are the first to suggest that autonomous motivation to reduce sedentary behaviour may 
offer a potential avenue for interventions targeting ‘too much sitting’ among people with RA. 
As such, SDT may offer a viable conceptual framework upon which sedentary behaviour 
change interventions, aiming to establish the potential health benefits of reducing free-living 
sedentary time among people with RA, can be based. 
 
Limitations and future directions 
The studies conducted within this thesis have generated novel and important insight 
into the accurate measurement of sedentary time and PA in people living with RA, as well as 
providing the first longitudinal evidence for associations between clinically-and patient-
important ‘physiological’ and ‘psychological’ health outcomes, with objectively-assessed 
sedentary time and PA in this patient group. Further, SDT-based psychosocial determinants of 
these behaviours have been hypothesised for the first time, and their potential for forming 
intervention targets to alleviate the disease burden of RA has been discussed. 
However, prior to developing such an intervention which addresses the issue of 
sedentarity in RA, additional research is required to confirm the associations observed herein, 
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and address the limitations of the work presented in this thesis. The following sections will 
outline limitations regarding measurement, study design and analytical techniques employed 
in this thesis, and suggest areas of future research that can seek to address these limitations. 
First, the activPAL and GT3X+ were shown to be valid for measurement of free-living 
sedentary time and PA in people with RA, however Bassett, Rowlands and Trost (2012) 
highlighted that several studies are required to determine the validity of an instrument for 
assessing these behaviours. For example, in the laboratory-based validation study comprising 
Chapter 2, we could not affirm the accuracy of the activPAL for measuring sit-stand transitions 
in RA patients. This is an essential area of future research, particularly if we may advocate the 
health promotion message of ‘sit less, stand more’ in this population. Indeed, as well as the 
total time engaged in sedentary behaviour, the manner by which sedentary time is accumulated 
has been shown to hold important implications for health in clinical and non-clinical 
populations (de Rezende et al., 2014; Healy et al., 2011b). In addition, the activPAL has only 
been validated in 1 study in ‘healthy adults’ for assessing the intensity of behaviour, which is 
currently based on step cadence, limiting its ability to measure PA (Lyden et al., 2017). Thus, 
the activPAL should be validated for measuring sit-stand transitions and intensity of free-living 
PA in people with RA. This would subsequently reduce the reliance on employing both the 
activPAL and GT3X+ in sedentary behaviour and PA research in this population.  
Importantly, if future research in the RA population involves measuring habitual 
sedentary time only, the activPAL should be employed for this purpose, as our data supports 
this device as the gold standard measure of free-living sedentary time (Chastin & Granat, 2010; 
Edwardson et al., 2017; Kozey-Keadle et al., 2011; Sellers et al., 2016). Thus, in RA studies 
that wish to quantify both sedentary time and PA in this patient group, the GT3X+ (applying 
newly-developed RA-specific accelerometer cut-points developed in Chapter 2) should be 
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employed in combination with the activPAL, as accelerometers afford the ability to capture the 
intensity of free-living behaviour. Further, compliance to monitor wear was high in this study 
for both devices, and when they were worn in combination. The protocols employed herein, 
may therefore help to inform methods in future RA studies, which involve administering these 
devices. 
The validated activPAL and GT3X+ (applying RA-specific accelerometer cut-points 
developed in Chapter 2) for measurement of free-living sedentary time and PA was employed 
in a longitudinal study (Chapters 4-6) within this thesis. Objective assessment of free-living 
sedentary time and PA in different populations has been recommended across the literature to 
generate more accurate estimates than those provided by methods offering a more subjective 
measure of these behaviours (e.g., self-report) (Atkin et al., 2012; Janz, 2006). With regard to 
count-based accelerometry, as well as employing population-specific cut-points to determine 
time spent in different intensities of free-living behaviour, the researcher must select non-wear 
criteria which has been termed the “structural foundation in the data reduction process” 
(Semanik et al., 2010). This involves deciding on how many minutes of consecutive ‘0’ counts 
constitute the participant not wearing the device, as opposed to them being sedentary. Indeed, 
activity counts representing sedentary time can include ‘0’ (e.g., ≤244 counts/min), and 
therefore this process is critical to the accurate exclusion of ‘non-wear time’ and inclusion of 
‘sedentary time’. In the longitudinal studies of this thesis, non-wear criteria = ≥60 min of 
consecutive ‘0’ counts (with a spike tolerance of 2 min) was applied to RA patients’ 
accelerometer data. Recent evidence suggests that ≥90 min of consecutive ‘0’ counts may be 
more appropriate to apply to accelerometer data in populations with reduced physical function, 
who may spend longer periods of time engaged in sitting/reclining/lying behaviours (e.g., older 
adults) (Choi et al., 2012). However, both these criteria have been advocated by (Semanik et 
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al., 2010) for the RA population, and ≥60 min of consecutive ‘0’ counts have been applied in 
previous accelerometry studies in this patient group (Fenton et al., 2017; Fenton et al., 2018c).  
 Compliance was high for both devices employed in these studies, but more so for the 
activPAL. The activPAL has demonstrated good compliance in different populations which, in 
part, has been attributed to the 24h/day wear protocol typically employed (Dall et al., 2018; 
Edwardson et al., 2017). Despite a 24h/day protocol improving compliance relative to that of 
accelerometers (Edwardson et al., 2017), it also results in time-consuming and challenging 
extraction of sleep-time from raw data. Winkler et al. (2016) have recently developed an 
algorithm for identifying periods of sleep in activPAL raw data, in order for these to be 
subsequently removed. However, the authors acknowledged that this algorithm may not be 
suitable for populations with impaired mobility (e.g., people with RA), as these individuals had 
minimal representation in their study.  
With this in mind, longitudinal studies in this thesis derived waking sedentary, standing 
and stepping time, by identifying sleep periods from wear time logbooks and parallel GT3X+-
derived sleep periods (period of non-wear). The GT3X+ provided a relatively sound indicator 
of waking vs. sleep time, as participants were instructed to remove the GT3X+ when they went 
to bed, and replace it when they woke up. These estimates were corroborated with data from 
wear time logbooks and close inspection of activPAL raw data. Specifically, free-living 
behaviour was being classified by the activPAL as ‘sitting/lying’ at the point of GT3X+ 
removal, and non-sedentary behaviour (‘standing’ and ‘stepping’) resumed at the point of 
GT3X+ replacement. Still, despite this aiding the process of manual sleep removal from 
activPAL data, there are some issues with this approach. For example, the GT3X+ 
demonstrated lower compliance relative to that of the activPAL, which meant that data relating 
to device removal/replacement was unavailable for days where the aforementioned non-wear 
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criteria excluded GT3X+ data from subsequent analysis (e.g., valid GT3X+ data for 4 days vs. 
valid activPAL data for 7 days). To address this limitation, we were able to refer to wear time 
logbooks only, which may have presented issues concerning the accuracy of self-report. 
Further, even when GT3X+ data were valid, such removal/replacement times may not have 
represented actual sleep periods. For example, participants may have gone to bed, removed the 
GT3X+ and then read a book for 45 min (waking sedentary behaviour). Alternatively, 
participants may not have replaced the GT3X+ immediately after waking. In an attempt to 
address this, participants were asked to keep wearing the GT3X+ in bed until ‘lights off’ and 
replace the device at ‘lights on’. Future research should focus on data reduction methods that 
can accurately identify sleep periods from activPAL data in people with RA. 
Despite the superior validity and reliability of device-based measures of sedentary 
behaviour and PA relative to self-report, accelerometers and posture sensors are limited by 
their inability to gauge the context in which free-living behaviour occurs. Gathering contextual 
information regarding sedentary behaviour is a critical area for future research in people with 
RA, to explore the ‘types’ of sedentary behaviour that predominantly accumulate towards their 
total sedentary time. This is because some sedentary behaviours have been suggested as 
beneficial for psychological well-being and cognitive function (e.g., reading, social activities), 
or essential during day-to-day life (e.g., eating), relative to more ‘passive’ sedentary behaviours 
(e.g., watching television) in different populations (Chastin et al., 2017; Hallgren et al., 2019; 
Hallgren et al., 2018). Indeed, it has been reported that RA patients engage in needlework and 
reading the newspaper (‘mentally active’ sedentary behaviours), as well as watching the 
television (‘passive’ sedentary behaviours) (Thomsen et al., 2015). Thus, given that people 
with RA have compromised mental health (Fiest et al., 2017), it might be that some sedentary 
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behaviours should not be reduced in this population. This has also been noted for intervention 
development in older adults (Chastin et al., 2017). 
Currently, no single measure exists that can assess all components of ‘SITT’ (Healy et 
al., 2011a; Tremblay et al., 2010), and would provide accurate information regarding the levels 
of sedentary time, patterns of accumulation and the context in which these behaviours occur. 
However, attempts can be made to assess as many facets of ‘SITT’ as possible using multiple 
measures, without placing too much of a burden on the participant. For example, future 
research in the RA population could employ self-report instruments or Ecological Momentary 
Assessment (real-time sampling of behaviour and experiences) in combination with the 
activPAL (Bann et al., 2015; Rosenberg et al., 2016; Shiffman, Stone, & Hufford, 2008), to 
provide estimates of sedentary, standing and stepping time, as well as indicating the context in 
which these behaviours took place. With this in mind, self-report measures of sedentary 
behaviour should be evaluated in terms of how suitable they are for people with RA, in order 
to increase the likelihood of accurate responses. This investigation has been conducted in 
patients with multiple sclerosis, whereby qualitative interviews gained insight into how patients 
respond to the content of currently employed sedentary behaviour questionnaires (Hensman et 
al., 2019).  
Shifting from the measurement of sedentary behaviour and PA (‘Phase 2’ of the 
Behavioural Epidemiology Framework [BEF]), ‘Phase 1’ of the BEF requires research to 
determine the associations between behaviour (e.g., sedentary behaviour, assessed employing 
validated measures from ‘Phase 2’) with health in the target population, to rationalise the 
importance of the development and delivery of behaviour change interventions. Chapter 4 of 
this thesis has provided the first evidence for longitudinal associations between objectively-
assessed sedentary time and PA with pertinent aspects of RA health, and has indicated these 
 225 
associations may be bi-directional in nature. These reciprocal relationships supported the 
assertion that interventions to reduce sedentary time may have the scope to improve clinically- 
and patient-important outcomes in RA. For example, longitudinal (and bi-directional) 
associations were revealed between self-reported pain and fatigue, with activPAL-assessed 
sedentary (positive) and standing (negative) time. However, these RA health outcomes were 
only measured at the end of the 7-day study week – given that pain and fatigue might fluctuate 
day-to-day in an individual living with RA (e.g., due to a flare-up), it might be apt to assess 
these symptoms daily, via diaries or questionnaires, in future research. This would heighten 
the burden placed on the participant, but could provide more accurate assessments of these 
particular RA symptomology.  
Findings pertaining to patients’ quality of life (‘physical health’), as measured by the 
World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) should be 
interpreted with caution, given its low internal reliability for this sample. This was attributed 
to the fact that the ‘physical health’ domain was extracted for analysis, reducing the number of 
items from the questionnaire (Tavakol & Dennick, 2011). Indeed, the WHOQOL-BREF in its 
entirety showed high internal reliability (α = .86).  
Future studies should consolidate these findings by analysing these associations in 
larger, more diverse samples of people with RA. A larger sample size would allow for testing 
more sophisticated bi-directional models, specifically to investigate whether health variables 
at Time Point 1 (T1) predicts change in the behaviour variable at Time Point 2 (T2), and vice 
versa. In addition, despite overcoming some issues of a cross-sectional design, this longitudinal 
study remains observational in nature, meaning cause and effect cannot be established. Thus, 
the relationships emerging from these data must be tested using more rigorous experimental 
study designs. 
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Intervention studies ‘controlling’ reductions in free-living sedentary time to examine 
associations with health outcomes in RA should be designed. However, it might be a challenge 
to ‘control’ levels of sedentary time in a free-living environment to ensure that the ‘dose’ of 
behaviour change required to examine associations with health is achieved. Acute experimental 
studies allow for superior control, and could be designed to examine whether prolonged 
sitting/reclining/lying (e.g., 3-5h of continuous sedentary time in a laboratory) (Trinity, 2017) 
has a dose-response relationship with, for example, RA inflammatory disease activity. This 
would also serve to provide some insight into the mechanistic processes underlying sedentary 
time in people with RA. Indeed, on the basis of emerging evidence for the association between 
sedentary time and inflammation, Fenton and Kitas (2016) hypothesised a cyclical relationship 
between sedentary time, inflammation and pertinent aspects of RA health. Specifically, high 
levels of sedentary time in RA may exacerbate already elevated systemic inflammation in these 
patients and contribute to the progression of RA outcomes, which in turn, may lead to high 
levels of sedentary time (‘sedentary-inflammation hypothesis’). Thus, based on results from 
Chapter 4, future studies could test this hypothesis to examine the mediating role of hsCRP in 
relationships between sedentary time and pertinent RA outcomes (e.g., pain, fatigue, physical 
function). 
With this in mind, future research could also examine other inflammation-driven health 
outcomes in RA not explored in this thesis. Indeed, the selected health variables (DAS-28, 
hsCRP, physical function, quality of life, subjective vitality, depressive symptoms) will not be 
the only clinically- and patient-important disease outcomes potentially affecting and being 
affected by sedentary behaviour change in RA. Specifically, sedentary time only accounted for 
between 7%-21% of the variance in RA outcomes in the longitudinal study. For example, future 
studies might seek to examine the relationship between sedentary time with cardiovascular 
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disease (CVD) risk, elevated in these patients due to the heightened inflammatory burden of 
RA (Avina-Zubieta et al., 2012). Preliminary cross-sectional research has been conducted in 
this area (Fenton et al., 2018a; Fenton et al., 2017), but prospective studies could offer more 
insight into how change in sedentary time is associated with change in CVD risk (e.g., 
employing the QRISK-3) over time. Additionally, acute studies examining the mediating role 
of inflammation in this relationship might specifically examine hsCRP, which is an indicator 
of CVD risk in people with RA (>3 mg/l = ‘high’ risk of CVD; >10 mg/l = ‘very high’ risk of 
CVD) (Graf, Scherzer, Grunfeld, & Imboden, 2009). 
Underlying all longitudinal studies of this thesis, is the strong inverse correlation 
observed between sedentary time and standing time in people with RA (ß = -.95). This is 
indicative of the proposition that ‘non-exercise’ behaviours (sedentary behaviour and LPA) 
comprise most of the waking day in people with RA (Hammam et al., 2019; Summers et al., 
2019). Replacing sedentary time with standing could represent an avenue through which 
behavioural interventions could attenuate the negative health outcomes in RA. We did not test 
this proposition, but this could be examined via; 1) isotemporal substitution analysis using free-
living device-assessed sedentary time and PA data, and 2) acute experimental studies. For 
example, isotemporal substitution models have shown that replacing sedentary time (e.g., 30 
min) with LPA holds positive associations with physical function in older adults (Buman et al., 
2010). Isotemporal substitution analysis may offer insight into the potential of replacing 
sedentary time with standing in this population, but cannot confirm directly, the health 
consequences of sedentary behaviour change (Keadle, Conroy, Buman, Dunstan, & Matthews, 
2017). This could be addressed in acute experimental studies, whereby laboratory-based 
studies might examine the effects of interrupting sitting with standing (and more broadly, LPA) 
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on different health outcomes (Crespo, Mullane, Zeigler, Buman, & Gaesser, 2016), such as 
inflammatory biomarkers in RA.  
Further, a recent line of thinking stipulates considering all behaviours undertaken 
during a 24-h period when examining the links between specific behaviours with health. 
Namely, compositional analysis should be considered in future research with the RA 
population that takes into account the independent and interacting impact of sleep, sedentary 
behaviour and PA when making conclusions about their associations with disease outcomes 
(Chastin, Palarea-Albaladejo, Dontje, & Skelton, 2015b). Future research should also consider 
the effect autonomous and controlled motivation to reduce sedentary behaviour has on different 
interrelating behaviours during a 24-h period in people with RA. Specifically, to identify 
whether autonomous and controlled motivation to reduce sedentary behaviour holds significant 
associations with sedentary time, aside from and together with the relationships it may have 
with PA (e.g., LPA, and specifically standing). However, there are a severe lack of instruments 
specifically measuring autonomous and controlled motivation to reduce sedentary behaviour 
in any population. To our knowledge, the only instrument that has been developed in this 
context, grounded in SDT, is the Motivation to Limit Screen-time Questionnaire (Lubans et 
al., 2013). This questionnaire was developed in adolescent boys and based on items of the 
BREQ-2. Thus, for use in Chapters 5 and 6 of this thesis, we adapted the BREQ-2 for 
measurement of autonomous and controlled motivation to reduce sedentary behaviour in 
people with RA. Although this scale demonstrated high internal reliability, (α = .81 and α = 
.87 for autonomous and controlled motivation, respectively), we were not able to test the 
measurement validity of the adapted BREQ-2 for measuring quality of motivation to reduce 
sedentary behaviour in this patient group. This should be addressed in future research. 
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Studies comprising Chapters 5 and 6 did not specifically investigate links between 
external, introjected, identified and intrinsic regulations to reduce sedentary behaviour, with 
levels of sedentariness and PA in RA. Instead, autonomous and controlled motivation to reduce 
sedentary behaviour were calculated (autonomous motivation = identified regulation + intrinsic 
regulation; controlled motivation = external regulation + introjected regulation) for statistical 
analysis. This method is consistent with previous research (Yu et al., 2015a; Vancampfort et 
al., 2013) and reduced the number of variables in regression models to increase statistical 
power, partly addressing the limitations associated with a small sample size in this thesis. 
Nevertheless, examining each regulation individually could provide insight into whether one 
regulation was ‘driving’ the emerging associations to a greater extent than another. Indeed, 
research in a sports context has supported distinguishing between regulations in data analysis 
to gain a clearer and advanced understanding of the relationships between motivation with 
short-term and long-term behaviour (Gillison, Osborn, Standage, & Skevington, 2009; 
Pelletier, Fortier, Vallerand, & Briere, 2001). For example, introjected regulation has been 
related to short-term maintenance of exercise via promoting autonomy, and represents 
progression towards internalisation of behaviour (Gillison et al., 2009; Pelletier et al., 2001). 
As stipulated in Chapter 3, this was preliminary work which aimed to examine the presence of 
relationships between, broadly, quality of motivation to reduce sedentary behaviour with 
device-assessed sedentary time and PA in people living with RA. Based on findings from the 
studies in Chapters 5 and 6, future research now has a rationale for investigating the role of 
external, introjected, identified and intrinsic regulations in sedentary behaviour and PA 
engagement/disengagement in this population, to further inform sedentary behaviour change 
interventions. 
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Amotivation was not included in statistical analysis in this thesis, as it is not considered 
a facet of autonomous or controlled motivation. Amotivated individuals “do not act, act without 
intent, or lack the intention to act” (Pelletier et al., 2001), and this state could have adverse 
implications if directed towards healthy behaviours (e.g., reducing sedentary behaviour, 
engagement in PA). Although beyond the scope of this body of work, future research should 
examine the relationships between amotivation to reduce sedentary behaviour with levels of 
sedentary behaviour and PA, and in turn, clinically- and patient-important health outcomes in 
RA. 
In addition, this thesis (Chapters 5 and 6) did not incorporate all tenets of SDT that 
might have been relevant to levels of sedentary time and PA in people with RA. An additional 
sub-theory of SDT, namely basic psychological needs satisfaction theory, postulates that 
humans have 3 basic psychological needs that enable them to foster intrinsic motivation. 
Specifically, ‘autonomy’, ‘competence’ and ‘relatedness’ (Deci & Ryan, 2000). Fulfilment of 
these needs leads to fostering more autonomous motivation towards a behaviour, as well as 
benefits in mental health (e.g., vitality and well-being) (Ryan & Deci, 2000). Thwarting these 
basic psychological needs results in more controlled motivation towards behaviour 
(Bartholomew, Ntoumanis, Ryan, & Thogersen-Ntoumani, 2011; Bartholomew, Ntoumanis, 
& Thogersen-Ntoumani, 2010). SDT suggests the social environment is central to the 
satisfaction of these basic needs, and holds implications for encouraging behaviour change 
through promoting more autonomous motivation (Deci & Ryan, 1987, 2000, 2008a, 2008b; 
Ryan & Deci, 2000). Specifically, the provision of autonomy support from an ‘important other’ 
(e.g., peer, parent, spouse, healthcare professional) is reported to hold positive implications for 
need satisfaction, quality of motivation and behavioural engagement.  
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Basic psychological needs satisfaction theory was not applied in this study. However, 
to date, research has not rigorously investigated quality of motivation for reducing sedentary 
behaviour as a determinant of free-living sedentary time in RA. Thus, prior to examining the 
basic psychological needs and their contribution to autonomous or controlled regulation, 
whether or not autonomous or controlled motivation to reduce sedentary behaviour is 
associated with free-living sedentary time in RA must first be established. For the same reason, 
autonomy support from an ‘important other’ was not examined in this study. Table 7.1 suggests 
ways in which autonomous motivation to reduce sedentary behaviour could be targeted, via 
satisfaction of the basic psychological needs, in future interventions in this patient group.  
Other limitations arising from the longitudinal studies of this thesis relate to the sample. 
First, data from the same sample was used throughout studies in this thesis, which could have 
inflated the risk of Type 1 error (e.g., in regression analysis). Second, only n = 54 participants 
returned for 6-month follow-up (reduced to n = 53 and n = 51 based on valid activPAL and 
GT3X+ data, respectively). However, this was predominantly attributed to termination of data 
collection, and not due to participants wishing to no longer undertake further visits. In addition, 
no significant differences were found (via t-test and chi-square analysis) between participants 
included at T2, and those lost to 6-month follow-up regarding demographic, RA duration and 
treatment regimen, health and behaviour variables. Still, despite applying bootstrapping to 
overcome some of the issues of small sample sizes (Scharkow, 2017; Wood, 2004), limitations 
remained in relation to particular statistical analysis. For example, path analysis in Chapters 4 
and 6 could not be conducted using full measurement models (structural equation modelling). 
For Chapter 4, this meant that bi-directional models could not explore the relationships between 
change in health variables and change in sedentary time in path models (and vice versa; 
diagonal paths in Figure 4.2) – prior regressions were required to explore these relationships 
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before testing for bi-directional associations in path analysis. Additionally, hypothesised 
models of sedentary behaviour change in Chapter 6 were not tested as full measurement 
models, whereby BREQ-2 questionnaire items were separate latent variables. Further, in both 
cases, multiple behaviours (e.g., sedentary and standing time) could not be included in the same 
model. However, the latter approach may have resulted in multicollinearity between these 
behaviours, as they comprise most of an RA patient’s waking day (Fenton et al., 2017; Paul et 
al., 2014; van der Ploeg & Hillsdon, 2017). 
Finally, generalisability of all findings from the present thesis are limited to the 
characteristics of the sample. RA patients were recruited from 1 hospital from a somewhat 
small geographical location in the UK. The sample also predominantly consisted of women 
and participants had an average age of 58 years old. Further, participants had moderate disease 
activity and severity. Yet, these descriptions are mostly representative of the RA population, 
where there is a higher prevalence of females and onset of disease usually occurs beyond the 
age of 30 (Wasserman, 2018). Furthermore, participants’ height, weight, BMI, body fat 
percentage, disease activity (DAS-28), disease severity (HAQ) and disease duration in this 
thesis, closely represented descriptive data from previous studies in this patient group (Metsios 
et al., 2009; Sokka et al., 2008; Stavropoulos-Kalinoglou et al., 2013).
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 This thesis provides pertinent preliminary evidence, addressing ‘Phase 1’ to ‘Phase 3’ 
of the BEF, and highlights areas for future research. The accurate measurement of free-living 
sedentary behaviour and PA in people with RA is vital to understand dose-response 
relationships between sedentary behaviour and PA with RA health, identify salient 
determinants of such behaviours to be targeted in interventions, and subsequently evaluate the 
efficacy of such interventions for improving RA health. Thus, the first empirical chapter of this 
thesis took essential first steps to extensively validate 2 readily-employed device-based 
measures (activPAL and GT3X+) of sedentary time and PA in this patient group.  
These devices were subsequently employed in the longitudinal studies comprising 
Chapters 4 to 6, which generated novel data regarding the role of sedentary behaviour and PA 
in RA health, and developed understanding regarding how these behaviours may be targeted 
through intervention. First, bi-directional associations were revealed between clinically- and 
patient-important RA disease outcomes with activPAL-assessed sedentary and standing time. 
This suggested there is scope to intervene to decrease sedentary time, in order to reduce the 
burden of disease for people with RA. The inverse relationships observed between standing 
time with these outcomes compared to sedentary time, also highlighted that replacing sedentary 
time with standing may offer a potential self-management strategy to improve pertinent aspects 
of RA health.  
Building on this, SDT-based psychosocial determinants of sedentary behaviour and PA 
were investigated. Results demonstrated that autonomous motivation to reduce sedentary 
behaviour was significantly associated with activPAL-assessed sedentary and standing time in 
people with RA. Finally, models of sedentary behaviour change were tested, which sought to 
bring together a new understanding of the role of sedentary time for health in RA, and the 
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malleable determinants of this behaviour. Results suggested that autonomous motivation to 
reduce sedentary behaviour was associated with sedentary and standing time, and in turn, 
several clinically- and patient-important RA disease outcomes.  
Together, the results of this thesis suggest that autonomous motivation to reduce 
sedentary behaviour may represent a modifiable determinant of sedentarity, and thus a viable 
intervention target in people with RA. In addition, this thesis provides the first evidence to 
indicate that addressing autonomous motivation to reduce sedentary behaviour in RA may 
encourage changes in this behaviour, to the extent that it might attenuate the burden of RA 
disease. However, experimental research is required to establish the value of SDT-informed 
interventions to reduce sedentary behaviour, and subsequently improve important health 


















Aadland, E., & Ylvisaker, E. (2015). Reliability of the Actigraph GT3X+ Accelerometer in 
Adults under Free-Living Conditions. PLoS One, 10(8), e0134606. 
doi:10.1371/journal.pone.0134606 
Abraham, C., & Michie, S. (2008). A taxonomy of behavior change techniques used in 
interventions. Health Psychol, 27(3), 379-387. doi:10.1037/0278-6133.27.3.379 
Agca, R., Heslinga, S. C., Rollefstad, S., Heslinga, M., McInnes, I. B., Peters, M. J., . . . 
Nurmohamed, M. T. (2017). EULAR recommendations for cardiovascular disease risk 
management in patients with rheumatoid arthritis and other forms of inflammatory joint 
disorders: 2015/2016 update. Ann Rheum Dis, 76(1), 17-28. doi:10.1136/annrheumdis-
2016-209775 
Aguilar-Farias, N., Brown, W. J., & Peeters, G. M. (2014). ActiGraph GT3X+ cut-points for 
identifying sedentary behaviour in older adults in free-living environments. J Sci Med 
Sport, 17(3), 293-299. doi:10.1016/j.jsams.2013.07.002 
Ainsworth, B. E., Haskell, W. L., Herrmann, S. D., Meckes, N., Bassett, D. R., Jr., Tudor-
Locke, C., . . . Leon, A. S. (2011). 2011 Compendium of Physical Activities: a second 
update of codes and MET values. Med Sci Sports Exerc, 43(8), 1575-1581. 
doi:10.1249/MSS.0b013e31821ece12 
Ajzen, I. (1985). From Intentions to Actions: A Theory of Planned Behavior. In J. Kuhl & J. 
Beckmann (Eds.), Action Control: From Cognition to Behavior (pp. 11-39). Berlin, 
Heidelberg: Springer Berlin Heidelberg. 
Aletaha, D., Neogi, T., Silman, A. J., Funovits, J., Felson, D. T., Bingham, C. O., 3rd, . . . 
Hawker, G. (2010). 2010 Rheumatoid arthritis classification criteria: an American 
 238 
College of Rheumatology/European League Against Rheumatism collaborative 
initiative. Arthritis Rheum, 62(9), 2569-2581. doi:10.1002/art.27584 
Aletaha, D., Smolen, J., & Ward, M. M. (2006). Measuring function in rheumatoid arthritis: 
Identifying reversible and irreversible components. Arthritis Rheum, 54(9), 2784-2792. 
doi:10.1002/art.22052 
Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., . . . Group, 
I. P. (2004). Health-related quality of life associated with chronic conditions in eight 
countries: results from the International Quality of Life Assessment (IQOLA) Project. 
Qual Life Res, 13(2), 283-298. doi:10.1023/B:QURE.0000018476.11278.35 
An, H. S., Kim, Y., & Lee, J. M. (2017). Accuracy of inclinometer functions of the activPAL 
and ActiGraph GT3X+: A focus on physical activity. Gait Posture, 51, 174-180. 
doi:10.1016/j.gaitpost.2016.10.014 
Angelotti, F., Parma, A., Cafaro, G., Capecchi, R., Alunno, A., & Puxeddu, I. (2017). One year 
in review 2017: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol, 35(3), 368-
378.  
Atkin, A. J., Gorely, T., Clemes, S. A., Yates, T., Edwardson, C., Brage, S., . . . Biddle, S. J. 
(2012). Methods of Measurement in epidemiology: sedentary Behaviour. Int J 
Epidemiol, 41(5), 1460-1471. doi:10.1093/ije/dys118 
Avina-Zubieta, J. A., Thomas, J., Sadatsafavi, M., Lehman, A. J., & Lacaille, D. (2012). Risk 
of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis 
of observational studies. Ann Rheum Dis, 71(9), 1524-1529. doi:10.1136/annrheumdis-
2011-200726 
Babic, M. J., Smith, J. J., Morgan, P. J., Lonsdale, C., Plotnikoff, R. C., Eather, N., . . . Lubans, 
D. R. (2016). Intervention to reduce recreational screen-time in adolescents: Outcomes 
 239 
and mediators from the 'Switch-Off 4 Healthy Minds' (S4HM) cluster randomized 
controlled trial. Prev Med, 91, 50-57. doi:10.1016/j.ypmed.2016.07.014 
Bailey, D. P. (2017). Editorial: Sedentary Behavior in Human Health and Disease. Front 
Physiol, 8, 901. doi:10.3389/fphys.2017.00901 
Balboa-Castillo, T., Leon-Munoz, L. M., Graciani, A., Rodriguez-Artalejo, F., & Guallar-
Castillon, P. (2011). Longitudinal association of physical activity and sedentary 
behavior during leisure time with health-related quality of life in community-dwelling 
older adults. Health Qual Life Outcomes, 9, 47. doi:10.1186/1477-7525-9-47 
Bandalos, D. L. (2018). Measurement Theory and Applications for the Social Sciences. NY: 
Guilford Publications. 
Bandura, A. (1986). Social foundations of thought and action: A social cognitive view. 
Englewood Cliffs, NJ, US: Prentice-Hall, Inc. 
Bandura, A. (2004). Health promotion by social cognitive means. Health Educ Behav, 31(2), 
143-164. doi:10.1177/1090198104263660 
Bann, D., Hire, D., Manini, T., Cooper, R., Botoseneanu, A., McDermott, M. M., . . . Group, 
L. S. (2015). Light Intensity physical activity and sedentary behavior in relation to body 
mass index and grip strength in older adults: cross-sectional findings from the Lifestyle 
Interventions and Independence for Elders (LIFE) study. PLoS One, 10(2), e0116058. 
doi:10.1371/journal.pone.0116058 
Bartholomew, K. J., Ntoumanis, N., Ryan, R. M., & Thogersen-Ntoumani, C. (2011). 
Psychological need thwarting in the sport context: assessing the darker side of athletic 
experience. J Sport Exerc Psychol, 33(1), 75-102.  
 240 
Bartholomew, K. J., Ntoumanis, N., & Thogersen-Ntoumani, C. (2010). The controlling 
interpersonal style in a coaching context: development and initial validation of a 
psychometric scale. J Sport Exerc Psychol, 32(2), 193-216.  
Bassett, D. R., Jr., Rowlands, A., & Trost, S. G. (2012). Calibration and validation of wearable 
monitors. Med Sci Sports Exerc, 44(1 Suppl 1), S32-38. 
doi:10.1249/MSS.0b013e3182399cf7 
Belza, B. L. (1995). Comparison of self-reported fatigue in rheumatoid arthritis and controls. 
J Rheumatol, 22(4), 639-643.  
Berner, C., Haider, S., Grabovac, I., Lamprecht, T., Fenzl, K. H., Erlacher, L., . . . Dorner, T. 
E. (2018). Work Ability and Employment in Rheumatoid Arthritis: A Cross-Sectional 
Study on the Role of Muscle Strength and Lower Extremity Function. Int J Rheumatol, 
2018, 3756207. doi:10.1155/2018/3756207 
Biswas, A., Oh, P. I., Faulkner, G. E., Bajaj, R. R., Silver, M. A., Mitchell, M. S., & Alter, D. 
A. (2015). Sedentary time and its association with risk for disease incidence, mortality, 
and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med, 
162(2), 123-132. doi:10.7326/M14-1651 
Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between 
two methods of clinical measurement. Lancet, 1(8476), 307-310.  
Blood Pressure UK. (2008). What is normal blood pressure? Retrieved from 
http://www.bloodpressureuk.org/BloodPressureandyou/Thebasics/Whatisnormal 
Boers, M., Kirwan, J. R., Wells, G., Beaton, D., Gossec, L., d'Agostino, M. A., . . . Tugwell, 
P. (2014). Developing core outcome measurement sets for clinical trials: OMERACT 
filter 2.0. J Clin Epidemiol, 67(7), 745-753. doi:10.1016/j.jclinepi.2013.11.013 
 241 
Bouchard, C., Tremblay, A., Leblanc, C., Lortie, G., Savard, R., & Theriault, G. (1983). A 
method to assess energy expenditure in children and adults. Am J Clin Nutr, 37(3), 461-
467. doi:10.1093/ajcn/37.3.461 
Brage, S., Wedderkopp, N., Franks, P. W., Andersen, L. B., & Froberg, K. (2003). 
Reexamination of validity and reliability of the CSA monitor in walking and running. 
Med Sci Sports Exerc, 35(8), 1447-1454. doi:10.1249/01.MSS.0000079078.62035.EC 
Brandstetter, S., Riedelbeck, G., Steinmann, M., Ehrenstein, B., Loss, J., & Apfelbacher, C. 
(2017). Pain, social support and depressive symptoms in patients with rheumatoid 
arthritis: testing the stress-buffering hypothesis. Rheumatol Int, 37(6), 931-936. 
doi:10.1007/s00296-017-3651-3 
Brooks, J. M., Kaya, C., Chan, F., Thompson, K., Sánchez, J., Cotton, B. P., & Fortuna, K. 
(2018). Validation of the Behavioural Regulation in Exercise Questionnaire-2 for adults 
with chronic musculoskeletal pain. 25(8), 395-404. doi:10.12968/ijtr.2018.25.8.395 
Bruce, B., & Fries, J. F. (2003). The Stanford Health Assessment Questionnaire: dimensions 
and practical applications. Health Qual Life Outcomes, 1, 20. doi:10.1186/1477-7525-
1-20 
Buman, M. P., Hekler, E. B., Haskell, W. L., Pruitt, L., Conway, T. L., Cain, K. L., . . . King, 
A. C. (2010). Objective light-intensity physical activity associations with rated health 
in older adults. Am J Epidemiol, 172(10), 1155-1165. doi:10.1093/aje/kwq249 
Byrne, B. M. (2010). Structural equation modeling with AMOS: basic concepts, applications, 
and programming (2nd ed.). NY: Routledge. 
Carlson, M. D., & Morrison, R. S. (2009). Study design, precision, and validity in observational 
studies. J Palliat Med, 12(1), 77-82. doi:10.1089/jpm.2008.9690 
 242 
Carson, V., Wong, S. L., Winkler, E., Healy, G. N., Colley, R. C., & Tremblay, M. S. (2014). 
Patterns of sedentary time and cardiometabolic risk among Canadian adults. Prev Med, 
65, 23-27. doi:10.1016/j.ypmed.2014.04.005 
Carter, S., Hartman, Y., Holder, S., Thijssen, D. H., & Hopkins, N. D. (2017). Sedentary 
Behavior and Cardiovascular Disease Risk: Mediating Mechanisms. Exerc Sport Sci 
Rev, 45(2), 80-86. doi:10.1249/JES.0000000000000106 
Caruana, E. J., Roman, M., Hernández-Sánchez, J., & Solli, P. (2015). Longitudinal studies. 
Journal of thoracic disease, 7(11), E537-E540. doi:10.3978/j.issn.2072-
1439.2015.10.63 
Chamberlain, S. R., Cavanagh, J., de Boer, P., Mondelli, V., Jones, D. N. C., Drevets, W. C., . 
. . Bullmore, E. T. (2019). Treatment-resistant depression and peripheral C-reactive 
protein. Br J Psychiatry, 214(1), 11-19. doi:10.1192/bjp.2018.66 
Chastin, S., Gardiner, P. A., Ashe, M. C., Harvey, J. A., Leask, C. F., Balogun, S., . . . Skelton, 
D. A. (2017). Interventions for reducing sedentary behaviour in community-dwelling 
older adults. Cochrane Database of Systematic Reviews(9). 
doi:10.1002/14651858.CD012784 
Chastin, S. F., Buck, C., Freiberger, E., Murphy, M., Brug, J., Cardon, G., . . . consortium, D. 
(2015a). Systematic literature review of determinants of sedentary behaviour in older 
adults: a DEDIPAC study. Int J Behav Nutr Phys Act, 12, 127. doi:10.1186/s12966-
015-0292-3 
Chastin, S. F., De Craemer, M., Lien, N., Bernaards, C., Buck, C., Oppert, J. M., . . . consensus, 
p. (2016). The SOS-framework (Systems of Sedentary behaviours): an international 
transdisciplinary consensus framework for the study of determinants, research priorities 
 243 
and policy on sedentary behaviour across the life course: a DEDIPAC-study. Int J 
Behav Nutr Phys Act, 13, 83. doi:10.1186/s12966-016-0409-3 
Chastin, S. F., & Granat, M. H. (2010). Methods for objective measure, quantification and 
analysis of sedentary behaviour and inactivity. Gait Posture, 31(1), 82-86. 
doi:10.1016/j.gaitpost.2009.09.002 
Chastin, S. F., Palarea-Albaladejo, J., Dontje, M. L., & Skelton, D. A. (2015b). Combined 
Effects of Time Spent in Physical Activity, Sedentary Behaviors and Sleep on Obesity 
and Cardio-Metabolic Health Markers: A Novel Compositional Data Analysis 
Approach. PLoS One, 10(10), e0139984. doi:10.1371/journal.pone.0139984 
Chastin, S. F. M., Dontje, M. L., Skelton, D. A., Cukic, I., Shaw, R. J., Gill, J. M. R., . . . 
Seniors, U. S. P. t. (2018). Systematic comparative validation of self-report measures 
of sedentary time against an objective measure of postural sitting (activPAL). Int J 
Behav Nutr Phys Act, 15(1), 21. doi:10.1186/s12966-018-0652-x 
Chastin, S. F. M., & Granat, M. H. (2010). Methods for objective measure, quantification and 
analysis of sedentary behaviour and inactivity. Gait Posture, 31(1), 82-86. 
doi:10.1016/j.gaitpost.2009.09.002 
Chaudhari, P. (2008). The impact of rheumatoid arthritis and biologics on employers and 
payers. Biotechnol Healthc, 5(2), 37-44.  
Chernick, M. R., & LaBudde, R. A. (2011). An Introduction to Bootstrap Methods with 
Applications to R: Wiley Publishing. 





Choi, L., Ward, S. C., Schnelle, J. F., & Buchowski, M. S. (2012). Assessment of wear/nonwear 
time classification algorithms for triaxial accelerometer. Med Sci Sports Exerc, 44(10), 
2009-2016. doi:10.1249/MSS.0b013e318258cb36 
Cleland, C., Ferguson, S., Ellis, G., & Hunter, R. F. (2018). Validity of the International 
Physical Activity Questionnaire (IPAQ) for assessing moderate-to-vigorous physical 
activity and sedentary behaviour of older adults in the United Kingdom. BMC Med Res 
Methodol, 18(1), 176. doi:10.1186/s12874-018-0642-3 
Cohen, J. (1992). A power primer. Psychol Bull, 112(1), 155-159.  
Colley, R. C., Garriguet, D., Janssen, I., Craig, C. L., Clarke, J., & Tremblay, M. S. (2011). 
Physical activity of Canadian adults: accelerometer results from the 2007 to 2009 
Canadian Health Measures Survey. Health Rep, 22(1), 7-14.  
Collings, P. J., Wijndaele, K., Corder, K., Westgate, K., Ridgway, C. L., Dunn, V., . . . Brage, 
S. (2014). Levels and patterns of objectively-measured physical activity volume and 
intensity distribution in UK adolescents: the ROOTS study. Int J Behav Nutr Phys Act, 
11, 23. doi:10.1186/1479-5868-11-23 
Cooney, J. K., Law, R. J., Matschke, V., Lemmey, A. B., Moore, J. P., Ahmad, Y., . . . Thom, 
J. M. (2011). Benefits of exercise in rheumatoid arthritis. J Aging Res, 2011, 681640. 
doi:10.4061/2011/681640 
Copeland, J. L., & Esliger, D. W. (2009). Accelerometer assessment of physical activity in 
active, healthy older adults. J Aging Phys Act, 17(1), 17-30.  
Costa, R., Bastos, T., Probst, M., Seabra, A., Vilhena, E., & Corredeira, R. (2018). Autonomous 
motivation and quality of life as predictors of physical activity in patients with 
schizophrenia. Int J Psychiatry Clin Pract, 22(3), 184-190. 
doi:10.1080/13651501.2018.1435821 
 245 
Craig, C. L., Marshall, A. L., Sjostrom, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., . . 
. Oja, P. (2003). International physical activity questionnaire: 12-country reliability and 
validity. Med Sci Sports Exerc, 35(8), 1381-1395. 
doi:10.1249/01.MSS.0000078924.61453.FB 
Crespo, N. C., Mullane, S. L., Zeigler, Z. S., Buman, M. P., & Gaesser, G. A. (2016). Effects 
of Standing and Light-Intensity Walking and Cycling on 24-h Glucose. Med Sci Sports 
Exerc, 48(12), 2503-2511. doi:10.1249/MSS.0000000000001062 
Cross, M., Smith, E., Hoy, D., Carmona, L., Wolfe, F., Vos, T., . . . March, L. (2014). The 
global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 
study. Ann Rheum Dis, 73(7), 1316-1322. doi:10.1136/annrheumdis-2013-204627 
Dall, P. M., Coulter, E. H., Fitzsimons, C. F., Skelton, D. A., Chastin, S., & Seniors, U. S. P. 
T. (2017). TAxonomy of Self-reported Sedentary behaviour Tools (TASST) framework 
for development, comparison and evaluation of self-report tools: content analysis and 
systematic review. BMJ Open, 7(4), e013844. doi:10.1136/bmjopen-2016-013844 
Dall, P. M., Skelton, D. A., Dontje, M. L., Coulter, E. H., Stewart, S., Cox, S. R., . . . Chastin, 
S. (2018). Characteristics of a protocol to collect objective physical activity/sedentary 
behaviour data in a large study: Seniors USP (understanding sedentary patterns). J 
Meas Phys Behav, 1(1), 26-31. doi:10.1123/jmpb.2017-0004 
De Cocker, K., De Bourdeaudhuij, I., Cardon, G., & Vandelanotte, C. (2015). Theory-driven, 
web-based, computer-tailored advice to reduce and interrupt sitting at work: 
development, feasibility and acceptability testing among employees. BMC Public 
Health, 15, 959. doi:10.1186/s12889-015-2288-y 
de Jong, Z., Munneke, M., Zwinderman, A. H., Kroon, H. M., Jansen, A., Ronday, K. H., . . . 
Hazes, J. M. (2003). Is a long-term high-intensity exercise program effective and safe 
 246 
in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis 
Rheum, 48(9), 2415-2424. doi:10.1002/art.11216 
de Rezende, L. F., Rey-Lopez, J. P., Matsudo, V. K., & do Carmo Luiz, O. (2014). Sedentary 
behavior and health outcomes among older adults: a systematic review. BMC Public 
Health, 14, 333. doi:10.1186/1471-2458-14-333 
Deane, K. D., Demoruelle, M. K., Kelmenson, L. B., Kuhn, K. A., Norris, J. M., & Holers, V. 
M. (2017). Genetic and environmental risk factors for rheumatoid arthritis. Best Pract 
Res Clin Rheumatol, 31(1), 3-18. doi:10.1016/j.berh.2017.08.003 
Deci, E. L., & Ryan, R. M. (1985). Intrinsic motivation and self-determination in human 
behaviour: New York: Plenum. 
Deci, E. L., & Ryan, R. M. (1987). The support of autonomy and the control of behavior. J 
Pers Soc Psychol, 53(6), 1024-1037.  
Deci, E. L., & Ryan, R. M. (2000). The “what" and “why" of goal pursuits: human needs and 
the self-determination of behavior. Psychological Inquiry, 11(4), 227-268.  
Deci, E. L., & Ryan, R. M. (2008a). Facilitating optimal motivation and psychological well-
being across life's domains. Canadian Psychology, 49(1), 14-23.  
Deci, E. L., & Ryan, R. M. (2008b). Self-determination theory: A macrotheory of human 
motivation, development, and health. Canadian Psychology, 49(3), 182-185.  
Demmelmaier, I., & Iversen, M. D. (2018). How Are Behavioral Theories Used in 
Interventions to Promote Physical Activity in Rheumatoid Arthritis? A Systematic 
Review. Arthritis Care Res (Hoboken), 70(2), 185-196. doi:10.1002/acr.23265 
Demoruelle, M. K., Deane, K. D., & Holers, V. M. (2014). When and where does inflammation 
begin in rheumatoid arthritis? Curr Opin Rheumatol, 26(1), 64-71. 
doi:10.1097/BOR.0000000000000017 
 247 
Dogan, N. O. (2018). Bland-Altman analysis: A paradigm to understand correlation and 
agreement. Turk J Emerg Med, 18(4), 139-141. doi:10.1016/j.tjem.2018.09.001 
Dogra, S., & Stathokostas, L. (2012). Sedentary behavior and physical activity are independent 
predictors of successful aging in middle-aged and older adults. J Aging Res, 2012, 
190654. doi:10.1155/2012/190654 
Doherty, A., Jackson, D., Hammerla, N., Plotz, T., Olivier, P., Granat, M. H., . . . Wareham, 
N. J. (2017). Large Scale Population Assessment of Physical Activity Using Wrist 
Worn Accelerometers: The UK Biobank Study. PLoS One, 12(2), e0169649. 
doi:10.1371/journal.pone.0169649 
Dontje, M. L., Dall, P. M., Skelton, D. A., Gill, J. M. R., Chastin, S. F. M., & Seniors, U. S. P. 
T. (2018). Reliability, minimal detectable change and responsiveness to change: 
Indicators to select the best method to measure sedentary behaviour in older adults in 
different study designs. PLoS One, 13(4), e0195424. 
doi:10.1371/journal.pone.0195424 
Druce, K. L., Jones, G. T., Macfarlane, G. J., & Basu, N. (2015). Determining Pathways to 
Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for 
Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Rheumatol, 
67(9), 2303-2310. doi:10.1002/art.39238 
Duda, J. L., Williams, G. C., Ntoumanis, N., Daley, A., Eves, F. F., Mutrie, N., . . . Jolly, K. 
(2014). Effects of a standard provision versus an autonomy supportive exercise referral 
programme on physical activity, quality of life and well-being indicators: a cluster 
randomised controlled trial. Int J Behav Nutr Phys Act, 11, 10. doi:10.1186/1479-5868-
11-10 
 248 
Duncan, S., Stewart, T., Bo Schneller, M., Godbole, S., Cain, K., & Kerr, J. (2018). Convergent 
validity of ActiGraph and Actical accelerometers for estimating physical activity in 
adults. PLoS One, 13(6), e0198587. doi:10.1371/journal.pone.0198587 
Edwardson, C. L., Winkler, E. A. H., Bodicoat, D. H., Yates, T., Davies, M. J., Dunstan, D. 
W., & Healy, G. N. (2017). Considerations when using the activPAL monitor in field-
based research with adult populations. J Sport Health Sci, 6(2), 162-178. 
doi:10.1016/j.jshs.2016.02.002 
Efron, B. (1987). Better Bootstrap Confidence Intervals. Journal of the American Statistical 
Association, 82(397), 171-185. doi:10.1080/01621459.1987.10478410 
Efron, B., & Tibshirani, R. (1986). Bootstrap Methods for Standard Errors, Confidence 
Intervals, and Other Measures of Statistical Accuracy. Statist. Sci., 1(1), 54-75. 
doi:10.1214/ss/1177013815 
Efron, B., & Tibshirani, R. J. (1994). An introduction to the bootstrap. Boca Raton, FL: CRC 
press. 
Ekelund, U., Steene-Johannessen, J., Brown, W. J., Fagerland, M. W., Owen, N., Powell, K. 
E., . . . Lancet Sedentary Behaviour Working, G. (2016). Does physical activity 
attenuate, or even eliminate, the detrimental association of sitting time with mortality? 
A harmonised meta-analysis of data from more than 1 million men and women. Lancet, 
388(10051), 1302-1310. doi:10.1016/S0140-6736(16)30370-1 
Ekwall, A., Lindberg, A., & Magnusson, M. (2009). Dizzy - why not take a walk? Low level 
physical activity improves quality of life among elderly with dizziness. Gerontology, 
55(6), 652-659. doi:10.1159/000235812 
Englbrecht, M., Kruckow, M., Araujo, E., Rech, J., & Schett, G. (2013). The interaction of 
physical function and emotional well-being in rheumatoid arthritis--what is the impact 
 249 
on disease activity and coping? Semin Arthritis Rheum, 42(5), 482-491. 
doi:10.1016/j.semarthrit.2012.09.003 
Epstein, L. H., & Roemmich, J. N. (2001). Reducing sedentary behavior: role in modifying 
physical activity. Exerc Sport Sci Rev, 29(3), 103-108.  
Evenson, K. R., Wen, F., Herring, A. H., Di, C., LaMonte, M. J., Tinker, L. F., . . . Buchner, 
D. M. (2015). Calibrating physical activity intensity for hip-worn accelerometry in 
women age 60 to 91 years: The Women's Health Initiative OPACH Calibration Study. 
Prev Med Rep, 2, 750-756. doi:10.1016/j.pmedr.2015.08.021 
Falconer, C. L., Cooper, A. R., Walhin, J. P., Thompson, D., Page, A. S., Peters, T. J., . . . 
Andrews, R. C. (2014). Sedentary time and markers of inflammation in people with 
newly diagnosed type 2 diabetes. Nutr Metab Cardiovasc Dis, 24(9), 956-962. 
doi:10.1016/j.numecd.2014.03.009 
Fasczewski, K. S., Gill, D. L., & Rothberger, S. M. (2018). Physical activity motivation and 
benefits in people with multiple sclerosis. Disabil Rehabil, 40(13), 1517-1523. 
doi:10.1080/09638288.2017.1300946 
Fenton, S. A., & Kitas, G. D. (2016). Rheumatoid arthritis: Sedentary behaviour in RA - a new 
research agenda. Nat Rev Rheumatol, 12(12), 698-700. doi:10.1038/nrrheum.2016.179 
Fenton, S. A. M., Duda, J. L., Appleton, P. R., & Barrett, T. G. (2017). Empowering youth 
sport environments: Implications for daily moderate-to-vigorous physical activity and 
adiposity. J Sport Health Sci, 6(4), 423-433. doi:10.1016/j.jshs.2016.03.006 
Fenton, S. A. M., Sandoo, A., Metsios, G. S., Duda, J. L., Kitas, G. D., & Veldhuijzen van 
Zanten, J. (2018a). Sitting time is negatively related to microvascular endothelium-
dependent function in rheumatoid arthritis. Microvasc Res, 117, 57-60. 
doi:10.1016/j.mvr.2018.01.005 
 250 
Fenton, S. A. M., Veldhuijzen van Zanten, J., Duda, J. L., Metsios, G. S., & Kitas, G. D. 
(2018b). Sedentary behaviour in rheumatoid arthritis: definition, measurement and 
implications for health. Rheumatology (Oxford), 57(2), 213-226. 
doi:10.1093/rheumatology/kex053 
Fenton, S. A. M., Veldhuijzen van Zanten, J., Kitas, G. D., Duda, J. L., Rouse, P. C., Yu, C. 
A., & Metsios, G. S. (2017). Sedentary behaviour is associated with increased long-
term cardiovascular risk in patients with rheumatoid arthritis independently of 
moderate-to-vigorous physical activity. BMC Musculoskelet Disord, 18(1), 131. 
doi:10.1186/s12891-017-1473-9 
Fenton, S. A. M., Veldhuijzen Van Zanten, J. J. C. S., Metsios, G. S., Rouse, P. C., Yu, C. A., 
Kitas, G. D., & Duda, J. L. (2018c). Autonomy support, light physical activity and 
psychological well-being in Rheumatoid Arthritis: A cross-sectional study. Mental 
Health and Physical Activity, 14, 11-18. 
doi:https://doi.org/10.1016/j.mhpa.2017.12.002 
Ferro, F., Elefante, E., Luciano, N., Talarico, R., & Todoerti, M. (2017). One year in review 
2017: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol, 35(5), 
721-734.  
Fiest, K. M., Hitchon, C. A., Bernstein, C. N., Peschken, C. A., Walker, J. R., Graff, L. A., . . 
. Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory, 
D. (2017). Systematic Review and Meta-analysis of Interventions for Depression and 
Anxiety in Persons With Rheumatoid Arthritis. J Clin Rheumatol, 23(8), 425-434. 
doi:10.1097/RHU.0000000000000489 
Fitzgerald, J. D., Johnson, L., Hire, D. G., Ambrosius, W. T., Anton, S. D., Dodson, J. A., . . . 
Group, L. S. R. (2015). Association of objectively measured physical activity with 
 251 
cardiovascular risk in mobility-limited older adults. J Am Heart Assoc, 4(2). 
doi:10.1161/JAHA.114.001288 
Ford, E. S., & Caspersen, C. J. (2012). Sedentary behaviour and cardiovascular disease: a 
review of prospective studies. Int J Epidemiol, 41(5), 1338-1353. 
doi:10.1093/ije/dys078 
Fortier, M. S., Duda, J. L., Guerin, E., & Teixeira, P. J. (2012). Promoting physical activity: 
development and testing of self-determination theory-based interventions. Int J Behav 
Nutr Phys Act, 9, 20. doi:10.1186/1479-5868-9-20 
Freedson, P. S., Melanson, E., & Sirard, J. (1998). Calibration of the Computer Science and 
Applications, Inc. accelerometer. Med Sci Sports Exerc, 30(5), 777-781.  
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980). Measurement of patient outcome 
in arthritis. Arthritis Rheum, 23(2), 137-145. doi:10.1002/art.1780230202 
Gaston, A., De Jesus, S., Markland, D., & Prapavessis, H. (2016). I sit because I have fun when 
I do so! Using self-determination theory to understand sedentary behavior motivation 
among university students and staff. Health Psychology and Behavioral Medicine, 4(1), 
138-154. doi:10.1080/21642850.2016.1170605 
Gettings, L. (2010). Psychological well-being in rheumatoid arthritis: a review of the literature. 
Musculoskeletal Care, 8(2), 99-106. doi:10.1002/msc.171 
Giavarina, D. (2015). Understanding Bland Altman analysis. Biochem Med (Zagreb), 25(2), 
141-151. doi:10.11613/BM.2015.015 
Giles, J. T., Bartlett, S. J., Andersen, R. E., Fontaine, K. R., & Bathon, J. M. (2008). Association 
of body composition with disability in rheumatoid arthritis: impact of appendicular fat 
and lean tissue mass. Arthritis Rheum, 59(10), 1407-1415. doi:10.1002/art.24109 
 252 
Gillison, F., Osborn, M., Standage, M., & Skevington, S. (2009). Exploring the experience of 
introjected regulation for exercise across gender in adolescence. Psychology of Sport 
and Exercise, 10(3), 309-319. doi:https://doi.org/10.1016/j.psychsport.2008.10.004 
Godin, G., & Shephard, R. J. (1985). A simple method to assess exercise behavior in the 
community. Can J Appl Sport Sci, 10(3), 141-146.  
Gorman, E., Hanson, H. M., Yang, P. H., Khan, K. M., Liu-Ambrose, T., & Ashe, M. C. (2014). 
Accelerometry analysis of physical activity and sedentary behavior in older adults: a 
systematic review and data analysis. Eur Rev Aging Phys Act, 11, 35-49. 
doi:10.1007/s11556-013-0132-x 
Graf, J., Scherzer, R., Grunfeld, C., & Imboden, J. (2009). Levels of C-reactive protein 
associated with high and very high cardiovascular risk are prevalent in patients with 
rheumatoid arthritis. PLoS One, 4(7), e6242. doi:10.1371/journal.pone.0006242 
Greene, B. L., Haldeman, G. F., Kaminski, A., Neal, K., Lim, S. S., & Conn, D. L. (2006). 
Factors affecting physical activity behavior in urban adults with arthritis who are 
predominantly African-American and female. Phys Ther, 86(4), 510-519.  
Hallgren, M., Nguyen, T. T., Owen, N., Stubbs, B., Vancampfort, D., Lundin, A., . . . Lagerros, 
Y. T. (2019). Cross-sectional and prospective relationships of passive and mentally 
active sedentary behaviours and physical activity with depression. Br J Psychiatry, 1-
7. doi:10.1192/bjp.2019.60 
Hallgren, M., Owen, N., Stubbs, B., Zeebari, Z., Vancampfort, D., Schuch, F., . . . Trolle 
Lagerros, Y. (2018). Passive and mentally-active sedentary behaviors and incident 
major depressive disorder: A 13-year cohort study. J Affect Disord, 241, 579-585. 
doi:10.1016/j.jad.2018.08.020 
 253 
Hamilton, M. T., Hamilton, D. G., & Zderic, T. W. (2014). Sedentary behavior as a mediator 
of type 2 diabetes. Med Sport Sci, 60, 11-26. doi:10.1159/000357332 
Hammam, N., Ezeugwu, V. E., Rumsey, D. G., Manns, P. J., & Pritchard-Wiart, L. (2019). 
Physical activity, sedentary behavior, and long-term cardiovascular risk in individuals 
with rheumatoid arthritis. Phys Sportsmed, 1-8. doi:10.1080/00913847.2019.1623995 
Hansen, S. M., Hetland, M. L., Pedersen, J., Ostergaard, M., Rubak, T. S., & Bjorner, J. B. 
(2016). Effect of Rheumatoid Arthritis on Longterm Sickness Absence in 1994-2011: 
A Danish Cohort Study. J Rheumatol, 43(4), 707-715. doi:10.3899/jrheum.150801 
Harvey, J. A., Chastin, S. F., & Skelton, D. A. (2015). How Sedentary are Older People? A 
Systematic Review of the Amount of Sedentary Behavior. J Aging Phys Act, 23(3), 
471-487. doi:10.1123/japa.2014-0164 
Hawker, G. A., Mian, S., Kendzerska, T., & French, M. (2011). Measures of adult pain: Visual 
Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill 
Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), 
Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and 
Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res 
(Hoboken), 63 Suppl 11, S240-252. doi:10.1002/acr.20543 
Hazes, J. M. (2003). Determinants of physical function in rheumatoid arthritis: association with 
the disease process. Rheumatology (Oxford), 42 Suppl 2, ii17-21. 
doi:10.1093/rheumatology/keg328 
Healy, G. N., Clark, B. K., Winkler, E. A., Gardiner, P. A., Brown, W. J., & Matthews, C. E. 
(2011a). Measurement of adults' sedentary time in population-based studies. Am J Prev 
Med, 41(2), 216-227. doi:10.1016/j.amepre.2011.05.005 
 254 
Healy, G. N., Matthews, C. E., Dunstan, D. W., Winkler, E. A., & Owen, N. (2011b). Sedentary 
time and cardio-metabolic biomarkers in US adults: NHANES 2003-06. Eur Heart J, 
32(5), 590-597. doi:10.1093/eurheartj/ehq451 
Healy, G. N., Wijndaele, K., Dunstan, D. W., Shaw, J. E., Salmon, J., Zimmet, P. Z., & Owen, 
N. (2008). Objectively measured sedentary time, physical activity, and metabolic risk: 
the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care, 31(2), 
369-371. doi:10.2337/dc07-1795 
Heesch, K. C., Hill, R. L., Aguilar-Farias, N., van Uffelen, J. G. Z., & Pavey, T. (2018). 
Validity of objective methods for measuring sedentary behaviour in older adults: a 
systematic review. Int J Behav Nutr Phys Act, 15(1), 119. doi:10.1186/s12966-018-
0749-2 
Hensman, M., Motl, R. W., Pilutti, L. A., Fenton, S. A. M., Duda, J. L., Douglas, M., & 
Veldhuijzen van Zanten, J. (2019). Comparison of sedentary behaviour questionnaires 
in people with multiple sclerosis. Disabil Rehabil, 1-8. 
doi:10.1080/09638288.2019.1597179 
Henson, J., Yates, T., Edwardson, C. L., Khunti, K., Talbot, D., Gray, L. J., . . . Davies, M. J. 
(2013). Sedentary time and markers of chronic low-grade inflammation in a high risk 
population. PLoS One, 8(10), e78350. doi:10.1371/journal.pone.0078350 
Hernandez-Hernandez, M. V., & Diaz-Gonzalez, F. (2017). Role of physical activity in the 
management and assessment of rheumatoid arthritis patients. Reumatol Clin, 13(4), 
214-220. doi:10.1016/j.reuma.2016.04.003 
Hernandez-Hernandez, V., Ferraz-Amaro, I., & Diaz-Gonzalez, F. (2014). Influence of disease 
activity on the physical activity of rheumatoid arthritis patients. Rheumatology 
(Oxford), 53(4), 722-731. doi:10.1093/rheumatology/ket422 
 255 
Hewlett, S., Cockshott, Z., Byron, M., Kitchen, K., Tipler, S., Pope, D., & Hehir, M. (2005). 
Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, 
ignored. Arthritis Rheum, 53(5), 697-702. doi:10.1002/art.21450 
Hewlett, S., Hehir, M., & Kirwan, J. R. (2007). Measuring fatigue in rheumatoid arthritis: a 
systematic review of scales in use. Arthritis Rheum, 57(3), 429-439. 
doi:10.1002/art.22611 
Hopkins, W. G., Marshall, S. W., Batterham, A. M., & Hanin, J. (2009). Progressive statistics 
for studies in sports medicine and exercise science. Med Sci Sports Exerc, 41(1), 3-13. 
doi:10.1249/MSS.0b013e31818cb278 
Howell, D. C. (2007). Statistical methods for psychology (6th ed.). Belmont, CA: Thomson 
Wadsworth. 
Hurkmans, E. J., Maes, S., de Gucht, V., Knittle, K., Peeters, A. J., Ronday, H. K., & Vlieland, 
T. P. (2010). Motivation as a determinant of physical activity in patients with 
rheumatoid arthritis. Arthritis Care Res (Hoboken), 62(3), 371-377. 
doi:10.1002/acr.20106 
Isik, A., Koca, S. S., Ozturk, A., & Mermi, O. (2007). Anxiety and depression in patients with 
rheumatoid arthritis. Clin Rheumatol, 26(6), 872-878. doi:10.1007/s10067-006-0407-y 
Iversen, M. D., Frits, M., von Heideken, J., Cui, J., Weinblatt, M., & Shadick, N. A. (2017). 
Physical Activity and Correlates of Physical Activity Participation Over Three Years 
in Adults With Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 69(10), 1535-
1545. doi:10.1002/acr.23156 
Janz, K. F. (2006). Physical activity in epidemiology: moving from questionnaire to objective 
measurement. Br J Sports Med, 40(3), 191-192. doi:10.1136/bjsm.2005.023036 
 256 
Katz, P. (2017a). Causes and consequences of fatigue in rheumatoid arthritis. Curr Opin 
Rheumatol, 29(3), 269-276. doi:10.1097/BOR.0000000000000376 
Katz, P. (2017b). Fatigue in Rheumatoid Arthritis. Curr Rheumatol Rep, 19(5), 25. 
doi:10.1007/s11926-017-0649-5 
Keadle, S. K., Conroy, D. E., Buman, M. P., Dunstan, D. W., & Matthews, C. E. (2017). 
Targeting Reductions in Sitting Time to Increase Physical Activity and Improve Health. 
Med Sci Sports Exerc, 49(8), 1572-1582. doi:10.1249/MSS.0000000000001257 
Kelly, M. P., & Barker, M. (2016). Why is changing health-related behaviour so difficult? 
Public Health, 136, 109-116. doi:10.1016/j.puhe.2016.03.030 
Khoja, S. S., Almeida, G. J., Chester Wasko, M., Terhorst, L., & Piva, S. R. (2016). Association 
of Light-Intensity Physical Activity With Lower Cardiovascular Disease Risk Burden 
in Rheumatoid Arthritis. Arthritis Care Res (Hoboken), 68(4), 424-431. 
doi:10.1002/acr.22711 
Kiecolt-Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015). Inflammation: depression fans 
the flames and feasts on the heat. Am J Psychiatry, 172(11), 1075-1091. 
doi:10.1176/appi.ajp.2015.15020152 
Kim, Y., & Welk, G. J. (2015a). Characterizing the context of sedentary lifestyles in a 
representative sample of adults: a cross-sectional study from the physical activity 
measurement study project. BMC Public Health, 15, 1218. doi:10.1186/s12889-015-
2558-8 
Kim, Y., & Welk, G. J. (2015b). Criterion Validity of Competing Accelerometry-Based 
Activity Monitoring Devices. Med Sci Sports Exerc, 47(11), 2456-2463. 
doi:10.1249/MSS.0000000000000691 
 257 
Kirwan, J. R., Minnock, P., Adebajo, A., Bresnihan, B., Choy, E., de Wit, M., . . . Hewlett, S. 
(2007). Patient perspective: fatigue as a recommended patient centered outcome 
measure in rheumatoid arthritis. J Rheumatol, 34(5), 1174-1177.  
Kirwan, J. R., & Reeback, J. S. (1986). Stanford Health Assessment Questionnaire modified 
to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol, 25(2), 
206-209.  
Kojima, M., Kojima, T., Suzuki, S., Oguchi, T., Oba, M., Tsuchiya, H., . . . Ishiguro, N. (2009). 
Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis 
Rheum, 61(8), 1018-1024. doi:10.1002/art.24647 
Koponen, A. M., Simonsen, N., & Suominen, S. (2017). Determinants of physical activity 
among patients with type 2 diabetes: the role of perceived autonomy support, 
autonomous motivation and self-care competence. Psychol Health Med, 22(3), 332-
344. doi:10.1080/13548506.2016.1154179 
Kowalski, K., Rhodes, R., Naylor, P. J., Tuokko, H., & MacDonald, S. (2012). Direct and 
indirect measurement of physical activity in older adults: a systematic review of the 
literature. Int J Behav Nutr Phys Act, 9, 148. doi:10.1186/1479-5868-9-148 
Kozey-Keadle, S., Libertine, A., Lyden, K., Staudenmayer, J., & Freedson, P. S. (2011). 
Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports 
Exerc, 43(8), 1561-1567. doi:10.1249/MSS.0b013e31820ce174 
Kramer, H. R., Fontaine, K. R., Bathon, J. M., & Giles, J. T. (2012). Muscle density in 
rheumatoid arthritis: associations with disease features and functional outcomes. 
Arthritis Rheum, 64(8), 2438-2450. doi:10.1002/art.34464 
Kruisdijk, F., Deenik, J., Tenback, D., Tak, E., Beekman, A. J., van Harten, P., . . . Hendriksen, 
I. (2017). Accelerometer-measured sedentary behaviour and physical activity of 
 258 
inpatients with severe mental illness. Psychiatry Res, 254, 67-74. 
doi:10.1016/j.psychres.2017.04.035 
Kwan, Y. H., Koh, E. T., Leong, K. P., & Wee, H. L. (2014). Association between helplessness, 
disability, and disease activity with health-related quality of life among rheumatoid 
arthritis patients in a multiethnic Asian population. Rheumatol Int, 34(8), 1085-1093. 
doi:10.1007/s00296-013-2938-2 
Larkin, L., Kennedy, N., Fraser, A., & Gallagher, S. (2017). 'It might hurt, but still it's good': 
People with rheumatoid arthritis beliefs and expectations about physical activity 
interventions. J Health Psychol, 22(13), 1678-1690. doi:10.1177/1359105316633286 
Larkin, L., Nordgren, B., Purtill, H., Brand, C., Fraser, A., & Kennedy, N. (2016). Criterion 
Validity of the activPAL Activity Monitor for Sedentary and Physical Activity Patterns 
in People Who Have Rheumatoid Arthritis. Phys Ther, 96(7), 1093-1101. 
doi:10.2522/ptj.20150281 
Lee, I. M., & Shiroma, E. J. (2014). Using accelerometers to measure physical activity in large-
scale epidemiological studies: issues and challenges. Br J Sports Med, 48(3), 197-201. 
doi:10.1136/bjsports-2013-093154 
Lee, J., Dunlop, D., Ehrlich-Jones, L., Semanik, P., Song, J., Manheim, L., & Chang, R. W. 
(2012). Public health impact of risk factors for physical inactivity in adults with 
rheumatoid arthritis. Arthritis Care Res (Hoboken), 64(4), 488-493. 
doi:10.1002/acr.21582 
Leenders, N. Y., Sherman, W. M., Nagaraja, H. N., & Kien, C. L. (2001). Evaluation of 
methods to assess physical activity in free-living conditions. Med Sci Sports Exerc, 
33(7), 1233-1240.  
 259 
Lok, E. Y., Mok, C. C., Cheng, C. W., & Cheung, E. F. (2010). Prevalence and determinants 
of psychiatric disorders in patients with rheumatoid arthritis. Psychosomatics, 51(4), 
338-338 e338. doi:10.1176/appi.psy.51.4.338 
Lonsdale, C., Hodge, K., & Rose, E. A. (2008). The behavioral regulation in sport 
questionnaire (BRSQ): instrument development and initial validity evidence. J Sport 
Exerc Psychol, 30(3), 323-355.  
Loppenthin, K., Esbensen, B. A., Ostergaard, M., Jennum, P., Tolver, A., Aadahl, M., . . . 
Midtgaard, J. (2015). Physical activity and the association with fatigue and sleep in 
Danish patients with rheumatoid arthritis. Rheumatol Int, 35(10), 1655-1664. 
doi:10.1007/s00296-015-3274-5 
Lubans, D. R., Lonsdale, C., Plotnikoff, R. C., Smith, J., Dally, K., & Morgan, P. J. (2013). 
Development and evaluation of the Motivation to Limit Screen-time Questionnaire 
(MLSQ) for adolescents. Prev Med, 57(5), 561-566. doi:10.1016/j.ypmed.2013.07.023 
Lyden, K., Keadle, S. K., Staudenmayer, J., & Freedson, P. S. (2017). The activPALTM 
Accurately Classifies Activity Intensity Categories in Healthy Adults. Med Sci Sports 
Exerc, 49(5), 1022-1028. doi:10.1249/MSS.0000000000001177 
Madsen, S. G., Danneskiold-Samsoe, B., Stockmarr, A., & Bartels, E. M. (2016). Correlations 
between fatigue and disease duration, disease activity, and pain in patients with 
rheumatoid arthritis: a systematic review. Scand J Rheumatol, 45(4), 255-261. 
doi:10.3109/03009742.2015.1095943 
Makinen, H., Kautiainen, H., Hannonen, P., Mottonen, T., Korpela, M., Leirisalo-Repo, M., . 
. . Sokka, T. (2007). Disease activity score 28 as an instrument to measure disease 
activity in patients with early rheumatoid arthritis. J Rheumatol, 34(10), 1987-1991.  
 260 
Manns, P. J., Dunstan, D. W., Owen, N., & Healy, G. N. (2012). Addressing the nonexercise 
part of the activity continuum: a more realistic and achievable approach to activity 
programming for adults with mobility disability? Phys Ther, 92(4), 614-625. 
doi:10.2522/ptj.20110284 
Margaretten, M., Julian, L., Katz, P., & Yelin, E. (2011). Depression in patients with 
rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol, 6(6), 
617-623. doi:10.2217/IJR.11.6 
Markland, D., & Tobin, V. (2004). A modification to the Behavioural Regulation in Exercise 
Questionnaire to include an assessment of amotivation. J Sport Exerc Psychol, 26(2), 
191-196.  
Marques, E. A., Baptista, F., Santos, D. A., Silva, A. M., Mota, J., & Sardinha, L. B. (2014). 
Risk for losing physical independence in older adults: the role of sedentary time, light, 
and moderate to vigorous physical activity. Maturitas, 79(1), 91-95. 
doi:10.1016/j.maturitas.2014.06.012 
Martin, A., Fitzsimons, C., Jepson, R., Saunders, D. H., van der Ploeg, H. P., Teixeira, P. J., . 
. . Mutrie, N. (2015). Interventions with potential to reduce sedentary time in adults: 
systematic review and meta-analysis. Br J Sports Med, 49(16), 1056-1063. 
doi:10.1136/bjsports-2014-094524 
Masse, L. C., Fuemmeler, B. F., Anderson, C. B., Matthews, C. E., Trost, S. G., Catellier, D. 
J., & Treuth, M. (2005). Accelerometer data reduction: a comparison of four reduction 
algorithms on select outcome variables. Med Sci Sports Exerc, 37(11 Suppl), S544-554.  
Matcham, F., Rayner, L., Steer, S., & Hotopf, M. (2013). The prevalence of depression in 
rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford), 
52(12), 2136-2148. doi:10.1093/rheumatology/ket169 
 261 
Matcham, F., Scott, I. C., Rayner, L., Hotopf, M., Kingsley, G. H., Norton, S., . . . Steer, S. 
(2014). The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: 
a systematic review and meta-analysis. Semin Arthritis Rheum, 44(2), 123-130. 
doi:10.1016/j.semarthrit.2014.05.001 
Matthews, C. E., Chen, K. Y., Freedson, P. S., Buchowski, M. S., Beech, B. M., Pate, R. R., & 
Troiano, R. P. (2008). Amount of time spent in sedentary behaviors in the United States, 
2003-2004. Am J Epidemiol, 167(7), 875-881. doi:10.1093/aje/kwm390 
Matthews, C. E., Hagstromer, M., Pober, D. M., & Bowles, H. R. (2012). Best practices for 
using physical activity monitors in population-based research. Med Sci Sports Exerc, 
44(1 Suppl 1), S68-76. doi:10.1249/MSS.0b013e3182399e5b 
Melzack, R. (1987). The short-form McGill Pain Questionnaire. Pain, 30(2), 191-197.  
Merksey, H., Lindblom, U., & Mumford, J. M. (1979). Pain terms: a list with definitions and 
notes on usage. Recommended by the IASP Subcommittee on Taxonomy. Pain, 6(3), 
249.  
Metsios, G. S., & Kitas, G. D. (2018). Physical activity, exercise and rheumatoid arthritis: 
Effectiveness, mechanisms and implementation. Best Pract Res Clin Rheumatol, 32(5), 
669-682. doi:10.1016/j.berh.2019.03.013 
Metsios, G. S., Stavropoulos-Kalinoglou, A., & Kitas, G. D. (2015). The role of exercise in the 
management of rheumatoid arthritis. Expert Rev Clin Immunol, 11(10), 1121-1130. 
doi:10.1586/1744666X.2015.1067606 
Metsios, G. S., Stavropoulos-Kalinoglou, A., Panoulas, V. F., Koutedakis, Y., Nevill, A. M., 
Douglas, K. M., . . . Kitas, G. D. (2008). New resting energy expenditure prediction 
equations for patients with rheumatoid arthritis. Rheumatology (Oxford), 47(4), 500-
506. doi:10.1093/rheumatology/ken022 
 262 
Metsios, G. S., Stavropoulos-Kalinoglou, A., Panoulas, V. F., Wilson, M., Nevill, A. M., 
Koutedakis, Y., & Kitas, G. D. (2009). Association of physical inactivity with increased 
cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev 
Rehabil, 16(2), 188-194. doi:10.1097/HJR.0b013e3283271ceb 
Metsios, G. S., Stavropoulos-Kalinoglou, A., Treharne, G. J., Nevill, A. M., Sandoo, A., 
Panoulas, V. F., . . . Kitas, G. D. (2011). Disease activity and low physical activity 
associate with number of hospital admissions and length of hospitalisation in patients 
with rheumatoid arthritis. Arthritis Res Ther, 13(3), R108. doi:10.1186/ar3390 
Michie, S., Hardeman, W., Fanshawe, T., Prevost, A. T., Taylor, L., & Kinmonth, A. L. (2008). 
Investigating theoretical explanations for behaviour change: the case study of 
ProActive. Psychol Health, 23(1), 25-39. doi:10.1080/08870440701670588 
Milne, H. M., Wallman, K. E., Guilfoyle, A., Gordon, S., & Corneya, K. S. (2008). Self-
determination theory and physical activity among breast cancer survivors. J Sport Exerc 
Psychol, 30(1), 23-38.  
Montoye, A. H. K., Pivarnik, J. M., Mudd, L. M., Biswas, S., & Pfeiffer, K. A. (2017). 
Evaluation of the activPAL accelerometer for physical activity and energy expenditure 
estimation in a semi-structured setting. J Sci Med Sport, 20(11), 1003-1007. 
doi:10.1016/j.jsams.2017.04.011 
Montoye, H. J. (2000). Introduction: evaluation of some measurements of physical activity and 
energy expenditure. Med Sci Sports Exerc, 32(9 Suppl), S439-441.  
Motl, R. W., Snook, E. M., Agiovlasitis, S., & Suh, Y. (2009). Calibration of accelerometer 
output for ambulatory adults with multiple sclerosis. Arch Phys Med Rehabil, 90(10), 
1778-1784. doi:10.1016/j.apmr.2009.03.020 
 263 




Nelson, E. C., Landgraf, J. M., Hays, R. D., Wasson, J. H., & Kirk, J. W. (1990). The functional 
status of patients. How can it be measured in physicians' offices? Med Care, 28(12), 
1111-1126.  
Nero, H., Benka Wallen, M., Franzen, E., Stahle, A., & Hagstromer, M. (2015). Accelerometer 
Cut Points for Physical Activity Assessment of Older Adults with Parkinson's Disease. 
PLoS One, 10(9), e0135899. doi:10.1371/journal.pone.0135899 
Nerurkar, L., Siebert, S., McInnes, I. B., & Cavanagh, J. (2019). Rheumatoid arthritis and 
depression: an inflammatory perspective. Lancet Psychiatry, 6(2), 164-173. 
doi:10.1016/S2215-0366(18)30255-4 
Ng, J. Y., Ntoumanis, N., Thogersen-Ntoumani, C., Deci, E. L., Ryan, R. M., Duda, J. L., & 
Williams, G. C. (2012). Self-Determination Theory Applied to Health Contexts: A 
Meta-Analysis. Perspect Psychol Sci, 7(4), 325-340. doi:10.1177/1745691612447309 
Nicholls, J. G. (1989). The competitive ethos and democratic education. Cambridge, MA, US: 
Havard University Press. 
Norton, K., Norton, L., & Sadgrove, D. (2010). Position statement on physical activity and 
exercise intensity terminology. J Sci Med Sport, 13(5), 496-502. 
doi:10.1016/j.jsams.2009.09.008 
O’Brien, C. M., Duda, J. L., Kitas, G. D., & Fenton, S. A. M. (2018). Sedentary Time. 
Encyclopedia of Behavioral Medicine: Springer, New York, NY. 
 264 
O’Brien, C. M., Duda, J. L., Kitas, G. D., Veldhuijzen van Zanten, J. J. C. S., Metsios, G. S., 
& Fenton, S. A. (2019). Objective measurement of sedentary time and physical activity 
in people with rheumatoid arthritis: protocol for an accelerometer and activPAL 
validation study. Mediterranean Journal of Rheumatology, 30(2), 125-134.    
O’Brien, C. M., Duda, J. L., Kitas, G. D., Veldhuijzen van Zanten, J. J. C. S., Metsios, G. S., 
& Fenton, S. A. M. (2018). Correlates of sedentary behaviour and light physical activity 
in people living with rheumatoid arthritis: protocol for a longitudinal study. 
Mediterranean Journal of Rheumatology, 29(2), 106-117. 
doi:https://doi.org/10.31138/mjr.29.2.106 
Okely, J. A., Cukic, I., Shaw, R. J., Chastin, S. F., Dall, P. M., Deary, I. J., . . . Seniors, U. S. 
P. t. (2019). Positive and negative well-being and objectively measured sedentary 
behaviour in older adults: evidence from three cohorts. BMC Geriatr, 19(1), 28. 
doi:10.1186/s12877-019-1026-1 
Olsen, C. L., Lie, E., Kvien, T. K., & Zangi, H. A. (2016). Predictors of Fatigue in Rheumatoid 
Arthritis Patients in Remission or in a Low Disease Activity State. Arthritis Care Res 
(Hoboken), 68(7), 1043-1048. doi:10.1002/acr.22787 
Overman, C. L., Kool, M. B., Da Silva, J. A., & Geenen, R. (2016). The prevalence of severe 
fatigue in rheumatic diseases: an international study. Clin Rheumatol, 35(2), 409-415. 
doi:10.1007/s10067-015-3035-6 
Owen, N., Sparling, P. B., Healy, G. N., Dunstan, D. W., & Matthews, C. E. (2010). Sedentary 
behavior: emerging evidence for a new health risk. Mayo Clin Proc, 85(12), 1138-1141. 
doi:10.4065/mcp.2010.0444 
Panoulas, V. F., Douglas, K. M., Milionis, H. J., Stavropoulos-Kalinglou, A., Nightingale, P., 
Kita, M. D., . . . Kitas, G. D. (2007). Prevalence and associations of hypertension and 
 265 
its control in patients with rheumatoid arthritis. Rheumatology (Oxford), 46(9), 1477-
1482. doi:10.1093/rheumatology/kem169 
Park, S., Thogersen-Ntoumani, C., Veldhuijzen van Zanten, J., & Ntoumanis, N. (2018). The 
Role of Physical Activity and Sedentary Behavior in Predicting Daily Pain and Fatigue 
in Older Adults: a Diary Study. Ann Behav Med, 52(1), 19-28. doi:10.1007/s12160-
017-9921-1 
Patterson, R., McNamara, E., Tainio, M., de Sa, T. H., Smith, A. D., Sharp, S. J., . . . Wijndaele, 
K. (2018). Sedentary behaviour and risk of all-cause, cardiovascular and cancer 
mortality, and incident type 2 diabetes: a systematic review and dose response meta-
analysis. Eur J Epidemiol, 33(9), 811-829. doi:10.1007/s10654-018-0380-1 
Paul, L., Rafferty, D., Marshall-McKenna, R., Gill, J. M., McInnes, I., Porter, D., & Woodburn, 
J. (2014). Oxygen cost of walking, physical activity, and sedentary behaviours in 
rheumatoid arthritis. Scand J Rheumatol, 43(1), 28-34. 
doi:10.3109/03009742.2013.802009 
Pedisic, Z., & Bauman, A. (2015). Accelerometer-based measures in physical activity 
surveillance: current practices and issues. Br J Sports Med, 49(4), 219-223. 
doi:10.1136/bjsports-2013-093407 
Pelletier, L. G., Fortier, M. S., Vallerand, R. J., Brière, N. M. J. M., & Emotion. (2001). 
Associations Among Perceived Autonomy Support, Forms of Self-Regulation, and 
Persistence: A Prospective Study. 25(4), 279-306. doi:10.1023/a:1014805132406 
Pfister, T., Matthews, C. E., Wang, Q., Kopciuk, K. A., Courneya, K., & Friedenreich, C. 
(2017). Comparison of two accelerometers for measuring physical activity and 
sedentary behaviour. BMJ Open Sport Exerc Med, 3(1), e000227. doi:10.1136/bmjsem-
2017-000227 
 266 
Phillips, L. A., & Johnson, M. A. (2018). Interdependent Effects of Autonomous and 
Controlled Regulation on Exercise Behavior. Pers Soc Psychol Bull, 44(1), 49-62. 
doi:10.1177/0146167217733068 
Plasqui, G. (2008). The role of physical activity in rheumatoid arthritis. Physiol Behav, 94(2), 
270-275. doi:10.1016/j.physbeh.2007.12.012 
Prevoo, M. L., van 't Hof, M. A., Kuper, H. H., van Leeuwen, M. A., van de Putte, L. B., & 
van Riel, P. L. (1995). Modified disease activity scores that include twenty-eight-joint 
counts. Development and validation in a prospective longitudinal study of patients with 
rheumatoid arthritis. Arthritis Rheum, 38(1), 44-48. doi:10.1002/art.1780380107 
Prince, S. A., Saunders, T. J., Gresty, K., & Reid, R. D. (2014). A comparison of the 
effectiveness of physical activity and sedentary behaviour interventions in reducing 
sedentary time in adults: a systematic review and meta-analysis of controlled trials. 
Obes Rev, 15(11), 905-919. doi:10.1111/obr.12215 
Prioreschi, A., Hodkinson, B., Tikly, M., & McVeigh, J. A. (2014). Changes in physical 
activity measured by accelerometry following initiation of DMARD therapy in 
rheumatoid arthritis. Rheumatology (Oxford), 53(5), 923-926. 
doi:10.1093/rheumatology/ket457 
Puth, M. T., Neuhauser, M., & Ruxton, G. D. (2015). On the variety of methods for calculating 
confidence intervals by bootstrapping. J Anim Ecol, 84(4), 892-897. doi:10.1111/1365-
2656.12382 
Quartiroli, A., & Maeda, H. (2014). Self-determined Engagement in Physical Activity and 
Sedentary Behaviors of US College Students. Int J Exerc Sci, 7(1), 87-97.  
Quested, E., & Duda, J. L. (2011). Perceived autonomy support, motivation regulations and 
the self-evaluative tendencies of student dancers. J Dance Med Sci, 15(1), 3-14.  
 267 
Radner, H., Smolen, J. S., & Aletaha, D. (2011). Comorbidity affects all domains of physical 
function and quality of life in patients with rheumatoid arthritis. Rheumatology 
(Oxford), 50(2), 381-388. doi:10.1093/rheumatology/keq334 
Radner, H., Smolen, J. S., & Aletaha, D. (2014). Remission in rheumatoid arthritis: benefit 
over low disease activity in patient-reported outcomes and costs. Arthritis Res Ther, 
16(1), R56. doi:10.1186/ar4491 
Rahnama, N., & Mazloum, V. (2012). Effects of strengthening and aerobic exercises on pain 
severity and function in patients with knee rheumatoid arthritis. Int J Prev Med, 3(7), 
493-498.  
Ramey, D. R., Raynauld, J. P., & Fries, J. F. (1992). The health assessment questionnaire 1992: 
status and review. Arthritis Care Res, 5(3), 119-129.  
Rausch Osthoff, A. K., Niedermann, K., Braun, J., Adams, J., Brodin, N., Dagfinrud, H., . . . 
Vliet Vlieland, T. P. M. (2018). 2018 EULAR recommendations for physical activity 
in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis, 77(9), 1251-
1260. doi:10.1136/annrheumdis-2018-213585 
Repping-Wuts, H., Uitterhoeve, R., van Riel, P., & van Achterberg, T. (2008). Fatigue as 
experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs 
Stud, 45(7), 995-1002. doi:10.1016/j.ijnurstu.2007.06.007 
Rollo, S., Gaston, A., & Prapavessis, H. (2016). Cognitive and Motivational Factors Associated 
with Sedentary Behavior: A Systematic Review. AIMS Public Health, 3(4), 956-984. 
doi:10.3934/publichealth.2016.4.956 
Rongen-van Dartel, S. A., Repping-Wuts, H., Flendrie, M., Bleijenberg, G., Metsios, G. S., 
van den Hout, W. B., . . . Fransen, J. (2015). Effect of Aerobic Exercise Training on 
 268 
Fatigue in Rheumatoid Arthritis: A Meta-Analysis. Arthritis Care Res (Hoboken), 
67(8), 1054-1062. doi:10.1002/acr.22561 
Rosa-Goncalves, D., Bernardes, M., & Costa, L. (2018). Quality of life and functional capacity 
in patients with rheumatoid arthritis - Cross-sectional study. Reumatol Clin, 14(6), 360-
366. doi:10.1016/j.reuma.2017.03.002 
Rosenberg, D. E., Bellettiere, J., Gardiner, P. A., Villarreal, V. N., Crist, K., & Kerr, J. (2016). 
Independent Associations Between Sedentary Behaviors and Mental, Cognitive, 
Physical, and Functional Health Among Older Adults in Retirement Communities. J 
Gerontol A Biol Sci Med Sci, 71(1), 78-83. doi:10.1093/gerona/glv103 
Rouse, P. C., Veldhuijzen Van Zanten, J. J., Metsios, G. S., Ntoumanis, N., Yu, C. A., 
Koutedakis, Y., . . . Duda, J. L. (2014). Fostering autonomous motivation, physical 
activity and cardiorespiratory fitness in rheumatoid arthritis: protocol and rationale for 
a randomised control trial. BMC Musculoskelet Disord, 15, 445. doi:10.1186/1471-
2474-15-445 
Rouse, P. C., Veldhuijzen Van Zanten, J. J., Ntoumanis, N., Metsios, G. S., Yu, C. A., Kitas, 
G. D., & Duda, J. L. (2015). Measuring the positive psychological well-being of people 
with rheumatoid arthritis: a cross-sectional validation of the subjective vitality scale. 
Arthritis Res Ther, 17, 312. doi:10.1186/s13075-015-0827-7 
Ryan, D. J., Wullems, J. A., Stebbings, G. K., Morse, C. I., Stewart, C. E., & Onambele-
Pearson, G. L. (2018). Reliability and validity of the international physical activity 
questionnaire compared to calibrated accelerometer cut-off points in the quantification 
of sedentary behaviour and physical activity in older adults. PLoS One, 13(4), 
e0195712. doi:10.1371/journal.pone.0195712 
 269 
Ryan, R. M., & Deci, E. L. (2000). Self-determination theory and the facilitation of intrinsic 
motivation, social development, and well-being. Am Psychol, 55(1), 68-78.  
Ryan, R. M., & Frederick, C. (1997). On energy, personality, and health: subjective vitality as 
a dynamic reflection of well-being. J Pers, 65(3), 529-565.  
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., . . . American 
College of, R. (2008). American College of Rheumatology 2008 recommendations for 
the use of nonbiologic and biologic disease-modifying antirheumatic drugs in 
rheumatoid arthritis. Arthritis Rheum, 59(6), 762-784. doi:10.1002/art.23721 
Sallis, J. F., Owen, N., & Fotheringham, M. J. (2000). Behavioral epidemiology: a systematic 
framework to classify phases of research on health promotion and disease prevention. 
Ann Behav Med, 22(4), 294-298. doi:10.1007/BF02895665 
Sandroff, B. M., Riskin, B. J., Agiovlasitis, S., & Motl, R. W. (2014). Accelerometer cut-points 
derived during over-ground walking in persons with mild, moderate, and severe 
multiple sclerosis. J Neurol Sci, 340(1-2), 50-57. doi:10.1016/j.jns.2014.02.024 
Santos, D. A., Silva, A. M., Baptista, F., Santos, R., Vale, S., Mota, J., & Sardinha, L. B. (2012). 
Sedentary behavior and physical activity are independently related to functional fitness 
in older adults. Exp Gerontol, 47(12), 908-912. doi:10.1016/j.exger.2012.07.011 
Santos, E. J. F., Duarte, C., Marques, A., Cardoso, D., Apostolo, J., da Silva, J. A. P., & 
Barbieri-Figueiredo, M. (2019). Effectiveness of non-pharmacological and non-
surgical interventions for rheumatoid arthritis: an umbrella review. JBI Database 
System Rev Implement Rep, 17(7), 1494-1531. doi:10.11124/JBISRIR-D-18-00020 
Santos-Lozano, A., Santin-Medeiros, F., Cardon, G., Torres-Luque, G., Bailon, R., Bergmeir, 
C., . . . Garatachea, N. (2013). Actigraph GT3X: validation and determination of 
 270 
physical activity intensity cut points. Int J Sports Med, 34(11), 975-982. doi:10.1055/s-
0033-1337945 
Sardinha, L. B., Santos, D. A., Silva, A. M., Baptista, F., & Owen, N. (2015). Breaking-up 
sedentary time is associated with physical function in older adults. J Gerontol A Biol 
Sci Med Sci, 70(1), 119-124. doi:10.1093/gerona/glu193 
Schaller, A., Rudolf, K., Dejonghe, L., Grieben, C., & Froboese, I. (2016). Influencing Factors 
on the Overestimation of Self-Reported Physical Activity: A Cross-Sectional Analysis 
of Low Back Pain Patients and Healthy Controls. Biomed Res Int, 2016, 1497213. 
doi:10.1155/2016/1497213 
Scharkow, M. (2017). Bootstrapping. In The International Encyclopedia of Communication 
Research Methods (pp. 1-5). 
Schermelleh-Engel, K., & Moosbrugger, H. (2003). Evaluating the fit of structural equation 
models: tests of significance and descriptive goodness-of-fit measures. Methods of 
Psychological Research Online, 8(2), 23-74.  
Schreiber, J. B., Nora, A., Stage, F. K., Barlow, E. A., & King, J. (2006). Reporting structural 
equation modeling and confirmatory factor analysis results: a review. The Journal of 
Educational Research, 99(6), 323-338. doi:10.3200/JOER.99.6.323-338 
Scott, I. C., Machin, A., Mallen, C. D., & Hider, S. L. (2018). The extra-articular impacts of 
rheumatoid arthritis: moving towards holistic care. BMC Rheumatol, 2, 32. 
doi:10.1186/s41927-018-0039-2 
Sedentary Behaviour Research Network (2012). Letter to the editor: standardized use of the 
terms “sedentary” and “sedentary behaviours”. Applied Physiology, Nutrition, and 
Metabolism, 37, 540-542. doi:10.1139/h2012-024 
 271 
Seguin, R., Lamonte, M., Tinker, L., Liu, J., Woods, N., Michael, Y. L., . . . Lacroix, A. Z. 
(2012). Sedentary Behavior and Physical Function Decline in Older Women: Findings 
from the Women's Health Initiative. J Aging Res, 2012, 271589. 
doi:10.1155/2012/271589 
Sellers, C., Dall, P., Grant, M., & Stansfield, B. (2016). Validity and reliability of the 
activPAL3 for measuring posture and stepping in adults and young people. Gait 
Posture, 43, 42-47. doi:10.1016/j.gaitpost.2015.10.020 
Semanik, P., Song, J., Chang, R. W., Manheim, L., Ainsworth, B., & Dunlop, D. (2010). 
Assessing physical activity in persons with rheumatoid arthritis using accelerometry. 
Med Sci Sports Exerc, 42(8), 1493-1501. doi:10.1249/MSS.0b013e3181cfc9da 
Senra, H., Rogers, H., Leibach, G., Altamar, M. L. P., Plaza, S. L. O., Perrin, P., & Duran, M. 
A. S. (2017). Health-related quality of life and depression in a sample of Latin 
American adults with rheumatoid arthritis. Int J Rheum Dis, 20(11), 1684-1693. 
doi:10.1111/1756-185X.12412 
Seymour, D. G., Ball, A. E., Russell, E. M., Primrose, W. R., Garratt, A. M., & Crawford, J. 
R. (2001). Problems in using health survey questionnaires in older patients with 
physical disabilities. The reliability and validity of the SF-36 and the effect of cognitive 
impairment. J Eval Clin Pract, 7(4), 411-418.  
Shiffman, S., Stone, A. A., & Hufford, M. R. (2008). Ecological momentary assessment. Annu 
Rev Clin Psychol, 4, 1-32.  
Shrivastava, A. K., Singh, H. V., Raizada, A., Singh, S. K., Pandey, A., Singh, N., . . . Sharma, 
H. (2015). Inflammatory markers in patients with rheumatoid arthritis. Allergol 
Immunopathol (Madr), 43(1), 81-87. doi:10.1016/j.aller.2013.11.003 
 272 
Singh, J. A., Saag, K. G., Bridges, S. L., Jr., Akl, E. A., Bannuru, R. R., Sullivan, M. C., . . . 
McAlindon, T. (2016). 2015 American College of Rheumatology Guideline for the 
Treatment of Rheumatoid Arthritis. Arthritis Rheumatol, 68(1), 1-26. 
doi:10.1002/art.39480 
Smets, E. M., Garssen, B., Bonke, B., & De Haes, J. C. (1995). The Multidimensional Fatigue 
Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom 
Res, 39(3), 315-325. doi:10.1016/0022-3999(94)00125-o 
Smith, J. J., Morgan, P. J., Lonsdale, C., Dally, K., Plotnikoff, R. C., & Lubans, D. R. (2017). 
Mediators of change in screen-time in a school-based intervention for adolescent boys: 
findings from the ATLAS cluster randomized controlled trial. J Behav Med, 40(3), 423-
433. doi:10.1007/s10865-016-9810-2 
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016a). Rheumatoid arthritis. Lancet, 388(10055), 
2023-2038. doi:10.1016/S0140-6736(16)30173-8 
Smolen, J. S., Breedveld, F. C., Burmester, G. R., Bykerk, V., Dougados, M., Emery, P., . . . 
van der Heijde, D. (2016b). Treating rheumatoid arthritis to target: 2014 update of the 
recommendations of an international task force. Ann Rheum Dis, 75(1), 3-15. 
doi:10.1136/annrheumdis-2015-207524 
Smolen, J. S., Landewe, R., Bijlsma, J., Burmester, G., Chatzidionysiou, K., Dougados, M., . . 
. van der Heijde, D. (2017). EULAR recommendations for the management of 
rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic 
drugs: 2016 update. Ann Rheum Dis, 76(6), 960-977. doi:10.1136/annrheumdis-2016-
210715 
Sokka, T. (2005). Assessment of pain in rheumatic diseases. Clin Exp Rheumatol, 23(5 Suppl 
39), S77-84.  
 273 
Sokka, T., Hakkinen, A., Kautiainen, H., Maillefert, J. F., Toloza, S., Mork Hansen, T., . . . 
Group, Q.-R. (2008). Physical inactivity in patients with rheumatoid arthritis: data from 
twenty-one countries in a cross-sectional, international study. Arthritis Rheum, 59(1), 
42-50. doi:10.1002/art.23255 
Solem, R. C. (2015). Limitation of a cross-sectional study. Am J Orthod Dentofacial Orthop, 
148(2), 205. doi:10.1016/j.ajodo.2015.05.006 
Sparling, P. B., Howard, B. J., Dunstan, D. W., & Owen, N. (2015). Recommendations for 
physical activity in older adults. 350, h100. doi:10.1136/bmj.h100 %J BMJ : British 
Medical Journal 
Stavropoulos-Kalinoglou, A., Metsios, G. S., Koutedakis, Y., Nevill, A. M., Douglas, K. M., 
Jamurtas, A., . . . Kitas, G. D. (2007). Redefining overweight and obesity in rheumatoid 
arthritis patients. Ann Rheum Dis, 66(10), 1316-1321. doi:10.1136/ard.2006.060319 
Stavropoulos-Kalinoglou, A., Metsios, G. S., Veldhuijzen van Zanten, J. J., Nightingale, P., 
Kitas, G. D., & Koutedakis, Y. (2013). Individualised aerobic and resistance exercise 
training improves cardiorespiratory fitness and reduces cardiovascular risk in patients 
with rheumatoid arthritis. Ann Rheum Dis, 72(11), 1819-1825. 
doi:10.1136/annrheumdis-2012-202075 
Steeves, J. A., Bowles, H. R., McClain, J. J., Dodd, K. W., Brychta, R. J., Wang, J., & Chen, 
K. Y. (2015). Ability of thigh-worn ActiGraph and activPAL monitors to classify 
posture and motion. Med Sci Sports Exerc, 47(5), 952-959. 
doi:10.1249/MSS.0000000000000497 
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. 
(2015). Inflammation and clinical response to treatment in depression: A meta-analysis. 
Eur Neuropsychopharmacol, 25(10), 1532-1543. doi:10.1016/j.euroneuro.2015.06.007 
 274 
Stubbs, B., Gardner-Sood, P., Smith, S., Ismail, K., Greenwood, K., Farmer, R., & Gaughran, 
F. (2015). Sedentary behaviour is associated with elevated C-reactive protein levels in 
people with psychosis. Schizophr Res, 168(1-2), 461-464. 
doi:10.1016/j.schres.2015.07.003 
Summers, G., Booth, A., Brooke-Wavell, K., Barami, T., & Clemes, S. (2019). Physical 
activity and sedentary behavior in women with rheumatoid arthritis: a comparison of 
patients with low and high disease activity and healthy controls. Open Access 
Rheumatol, 11, 133-142. doi:10.2147/OARRR.S203511 
Sylvia, L. G., Bernstein, E. E., Hubbard, J. L., Keating, L., & Anderson, E. J. (2014). Practical 
guide to measuring physical activity. J Acad Nutr Diet, 114(2), 199-208. 
doi:10.1016/j.jand.2013.09.018 
Tan, X. L., Pugh, G., Humby, F., & Morrissey, D. (2019). Factors associated with physical 
activity engagement among adults with rheumatoid arthritis: A cross-sectional study. 
Musculoskeletal Care, 17(2), 163-173. doi:10.1002/msc.1385 
Tavakol, M., & Dennick, R. (2011). Making sense of Cronbach's alpha. Int J Med Educ, 2, 53-
55. doi:10.5116/ijme.4dfb.8dfd 
Taylor, P. C., Moore, A., Vasilescu, R., Alvir, J., & Tarallo, M. (2016). A structured literature 
review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a 
current perspective. Rheumatol Int, 36(5), 685-695. doi:10.1007/s00296-015-3415-x 
Taylor, W. J., Myers, J., Simpson, R. T., McPherson, K. M., & Weatherall, M. (2004). Quality 
of life of people with rheumatoid arthritis as measured by the World Health 
Organization Quality of Life Instrument, short form (WHOQOL-BREF): score 
distributions and psychometric properties. Arthritis Rheum, 51(3), 350-357. 
doi:10.1002/art.20398 
 275 
Teixeira, P. J., Carraca, E. V., Markland, D., Silva, M. N., & Ryan, R. M. (2012). Exercise, 
physical activity, and self-determination theory: a systematic review. Int J Behav Nutr 
Phys Act, 9, 78. doi:10.1186/1479-5868-9-78 
Thivel, D., Tremblay, A., Genin, P. M., Panahi, S., Riviere, D., & Duclos, M. (2018). Physical 
Activity, Inactivity, and Sedentary Behaviors: Definitions and Implications in 
Occupational Health. Front Public Health, 6, 288. doi:10.3389/fpubh.2018.00288 
Thomsen, T., Aadahl, M., Beyer, N., Hetland, M. L., Loppenthin, K., Midtgaard, J., . . . 
Esbensen, B. A. (2017). The efficacy of motivational counselling and SMS reminders 
on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial. 
Ann Rheum Dis, 76(9), 1603-1606. doi:10.1136/annrheumdis-2016-210953 
Thomsen, T., Beyer, N., Aadahl, M., Hetland, M. L., Loppenthin, K., Midtgaard, J., & 
Esbensen, B. A. (2015). Sedentary behaviour in patients with rheumatoid arthritis: A 
qualitative study. Int J Qual Stud Health Well-being, 10, 28578. 
doi:10.3402/qhw.v10.28578 
Tierney, M., Fraser, A., & Kennedy, N. (2012). Physical activity in rheumatoid arthritis: a 
systematic review. J Phys Act Health, 9(7), 1036-1048.  
Tierney, M., Fraser, A., Purtill, H., & Kennedy, N. (2013). Study to determine the criterion 
validity of the SenseWear Armband as a measure of physical activity in people with 
rheumatoid arthritis. Arthritis Care Res (Hoboken), 65(6), 888-895. 
doi:10.1002/acr.21914 
Treharne, G. J., Lyons, A. C., Booth, D. A., & Kitas, G. D. (2007). Psychological well-being 
across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stress. 
Br J Health Psychol, 12(Pt 3), 323-345. doi:10.1348/135910706X109288 
 276 
Tremblay, M. S., Aubert, S., Barnes, J. D., Saunders, T. J., Carson, V., Latimer-Cheung, A. E., 
. . . Participants, S. T. C. P. (2017). Sedentary Behavior Research Network (SBRN) - 
Terminology Consensus Project process and outcome. Int J Behav Nutr Phys Act, 14(1), 
75. doi:10.1186/s12966-017-0525-8 
Tremblay, M. S., Colley, R. C., Saunders, T. J., Healy, G. N., & Owen, N. (2010). Physiological 
and health implications of a sedentary lifestyle. Applied Physiology, Nutrition, and 
Metabolism, 35(6), 725-740. doi:10.1139/H10-079 
Treuth, M. S., Schmitz, K., Catellier, D. J., McMurray, R. G., Murray, D. M., Almeida, M. J., 
. . . Pate, R. (2004). Defining accelerometer thresholds for activity intensities in 
adolescent girls. Med Sci Sports Exerc, 36(7), 1259-1266.  
Trinity, J. D. (2017). Something is definitely better than nothing: simple strategies to prevent 
vascular dysfunction. Clin Sci (Lond), 131(11), 1055-1058. doi:10.1042/cs20170130 
Troiano, R. P., Berrigan, D., Dodd, K. W., Masse, L. C., Tilert, T., & McDowell, M. (2008). 
Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc, 
40(1), 181-188. doi:10.1249/mss.0b013e31815a51b3 
Troiano, R. P., McClain, J. J., Brychta, R. J., & Chen, K. Y. (2014). Evolution of accelerometer 
methods for physical activity research. Br J Sports Med, 48(13), 1019-1023. 
doi:10.1136/bjsports-2014-093546 
Uhlig, T., Moe, R. H., & Kvien, T. K. (2014). The burden of disease in rheumatoid arthritis. 
Pharmacoeconomics, 32(9), 841-851. doi:10.1007/s40273-014-0174-6 
van der Berg, J. D., Bosma, H., Caserotti, P., Eiriksdottir, G., Arnardottir, N. Y., Martin, K. R., 
. . . Koster, A. (2014). Midlife determinants associated with sedentary behavior in old 
age. Med Sci Sports Exerc, 46(7), 1359-1365. doi:10.1249/MSS.0000000000000246 
 277 
van der Ploeg, H. P., & Hillsdon, M. (2017). Is sedentary behaviour just physical inactivity by 
another name? Int J Behav Nutr Phys Act, 14(1), 142. doi:10.1186/s12966-017-0601-0 
van Gestel, A. M., Haagsma, C. J., & van Riel, P. L. (1998). Validation of rheumatoid arthritis 
improvement criteria that include simplified joint counts. Arthritis Rheum, 41(10), 
1845-1850. doi:10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K 
van Steenbergen, H. W., Tsonaka, R., Huizinga, T. W., Boonen, A., & van der Helm-van Mil, 
A. H. (2015). Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal 
study. RMD Open, 1(1), e000041. doi:10.1136/rmdopen-2014-000041 
van Tuyl, L. H., & Boers, M. (2015). Patient-reported outcomes in core domain sets for 
rheumatic diseases. Nat Rev Rheumatol, 11(12), 705-712. 
doi:10.1038/nrrheum.2015.116 
Vancampfort, D., De Hert, M., Vansteenkiste, M., De Herdt, A., Scheewe, T. W., Soundy, A., 
. . . Probst, M. (2013). The importance of self-determined motivation towards physical 
activity in patients with schizophrenia. Psychiatry Res, 210(3), 812-818. 
doi:10.1016/j.psychres.2013.10.004 
Veldhuijzen van Zanten, J. J., Rouse, P. C., Hale, E. D., Ntoumanis, N., Metsios, G. S., Duda, 
J. L., & Kitas, G. D. (2015). Perceived Barriers, Facilitators and Benefits for Regular 
Physical Activity and Exercise in Patients with Rheumatoid Arthritis: A Review of the 
Literature. Sports Med, 45(10), 1401-1412. doi:10.1007/s40279-015-0363-2 
Verhoeven, F., Tordi, N., Prati, C., Demougeot, C., Mougin, F., & Wendling, D. (2016). 
Physical activity in patients with rheumatoid arthritis. Joint Bone Spine, 83(3), 265-
270. doi:10.1016/j.jbspin.2015.10.002 
Versteeg, G. A., Steunebrink, L. M. M., Vonkeman, H. E., Ten Klooster, P. M., van der Bijl, 
A. E., & van de Laar, M. (2018). Long-term disease and patient-reported outcomes of 
 278 
a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily 
clinical practice. Clin Rheumatol, 37(5), 1189-1197. doi:10.1007/s10067-017-3962-5 
Vlietstra, L., Stebbings, S., Meredith-Jones, K., Abbott, J. H., Treharne, G. J., & Waters, D. L. 
(2019). Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-
reported fatigue, physical function and obesity. PLoS One, 14(6), e0217462. 
doi:10.1371/journal.pone.0217462 
Walsh, D. A., & McWilliams, D. F. (2014). Mechanisms, impact and management of pain in 
rheumatoid arthritis. Nat Rev Rheumatol, 10(10), 581-592. 
doi:10.1038/nrrheum.2014.64 
Wan, S. W., He, H. G., Mak, A., Lahiri, M., Luo, N., Cheung, P. P., & Wang, W. (2016). 
Health-related quality of life and its predictors among patients with rheumatoid 
arthritis. Appl Nurs Res, 30, 176-183. doi:10.1016/j.apnr.2015.07.004 
Wanner, M., Probst-Hensch, N., Kriemler, S., Meier, F., Autenrieth, C., & Martin, B. W. 
(2016). Validation of the long international physical activity questionnaire: Influence 
of age and language region. Prev Med Rep, 3, 250-256. 
doi:10.1016/j.pmedr.2016.03.003 
Wasserman, A. (2018). Rheumatoid Arthritis: Common Questions About Diagnosis and 
Management. Am Fam Physician, 97(7), 455-462.  
Weinblatt, M. E., Keystone, E. C., Furst, D. E., Kavanaugh, A. F., Chartash, E. K., & Segurado, 
O. G. (2006). Long term efficacy and safety of adalimumab plus methotrexate in 
patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis, 
65(6), 753-759. doi:10.1136/ard.2005.044404 
 279 
Wendel-Vos, G. C., Schuit, A. J., Saris, W. H., & Kromhout, D. (2003). Reproducibility and 
relative validity of the short questionnaire to assess health-enhancing physical activity. 
J Clin Epidemiol, 56(12), 1163-1169. doi:10.1016/s0895-4356(03)00220-8 
White, D. K., Lee, J., Song, J., Chang, R. W., & Dunlop, D. (2017). Potential Functional 
Benefit From Light Intensity Physical Activity in Knee Osteoarthritis. Am J Prev Med, 
53(5), 689-696. doi:10.1016/j.amepre.2017.07.008 
World Health Organisation. (1998). Development of the World Health Organization 
WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med, 
28(3), 551-558.  
World Health Organisation. (2019a). Depression: let’s talk. Retrieved from 
https://www.who.int/mental_health/management/depression/en/ 
World Health Organisation. (2019b). WHOQOL: Measuring Quality of Life. Retrieved from 
https://www.who.int/healthinfo/survey/whoqol-qualityoflife/en/ 
Wijndaele, K., Westgate, K., Stephens, S. K., Blair, S. N., Bull, F. C., Chastin, S. F., . . . Healy, 
G. N. (2015). Utilization and Harmonization of Adult Accelerometry Data: Review and 
Expert Consensus. Med Sci Sports Exerc, 47(10), 2129-2139. 
doi:10.1249/MSS.0000000000000661 
Winkler, E. A., Bodicoat, D. H., Healy, G. N., Bakrania, K., Yates, T., Owen, N., . . . 
Edwardson, C. L. (2016). Identifying adults' valid waking wear time by automated 
estimation in activPAL data collected with a 24 h wear protocol. Physiol Meas, 37(10), 
1653-1668. doi:10.1088/0967-3334/37/10/1653 
Wood, M. (2004). Statistical inference using bootstrap confidence intervals. Significance, 1(4), 
180-182. doi: https://doi.org/10.1111/j.1740-9713.2004.00067.x 
 280 
Wright, D. B., London, K., & Field, A. P. (2011). Using bootstrap estimation and the plug-in 
principle for clinical psychology data. Journal of Experimental Psychopathology, 2(2), 
252-270. doi:doi.org/10.5127/jep.013611 
Yngve, A., Nilsson, A., Sjostrom, M., & Ekelund, U. (2003). Effect of monitor placement and 
of activity setting on the MTI accelerometer output. Med Sci Sports Exerc, 35(2), 320-
326. doi:10.1249/01.MSS.0000048829.75758.A0 
Yu, C. A., Rouse, P. C., Van Zanten, J. V., Metsios, G. S., Ntoumanis, N., Kitas, G. D., & 
Duda, J. L. (2015a). Motivation-related predictors of physical activity engagement and 
vitality in rheumatoid arthritis patients. Health Psychol Open, 2(2), 
2055102915600359. doi:10.1177/2055102915600359 
Yu, C. A., Rouse, P. C., Veldhuijzen Van Zanten, J. J., Ntoumanis, N., Kitas, G. D., Duda, J. 
L., & Metsios, G. S. (2015b). Subjective and objective levels of physical activity and 
their association with cardiorespiratory fitness in rheumatoid arthritis patients. Arthritis 
Res Ther, 17, 59. doi:10.1186/s13075-015-0584-7 
Yu, Z., Kim, S. C., Vanni, K., Huang, J., Desai, R., Murphy, S. N., . . . Liao, K. P. (2018). 
Association between inflammation and systolic blood pressure in RA compared to 
patients without RA. Arthritis Res Ther, 20(1), 107. doi:10.1186/s13075-018-1597-9 
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta 














APPENDIX 1: Information sheet and consent forms 
 
APPENDIX 2: ActivPAL and ActiGraph GT3X+ wear time logbooks for longitudinal study 
  






































































































































Aim	one:	The	main	aim	of	 this	study	 is	 to	 investigate	 the	physical	 (e.g.,	pain	and	 fatigue),	
psychological	(e.g.,	wellbeing	and	motivation),	and	environmental	(e.g.,	your	perception	of	
the	 local	 environment,	 local	 safety,	 and	 availability	 of	 green	 space)	 factors	 that	 may	 be	
associated	with	sedentary	behaviour	(i.e.,	the	time	you	spend	sitting	or	reclining)	and	levels	




engagement	affect	health	 (e.g.,	 cardiovascular	disease	risk	and	psychological	wellbeing)	 in	
patients	with	Rheumatoid	Arthritis	and	Osteoarthritis.		
	
There	 is	 currently	 little	 information	 available	 on	 the	 above	 relationships	 in	 Rheumatoid	
Arthritis	and	Osteoarthritis	-	this	research	will	begin	to	help	our	understanding.	We	hope	to	
be	able	to	use	the	information	obtained	from	this	research,	to	help	develop	interventions	that	





physical	 activity	 and	 sedentary	 behaviour	 in	 people	 with	 Rheumatoid	 Arthritis.	 This	 is	











































































































































































and	 activPAL	 postural	 movement	 sensor	 whilst	 carrying	 out	 different	 activities	 in	 the	
laboratory	 in	 the	hospital.	These	activities	will	be	made	up	of	 some	sedentary	behaviours	
(e.g.,	 doing	 a	 crossword	 and	 reading	 a	 newspaper)	 and	 some	 light	 to	moderate	 intensity	
physical	activities	(walking	on	a	treadmill	at	a	slow	to	moderate	pace).	Whilst	you	undertake	












The	 indirect	 calorimeter	 is	 worn	 using	 a	 mouth	 piece	 and	 a	 nose	 clip.	 This	 will	 enable	
measurement	 of	 your	 inspired	 and	 expired	 gases	 during	 the	 activities	 we	 ask	 you	 to	





































in	 the	 Clinical	 Research	 Unit	 at	 Russells	 Hall	 Hospital.	 This	 data	 will	 be	 accessed	 only	 by	
members	of	the	research	team.	Biological	samples	will	be	analysed	by	laboratory	employees.	
Once	 analysed,	 this	 data	 will	 also	 be	 anonymised	 and	 accessed	 only	 by	members	 of	 the	
research	 team.	Data	 to	 be	 used	 at	 the	University	 of	 Birmingham	will	 be	 anonymised	 and	
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Hall	 Hospital	 for	 10	 years	 after	 study	 completion.	 Only	 Clinical	 Research	 Unit	 staff	 and	
members	of	the	research	team	will	have	access	to	this	archive.	Electronic	data	will	be	stored	















































































subject	 number.	 Any	 questionnaires,	 physical	 information	 and	 information	 regarding	
measures	 of	 sedentary	 behaviour/physical	 activity	will	 be	 identified	 in	 the	 same	way.	No	
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1. I	confirm	I	have	read	and	understood	the	study	information	sheet.	 	 	
	
2. Somebody	else	has	explained	this	study	to	me.	 	 	 	 	
	
3. I	fully	understand	the	purpose	of	this	study.		 	 	 	 	
	
4. I	have	had	the	opportunity	to	discuss	the	study	and	ask	any	questions.	 	





















































































1. I	confirm	I	have	read	and	understood	the	study	information	sheet.	 	 	
	
2. Somebody	else	has	explained	this	study	to	me.	 	 	 	 	
	
3. I	fully	understand	the	purpose	of	this	study.		 	 	 	 	
	
4. I	have	had	the	opportunity	to	discuss	the	study	and	ask	any	questions.	 	


















































































































































































































































































































































































































































































































































































	 	 	 	
Shampoo	your	hair?		
	

















	 	 	 	
Get	in	and	out	of	bed?	
	

















	 	 	 	
Lift	a	full	cup	or	glass	to	your	mouth?	
	
	 	 	 	
Open	a	new	carton	of	milk	(or	soap	powder)?	
	

















	 	 	 	
Climb	up	five	steps?	
	






































	 	 	 	
Take	a	bath?	
	
	 	 	 	
Get	on	and	off	the	toilet?	
	

















	 	 	 	
Bend	down	to	pick	up	clothing	off	the	floor?	
	

























	 	 	 	
Open	jars	which	have	been	previously	opened?	
	
	 	 	 	
Turn	taps	on	and	off?	
	

































	 	 	 	
Get	in	and	out	of	a	car?	
	
	 	 	 	
Do	chores	such	as	vacuuming,	housework	or	light	
gardening?		
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Physical	Activity,	Reducing	Sedentary	Behaviour,	and	Breaking	U
p	Sitting	Tim
e	
		
Key	term
	
Definition	
Exam
ples	
Physical	Activity	
Any	m
ovem
ent	by	your	body	that	w
orks	your	
m
uscles,	and	requires	energy	greater	than	
resting.	
• 
W
alking	the	dog	
• 
Jogging	
• 
Playing	tennis	
• 
Gardening	
• 
Yoga	
• 
Sw
im
m
ing	
Sedentary	Behaviour	
Behaviour	that	uses	very	little	energy	w
hilst	
aw
ake	and	sitting	or	reclining.	
• 
Sitting	dow
n	w
hilst	w
atching	TV.	
• 
Sitting	dow
n	w
hilst	doing	a	crossw
ord	puzzle.	
• 
Reclining	w
hilst	reading	a	book.	
Reducing	Sedentary	
Behaviour	
Refers	to	your	overall	attem
pts	to	spend	less	
tim
e	sitting	or	lying	dow
n,	not	just	your	
attem
pts	to	m
ore	frequently	interrupt	periods	
of	sitting	w
ith	physical	activity	or	standing	
(i.e.,	w
hich	is	called	breaking	up	your	sitting	
tim
e).	
• 
Getting	off	the	bus	at	a	station	before	the	
station	nearest	to	your	destination	so	that	
you	have	to	w
alk	further	and	sit	for	less	tim
e.	
• 
Deciding	to	not	w
atch	TV	for	an	hour,	but	to	
go	out	for	a	w
alk	instead.	
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Behavioural	Regulation	in	Exercise	Q
uestionnaire-2	(BREQ
-2	[adapted	–	quality	of	m
otivation	to	reduce	sedentary	behaviour])	
	Please	indicate	to	w
hat	extent	you	agree	or	disagree	w
ith	each	of	the	follow
ing	item
s	w
ith	regard	to	reducing	sedentary	behaviour	and	breaking	up	
sitting	tim
e	by	circling	a	num
ber	in	the	table	below
;	bear	in	m
ind	how
	you	GEN
ERALLY	felt	during	the	past	4	w
eeks.		
	
	
I	aim
	to	reduce	m
y	sedentary	behaviour…
	
Strongly	
Disagree	
Disagree	
N
eutral	
Agree	
Strongly	
Agree	
1. 
Because	other	people	say	I	should	
1	
2	
3	
4	
5	
2. 
Because	I	feel	guilty	w
hen	I	am
	not	doing	this	
1	
2	
3	
4	
5	
3. 
Because	I	value	the	benefits	of	doing	this	
1	
2	
3	
4	
5	
4. 
Because	it	is	fun	
1	
2	
3	
4	
5	
5. 
But	I	don’t	see	w
hy	I	should	
1	
2	
3	
4	
5	
6. 
Because	m
y	friends	and	fam
ily	say	I	should	
1	
2	
3	
4	
5	
7. 
Because	I	feel	asham
ed	w
hen	I	am
	not	doing	this	
1	
2	
3	
4	
5	
8. 
Because	it	is	im
portant	for	m
e	to	try	to	do	this	on	a	regular	basis	
1	
2	
3	
4	
5	
9. 
But	I	can’t	see	w
hy	I	should	bother	
1	
2	
3	
4	
5	
10. Because	I	enjoy	doing	this	
1	
2	
3	
4	
5	
11. Because	others	w
ill	not	be	pleased	w
ith	m
e	if	I	am
	not	doing	this	
1	
2	
3	
4	
5	
12. But	I	don’t	see	the	point	in	doing	this	
1	
2	
3	
4	
5	
13. Because	I	felt	like	a	failure	w
hen	I	have	not	been	doing	this	in	a	w
hile	
1	
2	
3	
4	
5	
14. Because	I	think	it	is	im
portant	to	m
ake	the	effort	to	do	this	regularly	
1	
2	
3	
4	
5	
15. Because	I	find	doing	this	pleasurable	
1	
2	
3	
4	
5	
16. Because	I	feel	under	pressure	from
	others	to	do	this	
1	
2	
3	
4	
5	
17. Because	I	get	restless	if	I	am
	not	doing	this	regularly	
1	
2	
3	
4	
5	
18. Because	I	get	pleasure	and	satisfaction	from
	doing	this	
1	
2	
3	
4	
5	
19. But	I	think	doing	this	is	a	w
aste	of	tim
e	
1	
2	
3	
4	
5	



